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Reactive  arthritis  (ReA)  is  a  sterile  joint  inflammation  triggered  by  bacterial 
infection  and  is  associated  with  the  MHC  class  I  molecule  HLA-B27.  Bacterial 
antigens  have  been  detected  in  synovial  tissues  from  ReA  patients,  but  how 
they are transported to the joints from the site of infection  is  not known.  In this 
project, we have tested the  role of infected macrophages and dendritic cells as 
carriers of bacterial antigens in a mouse model for ReA.
Bone marrow derived  macrophages (BMMac) and  dendritic cells (BMDC) were 
infected  with  Salmonella,  a  known  causative  agent  of  ReA,  and  adoptively 
transferred  to  HLA-B27  transgenic  mice.  We  found  a  differential  migration 
profile  for  Salmonella  infected  macrophages  vs  dendritic  cells.  In  contrast  to 
their uninfected  counterparts,  both  populations emigrated  significantly from the 
peritoneal cavity after intraperitoneal  (i.p.)  injection.  Sa/mone//a-infected  BMDC 
showed  a  significantly  increased  ability  to  migrate  to  secondary  lymphoid 
organs  (SLO)  (spleen  and  mesenteric  lymph  nodes).  Moreover,  results  from 
CCR7  deficient  mouse  clearly  showed  that the  migration  of  infected  BMDC  to 
the mesenteric lymph nodes (MLN), but not the spleen, was mediated by CCR7. 
Unlike  BMDC,  Salmonella  infected  BMMac were  prone  to  migrate  to  inflamed 
joints.
Although  both  BMDC  and  BMMac  were  able  to  present  bacterial-derived 
peptides  and  stimulate  antigen  experienced  cytotoxic  T  cells  in  vitro,  only 
BMDC were capable of activating  antigen  specific naive T cells.  By co-transfer 
HLA-B27 transgenic BMDC and  naive T cells from GRb transgenic mice, which
2express  a  HLA-B27-restricted  TCR  specific  for  an  influenza  peptide,  BMDC 
infected with  recombinant Salmonella expressing the flu epitope were shown to 
induce T cells activation in vivo.
The  results  of this  study  suggest  distinct  roles  for  macrophages  and  dendritic 
cells  as  antigen  transporters  following  Salmonella  infection,  and  have 
implications  for  both  the  pathogenesis  of  ReA,  and  the  generation  of  anti- 
Salmonella immunity.
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16Chapter 1: Introduction
1.1  Reactive Arthritis
1.1.1 Definition
Reactive  Arthritis  (ReA)  is  usually  defined  as  an  immune-mediated  sterile 
synovitis  triggered  by  a  distant  infection  through  the  urogenital  or 
gastrointestinal  tract  (Childs,  2004;  Toivanen  and  Toivanen,  2004).  Common 
infections  triggering  ReA  include  Chlamydia  trachomatis  and  Salmonella, 
Shigella,  Yersinia,  and  Campylobacter  (Colmegna  et  al.,  2004;  Hughes  and 
Keat,  1994). Another distinctive feature of ReA is its association with the MHC I 
molecule  HLA-B27,  for  which  ReA  has  been  classified  as  one  type  of 
seronegative spondyloarthropathy (SpA).
SpA  is  a  family  of  arthritides  sharing  certain  clinical  features,  such  as  being 
rheumatoid  factor  negative  in  the  sera,  and  having  a  strong  association  with 
HLA-B27  (Kim  et  al.,  2005).  Other  members  in  this  family  include  ankylosing 
spondylitis,  psoriatic  arthritis,  arthritis  related  to  inflammatory  bowel  diseases, 
juvenile spondyloarthritis as well as undifferentiated SpA. Ankylosing spondylitis 
is  a  progressive  disease  in  which  chronic  inflammation  can  lead  to  extensive 
new  bone  formation  throughout  the  spine,  and  in  ankylosing  spondylitis  more 
than  90% of patients are  HLA-B27 positive.  Up to 70-90% of patients with  ReA 
are  HLA-B27  positive,  and  evidence  has  been  presented  that  in  HLA-B27 
positive  individuals  the  disease  is  more  severe  and  the  prognosis  poorer  (al- 
Khonizy and Reveille,  1998;  Khan and Kellner,  1992;  Leirisalo et al.,  1982).
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association  with  HLA-B27,  which  makes  it a  suitable  model  to  investigate  the 
role  of  bacteria  in  immune-mediated  disorders,  and  also  to  help  clarify  the 
pathogenesis of the whole group of SpA.
1.1.2 Epidemiology
ReA is seen  all over the world, with  a  prevalence estimated to be 30-40 cases 
per  100  000  adults  (Toivanen  and  Toivanen,  2004).  Caucasians  are  affected 
more  often  than  other  ethnic  groups,  e.g.,  African  American,  by  a  4:1  ratio 
(Childs,  2004).  ReA is a common  arthritis,  affecting  persons  between  the ages 
of 20 and 40 years. Three percent of all men with a sexually transmitted disease 
will  develop  ReA.  Women  are  also  at  risk;  however,  they  are  nine  times  less 
likely  to  develop  ReA  after  venereal  infection  and  symptoms  are  often  more 
subtle  and  less  severe.  Enteric  infections  precipitating  ReA  affect  males  and 
females equally (Childs, 2004; Kohnke, 2004).
1.1.3 Clinical Presentation
The most common first symptom is joint discomfort, which occurs usually one to 
three weeks following the infection.  However,  it is not unusual that the triggering 
infection  such  as  diarrhea  and  urogenital  infection  has  passed  unnoticed  for 
some  patients.  Therefore,  it  is  important  to  precisely  inquire  about  the  past 
history of infection in order to distinguish it from other arthritis.  ReA is a disease 
with systemic symptoms such as malaise, fever and fatigue with the arthritis as 
the  leading symptom.  The disease primarily affects the  large joints of the lower
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and  additive  nature.  The  severity of the arthritis varies from  mild  and  transient 
swelling or discomfort to serious, severely invalidating conditions. Enthesitis and 
sacroilitis  are  also  common  presentations.  In  particular,  the  presence  of 
enthesitis,  inflammation  of  the  ligaments  and  tendons  at  the  sites  of  their 
insertion  into the  bone,  is a  helpful distinguishing  characteristic.  Low back pain 
and  buttock pain  are common  and  can  signal  spinal  or sacroiliac involvement. 
Extraarticular  presentations  including  skin  and  mucous  symptoms  and  ocular 
lesions can  be  seen  in  some  patients  (Kohnke,  2004;  Toivanen  and  Toivanen, 
2004).
The  prognosis  of  ReA  is  generally  considered  good.  The  disease  is  generally 
self-limiting,  resolving  in  3-12  months.  Up to  15%  of cases progress to chronic 
arthritis  lasting  longer than  12  months  (Kohnke,  2004).  Recurrences can  occur 
in  15%  of ReA  cases,  and  approximately  10%  of ReA  patients  may with  time 
progress to ankylosing spondylitis (Kohnke, 2004).  It has also been established 
that  recurrences  and  chronic  development  are  more  common  in  HLA-B27 
positive individuals (Leirisalo et al.,  1982).
Non-steroidal  anti-inflammatory  drugs  (NSAIDs)  form  the  cornerstone  of  the 
treatment of ReA, and many patients will attain satisfactory control of symptoms 
with  these  agents  alone.  For  chronic  ReA,  especially  if  progression  to 
ankylosing spondylitis is suspected, disease-modifying anti-rheumatic drugs can 
be considered.  Sulfasalazine and methotrexate are both beneficial in controlling 
joint  pain  and  inflammation  but  need  to  be  monitored.  Recently,  biological
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increasingly  used  in  the  treatment  of  ReA  (Reveille  and  Arnett,  2005). 
Additionally, as ReA is definitely caused by an infection,  it is natural to consider 
antibiotic treatment.  However,  it has  been  concluded  that a  short conventional 
course  of  antibiotics  is  effective  only  if  given  early  enough  during  the 
pathogenetic  process  of  ReA.  Later,  after the  process  has  started,  antibiotics 
are of little if any value (Toivanen and Toivanen,  2004).  Nevertheless,  a  recent 
follow-up  of a  clinical  study  has  suggested  that  long-term  antibiotic  treatment 
may,  especially  in  HLA-B27  positive  individuals,  reduce  later  morbidity  (Yli- 
Kerttula et al., 2000).
1.1.4  Pathogenesis of ReA
1.1.4.1 Genetic factors
1.1.4.1.1 HLA-B27
HLA-B27  makes a  strong genetic contribution  to the development of SpA.  The 
most striking association is observed for ankylosing spondylitis, 94% of patients 
express  HLA-B27  compared  with  approximately  9%  of the  general  population 
(Brown et al.,  1996).  The association of HLA-B27 with  ReA is  illustrated  by the 
fact that the prevalence of disease in  HLA-B27-positive individuals is five times 
greater  than  in  the  general  population;  in  HLA-B27  relatives  of  patients  with 
ReA,  the  prevalence  is  another  10  times  greater  (Feltkamp,  1995).  Direct 
evidence  comes from  transgenic  animals.  HLA-B27  transgenic  rats  develop  a 
multi-system  disease  with  many  features  resembling  the  human  HLA-B27- 
associated  diseases  (Hammer  et  al.,  1990b).  In  addition,  symptoms  develop
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conditions (Khare et al.,  1995). Moreover, in transgenic animals, susceptibility to 
disease  is  clearly  related  to the  gene  copy  number and  level  of expression  of 
HLA-B27  (Taurog  et al.,  1993),  and  requires the  presence  of HLA-B27+  bone 
marrow cells (Breban et al.,  1993) and T cells (Breban et al.,  1996),  consistent 
with the features of immune mediated disease.
HLA-B27  is  an  MHC  class  I  molecule,  which  comprises  a  glycosylated  heavy 
chain  (45Kda)  non-covalently  associated  with  p2-microglobulin  (p2m)  (12Kda). 
The class I heavy chain consists of three extracellular domains, ai  (N-terminal), 
a2  and  013,  the  transmembrane  region  and  a  cytoplasmic  tail.  The  a i  and  a2 
domains  constitute  a  platform  of  8  anti-parallel  p  strands  supporting  2  anti­
parallel  a  helices,  which  form  a  highly  polymorphic  peptide-binding  cleft 
comprising of 6 pockets (A,  B, C,  D,  E,  F) (Bjorkman et al.,  1987;  Madden et al., 
1991;  Madden  et al.,  1992).  The most distinctive structural feature of HLA-B27 
is  its  B  pocket,  with  a  glutamic  acid  at  its  base  and  a  cysteine  residue  at  its 
mouth.  This  pocket  is  surrounded  by  a  unique  combination  of residues  that  is 
found  in all disease-associated  HLA-B27 subtypes and  confers the  HLA-B27  B 
pocket with a strong specificity for an arginine side chain at the second position 
of  bound  peptides  (Colbert  et  al.,  1994).  Moreover,  another  unique 
characteristic of the HLA-B27 molecule is the presence of an unpaired cysteine- 
67 residue within the extracellular a 1  domain, which facilitates adherence of the 
two  heavy  chains  to  each  other  via  disulfide  binding  to  form  a  “homodimer”  
(Allen  et al.,  1999)  (Bird  et al.,  2003;  Bowness et al.,  1999).  These  unique and
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be of pathogenic significance.
Over 25 molecular subtypes of HLA-B27 have been described so far. The most 
common  subtypes  (HLA-B*2705,  B*2702,  B*2704,  B*2707)  are  clearly 
associated  with  a  risk  for  spondyloarthritis.  Among  them,  B*2705  is  the 
dominant  subtype  and  is  associated  with  spondylitis  across  broad  ethnic  and 
geographic  boundaries.  Two  subtypes  of  HLA-B27,  HLA-B*2706  (found  in 
Southeast Asia)  and  B*2709  (found  in  Sardinia)  appear  not  to  be  associated 
with  spondylitis  (Mody  et  al.,  2003).  This  is  possibly  due  to  amino  acid 
differences in the “C” or “F” pockets of the HLA antigen binding cleft which alter 
the composition of peptides presented  by these HLA-B27 subtypes (Hulsmeyer 
et al., 2004; Montserrat et al., 2003).
Although  HLA-B27  has  remained  a  centre  of  extensive  research,  the  exact 
mechanism  underlying  the effect of HLA-B27 on  disease  susceptibility still  has 
not  been  determined.  Moreover,  why  HLA-B27-associated  diseases  attack 
certain organ systems, such as the joint, the spine, the gut and the eye, and not 
others, is unknown. Several different hypotheses have been proposed.
Based  on  the  major function  of HLA-B27  as  a  class  I  antigen  in  presention  of 
antigenic  peptides  to  cytotoxic  lymphocytes,  the  arthritogenic  peptide  model 
proposes  that  the  disease  is  the  product  of  a  cytotoxic  T  cell  response  to  a 
peptide found  only in joint tissues that can specifically be bound and  presented 
by all  HLA-B27  subtypes through their shared  structural  motif.  However,  under
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recognition either for clonal deletion or for initiating an  immune response.  Upon 
infection,  bacteria  may  carry  proteins  with  sequence  motifs  similar  to  the 
arthritogenic  peptide.  Infection  would  then  sensitise  T  cells  so  that they  could 
detect low levels of presentation of the arthritogenic peptide and initiate an anti­
self  response.  From  this  point  of  view,  SpA  is  an  autoimmune  response 
mediated by T cells against self antigens after a breakdown  in self tolerance by 
the triggering  bacterial  infection  (Benjamin  and  Parham,  1990).  It was  recently 
reported  that  CD4+  T  cells  may  also  be  involved  in  class  l-restricted  immune 
recognition  (Boyle  et al.,  2004),  and  consequently,  SpA could  involve  an  HLA- 
B27-restricted CD8+ or CD4+ T cell response to microbial or self-peptides.
The  arthritogenic  peptide  hypothesis  would  require  particularly  stringent 
selection of unique peptide epitopes by HLA-B27.  Peptide presentation by HLA- 
B27  is  known  to  be  influenced  by  subtype  polymorphisms  within  the  peptide 
binding  groove.  Although  subtypes  of  HLA-B27  differ  at  other  key  positions 
within  the  peptide  binding  groove,  their  characteristic  B  pocket  is  conserved 
(Madden  et  al.,  1991).  Evidence  for  this  hypothesis  comes  from  the 
identification of HLA-B27-restricted peptides from  Chlamydia trachomatis (Kuon 
et  al.,  2001),  as  well  as  from  molecular  mimicry  between  endogenous  B27 
peptides and environmental antigens (Dulphy et al.,  1999; Fiorillo et al., 2000).
Recently,  enthesitis  has  received  more  attention  as  the  hallmark  that 
distinguishes SpA from all other arthritides (Granfors et al., 2002). The cartilage 
proteoglycans versican  and  aggrecan  and the  link protein  are being  studied  as
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demonstrated  that  HLA-B27-restricted  epitopes  derived  from  human  aggrecan 
are  involved  in  the  induction  of typical  inflammation  of  SpA  (tenosynovitis)  in 
BALB/C-B27 transgenic mice (Kuon et al., 2004). Overall, however, although the 
theory of “arthritogenic peptides” was received much attention,  the arthritogenic 
capacity of candidate peptides has proved difficult to define.
There  has  been  considerable  interest  in  aberrant  processing  or folding  of the 
heavy  chain  of  HLA-B27.  Under  normal  circumstances  cell  surface  HLA-B27, 
consisting  of  a  heavy  chain  bound  to  P2IT1   and  peptide,  is  formed  in  the 
endoplasmic  reticulum  (Pamer  and  Cresswell,  1998).  It  has  been  recently 
described  that,  as  a  result  of  its  unique  B  pocket  architecture,  newly 
synthesised  HLA-B27  is  slow  to  fold  and  associate  with  p2m,  and  has  a 
tendency to misfold (Ortmann et al.,  1997). The accumulation of misfolded HLA- 
B27  protein  may  result  in  a  proinflammatory  “unfolded  protein  response”  
intracellularly  in the endoplasmic reticulum,  and  contribute to the  pathogenesis 
of  HLA-B27-associated  disease  (Mear  et  al.,  1999).  In  addition  to  the 
misfolding,  heavy  chains  of  HLA-B27  have  been  shown  to  refold  to  form 
disulfide-bonded homodimers in the absence of p2m, which is dependent on the 
presence of an unpaired cysteine-67 residue (Allen et al.,  1999).  Furthermore,  it 
has  been  shown  that  these  homodimers  of  HLA-B27  heavy  chains  are 
expressed on the surface of human lymphoid cell lines (Bird et al., 2003) and  in 
HLA-B27-positive  patients with  SpA (Kollnberger et al.,  2002).  HLA-B27  heavy 
chain  homodimers  can  bind  peptides  and  present  them  to  T  lymphocytes  or 
natural  killer  cells,  particularly  when  the  cell’s  ordinary  antigen-presenting
24function is impaired (Kollnberger et al., 2004). Alternative recognition of different 
forms  of  HLA-B27  by  leukocytes  receptors  could  influence  their 
immunomodulatory  function  and  may  imply  a  role  in  the  development  of SpA 
(Allen et al., 2001), but evidence is lacking to define the pathogenic significance 
of this interaction (Kim et al., 2005).
Recently,  clear evidence  that  HLA-B27  itself is  recognised  by  human  CD4+  T 
cells  isolated  from  SpA  patients  has  been  provided  (Boyle  et  al.,  2001).  A 
variety of forms of the molecule,  including conventional HLA-B27 heterodimers, 
free  HLA-B27  heavy  chain  monomers,  and  unconventional  homodiers  are 
involved  in  this  unusual  recognition,  which  also  is  independent of MHC  II  and 
transporter  associated  with  antigen  processing  (TAP).  Supporting  these 
findings,  Roddis  et  al  (Roddis  et  al.,  2004)  have  recently  demonstrated  that 
CD4+  and  CD8+  T  cell  responses  induced  in  HLA-B27  restricted  TCR 
transgenic mice (GRb) are both functional; whether HLA-B27-restricted CD4+ T 
cells  also  occur  in  patients  and  consequently  play  a  pathogenic  role  requires 
further  investigation.  Adoptive  transfer  studies  have  shown  that  CD4+  T  cells 
are  more  important than  CD8+  T  cells  for  induction  of arthritis  (Breban  et  al., 
1996).  Together,  these observations suggest the  role of unusual  recognition of 
MHC l-restricted CD4+ T cells in the pathogenesis of SpA.
A  recent  hypothesis  to  explain  the  role  of  HLA-B27  in  SpA  proposes  “auto­
display” of HLA-B27  (Luthra-Guptasarma  and  Singh,  2004).  In  this  hypothesis, 
p2m-free,  peptide-free  heavy  chains  support  a  helix-coil  transition  from  the  < x2 
domain  to  the  013  domain,  facilitating  the  rotation  of  backbone  angles  around
25residues  167/168,  thereby occupying the  peptide  binding  cleft of the  molecule. 
This  auto-display  of  HLA-B27,  occurring  either  within  HLA-B27  molecules  or 
between  HLA-B27  molecules,  might  be  the  grounds  for  self-perpetuating 
inflammatory and  immune  stimulation,  although  experimental  evidence  proving 
the existence of such assemblies is lacking.
There is another theory involving fcrn deposition (Uchanska-Ziegler and Ziegler,
2003).  This  is  based  on  the  observation  that  disease  associated  HLA-B27 
subsets  exhibit  a  higher  rate  of  p2m  dissociation  from  the  surface  HLA-B27 
complex than  non-associated subsets, which results in the deposition of P2IT1  in 
synovial  fluid  in  the  form  of  amyloid  aggregates,  causing  immune  response 
against  such  aggregates.  However,  with  this  particular  hypothesis,  HLA-B27 
itself  appears  incidental  rather  than  central  to  the  disease  mechanism. 
Moreover,  transgenic animal  studies  point to the opposite  results showing  that 
p2m  deficiency  (without  expression  of  HLA-B27)  is  sufficient  to  cause 
spontaneous inflammatory arthritis (Kingsbury et al., 2000).
Intracellular  persistence  of arthritogenic  microorganisms  may  contribute to  the 
pathogenesis of ReA, suggesting the host/microbe interaction may be abnormal 
in  susceptible  individuals,  leading  to  inefficient  elimination  of  arthritogenic 
bacteria,  fragments  of them  or  both,  after the  initial  infection.  To  support  this 
notion,  studies  have  shown  that  HLA-B27  expression  decreases  arthritogenic 
bacteria  invasion  into  transfected  L  cells  (Mear  et  al.,  1999).  In  addition  to 
invasion,  HLA-B27  also  remarkably  impairs  the  elimination  of  Salmonella 
enteritidis within  transfected  human  monocytic  cells  (Laitio  et al.,  1997).  More
26recently,  HLA-B27-positive  monocytes  were  shown  to  kill  Salmonella  in  vitro 
less  efficiently  than  controls,  and  they  showed  upregulated  production  of 
interleukin  10  (IL-10) and to a  lesser extent,  TNFa (Ekman et al.,  2002;  Inman 
and  Payne,  2003),  indicating  that  HLA-B27  associated  modulation  of cytokine 
response  profiles  may  have  importance  in  the  pathogenesis  of disease.  From 
this  point  of  view,  the  function  of  HLA-B27  may  not  be  limited  to  antigen 
presentation.  However,  other studies have shown that arthritogenic bacteria fail 
to  affect  HLA-B27  peptide  presentation  (Ringrose  et  al.,  2004),  and  invasion 
and  persistence  of Salmonella  in  fibroblasts are  not affected  whether the  cells 
are  isolated  from  HLA-B27  positive  or  negative  individauls  (Huppertz  and 
Heesemann,  1997).  The  diverse  results  may  reflect the  properties  of different 
cells  and  bacterial  strains  used  in  these  studies,  as  both  elements  have  a 
crucial  effect on  the  outcome.  Although  the  findings  remain  controversial,  this 
theory  takes  account  of  the  effects  of  triggering  bacteria  and  genetic 
susceptibility  into  the  pathogenesis  of  ReA,  which  is  worthy  of  further 
investigation.
1.1.4.1.2  Other genes
Several  studies  have  been  reported  on  genes  other  than  HLA-B27  in  SpA 
(Zhang et al.,  2004). An early study showed that HLA-B60 increased the risk of 
ankylosing spondylitis in  HLA-B27-positive Caucasian patients (Robinson et al.,
1989).  More recently,  it was further shown that HLA-B60 and B61  increased the 
susceptibility to ankylosing spondylitis in  HLA-B27-negative patients (Wei et al.,
2004).  In addition, another study reported that HLA-DR1  is also associated with 
ankylosing spondylitis (Brown et al.,  1998).
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presentation  (which  act  as  chaperones  for  peptide  transport)  have  also  been 
studied  in  the  context  of  ankylosing  spondylitis,  but  with  varying  conclusions 
(Burney et al.,  1994; Vargas-Alarcon et al., 2004). In addition, a number of other 
non-MHC candidate genes including IL-1  (Timms et al., 2004), TNF-a (Milicic et 
al., 2000), matrix metalloproteinase-3 (Jin et al., 2005) and transforming growth 
factor  (TGF)-p  (Howe  et  al.,  2005)  have  been  examined  for  susceptibility  to 
SpA.  The  potential  involvement of additional genes beyond  HLA-B27 suggests 
a polygenic model of genetic susceptibility for SpA.  It also offers an explanation 
for the fact that not all SpA patients display HLA-B27 expression.
1.1.4.2  Environmental factors
It  is  well  established  that  ReA  is  a  joint  inflammation  that  follows  infections 
caused  by  certain  Gram-negative  bacteria,  as  detailed  above,  although  the 
triggering  infection  is  less  clear in  other diseases  of the  SpA family.  HLA-B27 
transgenic  rats  in  a  germ-free  environment  do  not  develop  inflammatory 
pathology  in  the  gut  or  the  joints,  and  induction  of  arthritis  following 
re introduction  of commensal  gut flora  supports the  notion  that such  organisms 
play  an  important  role  in  the  pathogenesis  of  HLA-B27  associated  disease 
(Taurog et al.,  1994).
1.1.4.2.1  Evidence of bacteria or their products in the joints
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has  been  provided  using  a  number  of  different  techniques.  Chlamydia  DNA, 
mRNA,  rRNA,  and  intact  Chlamydia-Wke  cells  (live  but  non-culturable)  have 
been found in synovial tissues and peripheral blood (Bas et al.,  1995; Gerard et 
al.,  1998;  Hammer et al.,  1992;  Kuipers et al.,  1998;  Schumacher et al.,  1988; 
Taylor-Robinson et al.,  1992). The presence of mRNA and  rRNA (nucleic acids 
which  have  a  half-life  of  minutes  in  tissues)  of  Chlamydia  suggests  the 
occurrence  of  transcription  and  hence  active  multiplication  of  the  bacteria 
(Gerard  et  al.,  1998).  The  fact  that  an  inverse  relationship  between  the 
presence  of  Chlamydial  DNA  in  the  joint  and  synovial  Chlamydia-spectf'ic 
lymphocyte  proliferation  has been found  (Sieper et al.,  1999)  suggests that an 
impaired T-cell  response,  possibly related to the expression  of HLA-B27,  might 
contribute to the persistence of bacteria.
Attempts  to  cultivate  viable  Yersinia  or  Salmonella  from  affected  joints  have 
failed.  However,  DNA  of  Yersinia,  Shigella,  or  Campylobacterer  has  been 
identified in some studies (Granfors et al.,  1990;  Granfors et al.,  1989;  Hammer 
et al.,  1990a)  (Colmegna  et al.,  2004;  Sibilia  and  Limbach,  2002).  Antigens  of 
these  bacteria  have  been  demonstrated  in  samples  of  synovial  tissue  or 
synovial  fluid  from  patients  (Granfors  et  al.,  1989;  Hammer  et  al.,  1990a). 
Bacterial  products  including  lipopolysaccharide  (LPS)  of  Yersinia,  Salmonella, 
Shigella  (Granfors  et  al.,  1990;  Granfors  et  al.,  1992;  Granfors  et  al.,  1989), 
Chlamydia trachomatis (Jendro et al., 2000), and the YadA protein  (Hammer et 
al.,  1990a) and  heat shock protein (Granfors et al.,  1998) of Yersinia have been 
identified  in  the  joints  from  ReA  patients.  Moreover,  Yersinia  LPS  and  heat
29shock protein in the synovial fluid and peripheral blood cells have been detected 
for up to 4  years  in  ReA  patients  (Granfors et al.,  1998),  Salmonella  LPS  has 
been  found  in  synovial  tissue  2  years  after  initial  infection  (Granfors  et  al.,
1990), and the presence for several months of antibodies at high concentrations 
in  serum  samples from  patients with  ReA  (Maki-lkola  et al.,  1991)  all  indicate 
the  persistence  of  bacteria  or  their  products  in  the  host  after  the  onset  of 
infection.
Microbes or their components may enter the synovial tissues via blood vessels 
either  as  whole  organisms  that  may  circulate  in  the  blood  (bacteraemia)  or 
within  the  cells  as  a  part  of  immune  complexes  (Colmegna  et  al.,  2004; 
Granfors  et  al.,  1990;  Schumacher  et  al.,  1988).  It  has  been  suggested  that 
monocytes,  including  macrophages,  may  serve  as  a  reservoir  or  as  a 
transporter  of  bacteria  to  synovial  tissue  (Colmegna  et  al.,  2004).  This  is 
supported  by  an  important  property  of  synovium,  which  is  that  approximately 
50%  of the cells that make  up the  lining  layer are  macrophages  recruited from 
peripheral blood  (Gaston,  1998). As tissue macrophages are differentiated from 
blood monocytes, bacteria or their components phagocytosed by the monocytes 
or macrophages  at the  site  of infection  (mucosa)  or in  the  blood will  inevitably 
find their way to the joints, with the dose being  influenced  by recruitment rates. 
Large  joints  and  joints  with  some  degree  of  inflammation  due  to  mechanical 
stress  would  recruit  greater  numbers,  and  this  factor  might  account  for  the 
preferential  involvement  of  large  lower  limb joints  in  ReA.  Some  experimental 
evidence  also  supports  this  notion,  since  peripheral  blood  mononuclear  cells 
that  contain  intracellular  bacterial  fragments  are  especially  prone  to  bind  to
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monolayer (Kirveskari  et al.,  1998).  In  addition,  monocytes  that  have  engulfed 
ReA-triggering  bacteria  can  induce  the  expression  of  P-selectin  on  cultured 
endothelial  cells,  and  this  molecule  is  important  for  homing  to  the  synovium 
(Salmi  and  Jalkanen,  2001).  However,  despite  these  findings  direct  evidence 
that monocytes/macrophages serve as transporters of bacterial antigens to the 
joints is still lacking.
It is also  likely that these bacteria survive at an extra-articular site,  in  particular 
in  the  mucosal  membranes  of  the  digestive  system  and/or  the  lymphocytic 
tissues, and are carried to the joint by monocytes,  probably in recurrent fashion 
(Granfors et al.,  1998;  Kirveskari et al.,  1999;  Kirveskari et al.,  1998). A recent 
study  has  depicted  the  dynamic  picture  of  invasion,  degradation  and 
persistence of Yersinia and  Salmonella in synovial fluid  (Meyer-Bahlburg et al., 
2001).  In this study,  Infection of synovial fluid with these bacteria was shown to 
start  with  the  adhesion  of  the  bacteria  to  synovial  cell  membrane  and  was 
followed  by  uptake  of the  morphologically  intact  bacteria  into  the  cells.  A few 
hours  after  infection,  the  bacteria  showed  very  slow  metabolic  activity  and 
started  a  process  that  finally  led  to  the  total  disappearance  of  the  bacterial 
cytosol.  This  may  help  to  partially  explain  the  clinical  feature  of  frequent 
recurrences in some ReA patients.
1.1.4.2.2  Common features of triggering bacteria
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able  to  live  intracellularly,  they  have  LPS  as  an  important  component  of  the 
outer  membrane,  and  they  infect  at  a  mucosal  surface  (Reveille  and  Arnett,
2005).  It  is  still  not  clear  how  these  different  bacteria  can  lead  to  a  similar 
clinical  picture  and  have  a  similar association  with  HLA-B27.  The  identification 
of  immunodominant  antigens  of  these  bacteria  is  of  great  importance  to  aid 
understanding  of the  pathogenesis.  A  common  antigen  shared  by  all  bacteria 
has not yet been identified.
It has been  suggested that the  potential  immunodominant antigen  has to meet 
four  requirements:  first,  it  needs  to  be  expressed  in  the  synovial 
microenvironment;  second,  it  has  to  be  conserved  across  several  bacterial 
species;  third,  cross-reactivity  must  exist  between  human  and  bacterial 
antigens; finally, it must enable bacteria to evade the immune response.
For years,  an  intensive  search  for the  decisive  arthritogenic  antigen  has  been 
going on and so far not one has been found.  Bacterial heat shock protein (hsp) 
60  seems  to  be  a  major  target  of  the  T-cell  response  in  ReA,  and  cross­
reactivity  against  autologous  hsp60  has  been  discussed  as  a  cause  of 
autoimmunity  (Sieper et  al.,  2000).  However,  the  T  cells  specific for  hsp60  of 
Chlamydia  fail  to  cross-react  with  hsp60  from  enterobacteria  (Deane  et  al., 
1997).  Alternative  candidates  have  also  been  identified  among 
immunodominant antigens in  Yers/n/a-induced  ReA,  including a cationic 19-kDa 
urease B subunit and  ribosomal protein L23. The fact that the urease subunit is 
highly  conserved  among  bacteria  supports the  possibility that  autoimmunity  in
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epitopes (Mertz et al., 1994).
Rather than causing autoimmunity, bacterial LPS has been documented to play 
an  important  role  in  the  pathogenesis of ReA because  it contributes greatly to 
the  virulence  of  the  bacteria  and  acts  to  modulate  the  immune  system.  In 
patients  with  Sa/mone//a-induced  ReA,  the  persisting  humoral  immune 
response and intra-articular antibodies are directed primarily against LPS (Maki- 
Ikola  et al.,  1992).  In  addition,  LPS  in  synovial  tissue  is  a  potent  macrophage 
stimulator  and  can  induce  a  range  of  inflammatory  cytokines,  largely  via  the 
nuclear factor-KB  (NF-kB)  pathway  (Deng  et  al.,  1999).  LPS  also  induces  the 
chemokine,  monocyte  chemotactic  protein,  enhances  secretion  of  the 
polymorphonuclear  leukocyte  chemotactic and  activating  chemokine  IL-8  from 
chondrocytes  (Gaston  et  al.,  1999),  and  decreases  C5aR  expression  on 
monocytes  (Gerard  et al.,  1998).  All  these  changes  lead  to  the  recruitment of 
leukocytes  into the  synovium  and to the  persistence of activated  macrophages 
within the synovium and the ensuing chronic inflammation.
Bacterial  DNA  which  contains  more  nonmethylated  CpG  motifs  than 
mammalian  DNA,  can  intensely  stimulate  monocytes/macrophages,  and  thus 
may also contribute to inflammation. This idea is supported  by a study showing 
that experimental  intra-articular injection  of bacterial  DNA is sufficient to induce 
arthritis in mice (Deng et al.,  1999).
1.1.4.3 Interaction of bacteria and host in ReA
331.1.4.3.1 Humoral immune response
Although  bacteria-specific  antibodies  are  of  diagnostic  value,  the  humoral 
immune  response  does  not  explain  the  immunopathogenesis  and  MHC- 
association  of  this  disease.  However,  it  may  correlate  with  the  severity  and 
duration of the disease (Thomson et al.,  1995). The production of IgM,  IgG and 
IgA classes of antibody has been observed in Sa/mone//a-triggered ReA (1991). 
The  mainly  humoral  response  is  IgA  (especially  in  enteric  ReA),  implying 
chronic  stimulation  of  the  gut  mucosa  (Kingsley  and  Panayi,  1992).  The 
persistence  of antibodies  may  indicate  persistence  of bacterial  antigens  in  the 
arthritic  patients,  which  also  suggests  an  impaired  cellular  immunity  (Kingsley 
and  Panayi,  1992).  Analysis  of  B  cells  isolated  from  lymphoid  infiltrates  from 
synovial tissue of ReA patients suggests that B cell differentiation  occurs in  an 
antigen-driven,  T cell-dependent manner (Schroder et al.,  1997).  Nevertheless, 
the fact that antibody  responses  may  be absent in  ReA patients  indicates that 
they  play only  a  secondary  role  in  the  pathogenesis of synovitis  (Kingsley and 
Panayi,  1992).
1.1.4.3.2 Cellular immune response
In the pathogenesis of ReA,  T cells play a central  role (Colmegna et al.,  2004) 
and  antigen-specific  CD4+  and  CD8+  T  cells  have  been  detected  in  synovial 
fluid  of ReA patients  (Beacock-Sharp et al.,  1998).  The function of HLA-B27  is 
to present peptides to cytotoxic T cells,  and  HLA-B27  restricted cytotoxic T cell 
clones  against  bacterial  antigens  have  been  demonstrated  (Figure  1.1  a) 
(Hermann et al.,  1993;  Ugrinovic et al.,  1997) (Appel et al.,  2004a).  In addition, 
multiple T lymphocyte expansions are found in both the blood and synovial fluid
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CD8+ compartment, where they appear to express both activation and memory 
markers  (Allen  et  al.,  1997).  These  results  suggest  that  HLA-B27  restricted 
CD8+ T cells may be pathogenic.
However, studies with HLA-B27 transgenic mice have suggested that the role of 
HLA-B27 in joint disease may not simply be as a restriction element for CD8+ T 
cells,  since  HLA-B27 transgenic mice lacking  p2m  have extremely low levels of 
CD8+  T cells  but still  develop  inflammatory  disease  (Khare  et al.,  2001).  Also 
induction  of disease  in these  mice  is  independent of the  TAP-1  gene,  which  is 
required  for  the  loading  peptide  onto  MHC  class  I  molecules  (Khare  et  al., 
2001).  In  addition,  adoptive  transfer  studies  have  demonstrated  that  CD4+  T 
cells are  more  efficient in transferring  inflammatory disease than CD8+  T cells 
when the separate T cell subsets are transferred to nude HLA-B27+ transgenic 
rats  (Breban  et al.,  1996).  These observations  suggest that CD4+  T cells  may 
be more important than CD8+ T cells in the pathogenesis of ReA.
Although  early  studies  have  found  predominant  HLA  class  II  restricted  CD4+ 
responses  to  the  triggering  organisms  (Figure  1.1  d)  (Hassell  et  al.,  1993; 
Sieper et al.,  1993), more recently it has been suggested that MHC II molecules 
are  not  required  for disease  development  because  MHC-II  negative  HLA-B27 
transgenic  mice  still  develop  spontaneous  disease  (Khare  et  al.,  1998).  This 
raises  the  possibility  that  recognition  of  HLA-B27  by  CD4+  T  cells  may  be 
involved  in  disease  pathogenesis.  As  discussed  above,  there  is  evidence  that
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2001;  Roddis et al., 2004).
Various studies  have focused  on  analysis of homodimers formed  by free  HI_A- 
B27  heavy chain  that is  not associated with  p2m  (Allen  et al.,  1999;  Bird et al., 
2003;  Kollnberger  et  al.,  2004).  Expression  of  these  homodimers  has  been 
found on the surface of human lymphoid cell lines (Allen et al.,  1999;  Bird et al.,
2003)  and  in  HLA-B27-positive  patients with  SpA  (Kollnberger et al.,  2002).  It 
has been suggested that the formation of homodimers enables the binding of an 
altered  repertoire  of antigenic  peptides,  or  might  simply  resemble  the  MHC  II 
molecule leading to the  recognition by CD4+ T cells (Bowness et al.,  1999).  In 
addition  to  their  classical  antigen-presenting  role,  different forms  of  HLA-B27, 
including  either  classic  or  free  heavy  chain  monomer  or  homodimers,  are 
recognised  by  members  of  the  killer  immunoglobulin  receptor  and  leukocyte 
immunoglobulin-like  receptor  families  (Allen  et  al.,  2001).  Therefore,  as  the 
ligands for paired  Ig-like  receptors,  which  are  expressed  on  natural  killer cells, 
the  interaction  of HLA-B27 with  natural  killer cells  has  been  implicated  (Figure
1.1  f);  exactly  how  this  interaction  contributes  to  the  disease  pathogenesis 
remains to be shown.
Taken  together,  the  accumulated  data appear to show that CD4+  and  CD8+ T 
cells may both  play an  important part in the pathogenesis of ReA, while role of 
HLA-B27  homodimer  recognition  by  CD4+  T  cells  has  drawn  more  recent 
attention.
36Figure  1.1  Schema for a  number of possible recognitions  related to HLA-B27  molecules 
in the pathogenesis of ReA. Adapted from Reveille et al (Reveille and Arnett, 2005). (a) HLA- 
B27/(32m  and  peptide  complex  recognised  by  CD8+  T  cells,  (b)  HLA-B27/(32m  and  peptide 
complex recognised by CD4+ T cells,  (c)  Free HLA-B27 heavy chain alone reacting with CD4+ 
T cells,  (d)  HLA class  II (DR,  DQ,  DP)  presenting  HLA-B27 restricted  peptide to CD4+ T cells, 
(e)  HLA-B27  homodimers  reacting with CD4+ T cells,  (f)  HLA-B27  homodimers recognised  by 
receptors on NK cells.
371.1.4.3.3  Cytokines
Although  in  the  majority  of  patients  ReA  runs  a  benign  course,  up  to  15%  of 
cases  progress  to  chronic  arthritis  lasting  longer  than  12  months  (Kohnke, 
2004).  As stated  before,  bacterial antigens  have  been detected  in  the synovial 
tissues (Colmegna et al., 2004; Granfors et al.,  1990;  Granfors et al.,  1989) and 
some  antigens  can  be found  in  synovial fluid  and  peripheral  blood  for up to 4 
years  in  ReA patients (Granfors et al.,  1998). A synovial antigen-specific T cell 
response  has  been  demonstrated  (Appel et al.,  2004a;  Ugrinovic et al.,  1997), 
suggesting  that  persisting  bacteria  may  drive  the  immune  response  locally. 
Another  indicator for the  persistence  of bacteria  is  the  high  concentrations  of 
antibodies presented in serum of ReA patients (Maki-lkola et al.,  1991).  It is not 
clear why  the  immune  system  fails to  eliminate  these  bacteria,  although  HLA- 
B27 may modulate the invasion and  persistence of bacteria thus leading to the 
impaired  immune  response  (Saarinen  et  al.,  2002).  However,  secretion  of the 
appropriate cytokines  is  known  to  be crucial for an  effective  immune  response 
to eliminate bacterial infection (Yin et al.,  1997). Among cytokines active in host 
defense  against  intracellular  bacteria,  Th1  and  Th2  cytokines  are  of particular 
importance.  Thus,  the Th1  and  Th2  balance  has  been  suggested  to determine 
the  outcome  of  infection  with  the  ReA-associated  bacteria  (Burmester  et  al.,
1995).  TNF-a and  IFN-y are  potent antibacterial Th1  cytokines and  involved  in 
promoting  cell-mediated  immunity,  which  is  required  for  an  effective  cellular 
immune responses against intracellular bacteria, whereas IL-4,  IL-5,  IL-9 and  Il­
ls are Th2 cytokines and  more involved  in the generation  of humoral immunity 
and  allergic  responses.  In  addition,  production  of  Th2  cytokines  also  has  an
38inhibitory  effect  on  the  function  of  Th1  cytokines  (Hitchon  and  El-Gabalawy, 
2002;  Paul and Seder,  1994).
The  issue  of  which  cytokine  secretion  pattern  predominates  the  milieu  of 
synovial fluid of ReA patients is controversial. An early study showed that a Th1 
cytokine  pattern  was  predominant  in  synovial  fluid  of  patients  with  Yersina 
induced  ReA  (Schlaak  et  al.,  1992),  which  has  been  confirmed  by  another 
recent  study  (Butrimiene  et  al.,  2004).  High  production  of  TNF-a  and  IFN-y 
detected  in  chronic  ReA  supports  the  possible  use  of  anti-TNF-a  treatment, 
which  has shown a promising effect in the clinic, especially for cases of chronic 
ReA (Reveille and Arnett, 2005). On the contrary, impaired Th1  (TNFa) cytokine 
production  has  also  been  observed  to  correlate  with  longer  disease  duration 
(Braun  and  Sieper,  1999).  Concomitantly,  there  are  some  other  studies 
suggesting  that  cytokines  associated  with  Th2  subsets  (such  as  IL-4)  are 
prominent in  the  synovium of patients with  ReA (Simon  et al.,  1994;  Yin  et al.,
1997),  which  may  delay  elimination  of bacteria,  thus  leading  to  persistence  of 
the pathogen.  In addition,  since the disease  resolves in the  majority of patients 
with  ReA  (although  often  taking  12  months to  do  so)  (Kohnke,  2004),  another 
explanation  for  the  significance  of  a  detectable  Th2  cytokine  profile  in  the 
development of disease  is the  appearance of anti-inflammatory Th2  cytokines, 
which  may function  to  control joint  inflammation  (Gaston,  1998).  This  notion  is 
supported  by a study of animal models of arthritis showing that IL-4 can down- 
regulate  joint  inflammation  (Joosten  et  al.,  1997).  The  differences  in  synovial 
tissue  cytokine  profiles  demonstrated  in  the  above  studies  are  difficult  to 
reconcile, and may relate to patient selection, sampling of the synovial tissue, or
39in  vitro processing  techniques.  The  underlying  mechanism that determines the 
differentiation  of  T  helper  lymphocytes,  thus  resulting  in  a  skewing  of  the 
cytokine secretion  profile,  is unclear. The local inflammatory milieu, the amount 
of  IL-12  during  T  cell  priming,  differences  among  antigen-presenting  cells 
(APCs)  and  antigen  dose  have  been  discussed  as  likely  factors  (Moser  and 
Murphy, 2000; Paul and Seder,  1994; Sherand Coffman,  1992).
Another subset  of CD4+  T  lymphocytes  producing  IL-10  and  TGF-p  has  been 
proposed  to  have  a  regulatory  role,  and  an  elevated  level  of IL-10  and  TGF-p 
secretion  has been detected  in  the synovial  membrane of ReA patients (Appel 
et  al.,  2004b).  Whether this  is  a  general  phenomenon,  and  how  it  affects  the 
Th1  and Th2 balance, remains to be determined.
1.2  Macrophages
Macrophages are bone marrow derived cells that enter the blood as monocytes, 
which,  after  approximately  a  day  in  the  blood  stream,  enter  and  reside  in 
several  different  tissues  and  organs  where  they  differentiate  into  resident 
macrophages.  Macrophages  are  actively  phagocytic  and  endocytic  cells, 
playing  a  key  role  in  innate  immunity  because they can  recognise,  ingest,  and 
destroy many pathogens without the aid of an adaptive immune response. They 
are  the  first  line  of  host  defense  to  encounter  pathogens.  Macrophages 
recognise  pathogens  by  means  of  cell-surface  receptors  including  the 
macrophage  mannose  receptor,  scavenger  receptors,  glucan  receptors  and 
Toll-like  receptors.  (Aderem  and  Underhill,  1999;  Takeuchi  et  al.,  1999; 
Underhill  et  al.,  1999).  Phagocytosis  by  macrophages  can  be  dramatically
40enhanced  through  binding  of  pathogens  with  Fc  receptors  and  complement 
receptors,  a  process  called  opsonisation.  After  phagocytosis,  macrophages 
produce  a  variety  of toxic  products  that  help  kill  the  engulfed  microorganism. 
The  most  important  of these  are  reactive  oxygen  species  (ROS)  and  reactive 
nitrogen  species  (RNS),  which  are  generated  by  lysosomal  nicotinamide- 
adenine  dinucleotide  phosphate  (NADPH)  oxidases  and  other  enzymes  in  a 
process  known  as  the  respiratory  burst.  The  second  important  effect  of  the 
interaction  between  pathogens and  macrophages is activation  of macrophages 
to  release cytokines and  other mediators that establish  a state of inflammation 
in  the  tissue  and  recruit  large  numbers  of macrophages from  the  blood  to the 
site of local inflammation.  Due to their phagocytic capacity as well as their ability 
to upregulate MHC and co-stimulatory molecules upon activation, macrophages 
also  have  an  important  role  in  antigen  presentation.  Finally,  macrophages  are 
an  important  effector  of  cell-mediated  responses  following  exposure  to 
inflammatory  cytokines  such  as  IFN-y  produced  by  T  cells,  which  eventually 
facilitate the elimination of the invading pathogens.
1.3  Dendritic cells
Dendritic cells (DC) are a sparsely distributed,  migratory group of bone-marrow 
derived leukocytes that are specialised for the uptake, transport, processing and 
presentation  of  antigens  to  T  cells  (Shortman  and  Liu,  2002).  Owing  to  their 
distribution  throughout most tissues of the  body  and  being widely  accepted  as 
the most potent APCs in the immune system, DC are positioned at the centre of 
innate  and  adaptive  immunity and  have a  prominent  role  in  the  initiation  of the
41primary  immune  response  compared  to  other  APCs  such  as  macrophages 
(Steinman and Nussenzweig, 2002).
Recent evidence  suggests  that  in  both  mice  and  man  there  exist  at  least two 
major  subsets  of  DC,  namely  conventional  DC  and  plasmacytoid  DC  (PDC) 
(Cavanagh  and Von Andrian,  2002;  Klechevsky et al.,  2005).  Conventional  DC 
are the  classical T cell  priming  subset and  may  ultimately shape the type  of T 
cell  response  following  microbial  invasion  (Klechevsky  et  al.,  2005).  The 
function  of  PDC  is  less  clear.  These  cells  produce  large  amounts  of  IFNa  in 
response to viral  infection  and therefore may play an  important role in defence 
against pathogens (Colonna et al., 2002).
Several  subpopulations  have  been described  among  conventional  DC  in  mice. 
DC are  broadly defined  by expression  of CD11c and  MHC class  II,  but can  be 
further divided into subpopulations based on differential expression of the CD8a 
homodimer  and  CD4.  Three  subpopulations  have  been  defined  which  are 
present in  the spleen  and  lymph  nodes:  CD8a+CD4-,  CD8a-CD4+ and  CD8a- 
CD4-  (Moser  and  Murphy,  2000;  Shortman  and  Liu,  2002).  Some  functional 
differences  between  these  subpopulations  have  been  reported.  For  example, 
CD8a+  DC  have been  shown to  be superior in  inducing  a Th1-biased cytokine 
response,  endocytosing  apoptotic  cells  and  cross-presentation;  whereas, 
CD8a- DC tend to induce a Th2-biased  response (Shortman and  Liu, 2002).  In 
addition  to  these  three  subsets  additional  DC  subsets  are  present  in  lymph 
nodes  and  other tissues  (Shortman  and  Liu,  2002).  This  includes  Langerhans
42cells,  a  distinctive  DC  subtype  found  in  skin,  which  are  characterised  by 
expression of langerin (Shortman and Liu, 2002).
DC  exist  in  distinct  stages  of  maturation  depending  on  signals  received  from 
their  environment.  Immature  DC  reside  predominantly  in  peripheral  tissues  in 
the  absence  of  inflammatory  stimuli  or  microbial  products.  They  have  a  high 
capacity  for  antigen  uptake  and  processing,  but  a  relatively  poor  capacity  to 
stimulate  naive  T cells  (Banchereau  and  Steinman,  1998)  (Banchereau  et al., 
2000).  Immature  DC  express  low  levels  of  MHC  class  I  and  MHC  class  II 
molecules  and  costimulatory  molecules  such  as  CD80,  CD86,  CD40  and  the 
adhesion  molecule  CD54  (ICAM-1) that are  all  important for interaction  with  T 
cells.  In  addition,  immature  DC  also express  chemokine  receptors that bind  to 
chemokine  ligands  that  are  considered  to  be  pro-inflammatory,  which  are 
important for  positioning  and  recruitment of different  DC  subsets  into  different 
peripheral  tissues  (Cravens  and  Lipsky,  2002).  Immature  DC  monitor  their 
environment for signs of danger and  can  interact directly with  microbial  stimuli 
through  pattern  recognition  receptors such  as Toll-like  receptors,  and  can take 
up  antigens  via  macropinocytosis  or,  in  the  case  of  apoptotic  cells,  by 
phagocytosis (Seya et al., 2001).
Toll-like  receptors  (TLRs)  are  innate  receptors  that  sense  microbial  products 
and  trigger  DC  maturation  and  cytokine  production,  thus  effectively  bridging 
innate and adaptive immunity (Napolitani et al., 2005). These receptors signal in 
response to conserved microbial components such as LPS by TLR4, flagellin by 
TLR5,  unmethylated  CpG oligonucleotides by TLR9, and double-stranded  RNA
43by  TLR3,  and  therefore  are  thought  to  be  critical  components  of the  immune 
response  (Napolitani  et  al.,  2005).  DC  express  a  broad  repertoire  of  TLRs 
through  which  they  can  recognise  a  wide  range  of  microbial  components.  In 
addition, cytokines such as IL-1 (3, TNF-a or engagement of CD40, are also able 
to  trigger  DC  to  mature  (Banchereau  et al.,  2000;  Banchereau  and  Steinman,
1998).
The  process  of maturation  leads to  the downregulation  of the  antigen  capture 
capacity,  increased  surface  expression  of  costimulatory  molecules,  enhanced 
cytokine  secretion  and  altered  chemokine  responsiveness.  The  latter  involves 
the  downregulation  of  chemokine  receptors  that  bind  to  pro-inflammatory 
chemokines and  an up-regulation of the chemokine receptor,  CCR7 (Ohl et al.,
2004), that binds to the chemokine CCL19 and CCL21  constitutively expressed 
in distinct sites of SLO  (Miyasaka and Tanaka,  2004).  This property allows  DC 
migration  from  inflamed  tissues  to  SLO  and  hence  optimal  positioning  to 
encounter antigen-specific T cells.
For experimental  use,  murine DC can  be obtained  by two ways.  BMDC can  be 
generated  by  cultivation  of bone  marrow cells  in  the  presence  of granulocyte- 
macrophage  colony-stimulating  factor  (GM-CSF)  for  6-8  days  (Inaba  et  al., 
1992;  Lutz et al.,  1999).  The  cells from  this  culture  represent  a  heterogenous 
population  of DC,  consisting  of  immature  DC,  defined  as  CD11c+  MHC  II  low , 
and  mature  DC,  which  are CD11c+  MHC  II  h ig h  (Cheminay et al.,  2002;  Lutz et 
al.,  1999).  Alternatively,  splenic  DC  can  be  purified  from  spleens  by  digestion 
with  collagenase,  after which  CD11c+  cells  are  enriched  by  positive  selection
44using  magnetic  beads.  This  method  also  applies  DC  purification  from  lymph 
nodes.
1.4  Salmonella
1.4.1  Serovar
The  genus  Salmonella  is  extremely  heterogeneous,  comprising  almost  2000 
serotypes,  of  which  only  a  few  are  major  human  pathogens.  The  serotype 
differences  are  based  on  differences  in  surface  antigens  such  as  LPS  and 
flagella (Monack et al., 2001).  Pathogenic Salmonella species are an important 
cause  of  infectious  diseases  throughout  the  world.  Salmonella  serovars  are 
responsible  for  human  diseases  that  range  from  self-limiting  gastroenteritis  to 
systemic  infections.  The  strict  human  pathogen,  Salmonella  enterica  serovar 
Typhi  (S.  typhi),  causes typhoid  fever,  a  systemic disease,  which  results  in  16 
million  illnesses  and  600,000  deaths  worldwide  each  year  (Jones,  2005). 
Transmission of this disease within the human population is generally a result of 
poor  sanitation  of water  and  food  supplies  in  developing  countries.  Whereas 
Salmonella enterica serovars Enteriditis and Typhimurium cause the majority of 
human  gastroenteritis  infections,  up to  1.3  billion  cases of acute gastroenteritis 
are  caused  by  non-typhoid  salmonellosis,  leading  to  3  million  deaths  annually 
(Pang et al.,  1995). These broad  host-range Salmonella serovars are prevalent 
within  warm-blooded  animal  populations that  make  up the  human  food  supply 
and  bacterial  transmission  generally  results  from  consumption  of  raw  or 
undercooked  food  products  (Darwin  and  Miller,  1999).  Therefore,  these  high 
numbers  of infections emphasise the  importance of this  intracellular pathogen.
45While  mortality  due  to  Salmonella  infections  is  mainly  a  health  problem  in 
developing  countries,  morbidity  due  to  acute  Salmonella  infections  also  has 
important  socio-economic  impact  in  developed  countries  (Hansen-Wester and 
Hensel, 2001).
1.4.2  Significance of Salmonella study
In  addition  to  its  clinical  importance,  Salmonella  is  an  interesting  model 
organism  for  the  study  of  host-pathogen  interaction  on  the  molecular  level. 
Salmonella  enterica serovar Typhimurium  (S.  typhimurium)  is frequently  used 
for  this  purpose,  since  this  organism  has  a  broad  host  range  and  causes 
disease in a variety of animals.  It causes a self-limited gastroenteritis in humans 
and  a  systemic  typhoid-like  disease  in  mice,  thus  serving  as  an  experimental 
model for typhoid fever. Moreover, this model also illustrates that mice are more 
susceptible  to  S.  typhimurium  than  humans,  which  is  probably  controlled  by 
genes that include SLc11a  (Fortier et al.,  2005).  Furthermore,  Salmonella spp. 
are  interesting  candidates  for  use  as  live  recombinant  vaccines  and  may  be 
useful for the mucosal delivery of recombinant vaccine antigens (Hopkins et al., 
2000).
S.  typhimurium  infection  of  mice  and  S.  typhi  infection  of  humans  are 
characterised  by  inflammation  at  the  site  of  bacterial  entry  and  in  deeper 
infected  tissues  (Jones  and  Falkow,  1996).  Salmonella  invasion  results  in 
characteristic  tissue  changes,  including  infiltration  of  neutrophils  and 
monocytes/macrophages,  which  contribute  to  the  erosion  of  the  intestinal
46mucosa  (Darwin  and  Miller,  1999).  After  Salmonella  transverses  the  epithelial 
barrier,  it  preferentially  infects  phagocytes  within  the  lamina  propria  and 
subsequently  enters  the  lymphatics  and  bloodstream  and  spreads  to  the  liver 
and the spleen (Vazquez-Torres et al.,  1999).
1.4.3 Salmonella and ReA
Salmonella  is  one  of the  most common  ReA  inducing  agents,  as  33%  enteric 
ReA is triggered  by Salmonella infection (Colmegna et al., 2004).  According to 
previous  Salmonella  outbreak  reports,  1-15%  of  patients  with  Salmonella 
gastroenteritis develop ReA as a postinfection complication (Inman et al.,  1988; 
Locht et al.,  1993).  Of the  2000 different Salmonella  serotypes,  22  have  been 
reported  to trigger ReA,  although  about 60%  of ReA cases are triggered  by S. 
typhimurium (Maki-lkola O,  1991).
1.4.4 Major virulence mechanisms of Salmonella
Salmonella  has  evolved  sophisticated  virulence  mechanisms  to  infect  and 
colonise  their  hosts  and  these  functions  are  exerted  through  bacterial  type  III 
secretion  systems  (TTSS).  TTSS  are  specialised  organelles  that  translocate 
bacterial virulence  proteins (effectors) from the  bacterial cytoplasm directly  into 
the  host-cell  cytoplasm  (Kimbrough  and  Miller,  2002).  These  translocated 
effectors alter such basic host-cell functions as signal transduction, cytoskeletal 
architecture,  membrane  trafficking,  and  cytokine  gene  expression  (Waterman 
and  Holden,  2003).  Two  distinct  virulence-associated  TTSS  have  been 
described,  and  they  perform  different  functions  during  Salmonella-host
47interaction. The Salmonella Pathogenicity Island 1   (SPI-1) locus is a 40-kb gene 
cluster  at  centisome  63  of  the  Salmonella  chromosome  (Galan  and  Curtiss, 
1989).  It  delivers  at  least  13  effector  proteins  through  the  host  cell  plasma 
membrane,  most  of  which  are  involved  in  actin  cytoskeleton  rearrangement, 
leading to membrane ruffling, thus resulting  in  Salmonella invasion of intestinal 
epithelial  cells  or  facilitating  uptake  of  organism  into  a  Salmonella-containing 
vacuole  (SCV)  (Waterman  and  Holden,  2003).  In  addition,  SPI-1  effectors 
induce  IL-8  and  pathogen-elicited  epithelial  chemoattractant  secretion  in 
intestinal  epithelial  cells,  resulting  in  transmigration  of  neutrophils  (Lee  et  al.,
2000).  The  SPI-1  translocon  protein  SipB  binds  to  and  activates  caspase-1, 
leading to the induction of apoptosis in macrophages (Hersh et al.,  1999).
Following  invasion,  Salmonella  infection  of  the  intestinal  mucosa  leads  to 
phagocytosis  by  macrophages;  survival  and  proliferation  inside  macrophages 
that  eventually  renders  the  development  of  systemic  disease  (Fields  et  al., 
1986).  The  intracellular  phase  of  Salmonella  infection  is  characterised  by 
processing  of  the  SCV  along  a  unique  path  of  vesicular  trafficking,  which 
requires expression  of the genes in  SPI-2,  as well as loci controlled  by the two 
component  regulatory system  PhoPQ  (Holden,  2002).  The  SPI-2  TTSS,  which 
encompasses  a  25  kb  cluster  of  genes  at  centisome  30.7  of  the  Salmonella 
chromosome,  encodes a  second  TTSS that delivers virulence effector proteins 
produced by organisms in the SCV across the vacuolar membrane and  into the 
cytoplasm  of  the  host  cell  (Waterman  and  Holden,  2003).  SPI-2  has  been 
shown  to  be  required  for  inhibition  of various  aspects  of endocytic trafficking, 
including  fusion  between  lysosomes  and  SCVs  (Uchiya  et  al.,  1999),  an
48avoidance of NADPH oxidase-dependent killing by macrophages (Gallois et al., 
2001; Vazquez-Torres et al., 2000b), delayed apoptosis-like cell death (van der 
Velden  et al., 2000),  control of SCV membrane dynamics (Beuzon et al., 2000; 
Ruiz-Albert  et  al.,  2002),  the  assembly  of  a  meshwork  of  F-actin  around  the 
SCV (Meresse et al.,  2001),  cholesterol accumulation  around the SCV (Catron 
et  al.,  2002)  and  interference  with  the  localisation  of  inducible  nitric  oxide 
synthesas to the SCV (Chakravortty et al., 2002).
Analysis by electron  microscopy revealed that the TTSS encoded by SPI-1  is a 
membrane-bound  assembly  with  a  typical  needle-like  structure,  termed  the 
“needle complex” (Kubori et al.,  1998). Although there is no direct experimental 
evidence,  it  can  be  assumed  that  the  SPI-2-encoded  TTSS  shows  structural 
and  functional  similarity  to  the  SPI-1  system.  The  “needle  complex”  is  a  long 
hollow structure about  120  nm  long and  is composed  of two clearly identifiable 
domains:  a  needlelike  portion  projecting  outward  from  the  surface  of  the 
bacterial  cell and  a cylindrical  base that anchors the  structure to the  inner and 
outer membranes (Figure  1.2).  Biochemical analysis of purified needle complex 
revealed that they are composed  of at least three  proteins:  InvG  (a  member of 
the  secretin  family)  and  two  lipoproteins,  PrgH  and  PrgK  (Galan  and  Collmer,
1999)  (Figure  1.2  D).  It is thought that the TTSS “needle complex” serves as a 
hollow conduit through which the type  III  secreted  proteins are delivered to the 
host  cell  cytoplasm  (Galan  and  Collmer,  1999).  More  recently,  by  using  time- 
lapse  microscopy,  delivery of the  Salmonella type  III  effector  proteins  such  as 
SopE  into  animal  cells  in  real  time  has  been  imaged  (Schlumberger  et  al.,
2005). This mechanism of S. typhlmurium has been used to deliver
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Figure 1.2 Electron micrographs of needle complexes from osmotically shocked S. typhimurium 
on the bacterial envelope (A), purified (B), enlarged (C), and schematic representation and its 
major components (D). These graphs are adapted from Galan et al (Galan and Collmer,  1999) 
and Kimbrough et al (Kimbrough and Miller, 2002).
50heterologous  epitopes  fused  with  bacterial  effector  proteins  into  the  host-cell 
cytosol  to  elicit  class  l-restricted  immune  response  (Russmann  et  al.,  1998), 
and  this  antigen  delivery  system  has  been  shown  to  result  in  efficient 
stimulation  of  class  l-restricted  protective  antiviral  immune  responses 
(Russmann  et  al.,  1998).  Use  of this  antigen  delivery  system  will  expand  the 
efficient  use  of  S.  typhimurium  as  a  carrier  of  heterologous  antigens  to 
vaccinate against infections and/or tumour diseases in which a class l-restricted 
Cytotoxic T cell lines (CTL) response is crucial for protection.
1.4.5  Genetic susceptibility of mice to Salmonella infection
Solute  carrier  family  11a  member  1   (Slc11a1),  formerly  known  as  Nrampl 
(natural  resistance-associated  macrophage protein  1),  has been  identified as a 
major regulator of mouse susceptibility to Salmonella infection (Plant and Glynn, 
1974;  White  et  al.,  2004).  Slc11a1  was  mapped  to  mouse  chromosome  1.  In 
mice,  this  gene  confers  susceptibility  to  a  range  of  phylogenetically  distinct 
intracellular  pathogens  including  S.  typhimurium  (Plant  and  Glynn,  1976), 
leishmania  donovani  (Bradley  et  al.,  1979),  and  Mycobacterium  bovis  BCG 
(Gros et al.,  1981). A naturally occurring Gly-Asp mutation at amino acid  169 of 
Slc11a1  in  mice  leads  to  unrestricted  bacterial  replication  in  the  liver  and 
spleen,  resulting  in  a  lethal  infection  of  Salmonella  (Vidal  et  al.,  1995b).  In 
human,  Slc11a1  is  associated  with  infectious  and  autoimmune  diseases 
(Blackwell et al., 2003).
51Identification of the mouse Slc11a1  found that the Slc11a family was an ancient 
family,  encoding  proteins  with  high  homology to  membrane-bound  transporter 
proteins, which  is highly conserved from yeast to humans (Cellier et al.,  1996). 
The  mammalian  Slc11a  family  is  divided  into  two  classes,  Slc11a1  and 
Slc11a2.  Slc11a1  is  exclusively  expressed  in  the  late  endosomes/lysosomes 
and  phagosomes  of  phagocytic  cells  such  as  monocytes/macrophages  and 
granulocytes  (Govoni  et  al.,  1997;  Vidal  et  al.,  1995a).  Slc11a2  ubiquitously 
localizes  to  early  endosomes  in  macrophages  (Gruenheid  et  al.,  1999)  and 
other cell types throughout the body.
Although  Slc11a1  was  identified  before  Slc11a2,  the  biochemical  function  of 
Slc11a2  has  been  determined,  while  that  of  Slc11a1  remains  unclear.  Using 
Xenopus oocytes, it was shown that Slc11a2 protein is a pH-dependent divalent 
cation  transporter,  capable  of transporting  divalent  cations  including  Fe2+  and 
Mn2+  (Gunshin  et  al.,  1997).  The  same  study  claimed  that  Slc11a1  can  also 
transport  Fe2+ and  Mn2+,  but with  less  efficiency  than  Slc11a2.  More  recently, 
another  study  has  suggested  that  Slc11a1  is  a  more  efficient  transporter  of 
Mn2+ than  Fe2+  (Fortier et  al.,  2005).  In  conjunction  with  their  localizations,  a 
potential model for iron homeostasis in macrophages was proposed. Slc11a2 in 
early endosomes delivers extracellularly acquired divalent cations (Fe2+) into the 
cytosol;  and  Slc11a1  in  late  endosomes/lysosomes  delivers  divalent  cations 
from  the  cytosol  to this  acidic compartment.  Subsequently,  the  Fenton  and  or 
Haber-Weiss  reaction  can  use  ferrous  iron  to  generate  toxic  hydroxyl  (OH«) 
radicals  (Zwilling  et  al.,  1999).  This  model  provides  one  mechanism  by which 
Slc11a1  could  directly  contribute  to  antimicrobial  activity  in  macrophages.
52However,  some  other  studies  proposed  that  Slc11a1  also  delivers  divalent 
cations  into  the  cytosol  (Fortier  et  al.,  2005;  Gomes  and  Appelberg,  1998; 
Jabado  et  al.,  2000).  Conversely,  Goswami  and  colleagues  (Goswami  et  al.,
2001)  demonstrated  that  Slc11a1  can  flux  divalent  cations  in  either  direction 
depending  upon the pH on either side of the membrane.  Hence the direction of 
transport of divalent cations by Slc11a1  remains controversial.
Slc11a1  mediated  divalent  metal  ion  transport  at  the  vesicular  compartments 
has  many  pleiotropic  effects  on  macrophage  activation,  including  induction  of 
inducible  nitric  oxide  synthesas  (iNOS),  nitric  oxide  (NO)  release,  L-arginine 
flux, oxidative burst and regulation of cytokines such as IL-1p, TNF-a (Blackwell 
et  al.,  2003).  These  effects  appear  to  be  crucial  for  Slc11a1  mediated 
resistance  in  vivo.  In  addition,  Zaharik  et  al  have  demonstrated  that  the 
presence  of  Slc11a1  up-regulates  the  expression  of  SPI-2  virulence  genes 
(ssrA,  sseA  and  sseJ),  which  are  critical  for  intra-macrophage  survival  of 
bacterium  in  Slc11a1-transfected  cell  lines  and  murine  systemic  Salmonella 
infection  (Zaharik  et  al.,  2002).  Hence,  this  delineates  an  active  interplay 
between SPI-2 and the innate genetic host defence mechanism during infection.
Although  numerous  studies  have  attempted  to  elucidate  the  true  biochemical 
function of Slc11a1  in macrophages, a clear and definitive answer has not been 
achieved.  In  addition,  further  studies  required  to  determine  the  underlying 
molecular  basis  of  disease  susceptibility  mediated  by  Slc11a1  in  human 
diseases.
531.4.6 T cell responses in Salmonella infection
It  has  been  clearly  shown  that  T  cells  play  a  central  role  in  the  control  of  S. 
typhimurium infection, with  B  cells also contributing  (Mittrucker and  Kaufmann,
2000).  Although  y5 T cells  represent a  large fraction  of T cells  in  the  intestinal 
epithelium,  and  depletion  of y5 T cells  results in  increased  susceptibility to oral 
Salmonella  infection,  mice with  depletion  of ap  T  cells  show a  more  profound 
defect (Mixter et al.,  1994), which  suggests that ap T cells are more  important 
for protective  immunity against Salmonella infection.  Depletion  of CD8+ T cells 
from  donor  cells  reduces  the  capacity  to  passively  transfer  protection  against 
virulent S.  typhimurium,  indicating a specific role for CD8+ T cells (Mastroeni et 
al.,  1992;  Nauciel,  1990).  By  differentiation  into  cytolytic  T  cells,  which  then 
produce  cytokines such  as  IFN-y and  TNF-a and  release  granulysin,  a  protein 
with the direct antibacterial activity (Stenger et al.,  1998),  CD8+ T cells are able 
to  lyse  infected  cells.  This  leads  to  release  of  bacteria  from  their  protective 
environment, as well as contributing directly in bacterial killing.
Various data indicate that CD4+ T cells are more important than CD8+ T cells in 
ani\-Salmonella response, as transfer of CD4+ T cells from vaccinated mice into 
naive  recipients  resulted  in  higher levels of protection  than  transfer of CD8+ T 
cells  (Mastroeni  et al.,  1992;  Nauciel,  1990;  Pie  et al.,  1997).  In  addition,  mice 
deficient in CD4+ T cells (MHC ll-deficient mice) failed to clear infection with an 
attenuated strain of S.  typhimurium and developed chronic disease (Hess et al.,
1996).  In  general,  CD4+  T  cells  function  by  differentiating  into  Th1  and  Th2 
cells,  characterised  by  secretion  of  distinct  cytokines.  Studies  have 
demonstrated  that  infection  of  mice with  Salmonella  induces  a  Th1  response,
54indicated  by  the  production  of  large  amounts  of  IFN-y  (Ramarathinam  et  al., 
1991; Thatte et al.,  1993).  The importance of IFN-y in the control of Salmonella 
was demonstrated in mouse mutants deficient in the IFN-y receptor, which were 
highly  susceptible  to  attenuated  Salmonella  (Hess  et  al.,  1996).  Salmonella- 
specific  Th1  cells  are  most  likely  the  major  source  of  IFN-y  during  the  later 
stages  of  infection,  and  especially  during  the  secondary  response  (Mittrucker 
and  Kaufmann,  2000).  Th1  cells  can  also  produce  TNF-a  (Mastroeni  et  al., 
1992;  Tite et al.,  1991),  with  additional sources of TNF-a being  macrophages. 
TNF  -a also plays a critical  role during  Salmonella infection,  since neutralisation 
of TNF-a In vivo can prevent the host from mounting a protective response, and 
the  animals  succumb  to  the  infection  (Everest  et  al.,  1998;  Mastroeni  et  al., 
1993).  Th2  cytokines that have  been  analysed  in  Salmonella  infection  are  IL-4 
and  IL-10  (Pie  et  al.,  1996;  Pie  et  al.,  1997).  These  are  not  involved  in 
protection,  but  rather  impair  control  of  Salmonella  infection  (Mittrucker  and 
Kaufmann, 2000).
1.5  Chemokines and chemokine receptors
Chemokines  are  small  (around  10  kDa)  secreted  chemotactic  cytokines  that 
regulate  the  migration  of  leukocytes  under  steady-state  and  inflammatory 
conditions  (Sozzani,  2005).  More than 40  chemokines  have  been  identified  so 
far  (Rot  and  von  Andrian,  2004).  Based  on  their  amino  acid  composition,  4 
chemokine families  have  been  described  (Table  1.1),  C,  CC,  CXC  and  CX3C, 
according to the motif displayed by the first two of four cysteine residues at the 
N terminus  of the  molecule.  CXC  and  CC  are  the two  major families,  with  the 
two cysteine residues separated by a single amino acid or in adjacent positions.
55Table 1.1 Chemokines and their receptors and their classification
Chemokine Original names Receptor Class
CC chemokine
CCL1 I-309, TCA-3 CCR8 D
CCL2 MCP-1, MCAF, JE CCR2 I
CCL3 MIP-1oc CCR1.CCR5 I
CCL4 MIP-ip CCR5 I
CCL5 RANTES CCR1, CCR3, CCR5 I
CCL6 (mouse) MRP-1 CCR1 I
CCL7 MCP-3, MARC CCR1, CCR3, CCR5 I
CCL8 MCP-2 CCR3 I
CCL9 (mouse) MRP-2, MIP-1y CCR1, CCR2, CCR3 I
CCL10 (mouse) CCF18 unknown unknown
CCL11 Eotaxin CCR3 I
CCL12 (mouse) MCP-5 CCR2 I
CCL13 MCP-4 CCR2, CCR3 I
CCL14 HCC-1, Ckp-1 CCR1 I
CCL15 HCC-2, Lkn-1, MIP-5 CCR1, CCR3 I
CCL16 HCC-4, LEC, Mtn-1, LCC-1 CCR1 I
CCL17 TARC CCR4 D
CCL18 DC-CK1,  PARC unknown H
CCL19 ELC, MIP-3P CCR7 H
CCL20 MIP-3a, LARC CCR6 D
CCL21 6Ckine, SLC, CKp-9, TCA-4 CCR7 H
CCL22 MDC, STCP-1 CCR4 D
CCL23 MPIF-1, CKb-8 CCR1 I
CCL24 MPIF-2, Eotaxin-2 CCR3 I
CCL25 TECK CCR9 D
CCL26 Eotaxin-3 CCR3 I
CCL27 CTACK, ILC, ALP, Eskine CCR10 I
CCL28 MEC CCR3, CCR10 I
CXC chemokine
CXCL1 GROa, MGSA, MIP-2,  KC CXCR2 I
CXCL2 GROP, MIP-2a CXCR3 I
CXCL3 GROy, MIP-2P CXCR4 I
CXCL4 PF-4 unknown unknown
CXCL5 ENA-78, LIX CXCR2 I
CXCL6 GCP-2, CKa-3 CXCR1, CXCR2 I
CXCL7 NAP-2 CXCR I
CXCL8 IL-8 CXCR1, CXCR2 I
CXCL9 MIG CXCR3 D
CXCL10 IP-10, CRG-2 CXCR3 D
CXCL11 l-TAC CXCR3 D
CXCL12 SDF-1 CXCR4 H
CXCL13 BLC, BCA-1 CXCR5 H
CXCL14 BRAK, bolekine unknown H
CXCL15 (mouse) Lungkine unknown unknown
CXCL16 CXCR6 D
XC chemokine
XCL1 Lymphotactin, SCM-1, ATAC XCR1 I
XCL2 XCR2 I
CX3C chmokine
CX3CL1 Fractalkine, Neurotactin CX3CR1 I
Chemokines  can  be  classified  as  inflammatory  (I),  homeostatic  (H)  or  dual  function  (D)
according to their expression pattern and function (Kim, 2004;  Moser et al., 2004;  Paixao et al., 
2005) (McColl, 2002).
56C  and  CX3C  chemokines  are  minor  families,  which  include  two  with  a  single 
cysteine  residue  and  one  with  three  amino  acids  separating  the  two  cysteine 
residues (Moser et al., 2004).
Chemokines play a critical role in the directed movement of leukocytes from the 
bloodstream  to  tissues  as  well  as  localisation  of  cells  within  the  tissues. 
However, emerging data  have shown that various members of the chemokines 
exert a  range  of biological effects  beyond  chemotaxis,  including  angiogenesis, 
hematopoiesis,  morphogenesis  and  autoimmunity  (Cravens  and  Lipsky,  2002; 
Moser et al., 2004).
According  to  their expression  patterns  and  various functions,  chemokines  can 
also  be  divided  into  three  groups  termed  “inflammatory”,  “homeostatic”  and 
“dual-function” chemokines.  Inflammatory chemokines, for example CXCL8 and 
CCL5,  expressed  in  inflamed  tissue,  control  the  recruitment  of  effector 
leukocytes  in  infection,  inflammation,  tissue  damage  and  tumours.  Many  of 
them  have  broad  target-cell  selectivity  and  act  on  cells  of  the  innate  and 
adaptive  immune  system.  Homeostatic  chemokines,  for  example  CCL19, 
CCL21,  CXCL13,  expressed  constitutively  in  SLO,  navigate  leukocytes  during 
hematopoiesis  in  the  bone  marrow  and  thymus,  during  initiation  of  adaptive 
immune  responses  in  the  SLO,  and  in  immune  surveillance  of  peripheral 
tissues.  In contrast, dual-function chemokines have been defined more recently 
due to several  chemokines with  overlapping functions that cannot be  assigned 
to either of the above two groups. They participate in immune defence functions
57and  also  target  precursor and  resting  mature  leukocytes  at  sites  of  leukocyte 
development and immune surveillance (Moser et al., 2004).
Chemokines  exert  their  various  biological  functions  by  binding  to  specific 
receptors,  which  are  a  group  of  G-protein  coupled  receptors  (GPCR).  GPCR 
are  proteins with  seven transmembrane spanning  domains and  are coupled to 
G proteins. The heterotrimeric G  proteins are composed of three subunits, a,  p 
and  y  (Rot  and  von  Andrian,  2004).  After  binding  of  the  chemokines  to  the 
amino terminus of the receptors, the activated G-proteins dissociate into a- and 
py-subunits.  The py-subunits activate the phosphotidylinositol-3 kinases (PI3K), 
which  leads to generation of phosphoinositide-3,4,5-trisphosphate  (PIP3).  PI3K 
and  its  product  PIP3  translocate  and  colocalise  with  the  small  GTPase  Rac. 
PIP3 activates Rac through specific guanine nucleotide exchange factors, which 
subsequently  enhances  actin  polymerisation  and  activates  the  focal  adhesion 
apparatus, inducing formation of lamellipodia and filopodia. This reorganises the 
cytoskeleton  of  the  cells,  promoting  the  polarisation  toward  the  concentration 
gradient of chemokines,  resulting  in  cell  motility and  chemotaxis  (Maghazachi, 
2000; Rot and von Andrian, 2004).
In  addition  to  activation  of  signalling  pathways,  GPCRs  also  regulate  the 
process  of  desensitisation,  which  can  occur  upon  prolonged  and  repeated 
exposure  to  chemokines  (Kohout  et  al.,  2004).  Again,  the  heterotrimeric  G 
proteins coupled to GPCRs dissociate  into a and  py subunits. The latter recruit 
G  protein  coupled  receptor kinases, which  phosphorylate the carboxy terminus 
of the  receptors.  Phosphorylated  receptors  bind  p-arrestins,  which  recruit  non­
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phosphorylate  dynamin,  which  binds  clathrin-coated  endocytic  pits,  facilitating 
the  internalisation  of the  receptors.  This  pathway  results  in  the  termination  of 
the  signals  (Maghazachi,  2000).  Such  agonist-induced  phosphorylation  of 
chemokine  receptors  followed  by  internalisation  of  the  receptors  is  called 
“homologous desensitisation”  (Ali et al.,  1999).  Chemokine  receptors may also 
be  subjected  to  “heterologous  desensitisation”  when  a  receptor  loses  its 
responsiveness  following  phosphorylation  by  second  messager-activated 
kinases, i.e. protein kinase A or protein kinase C, which have been activated by 
unrelated  receptors  or  signalling  processes  (Ali  et  al.,  1999).  For  example, 
activation  of formyl  peptide  receptor,  the  receptor for the  bacterial chemotactic 
peptide  fMLF,  effectively  desensitises  a  number of chemoattractant  receptors, 
including  the  receptors  for  the  chemokine  CXCL8/IL-8  (Ali  et  al.,  1999).  Both 
homologous  and  heterologous  desensitisation  results  in  diminished 
responsiveness  of chemokine  receptors to further stimulation  by their cognate 
ligands (Le et al., 2001).
“Homologous  desensitisation”  of  a  number  of  chemokine  receptors,  induced 
using  their  specific  agonists,  has  been  used  as  a  tool  in  various  studies.  For 
example, CCR2 on the murine monocytoid WEHI78/24 cell line has been shown 
to  be  desensitised  by  40  minutes  preincubation  with  500  nM  CCL2/MCP-1 
(Palframan  et  al.,  2001).  Similarly,  CCR7  on  murine  splenic  effector  T  cells 
could be desensitised by incubation for 60 minutes with up to 5 pg/ml of CCL19- 
Ig  fusion  protein  (Unsoeld  et al.,  2004).  Furthermore,  as  co-ligands for CCR7,
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been compared (Kohout et al., 2004).
1.6  The role of macrophages during S. typhimurium infection
Macrophages  play  important  roles  in  different  stages  of  S.  typhimurium 
infection. A genetic factor for the potential of macrophages to kill S. typhimurium 
is the expression of functional SLc11a 1. Deletion of functional SLc11a 1   protein 
in  certain  mouse  strains  dramatically  reduces  the  efficacy  with  which 
macrophages  kill  S.  typhimurium,  resulting  in  a  high  susceptibility  to  infection 
(Fortier et al.,  2005;  Govoni et al.,  1999;  Vidal  et al.,  1995b).  During the  initial 
stages  of  infection,  macrophages  phagocytose  bacteria,  produce  reactive 
oxygen  and  nitrogen  intermediates  and  secrete  pro-inflammatory  cytokines 
such  IL-6,  IL-12  and  TNF-a  to  control  bacterial  replication  (Eckmann  and 
Kagnoff,  2001;  Norimatsu  et al.,  2003;  Yrlid  et al.,  2000).  However,  this  is  not 
simple  one-way  process directed  by the  macrophages alone.  By  means of the 
TTSS, bacterial proteins are injected into the host cells, allowing S.  typhimurium 
to  interfere  with  the  signalling  machinery  (Gallois  et  al.,  2001;  Schwan  and 
Kopecko,  1997),  promoting  intracellular  survival  of the  pathogen  and  causing 
apoptosis  of  infected  macrophages  (Chen  et  al.,  1996a;  Hersh  et  al.,  1999; 
Schwan et al., 2000).  Macrophages also contribute to anti-Salmonella immunity 
as  APCs.  Studies  have  shown  that  macrophages  are  able  to  process  and 
present peptides on  MHC-I  and  MHC-II  molecules to  CD8+  and  CD4+  T cells. 
In the following sections, a few aspects of the interaction between macrophages 
and Salmonella infection are highlighted and introduced.
601.6.1 Invasion and survival
S.  typhimurium  infect  the  host  through  the  intestinal  tract  and  cross  the 
epithelial barrier at the level of the  ileum or the colon  preferentially by invading 
M  cells  (Jepson  and  Clark,  2001;  Jones  et  al.,  1994).  This  cell  type,  which 
functions to  sample  luminal antigens,  overlies the  lymphoid  follicles  (Neutra et 
al.,  1996a).  The  bacteria  subvert the  normal function  of M  cells and  are taken 
up  by  inducing  membrane  ruffling  in  these  cells,  which  requires  the  invasion- 
associated genes of SPI-1  (Collazo and  Galan,  1997;  Lee et al.,  1992;  Lostroh 
and  Lee,  2001).  After passing  epithelium,  the  bacteria  reach  the  subepithelial 
dome  of  the  Peyer’s  Patch  (Jones  et  al.,  1994)  and  encounter  an  extensive 
network of resident macrophages and  DC  (Jones and  Falkow,  1996;  Neutra et 
al.,  1996b).  However,  an  alternative  M  cell-independent  invasion  mechanism 
has  been  demonstrated,  whereby  S.  typhimurium  is  transported  from  the 
gastrointestinal  tract  to  the  bloodstream  by  CD18-expressing  phagocytes, 
possibly  consisting  of  DC  and/or tissue  macrophages  (Vazquez-Torres  et  al., 
1999).  After  being  engulfed  by  phagocytes,  S.  typhimurium  are  thought  to 
principally reside and  multiply inside macrophages (Santos and  Baumler, 2004; 
Weinstein  et  al.,  1984).  Mutants which  fail  to  survive  within  macrophages  are 
avirulent  (Fields  et  al.,  1986).  In  addition,  Finlay  et  al  have  demonstrated  by 
confocal  microscopy that S.  typhimurium colocalised  in  vivo with  macrophages 
and  resided  intracellularly  inside  macrophages  in  the  liver  at  later  stages  of 
disease (Richter-Dahlfors et al.,  1997).
611.6.2  Cross talk: NADPH system and type ill secretion system
Since  S.  typhimurium  survive  and  replicate  inside  macrophages,  remaining 
confined  inside  vacuoles  in  the  infected  cells  (Oh  et  al.,  1996),  macrophages 
play  a  particular  role  in  the  pathogenesis  of Salmonella  infection  by  providing 
such  protected  sites for  intracellular  replication  and  a  means  of extraintestinal 
dissemination  (Vazquez-Torres et al., 2000a). Soon after internalisation,  F-actin 
is  depolymerised  from  the  phagosome,  and  the  newly  denuded  vacuole 
membrane  becomes  accessible  to  early  endosomes  (Aderem  and  Underhill,
1999).  Through  a  series  of fusion  and  fission  events,  the  vacuolar membrane 
and  its  contents  mature,  fusing  with  the  late  endosome  and  ultimately 
lysosomes, to form a phagolysosome.  Following phagocytosis, two biochemical 
pathways  contribute  to  the  ability  of  macrophages  to  eliminate  intracellular 
pathogens (Aderem and Underhill,  1999).
The  NADPH  phagocyte  oxidase  is  among  the  most  effective  antimicrobial 
weapons.  This  enzymatic  complex  catalyses  the  univalent  reduction  of 
molecular oxygen to superoxide, a radical with  modest antibacterial activity that 
serves as a precursor to more toxic derivatives including hydrogen peroxide and 
hydroxyl radical, which are collectively known as ROS.  ROS have recently been 
shown  to  play  a  role  in  intracellular  signalling  (Ehrt  et  al.,  2001).  Like 
superoxide,  NO  is  also  synthesised  in  infected  macrophages  by  a 
multicomponent enzyme,  and  is the  precursor of a  range  of toxic  radicals  and 
ions, collectively known as RNS.  RNS exert direct microbicidal and microbistatic 
effects  (MacMicking et al.,  1997).  NO  also  plays a  role  in  signalling  (Coleman,
2001).  In  innate  immunity,  NO  is  required  for  IL-12  activation  of  natural  killer
62(NK)  cells  (Diefenbach  et  al.,  1999)  and  is  implicated  in  several  other 
immunoregulatory  roles  and  iron  metabolism  in  macrophages  (Bogdan,  2001; 
Bogdan et al., 2000). Fang and colleagues (Vazquez-Torres et al., 2000a) have 
demonstrated  that  the  ROS  and  RNS  both  contribute  to  the  anti-Salmonella 
activity of macrophages. ROS dependent killing is confined to the first few hours 
after  phagocytosis,  whereas  RNS  contribute  to  both  early  and  late  phases  of 
anti-bacterial  activity.  RNS  initially  synergize  with  ROS  to  kill  S.  typhimurium 
and subsequently exert prolonged oxidase-independent bacteriostatic activity.
Rather than  being  destroyed  by  phagocytes  after  being  engulfed,  Salmonella 
has evolved several mechanisms to survive in the harsh milieu of macrophages 
mainly  by  utilising  SPI-2  TTSS.  After  uptake,  Salmonella  resides  in  the  SCV 
within macrophages.  First, the SCV is acidified within an hour of uptake (Garvis 
et al., 2001;  Rathman et al.,  1997), which is required for Salmonella replication, 
probably because a low pH is necessary for secretion of SPI-2 proteins (Beuzon 
et al.,  1999;  Nikolaus  et  al.,  2001).  Second,  Salmonella  actively  maintain  and 
modify  the  vacuole  and  turn  it  into  a  “spacious  phagosome”   characteristic  of 
owning a tightly opposed membrane. SifA (Brumell et al., 2001) and SseJ (Ruiz- 
Albert  et  al.,  2002),  two  SPI-2  TTSS  effector  proteins  are  required  in  this 
process. Third, maturation of the SCV is disturbed and wild-type S. typhimurium 
rapidly  becomes  inaccessible  to  incoming  endocytic  materials  and  remains 
segregated  from  lysosomes  and/or  late  endosomes  (Garvis  et  al.,  2001; 
Rathman et al.,  1997).  It has been  reported that another SPI-2 effector,  SpiC is 
involved  in  this  process  (Uchiya  et  al.,  1999).  Finally,  S.  typhimurium  has 
several  enzymes  defending  it  from  oxidative  stress,  which  include  the
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Fang  et  al.,  1999;  Farrant  et  al.,  1997),  and  glucose  6-phosphate 
dehydrogenase  (Lundberg  et  al.,  1999).  The  latter  is  required  for  NADPH 
synthesis,  which  allows  Salmonella  to  maintain  its  redox  state  and  repair 
oxidative damage;  another TTSS  effector protein,  SspJ,  may also  be  involved 
(van  der  Straaten  et  al.,  2001).  No  SPI-2  proteins  have  been  found  that  are 
specifically to defend  RNS, although the SPI-2 TTSS plays a  role in limiting the 
bacteriostatic effects mediated by iNOS (Chakravortty et al., 2002).
1.6.3  Cytotoxicity and apoptosis
Chen  and  colleagues  have  shown  that  Salmonella  is  cytotoxic  for  cultured 
macrophages in vitro (Chen et al.,  1996a). The cytotoxicity is initially manifested 
by  an  inhibition  of  membrane  ruffling  and  macropinocytosis  in  infected 
macrophages,  and  is  followed  by  cell  death.  The  cytotoxic  effects  are  strictly 
dependent  upon  the  expression  of  the  invasion-associated  SPI-1  TTSS, 
because  bacteria  with  mutations  in  invJ,  spaO,  sipB,  sipC  and  sipD  fail  to 
induce cytotoxicity. Growth of S.  typhimurium under conditions that do not allow 
optimal expression of TTSS also abolishes the cytotoxicity (Chen et al.,  1996a). 
As  mentioned  above,  SPI-1  is  required  to  control  bacterial  invasion  at  early 
stages  of  infection  (Baumler,  1997).  It  has  been  shown  that  the  invasion 
process triggers a signal transduction pathway within macrophages that induces 
apoptosis  (programmed  cell  death)  (Monack  et  al.,  1996).  In  addition, 
Zychlinsky  et  al  have  reported  that  Salmonella  invasin  SipB  induces 
macrophages apoptosis by binding to caspase-1  (Chen et al.,  1996b;  Hersh et
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cysteine  proteases,  intimately  involved  in  the  initiation  and  execution  of 
“classical apoptosis”. They are synthesised as precursors that are converted to 
the  active  enzyme  form  by  proteolytic  processing  (Hersh  et  al.,  1999). 
Caspases  participate  in  both  the  initiation  of apoptosis and  the  process of cell 
disassembly  in  response  to  apoptotic  stimuli.  The  exact  mechanisms  of 
caspase-mediated cell death are still not known yet.
Recent publications  indicate that S.  typhimurium grown to stationary  phase do 
not induce the early caspase-1  killing but,  instead,  can  kill macrophages  18-24 
hour postinfection  (Libby et al.,  2000;  Lindgren  et al.,  1996;  van  der Velden  et 
al., 2000). The later stage of macrophage death exhibits some characteristics of 
apoptosis  (Libby  et  al.,  2000).  Notably,  SPI-2  proteins  are  required  to  induce 
this  late  macrophage  death  (van  der  Velden  et  al.,  2000),  indicating  that 
Salmonella  uses  distinct  TTSS  to  induce  cell  death  at  different  stages  of 
infection.
The  ability  of  Salmonella  to  promote  apoptosis  may  be  important  for  the 
initiation of infection,  bacterial survival and dissemination.  The  rapid  SPI-1  and 
caspase-1-dependent cell killing  in the gut-associated  lymphoid tissue results in 
the  processing  and  release  of the  proinflammatory  cytokines  IL-1p  and  IL-18 
(Hersh et al.,  1999;  Mastroeni et al.,  1999), which  likely are responsible for the 
rapid  inflammation  and  recruitment  of  additional  phagocytic  cells,  along  with 
their  trafficking  thus  leading  to  dissemination.  In  contrast,  once  dissemination 
and  replication  have  occurred,  macrophages  are  killed  by  SPI-2-dependent
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macrophages,  which  may  lead  to  further  spread  of  bacteria  and  initiation  of 
acquired immune response.
However, some recent studies have raised the question of whether Salmonella- 
induced  cell  death  occurs  by  necrosis  or  apoptosis  (Brennan  and  Cookson, 
2000;  Watson  et  al.,  2000).  Conventionally,  apoptosis  has  a  characteristic 
morphological  appearance:  cell  shrinkage,  membrane  blebbing,  intense 
perinuclear condensation,  cytoplasmic vacuolisation,  maintenance of organelle 
structure,  and  eventually the formation  of apoptotic bodies.  In  addition,  lack of 
inflammation  is  another  hallmark  of  death  by  apoptosis.  In  contrast,  necrotic 
cells  exhibit  a  loss  of membrane  integrity  and  an  enlargement  of the  nucleus 
and  cellular  organelles  like  mitochondria.  Widespread  necrosis  is  pro- 
inflammatory in  vivo (Majno and  Joris,  1995).  Although  apoptosis and  necrosis 
are considered as distinct forms of cell death, there  is increasing evidence that 
the  morphological  and  biochemical  characteristics  of  classical  apoptosis  and 
necrosis  represent  only the  extreme  ends  of a  wide  range  of possible  deaths 
(Nicotera  et  al.,  1999)  and  they  may  share  common  molecular  pathways. 
Moreover,  the  two  processes  have  been  found  to  be  functionally  linked 
(Nicotera  et al.,  1999;  Tsujimoto et al.,  1997).  Thus,  it is sometimes difficult to 
distinguish  between  apoptosis  and  necrosis  (Hirsch  et  al.,  1997;  Leist  et  al., 
1997).  Based on these difficulties,  Falkow et al just refer to Salmonella-Induced 
macrophage  cytotoxicity  as  host  cell  death  rather  than  applying  any  precise 
term to the mechanism (Monack et al., 2001).
661.6.4 Antigen Presentation
The  antigen  presentation  capacity  of  macrophages  is  less  potent  than  DC.  It 
has  been  shown  that macrophages  and  DC  both  are  able to  phagocytise  and 
process bacteria for presentation of bacterial peptides on both MHC-I and MHC- 
II  (Pfeifer et  al.,  1993;  Pfeifer et al.,  1992;  Svensson  et  al.,  1997b;  Svensson 
and Wick,  1999).  Co-incubation  of BMDC  or  BMMac with  S.  typhimurium  has 
been  shown  to  result  in  upregulation  of  number  of  cell  surface  antigens 
including CD80,  CD86,  MHC-I  and  MHC-II,  and this response does not require 
internalisation of the  bacteria or that the  bacteria are viable  (Yrlid et al.,  2000). 
More  recently,  the  study  of Villarreal-Ramos  and  colleagues  showed  that  DC 
infected  with  S.  typhimurium  up-regulated  cell  surface  expression  of  MHC-I, 
MHC-II,  CD40,  CD80  and  CD86,  while  in  contrast,  infected  macrophages  did 
not exhibit detectable changes  in  expression  of cell  surface  molecules,  except 
for  a  increase  in  CD40  (Norimatsu  et  al.,  2003).  Due  to  insufficient  surface 
expression  of  MHC  and  co-stimulatory  molecules,  macrophages  are  less 
efficient in triggering naive T cells and initiating primary immune responses than 
DC.  BMMac  and  peritoneal  elicited  macrophages  can  process  and  present 
bacterial antigens on  MHC-II,  but the cells need  to  be  stimulated with  IFN-y to 
induce sufficient levels of MHC-II expression;  in  contrast,  BMDC do not require 
IFN-y pre-treatment to present antigen on MHC-II  (Yrlid et al., 2000; Yrlid et al., 
2001b).
The antigen  processing  and  presentation  pathways  used  by macrophages and 
DC may not be identical.  For instance, for presentation of bacterial antigens on 
MHC-I,  DC  use a  cytosolic pathway,  which  requires  newly synthesised  MHC-I,
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and  peritoneal-elicited  macrophages  use  a  non-cytosolic pathway,  which  does 
not  require  the  protease  and  TAP;  at  a  later time,  the  cytosolic  pathway  may 
contribute  significantly  (Yrlid  et  al.,  2000).  The  cytosolic  pathway  is  the  best 
characterised  MHC class  I  antigen  presenting  pathway,  while the  mechanisms 
involved  in  the  non-cytosolic  pathway  are  not  fully  understood.  Peptide 
regurgitation,  a  process  of  loading  Salmonella-derived  peptides  to  post-Golgi, 
but  not  newly  synthesised,  MHC-I  molecules  might  be  involved  (Yrlid  et  al.,
2000).
Besides  direct  antigen  presentation,  indirect  antigen  presentation  also 
contributes  to  the  pathogenesis  of  Salmonella  infection.  This  is  because  S. 
typhimurium  induces  large  amounts  of  macrophage  cell  death  (as  discussed 
earlier).  Wick  and  Yrlid  have  demonstrated  that  bystander  DC  but  not 
macrophages present antigens from  bacterial-induced  apoptotic macrophages, 
despite  the  fact  that  both  cell  types  internalise  apoptotic  macrophages  (Yrlid 
and Wick, 2000). This difference may be due to enhanced degradative capacity 
of macrophages compared to DC such that antigenic epitopes are destroyed  in 
the macrophages containing  apoptotic material (Linehan and  Holden,  2003).  In 
addition,  the  Salmonella  virulence  system  pho-P  regulates  gene  products that 
could decrease the processing and  presentation  of S.  typhimurium antigens by 
activated macrophages (Wick et al.,  1995).
681.7 The roles of dendritic cells during Salmonella infection
DC play an important role during Salmonella infection, especially with respect to 
linking innate and acquired immune responses.  In the following section, several 
aspects of DC function during Salmonella infection will be discussed.
1.7.1  Entry and dissemination
DC  play  a  key  role  in  initiating  immune  responses  to  bacterial  infections 
including S.  typhimurium. The natural route of Salmonella infection is oral, most 
commonly in contaminated food. Thus, the intestinal tract is the first barrier the 
bacteria  face.  Subsequently,  S.  typhimurium  invades  the  intestinal  mucosa 
mainly through specialized epithelial cells, called M cells, that are located in the 
epithelium  overlaying  Peyer’s  patches  (Jepson  and  Clark,  2001;  Neutra  et al., 
1996a).  Penetration  of M  cells  by  bacteria  requires the  expression  of invasion 
proteins encoded by SPI-1  (Collazo and Galan,  1997;  Lee et al.,  1992;  Lostroh 
and  Lee,  2001).  However,  S.  typhimurium that  are  deficient  in  invasion  genes 
encoded  by  SPI-1  are  still  able  to  reach  the  spleen  after  oral  administration 
(Galan  and  Curtiss,  1989),  which  suggests  an  M  cell-independent  pathway. 
Non-invasive  Salmonella are  unable to invade CD 18-deficient mice,  implicating 
CD18-expressing phagocytes including DC and macrophages in this alternative 
route  (Vazquez-Torres  et  al.,  1999).  Hopkine  et  al  demonstrated  by  confocal 
microscopy analysis that attenuated  Salmonella were  internalised  and survived 
in  Peyer’s  patches  DC  after  oral  inoculation  (Hopkins  et  al.,  2000).  A  more 
recent  study  provided  further  evidence  that  DC  are  able  to  open  the  tight 
junctions between epithelial cells,  send their dendrites into the lumen of the gut
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bacterial  uptake mechanism  in the mucosal epithelium.  More recently,  Niess et 
al show  that  this  uptake  is  regulated  by  CX3CL1,  a  chemokine  produced  by 
intestinal epithelial cells (Niess et al., 2005), which provides an efficient way for 
DC  to  acquire  antigen  for  presentation  and  might  enhance  the  immune 
response against Salmonella infection.
After  invasion,  Salmonella  uses  SPI-2  TTSS  to  facilitate  their  intracellular 
survival  and  replication  and  induce  late-stage  apoptosis  of  infected  host  cells 
(Waterman  and  Holden,  2003).  Although  the  macrophage  is  the  predominant 
cell type to be used by  Salmonella to achieve this function,  some studies have 
demonstrated  that Salmonella  also efficiently enter and  survive within  cultured 
CD11c+ DC (Marriott et al.,  1999a) and murine Peyer’s patches DC (Hopkins et 
al.,  2000).  In  addition,  this  survival  does  not  depend  on  virulence  factors 
required  for  intracellular  survival  in  macrophages  (Hopkins  et  al.,  2000). 
Moreover,  a  significant  level  of  apoptosis  of  DC  has  been  observed  after 
Salmonella  infection,  which  occurs  in  a  dose-dependent  manner  (Yrlid  et  al., 
2001b).  In  concert  with  their  unique  localisation  in  the  subepithelial  dome  of 
Peyers’  patches  (Iwasaki  and  Kelsall,  2000)  and  ability  to  be  mobilised  upon 
infection,  DC may also serve as an  important host cell for dissemination of this 
pathogen  from  mucosal  sites  (Marriott  et  al.,  1999a;  Vazquez-Torres  et  al., 
1999).  This is similar to a dissemination  role documented  in L  monocytogenes 
infection (Pron et al., 2001).
701.7.2 Maturation upon S. typhimurium infection
After  encountering  S.  typhimurium,  immature  DC  can  be  activated  and 
converted into a mature state,  indicated by several aspects. (1) Up-regulation of 
surface expression of MHC and costimulatory molecules, such as MHC  I,  MHC 
II,  CD86,  CD40  and  CD54  (Niedergang  et  al.,  2000;  Svensson  et  al.,  2000). 
Neither bacterial viability nor internalisation  is required for this process to occur 
(Rescigno  et  al.,  2001).  (2)  Secretion  of  cytokines  upon  bacterial  interaction. 
Recent studies have shown that splenic DC produce TNF-a and  IL-12 after co­
culture with S. typhimurium (Marriott et al.,  1999a; Yrlid and Wick, 2002). Again, 
neither bacterial  internalisation  nor viability  is  required  for cytokine  production. 
Yrlid et al concluded that Salmonella infection was also able to induce BMDC to 
release  cytokines,  but  unlike  for  splenic  DC,  phagocytosis  was  required  for 
BMDC cytokine production (Svensson et al., 2000; Yrlid et al., 2000). (3) Altered 
chemokine  responsiveness.  Salmonella  infection  is  able  to  stimulate  intestinal 
epithelial  cell  lines to  constitutively  express  CCL20/MIP-3a  mRNA  (Izadpanah 
et  al.,  2001).  CCL20/MIP-3a  is  a  member  of  the  CC  chemokine  subfamily, 
expressed  by the  follicle-associated  epithelium  overlaying  the  Peyer’s  patches 
(Iwasaki  and  Kelsall,  2000),  which  selectively chemoattract  immature  DCs that 
express the cognate receptor CCR6 (Liao et al.,  1999;  Power et al.,  1997) to the 
subepithelial region of mucosal surfaces (Dieu et al.,  1998;  Iwasaki and  Kelsall, 
2000;  Sallusto  et  al.,  1998).  In  addition,  CCR6-expressing  DC  are  found  in 
tissues close to CCL20-expressing epithelial cells or keratinocytes (Caux et al., 
2000;  Iwasaki and Kelsall, 2000).  In CCR6 knockout mice, subepithelial myeloid 
DC are absent in the dome of Peyer’s patches, and mucosal immune responses 
are impaired (Cook et al., 2000). More recent research has identified flagellin as
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2003).  Furthermore,  it has  been  shown  that  Salmonella flagellin  stimulation  of 
intestinal epithelial cells triggers CCL20-mediated migration of DC (Sierro et al.,
2001). Therefore,  during  Salmonella infection,  CCL20-dependent DC trafficking 
may  serve  as  an  important  mechanism  to  recruit  immature  DC  to  the  site  of 
infection  and  subsequently  initiate  adaptive  immune  response  in  the  gut.  In 
contrast,  it  has  been  demonstrated  that  upon  encounter with  S.  typhimurium, 
BMDC  upregulate  chemokine  receptors  CCR7  mRNA  and  are  subsequently 
attracted  towards the chemokines CCL19 and  CCL21  (Cheminay et al.,  2002). 
Upregulated  CCR7  expression  enables  DC  to  traffic  out  of  the  tissues,  and 
migrate to the  blood  and  SLO  (Martln-Fontecha  et al.,  2003;  Ohl et al.,  2004), 
where they encounter antigen specific T cells.
1.7.3  Antigen presentation
As  the  most  important  consequence  of  maturation  and  migration,  DC  are 
competent to present antigen to T cells in SLO.  DC present Salmonella derived 
antigens on MHC I and  MHC  II to CD8+ and CD4+ T cells respectively (Yrlid et 
al.,  2001a;  Yrlid  et al.,  2000;  Yrlid  et al.,  2001b).  This  has  been  demonstrated 
for  bone  marrow  derived  DC  (Svensson  et  al.,  1997b;  Svensson  and  Wick, 
1999)  as well  as freshly isolated  splenic DC  (Yrlid  et al.,  2001a).  Furthermore, 
Yrlid et al have demonstrated that splenic DC isolated from Salmonella-infected 
mice present bacterial antigens on MHC-I and MHC-II to antigen specific CD8+ 
and  CD4+  T  cells  ex  vivo  (Yrlid  and  Wick,  2002).  In  addition,  cytochalasin  D 
(CCD) inhibition experiments have revealed that presentation by both pathways
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MHC-I  and  MHC-II  presentation  pathways  of  BMDC  as  well  (Yrlid  and  Wick,
2002).
Although  Salmonella  infection  can  induce  apoptosis  and  necrosis  of  BMMac 
and BMDC (Yrlid et al., 2001b; Yrlid and Wick, 2000), cell death in infected cells 
does not necessarily mean avoiding the induction of specific immunity, because 
in  addition  to  direct  presentation  of  Salmonella  antigens  by  DC  and 
macrophages,  bystander  DC  also  take  up  apoptotic  materials  from 
macrophages  that  have  undergone  apoptosis,  and  present  processed 
Salmonella-derived  OVA antigens by MHC-I  and  MHC-II  pathways respectively 
(Yrlid and Wick,  2000).  It has been demonstrated that this mechanism  requires 
virulent wild-type S.  typhimurium in a logarithmic growth state to be used in the 
infection. Otherwise, apoptosis failed to be induced in macrophages.  In addition, 
viability of bystander DC  is another prerequisite  as fixed  cells failed to  present 
antigen.  Of  note,  to  ensure  the  observed  presentation  was  not  due  to  direct 
presentation  by  infected  macrophages,  different  MHC  background
macrophages were  used  and  similar  results were  generated.  As  discussed  in 
section  1.6.4, this pathway is unique to DC, since bystander macrophages were 
not able to do so.  The existence of indirect antigen  presentation  suggests that 
apoptosis induced  by microbes can  lead to an  immune response  rather than to 
a “silent” nonimmunogenic death.
731.8  Chemokines and DC trafficking
It is generally  believed  that DC  precursors  in  the  peripheral  blood  migrate  into 
peripheral  tissues  and  differentiate  to  become  immature  DC.  The  fact  that 
mature  DC  are  constantly  migrating  from  peripheral  tissues  to  draining  lymph 
nodes suggests that there must be a constitutive process of recruitment of DC 
precursors in order to maintain a consistent density of DC in peripheral tissues. 
It  has  been  suggested  that  CCR2  and  its  ligands  are  involved  in  the  initial 
movement of myeloid  DC  precursors into  peripheral tissues  (Vanbervliet et al.,
2002).  Plasmacytoid  precursor  DC  cells  have  also  been  shown  to  express 
CXCR4 and migrate in response to CXCL12, indicating a role of this chemokine 
receptor in  DC  precursor entry into tissues  (Zou  et al.,  2001).  Different tissues 
produce a different profile of basal chemokine expression, which in combination 
with the differential chemokine receptor expression on DC precursors is likely to 
affect  the  rate  of  DC  entry  and  the  type  of  DC  precursors  entering  specific 
tissues.  This area  requires more  research for a better understanding  regarding 
which molecules are involved in precursor DC recruitment.
After entering  the  tissues,  precursor  DC  differentiate  into  immature  DC,  which 
make  up  the  majority  of  DC  in  peripheral  tissues.  Immature  DC  express  an 
array  of  chemokine  receptors  (Table  1.2).  The  receptors  that  bind  to 
inflammatory  chemokines  include  CCR1,  CCR2,  CCR3,  CCR5,  CXCR1, 
CXCR2  and  CXCR3.  The  receptors  that  bind  to  homeostatic  chemokines  are 
CXCR4  and  CXCR5  with  the  receptors  CCR4,  CCR6  and  CCR8  that  bind  to 
dual function chemokines CCL17, CCL20 and CCL1  respectively.
74Table  1.2  Chemokine  receptor expression  on  immature and  mature  MDC  and  PDC  and
their ligand specificity
Receptor MDC
Immature Mature
PDC
Immature Mature
Ligand/s
CCR1 + - - ND CCL3/5/7
CCR2 + - + - CCL2/7/13
CCR3 + - - ND CCL11
CCR4 + - + ND CCL17/22
CCR5 + - + - CCL3/4/5
CCR6 + - - ND CCL20
CCR7 - + + + CCL19/21
CCR8 + - - ND CCL1
CXCR1 + - + ND CXCL6/8
CXCR2 + - + ND CXCL1-3, 5-8
CXCR3 - - + - CXCL9/10
CXCR4 + + + - CXCL12
CXCR5 - + - ND CXCL13
This  table  is  adapted  from  Cavanagh  et al  (Cavanagh  and  Von  Andrian,  2002)  and  modified 
according to the references (Sozzani,  2005)  (Penna et al.,  2002)  (Saeki et al.,  2000).  ND,  not 
determined; MDC, monocyte-derived dendritic cell; PDC, plasmacytoid dendritic cell.
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infection.  Immature  DC  then  populate  the  tissue  and  migrate  towards  these 
chemokines, thus accumulating  at the site of infection.  This  is a very important 
mechanism  for  enhancing  antigen  uptake  by  immature  DC  during  the 
inflammatory  reaction  (McColl,  2002).  Furthermore,  it  has  been  shown  that 
different immature DC subsets display unique sensitivity to certain chemokines, 
which allows them to be recruited to various peripheral tissues where they play 
a  sentinel  role.  For  instance,  a  previous  study  has  reported  that  F4/80-B220- 
CD11c+  DC  expressing  CCR1  and  CCR5  are  mobilized  rapidly  into  the 
circulation  in  mice injected with  Propionibacterium acnes to induce granulomas 
in the  liver,  and  are  recruited  into  inflammatory tissue  by CCL3/MIP-1a,  which 
binds to  CCR1  and  CCR5  (Yoneyama  et al.,  2001).  CCL20/MIP-3a,  produced 
by keratinocytes, is important in recruiting Langerhans cells (skin dendritic cells) 
to the epidermis through CCR6 (Charbonnier et al.,  1999).  Recent data indicate 
that the ligand for CCR6,  CCL20 also is expressed in intestinal Peyer’s patches 
(McColl,  2002),  and  can  be  induced  in  human  intestinal  epithelium  by 
Salmonella infection  (Izadpanah et al., 2001).  Furthermore,  Salmonella flagellin 
has been  identified to be  responsible for this CCL20-mediated  migration  of DC 
(Sierro  et  al.,  2001).  These  observations  confirm  that  the  CCR6/CCL20  axis 
also  plays  an  important  role  in  migration  of  DC  within  the  peripheral  tissues, 
especially in the skin and mucosa.
Under  inflammatory  conditions,  an  array  of  chemokines  are  expressed  by 
resident cells and presented by activated endothelial cells. These include CCL2, 
CCL5,  CCL7,  CCL13,  CCL20  and  CCL22  (Rot  and  von  Andrian,  2004).  In
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tissue  macrophages  will  further  contribute  to  the  expression  of  inducible 
chemokines  by  virtually  all  cells  resident  in  the  area  (Sozzani,  2005).  As 
mentioned  above,  immature  DC  express  a  panel  of chemokine  receptors  that 
can  interact with these inflammatory chemokines.  Following antigen acquisition 
and  processing,  DC  undergo  the  process  of  maturation,  which  is  associated 
with  a  “switch”  in  chemokine  receptor expression  (Fleming  et al.,  2003;  Ohl et 
al., 2004; Yanagawa and Onoe, 2003). This involves loss of surface expression 
of inflammatory chemokine  receptors such  as CCR6,  CCR1,  CCR2 and  CCR5 
and  the  ability to  respond  to their  ligands  (Sozzani  et al.,  1999;  Vecchi  et  al., 
1999).  At the  same  time,  they  primarily gain  surface  expression  of CCR7  and 
the ability to respond to its ligands CCL19 and  CCL21  (Sallusto et al.,  1998).  It 
appears that both the downregulation of inflammatory chemokine receptors and 
up-regulation  of  CCR7  are  required  for  migration  of  mature  DC  to  draining 
lymph  nodes,  because the persistent production  of inflammatory chemokine by 
local  inflammatory  milieu  would  retain  mature  DC  in  the  periphery.  Mature  DC 
may also express other chemokine receptors apart from CCR7, such as CXCR4 
and  CXCR5.  The  former  is  known  to  regulate  homeostatic  trafficking  of 
leukocytes  (Sallusto  et  al.,  1998)  and  the  latter  is  found  to  regulate  the  DC 
migration to  B cell zone  in  lymph  nodes (Kim,  2005;  Saeki et al.,  2000). These 
chemokine  receptors  expressed  on  DC  may  be  involved  in  the  persistent 
interactions  between  DC  and T and  B cells after initiation  of immune  response 
(Cyster, 2005).
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and CCR7/CCL21  in guiding mature DC migration to SLO (Forster et al.,  1999; 
Martln-Fontecha et al., 2003; Ohl et al., 2004).  Firstly, constitutive expression of 
CCL19 and CCL21  in the T cell zone in the draining lymph nodes (Luther et al., 
2000; Willimann et al.,  1998) and by high endothelial venules lining the draining 
lymphatics  (Saeki  et  al.,  1999)  have  been  demonstrated.  Study  of  naturally 
occurring  CCL19 and  CCL21  mutant mice  (pit/pit) show that DC  in  these  mice 
fail  to  migrate  from  peripheral  tissues  to  draining  lymph  nodes  under  either 
normal  conditions  or during  an  immune  response  (Gunn  et al.,  1999;  Nakano 
and  Gunn,  2001;  Stein  et  al.,  2000).  In  addition,  treatment  of  mice  with 
neutralising anti-CCL21  antibodies prevents migration of antigen-loaded mature 
DC  from  ventral  skin  to  inguinal  lymph  nodes  (Saeki  et  al.,  1999).  Similarly, 
CCR7  deficient  mice  also  show  impaired  migration  of  mature  DC  to  draining 
lymph  nodes  under  either  steady-state  or  inflammatory  conditions  (Ohl  et  al.,
2004).  CCR7  mediated  steady-state  DC  migration  has  been  thought  to  be 
critical for DC to maintain  peripheral tolerance,  whereas migration to the T cell 
area  of  secondary  lymph  organs  under  inflammatory  condition  is  the 
prerequisite for mature DC to stimulate clonal expansion of naive T cells.
Besides  responding  to  chemokines  through  regulation  of  chemokine  receptor 
expression,  numerous studies  have shown that DC also produce a wide  range 
of chemokines  themselves.  Upon  stimulation  in  tissue,  immature  DC  produce 
inflammatory chemokines  including  CXCL8,  CXCL10,  CCL3,  CCL4  and  CCL5, 
which presumably further enhance recruitment of neutrophils and monocytes to 
the site of infection (Foti et al.,  1999;  Padovan et al., 2002; Sallusto et al.,  1999;
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regulate the cognate receptors of an array of inflammatory chemokines, such as 
CCR2,  CCR3,  CCR5  and  CCR6  (Table  1.2).  It  has  been  suggested  that  by 
producing  inflammatory  chemokines,  the  corresponding  receptors  are 
desensitised.  This  mechanism  may  potentially  further  reduce  the 
responsiveness  of  DC  to  these  chemokines,  therefore  enhancing  migration  of 
mature DC from peripheral tissues toward secondary lymphoid tissue.
As  DC  mature and  migrate to the  SLO,  there  is another “switch”  in  chemokine 
production. DC lose the capacity to produce those chemokines such as CXCL8, 
CXCL10,  CCL3,  CCL4  and  CCL5,  and  begin  to  produce  another  set  of 
chemokines,  which  include  CCL17,  CCL18,  CCL19  and  CCL22  (Imai  et  al., 
1999; Sallusto et al.,  1999; Vulcano et al., 2001). These chemokines function to 
attract  T  and  B  lymphocytes.  The  ability  of  DC  to  produce  chemokines  and 
switch  their  production  facilitates  the  generation  of  appropriate  immune 
response required for eliminating pathogens.
1.9  The interaction between chemokines and macrophages
Compared  to  DC,  there  are  limited  studies with  respect to  interaction  between 
chemokines  and  macrophages.  As  an  important component  of innate  immune 
system,  macrophages play a critical  role  in first line defence  against microbes, 
especially  in  the  initiation  of  inflammatory  responses.  During  the  course  of 
inflammation,  macrophages  are  known  to  be  a  major  source  of  inflammatory 
chemokines.  Since  rheumatoid  arthritis  is  a  chronic  inflammatory  disease 
associated  with  a  massive  infiltration  of  inflammatory  cells,  especially
79macrophages,  in  the  synovium  of  multiple  joints  (Nanki  et  al.,  2004),  the 
interaction  between  chemokines  and  macrophages  has  been  extensively 
studied  in  this  setting.  Macrophages  in  synovial  tissues  of rheumatoid  arthritis 
have  been  shown  to  constitutively  produce  a  group  of  chemokines  including 
CXCL8  (Koch  et  al.,  1991),  CXCL9  (Konig  et  al.,  2000;  Patel  et  al.,  2001), 
CCL20  (Page et al.,  2002),  CCL5  (Volin  et al.,  1998) and  CX3CL1  (Ruth et al.,
2001). LPS has been suggested to be the major inducer of these chemokines in 
the synovial tissues in ReA (Gaston et al.,  1999). Most of these chemokines are 
potent  chemotactic  factors  for  a  variety  of  cell  types  including  neutrophils, 
monocytes and T lymphocytes,  in addition, the expression of these chemokines 
can be elevated by the production of inflammatory cytokines such as IL-1, TNF- 
a,  IL-17 and IL-18 (Chabaud et al., 2001; Matsui et al., 2001).
Furthermore, as the precursor for tissue macrophages, monocytes also express 
a  wide  range  of chemokine  receptors,  including  CCR1,  CCR2,  CCR3,  CCR4, 
CCR5  and  CXCR4  (Fantuzzi  et  al.,  1999;  Katschke  et  al.,  2001;  Sica  et  al., 
1997),  through  which  monocytes  are  continuously  recruited  to  the  inflamed 
peripheral  tissues  and  differentiate  into  tissue  resident  macrophages.  CCR2 
and  CCR3  are  downregulated  during  differentiation  to  macrophages,  whereas 
the  expression  of  CCR1,  CCR4,  CCR5  and  CXCR4  remains  high  in 
macrophages (Fantuzzi et al.,  1999). These chemokine receptors are thought to 
play  an  important  role  in  maintaining  activated  macrophages  at  the  sites  of 
inflammation.
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inflamed  peripheral tissues,  and  macrophages and  their precursors  respond to 
these  inflammatory  chemokines  and  so  are  recruited  into  the  inflamed  areas 
from the blood stream.
1.10  Aim of the project
ReA  is  an  immune-mediated  synovitis  resulting  from  persistence  of  non- 
culturable bacteria  or immunogenetic bacterial antigens  in the joints,  and  HLA- 
B27  is  a  strong  genetic  predisposing  factor  in  the  development  of  ReA 
(Colmegna et al.,  2004).  Many studies have focused  on the  pathogenetic roles 
of aberrant forms of HLA-B27 molecules, which favour the notion that ReA is an 
autoimmune disease. However, studies on the persistence of bacterial antigens, 
T-cell  responses and cytokines also  indicate the essential contribution  of these 
factors  in  the  pathogenesis  of  ReA.  Bacterial  antigens  have  been  identified  in 
the joints of patients with ReA. As the infection initiates at mucousal surfaces,  it 
has been suspected that bacterial antigens are transported to the joints from the 
original infection site, possibly by monocytes and/or macrophages.  However, no 
study to date has provided direct evidence for this hypothesis.
Salmonella  is  one  of  the  most  common  triggering  bacteria  of  ReA.  The 
interactions  between  S.  typhimurium  and  DC  or  S.  typhimurium  and 
macrophages  have  been  extensively  studied  with  respect  to  DC  and 
macrophage  activation  and  subsequent antigen  presentation  to  different T cell 
subsets.  However,  the  in  vivo  behaviour  of  these  cells  upon  Salmonella
81infection,  and  potential  dissemination  of  bacteria  by  the  cells  remains  largely 
unknown.
The aim  of this  project was to  investigate the in  vivo behaviour of Salmonella- 
infected  macrophages and  DC,  utilising  an  HLA-B27 transgenic mouse  model. 
The  migration  pattern  of  infected  cells  was  analysed,  and  the  role  of specific 
chemokine receptors investigated.  In addition, TCR transgenic mice,  in which T 
cells are specific for a Salmonella-expressed,  HLA-B27-restricted antigen, were 
employed  to  examine  the  capacity  for  infected  APCs  to  present  antigens  to 
CD4+ and CD8+ T cells.
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2.1  Materials
2.1.1  Biochemical reagents
Reagent Catalogue Number Supplier
Iscove's Modified Dulbecco's Medium (IMDM) 31980-022 Gibco
Dulbecco's Modified Eagle Medium (DMEM) 31885-023 Gibco
RPM11640 Medium with glutamine 21875-034 Gibco
L-glutamine for DMEM medium 25033-010 Gibco
Foetal Bovine Serum for Mac 318A Autogenbioclear
Foetal Calf Serum for DC (Batch No. 3011101) S-0001E Harlan
EDTA E-7889 Sigma
DMSO D8779 Sigma
Sodium Azide (NaN3) S8032 Sigma
Recombinant murine GM-CSF 415-ML R&D Systems
Recombinant murine GM-CSF ABC033 Autogenbioclear
LPS from S. typhimurium SL1181 L9516 Sigma
IL-2 402-ML-100 R&D Systems
NP383 peptide n/a IAH
NP366 peptide n/a IAH
BG876 peptide n/a IAH
Recombinant mouse MIP3a (CCL20) 760-M3 R&D Systems
Recombinant mouse MIP3(3 (CCL19) 440-M3/CF R&D Systems
2-Mercaptoethanol M7522 Sigma
Sodium Pyruvate 11360-039 Gibco
Ampicillin A9393 Sigma
Penicillin/Streptomycin 115140-122 Gibco
Gentamicin  Solution G1397 Sigma
Accutase A6964 Sigma
Phosphate Buffered Saline (PBS) 14190-144 Gibco
Bovine Serum Albumin (BSA) A4503 Sigma
Trypan Blue T1854 Sigma
NycoPrepTM A 1002380 AXIS-SHIELD
Sodium Azide S8032 Sigma
Paraformaldehyde P6148 Sigma
Brefeldin-A B-7651 Sigma
Saponin S-4521 Sigma
Collagenase III 4183 Worthington
Dnase I DN-25 Sigma
VybrantTM CFDA SE Cell Tracer Kit V-12883 Molecular Probes
CellTracker Orange CMTMR C-2927 Molecular Probes
Betaplate Scint SC/9200/21 PerkinElmer
832.1.2 Fluorescence activated cell sorting (FACS) antibodies
Antigen
Source
species
Con­
jugate Isotype Clone
Final con­
centration
Catalogue
number Supplier
Mouse F4/80 Rat FITC lgG2b CI:A3-1 1:10 D** MCA497F Serotec
Mouse CD54 ArmH* FITC lgG1 3 E 2 5 pg/ml 553252 Pharmingen
Human HLA-B27 Mouse FITC lgG2a HLA-ABC-m3 1:10 D MCA116F Serotec
l-Ad/Ed Rat FITC lgG2a 2G9 2.5 pg/ml 06344D Pharmingen
Mouse H-2Dd Mouse FITC lgG2a 34-2-12 5 ng/ml 06134D Pharmingen
Mouse CD11b Rat FITC lgG2b M1/70 5 pg/ml 01714D Pharmingen
Mouse CD11c ArmH FITC lgG1 HL3 5 pg/ml 553801 Pharmingen
Mouse Gr-1 Rat FITC lgG2b RB6-8C5 5 pg/ml 01214D Pharmingen
Mouse CD40 Rat FITC lgG2a 3/2 3 5 pg/ml 09404D Pharmingen
Human TCR V(37 Mouse FITC lgG2a Zoe 1:10 D MCA1594F Serotec
Mouse F4/80 Rat PE lgG2b CI:A3-1 1:10 D MCA497PE Serotec
Mouse CD11c ArmH PE lgG1 HL3 2 pg/ml 557401 Pharmingen
Mouse IL-6 Rat PE igGl MP5-20F3 2 pg/ml 01345A Pharmingen
Mouse IL-12(P40) Rat PE igGl C15.6 2 pg/ml 18495A Pharmingen
Mouse H-2Kd Mouse PE lgG2a SF1-1.1 2 pg/ml 553566 Pharmingen
I-A/E Rat PE lgG2b M5/114.15.2 0.5 pg/ml 557000 Pharmingen
Mouse B220 Rat PE lgG2a RA3-6B2 2 pg/ml 01125B Pharmingen
Mouse CD86 Rat PE lgG2a GL1 2 pg/ml 09275B Pharmingen
HumanTCRVp7 Mouse RPE lgG2a Zoe 1:10 D MCA1594PE Serotec
Mouse F4/80 Rat Biotin lgG2b CI:A3-1 10 pg/ml MCA497B Serotec
Mouse CD80 ArmH Biotin IgG 16-10A1 5 pg/ml 09602D Pharmingen
Mouse CD86 Rat Biotin lgG2a GL1 5 pg/ml 09272D Pharmingen
Mouse CD40 Rat Biotin lgG2a 3/2 3 2 pg/ml 553789 Pharmingen
Mouse H-2Dd Mouse Biotin lgG2a 34-2-12 5 pg/ml 553578 Pharmingen
Mouse l-Ad/l-Ed Rat Biotin lgG2a 2G9 10 pg/ml 06342D Pharmingen
Mouse CD11c ArmH Biotin lgG1 HL3 5 pg/ml 09702D Pharmingen
Mouse CD11b Rat Biotin lgG2b M1/70 5 pg/ml 01712D Pharmingen
Mouse CD3 ArmH Biotin IgG 145-2C11 5 pg/ml 553059 Pharmingen
Mouse CD11c ArmH APC lgG1 HL3 2 pg/ml 550261 Pharmingen
Mouse TNF-a Rat APC lgG1 MP6-XT22 4 pg/ml 554420 Pharmingen
Mouse IFN-y Rat APC IgGl XMG1.2 4 pg/ml 554413 Pharmingen
Mouse CD8a Rat APC lgG2a 53-6.7 1  pg/ml 553035 Pharmingen
Human HLA-ABC Mouse APC lgG1 G46-2.6 1:2.5 D 555555 Pharmingen
Mouse CD4 Rat Cychrome lgG2a RM4-5 1  pg/ml 553050 Pharmingen
Annexin V n/a Cy5 n/a n/a 1:20 D 559934 Pharmingen
MouseCD 16/CD32 Rat Purified lgG2b 2.4G2 1  pg/ml 01241D Pharmingen
Streptavidin n/a PE-Cy5 n/a streptavidin 0.4 pg/ml 554062 Pharmingen
* AemH=American Hamster;  **D=dilution
842.1.3 FACS Isotvpe controls
Isotype
Source
species Conjugate Clone
Final
concentration Catalogue number Supplier
IgGl ArmH FITC G235-1 5 ng/ml 11134C Pharmingen
lgG2a Rat FITC R35-95 5 pg/ml 553929 Pharmingen
lgG2b Rat FITC A95-1 5 pg/ml 553988 Pharmingen
lgG2a Mouse FITC G155-178 5 pg/ml 553456 Pharmingen
lgG2a Mouse PE n/a 1:10 D MCA929PE Serotec
lgG1 Rat PE R3-34 5 pg/ml 20615A Pharmingen
lgG2a Rat PE R35-95 5 pg/ml 553930 Pharmingen
lgG2b Rat PE A95-1 5 pg/ml 20185A Pharmingen
lgG2b Rat Biotin A95-2 5 pg/ml 553987 Pharmingen
lgG2a Rat APC R35-95 5 pg/ml 553932 Pharmingen
lgG2b Rat APC A95-1 5 pg/ml 556924 Pharmingen
lgG1 Mouse APC MOPC-21 1:2.5 D 555751 Pharmingen
lgG2a Rat Cychrome R35-95 5 pg/ml 553931 Pharmingen
2.1.4  Molecular biological reagents
Reagent Catalogue Number Supplier
RNeasy Mini Kit 74103 Qiagen
Rnase-free Dnase 18068-015 Gibco Invitrogen
Oligo(dT)i2-u Primer 18418-012 Gibco Invitrogen
Reverse Transcriptase 12328-019 Gibco Invitrogen
Rnasin Ribonuclease Inhibitor N2111 Promega
Dithiothreitol (DTT) Y00147 Gibco Invitrogen
Deoxynucleoside triphosphates (dNTPs) U1240 Promega
BIOTAQ™DNA polymerase BIO-21040 Bioline
Reverse Transcriptase qPCR,M  Master Mix RT-QPRT-032X Eurogentec
Agarose electrophoresis grade 15510-027 Invitrogen
Gel loading buffer G-7654 Sigma
Ethdium bromide E-1510 Sigma
1Kb DNA ladder 15615-016 GibcoBRL
phiX174 DNA/Hae III Markers G1761 Promega
DEPC water 9906 Ambion
1Kb plus DNA ladder (1ug/ul) 10787-018 Invitrogen
852.1.5 Immunohistochemistrv reagents
Antigen
Source
species Conjugate Isotype Clone
Final con­
centration
Catalogue
number Supplier
Mouse F4/80 Rat Purified IgG CI:A3-1 10 pg/ml MCAP497 Serotec
Mouse F4/80 Rat Biotin lgG2b CI:A3-1 10 pg/ml MCA497B Serotec
Mouse CD11c ArmH Biotin IgGl HL3 5 pg/ml 09702D Pharmingen
Anti-FITC Rabbit Purified n/a Polyclonal 1:1000 D V0403 Dako
Salmonella 0 antiserum Rabbit Purified n/a Polyclonal 1:100 D 240984 BD
Anti-rat IgG Rabbit Biotin IgG Polyclonal 15 pg/ml BA-4001 Vector
Anti-rabbit IgG goat Biotin IgG Polyclonal 5 pg/ml BA-1000 Vector
2.2.6  Immunohistochemistrv auxiliary reagents
Reagent Catalogue number Supplier
Normal horse serum S-2000 Vector
Normal goat serum S-1000 Vector
Rabbit IgG 1-1000 Vector
Avidin/Biotin blocking kit SP-2001 Vector
Antigen unmasking solution H-3300 Vector
ABC reagent kit PK-6100 Vector
NovaRED substrate kit for peroxidase SK-4800 Vector
Diff-Quik staining set 130832 Dade Behring
Absolute Ethanol 10107 BDH, UK
Acetone 100034Q BDH, UK
30% H2O2 H1009 Sigma
Haematoxyline H-3401 Vector
Histoclear H/0468/017 Fisher Chemicals
VectorMount Mounting medium H-5000 Vector
DPX 08600E Surgipath Europe Ltd
2-Methylbutane 59080 Fluka
Tissue-YEK O.C.T. Compound 4583 Bayer
862.1.7 ELISA & ELI  Spot antibodies
Reagent Clone
Final con­
centration Catalogue Number Supplier
Purified anti-M-CSF(CSF-l) 5A1 1  pg/ml 552513 Pharmingen
Biotinylated anti-M-CSF D24 5 pg/ml 552514 Pharmingen
Purified anti-IFN-y R4-6A2 10 pg/ml 551216 Pharmingen
Biotinylated anti-IFN-y XMG1.2 2 pg/ml 554410 Pharmingen
2.1.8  ELISA & ELIS  pot reagents
Reagent Catalogue Number Supplier
Recombinant mouse M-CSF ABC 225 Autogenbioclear
Streptavidin HRP conjugate 554066 Pharmingen
Marvel dried skimmed milk n/a n/a
Tween 20 P-1379 Sigma
TMB substrate 52-00-00 Sure Blue
Methanol 101586B Sigma
Dimethylformamide D8654 Sigma
AEC substrate A6926 Sigma
Acetic acid 420-10 Sigma
Sodium acetate 102364Q BDH
NaHCOj S-6014 Sigma
Na2C03 S-6139 Sigma
2.1.9  Griess Assay reagents
Reagent Catalogue Number Supplier
Sodium Nitrite S2252 Sigma
Sulphanilamide S9251 Sigma
Napthylethylenediamine (NAP) N9125 Sigma
Phosphoric acid P6560 Sigma
872.2.10 Limulus Amebocvte Lysate (LAL)Assay reagents
Reagent Catalogue Number Supplier
LPS E110 Charles River Laboratories
LAL reagent R19000P Charles River Laboratories
2.1.11  Bacterial Strains
Strain Characteristics Reference
SL3261 aroA-auxotropic non-virulent mutant of S. typhimurium (Hoiseth and Stocker, 1981)
waaN S. typhimurium mutant with depletion-insertion in waaN gene (Khan et al., 1998)
C5 (TS)
Temperature sensitive (TS) mutant from S. typhimurium C5, optimal growth 
temperature is 30°C (Hormaeche et al., 1981)
Lb5010 Semi-rough and poorly invasive strain of S. typhimurium (Bullas and Ryu, 1983)
2.1.12  Transgenic Mice
Mouse Background Reference
HLA-B2705/human P2M Homozygote BALB/C (Weiss et al., 1990)
GRb TCR transgenic mice HLA-B27/b2M (Roddis et al., 2004)
2.1.13  Primers for PCR
Name Sequence Product
size(bp)
Producer Reference
P-actin Forward 5-TGG AAT CCT GTG GCA TCC ATG AAA C-3’ 400 Sigma-
Genosys
(Cheminay et al., 
2002) Reverse 5-TAA AAC GCA GCT CAG TAA CAG TCC G-3’
CCR7 Forward 5-CAT CAG CAT TGA CCG CTA CGT-3' 297 Sigma-
Genosys
(Cheminay et al., 
2002) Reverse 5-TAC GGA TGA TAA TGA GGT AGC A-3’
CCR6 Forward 5’-ACT CTT TGT CCT CAC CCT ACC G-3’ 300 Sigma-
Genosys
Designed by 
myself Reverse 5-ATC CTG CAG CTC GTA TTT CTT G-3’
882.1.14 Primers and probes used in real-time PCR
Name Sequence Producer
28SRNA Forward 5-CGCCGCTAGAGGT  GAAATT  CT-3’ Sigma-Genosys
Reverse 5’-CATT  CTT  GGCAAAT  GCTTT  CG-3’ Sigma-Genosys
Probe FAM-ACCGGCGCAAGACGCACCAG-TAMRA Eurogentec
CCR7 Forward 5'-CCCAAAACGACAGCCAAAA-3’ Sigma-Genosys
Reverse 5’-GGCCCCACAT  CCCT  CACT-3’ Sigma-Genosys
Probe FAM-AAAGT  GAGAGGCT  GCCACACTTT  CCG-TAM RA Eurogentec
CCR6 Forward 5-TTGGTGCAGGCCCAGAA-3’ Sigma-Genosys
Reverse 5’-CACGAGAACCACAGCGATCA-3’ Sigma-Genosys
Probe FAM-CCAAGAGGCACAGAGCAATCCGAGTC-TAMRA Eurogentec
2.1.15 Equipment
Item Model Supplier
Dual Laser FACScaliber Flow Cytometer n/a Becton Dickinson, UK
GeneAmp 9700 PCR Thermal System 4314879 Perkin-Elmer
TCS-NT Confocal Microscope n/a Leica, UK
Water Jacketed, Heated, C02  Incubator 3111 Forma Scientific, UK
1450 Microbeta Trilux Scintillation Counter 1450-028 Wallac, UK
ABI prism 7700 Sequence Detector 7700 PE Applied Biosystems
Microtiter Plate Reader SpectraMax 340 Molecular Devices
Cytospin Cytospins 3 Shandon
Cryostat CM 1900 Leica
Alpha Imager Digital Imaging System 2200 n/a Alpha Innotech, UK
96-well Automatic Plate Washer Skanwasher 300 Skantron, US
Gamma Cell Irradiator (Caesium1 *') Gamma cell Elite Nordion
GeneQuant pro RNA/DNA Calculator N/a Amersham pharmacia biotech
Walker Safty Cabinet Model 1.2 Holten LaminAir
GS-15R Centrifuge GS-15R Beckman
GS-6KR Centrifuge GS-6KR Beckman
GS-6R Centrifuge GS-6R Beckman
MicrofugeOR Centrifuge F241.5 Beckman
Clifton Unstirred Bath n/a Clifton
Heidolph Incubator 1000 1000 Heidolph
Heidolph Unimax 1010 1010 Heidolph
Slide Hybridisation/Incubation Chamber INH-110-01 OH Fish Scientific UK
uMACS Separator Unit 130-042-602 Miltenyi Biotec
892.1.16 Plasticware and sundries
Item Catalogue Number Supplier
Haemocytometer Hae2000 Scientific Laboratory Supplies
50 ml Centrifuge Tubes 3041016 BD Falcon
15 ml Centrifuge Tubes 4-2096-2 BD Falcon
90 mm Petridish 1029 BD Falcon
Terumo Needles 27 gx3/4" NN-2719R Terumo
Terumo Needles 25 gx5/8" NN-2516R Terumo
T125 Tissue Culture Flask 90151 TPP
T75 Tissue Culture Flask 90076 TPP
T25 Tissue Culture Flask 9025 TPP
1  ml Micro Tubes (FACS) B613 Scientific Laboratory Supplies
5 ml Polypropylene Tubes (FACS) 2054 BD Falcon
6-well Plate 140685 NUNC
24-well Plate 146485 NUNC
96-well Plate 163320 NUNC
Syringe Driven Fliter Unit (0.22um) SLGP033RS Millipore
500 ml 0.22 pm Filter Bottle TKV-246-021U Nalgene
Multiscreen IP Plates for ELISpots ELIIP10SSP Millipore
ELI-Puncher Kit Melipunch Millipore
96-well Maxi-Sorp Immuno Plate 442404 NUNC
Thermo-Fast®96, Non-Skirted PCR Tube AB-0600/G Abgene, UK
ThermoFast®96, Semi-skirted PCR Tube AB-0900 Abgene, UK
Domed Cap Strip AB-0265 Abgene, UK
24-well Transwell Plate (5 pm pore size) 3421 Corning Incorporated
Plate Sealer FIL1080 Sicentific Laboratory Supplies
Superfrost "plus" White Slides (for IHC staining) 08143G Surgipath Europe Ltd
Frosted Microscope Slides (for mashing tissue) 2951 Esco
CryoTube Vials 368632 Sicentific laboratory supplies
MACS Separation Column (LS) 130-042-401 Miltenyi Biotec
MACS Separation Column (MS) 130-042-201 Miltenyi Biotec
Glass Fibre Filter 1450-421 Wallac
Sample Bag 1450-432 PerkinElmer
902.2 Methods
2.2.1 Animats
All  mice  were  maintained  in  the  specific  pathogen-free  facility  at the  Institute for 
Animal Health (Compton, U.K.).
HLA-B27/p2m (BALB/c background) mice, expressing HLA-B2705 and  human P2 1 7 1  
were originally obtained from  E. Weiss  (Weiss et al.,  1990) and were  inbred as a 
homozygous  inbred  line. The  GRb transgenic  line,  expressing  both the a- and  p- 
chains  of the  GRb TCR,  was  maintained  as  a  heterozygous  line  backcrossed  to 
B27/p2m mice (GRb x B27/b2m) (Roddis et al., 2004).
All  animal  experiments  were  carried  out  under  a  Home  Office  project  license  in 
compliance  with  relevant  laws  and  local  guidelines  and  were  approved  by  the 
Institute for Animal Health ethical committee.
2.2.2 Cell culture
2.2.2.1  Maintenance of Ladmac cell line
To supply  macrophage-colony stimulating  factor (M-CSF,  also  named  CSF-1)  for 
growing  BMMac,  the  Ladmac  cell  line,  a  cell  line  secreting  the  growth  factor  M- 
CSF, was obtained  as a gift from  Dr.  Sam  Hou  in the  Edward Jenner Institute for 
Vaccine  Research. This cell  line was originally made  by transfecting  mouse bone
91marrow  cells,  highly  enriched  for  macrophage  progenitors,  with  a  human  R-myc 
oncogene (Sklar et al., 1985).
An  aliquot of Ladmac cells was  removed  from  liquid  nitrogen  and  defrosted  in  a 
37°C  water  bath  until  a  small  ice  pellet  remained.  Dulbecco’s  Modified  Eagle 
Medium (DMEM)/10 (DMEM,  10% FCS, 50 pM p-Mercaptoethanol (ME),  100 U/ml 
penicillin,  100 pg/ml streptomycin  and 2  mM  L-glutamine) was  prepared,  and  500 
pi of DMEM/10 was slowly added to the sample. The sample was transferred to a 
15  ml  centrifuge  tube  and  a  further  5  ml  media  was  added  dropwise.  After 
centrifugation  at 375  x  g for 5  minutes,  the cell  pellet was  resuspended  in  10  ml 
DMEM/10.  Cell  counting  was  performed  as follows:  10  pi  of cell  suspension  was 
diluted  1:2  or 1:10  in typan  blue depending on the estimated  density of the cells. 
Typan blue diluted cells,  in  10 pi, were then dropped onto a haemocytometer and 
the  cells  located  in  the  central  compartment  (25  squares)  were  counted  using  a 
light  microscope.  The  concentration  of  cell  suspension  was  worked  out  as  the 
number  counted  x  104/ml.  The  viability  of  cells  was  determined  by  dividing  the 
number of cells excluding the typan blue dye (indicating live cells) by total number 
of cells x  100%.
The cell suspension was transferred to a T175 tissue culture flask containing  150 
ml  DMEM/10  and  incubated  for 2  weeks  at 37°C,  5%  CO2.  Following  incubation, 
the cell supernatant was harvested, filtered through a 0.22 pm filter and stored at - 
20°C in 50 ml aliquots. These aliquots were subsequently used  as a source of M-
92CSF  in  the  growth  of  BMMac.  The  cells  remaining  adhered  to  the  flask  were 
flushed  with  10  ml  DMEM  (50  jjM  ,  100  U/ml  penicillin,  100  pg/ml  streptomycin) 
and  the  cell  suspension  was  centrifuged  at  375  x  g  for  10  minutes.  The 
supernatant  was  discarded  leaving  1   ml  of  media  in  which  the  cells  were 
resuspended. Cell suspension in 1   ml (approximately 5 x  106)was then added to a 
new T175 flask along with  150 ml DMEM/10 and the flasks incubated for 2 weeks 
at 37°C, 5% CO2 as before.
2.2.2.2  M-CSF Enzyme-Linked Immunosorbent Assay (ELISA)
To  quantitate the  secretion  of  M-CSF  in  the  Ladmac cell  culture  supernatant,  an 
ELISA  for  M-CSF  was  used.  A  96-well  Maxi-Sorp  Immuno  plate  was  coated 
overnight  at  4°C  with  the  capture  antibody,  anti-murine  M-CSF  monoclonal 
antibody  diluted  (final  concentration  1   pg/ml)  in  carbonate  buffer  (0.045  M 
NaHC03,  0.018  M  Na2C03,  pH  9.6).  The  plate  was  blocked  for  1   hour  at  room 
temperature with 4%  marvel  in  PBS-T (0.05% Tween 20  in  PBSa). After washing 
six times with  150 pi  PBS-T,  different batches of Ladmac cell culture supernatant 
(neat or tenfold diluted) were added to the wells in triplicate.  Seven two-fold serial 
dilutions (156-10000 pg/ml) of murine recombinant M-CSF were used to make the 
standard  curve  with  the  no  addition  wells  as  negative  control.  After  a  two  hour 
incubation at room temperature, the plate was washed with  PBS-T.  Following this, 
100  pi  biotinylated  rat  anti-mouse  M-CSF  diluted  in  1%  (w/v)  marvel  PBS-T  (5 
pg/ml final concentration) was added  as the detection  antibody and the plate was 
incubated for two hours at room temperature followed by PBS-T wash. Horseradish
93peroxidase  (HRP)-conjugated  streptavidin  diluted  1:1000  in  PBS-T was  added  to 
the wells. After washing six times with  150 pi  PBS,  bound  HRP was visualised by 
addition of 100 pi TMB Microwell Peroxidase/Substrate. The plate was left for 5-10 
minutes,  the  colour  reaction  stopped  by  addition  of  25  pi  1   M  H2S04  (final 
concentration 0.2  M),  and the absorbance of reaction was measured at 450 nm  in 
a  microtiter  plate  reader.  The  amount  of  M-CSF  in  supernatant  was  calculated 
according to the standard curve of recombinant M-CSF.
2.2.2.3  Preparation and culture of BMMac
To  obtain  BMMac,  femurs  and  tibiae  were  removed  from  mice  sacrificed  by  an 
increasing  concentration  of  CO2.  Following  soaking  in  70%  (v/v)  ethanol  for  30 
seconds and air drying, excess fat and tissue were removed and bone marrow was 
exposed by cutting both ends of the bones with scissors. Bone marrow was flushed 
out with  PBS  under sterile  conditions  using  a  syringe  with  a  25  G  needle.  After 
pipetting  and  washing  in  PBS,  a  single  cell  suspension  was  pelleted  and 
resuspended in 2 ml of red cell lysis buffer (0.15 M NH4CL, 10 mM KHCO3, 0.1  mM 
Na2EDTA,  pH  7.2-7.4).  After  incubating  for  3  minutes  on  ice,  8  ml  of  PBS  was 
added and the cell suspension filtered through 40 pm strainer and centrifuged for 5 
minutes  at  375  x  g.  The  pellet  was  resuspended  in  10  ml  of  Iscove’s  Modified 
Dulbecco’s Medium (IMDM)/10 (IMDM,  10% FCS, 50 pM p-ME,  100 U/ml penicillin 
and  100ug/ml streptomycin).  Bone  marrow cells  (1-3  x  107) were  aliquoted  into a 
T75  tissue  culture  flask  containing  20  ml  of  IMDM/10  supplemented  with  20% 
Ladmac  cell  supernatant  (final  concentration  equivalent to  10  ng/ml  recombinant
94murine  M-CSF  as  determined  by  ELISA  as  detailed  in  2.2.22).  The  flask  was 
incubated  for  3  weeks  at  37°C,  5%  C02.  A  further  10  ml  IMDM/10  with  20% 
Ladmac  cell  supernatant  was  added  every  3  days.  The  adherent  cells  were 
harvested by unidirectionally scraping the surface of the flask with a cell scraper.
2.2.2.4  LAL assay
Different batches of foetal calf serum (FCS) may contain various level of endotoxin, 
which could mature dendritic cells in culture. In order to choose low-endotoxin FCS 
for BMDC culture and therefore obtain immature DC, a panel of FCS was screened 
using the  LAL assay.  Firstly,  three tenfold  serial dilutions of standard  solutions of 
endotoxin were prepared for making standard curve (0.5-50 EU/ml with absence of 
endotoxin wells  as  negative  control).  All the  FCS  samples were tenfold  diluted  in 
endotoxin-free water and  10 pi of this dilution was added to each well of a 96-well 
plate; triplicate were performed for samples and duplicates for the standard curve. 
The  plate  was  incubated  on  a  preheated  (37°C)  microtiter  plate  reader  for  10 
minutes without shaking.  LAL solution was freshly prepared  by adding  endotoxin- 
free  water to  the  LAL  reagent following  the  manufacturer’s  instruction,  100  pi  of 
which was then added to the wells. The cloudier the reaction  indicates the greater 
presence  of endotoxin  contamination  in  the  samples.  No  more  than  10  minutes 
after addition of LAL solution, the absorbance of the reaction was measured at 450 
nm  in  a  microtiter  plate  reader.  The  endotoxin  level  of  samples  was  calculated 
according to the standard curve.
952.2.2.5 Preparation and culture of BMDC
BMDC  were  generated  essentially  based  on  a  published  protocol  (Lutz  et  al., 
1999).  Bone  marrow was  prepared  as  described  2.2.2.3.  Approximately  2  x  106 
erythocyte-depleted bone marrow cells were cultured in T75 tissue culture flasks or 
100 mm petri-dishes. IMDM/10 in 10 ml along with 20 ng/ml of recombinant murine 
GM-CSF was added and the cells were incubated in a 37°C, 5% C02  incubator for 
7  days.  At day 3 and 6,  a further  10 ml of fresh  media was supplemented to the 
culture  in  the  presence  of  20  or  10  ng/ml  of  GM-CSF  respectively.  The  non­
adherent cells were harvested by collecting the culture supernatant. The adherent 
cells were  obtained  by adding  2  ml  of accutase and  incubating for 15  minutes at 
37°C.  Following  this,  5  ml  of  media  was  added  and  the  cells  were  harvested 
(gentle scraping was applied if necessary). Cells were centrifuged for 5 minutes at 
375  x  g,  and  the  pellet  was  resuspended  in  fresh  media  and  used  for  further 
experiments.
2.2.2.6 Culture of CTL cell lines
To analyse T cell responses in vitro, different CTL lines were used. These cell lines 
were made by Clare Thompson  in our laboratory.  In  brief,  a  HLA-B27  mouse was 
immunised  intraperitoneally with  107  p.f.u.  recombinant vaccinia  virus  expressing 
influenza A virus nucleoprotein  (NP) and  p-galactosidase (p-gal).  The mouse was 
culled 2 weeks after infection, and the spleen was removed and mashed to obtain 
the splenocytes,  5  x  106 of which were pulsed for 30 minutes at 37°C with  1   jiM  of 
either NP383-391 (SRYWAIRTR) peptide in order to obtain  NP383-391 CTL or p-gal876-
96884 (TPHPARIGL)  to  gain  BG876-884 CTL.  These  cells  were  mixed  with  1.5  x  107  
original  splenocytes  and  cultured  for  10  days  in  the  presence  of  mouse 
recombinant  IL-2  (final  concentration  5  U/ml).  For  subsequent  stimulations, 
irradiated  splenocytes were  used  as stimulators.  For this,  a  spleen was  removed 
from  a  HLA-B27  mouse  and  mashed  to  obtain  the splenocytes,  which were then 
irradiated  with  3000  rads  y-irradiation  generated  from  a  gamma  cell  irradiator. 
Irradiated splenocytes (approximately 1   x  108 cells per spleen) were then washed 
and resuspended in 2 ml of T-cell media (RPMI  1640, 10% FCS, 50 pM p-ME ,  100 
U/ml  penicillin,  100  pg/ml  streptomycin  and  1   mM  sodium  pyruvate),  and  peptide 
was added  at a final concentration  of 1   pM. After 30 minutes  incubation  at 37°C, 
the splenocytes were then washed and resuspended into the T-cell media at a final 
cell density of 2 x  106/ml.  NP383-39i  CTL or BGs76-884 CTL were  harvested at a cell 
density of 2  x  105/ml in T-cell media.  Equal volumes of irradiated splenocytes and 
CTL cell suspension were mixed and mouse recombinant IL-2  (final concentration 
5 U/ml) was added to the culture. The cell mixture was then incubated at 37°C, 5% 
CO2  in  a flask or a 24-well or 6-well  plate depending  on the final culture volume. 
On day 5 and 8, the culture was fed respectively by replacing half volume of culture 
supernatant with  fresh  media  containing  IL-2  (final  concentration  5  U/ml)  without 
disturbing cells in the bottom. Every 10 days, the stimulation was repeated.
2.2.3  Infection of cells with S. typhimurium
2.2.3.1  Bacterial strains
97There is a panel of attenuated strains of S.  typhimurium available in our laboratory. 
SL3261  is  an  aroA'  mutant  of  S.  typhimurium  generated  by  insertion  of  a 
transposon in the gene aroA (Hoiseth and Stocker,  1981), which renders it virtually 
non-virulent and allows it to be used as a live vaccine strain. waaN (also known as 
MsbB) is a mutant with a depletion-insertion in the waaN gene, which encodes the 
enzyme that catalyses the reaction that completes lipopolysaccharide (LPS) lipid A 
biosynthesis. This mutant possesses less toxicity of lipid A, the main component of 
endotoxin (Khan et al.,  1998). C5 (TS) is a temperature sensitive (TS) mutant from 
S.  typhimurium  C5,  which  optimally  grows  at  30°C  but  ceases  to  grow  at  37°C 
(Hormaeche  et  al.,  1981).  Lb5010  is  a  poorly  invasive  strain  derived  from  S. 
typhimurium LT2 (Bullas and Ryu, 1983).
We also  have  recombinant strains generated from  SL3261,  called  SL3261  NP383- 
391,  SL3261  NP366-374 and  SL3261  BG876-884,  which  were  made  by  Michael Wood 
and  Edouard  Galyov from  Institute for Animal  Health.  These  recombinant strains 
express  the  class  I  restricted  epitopes,  amino  acids  383-391  (restricted  by  HLA- 
B27)  and  amino  acids  366-374  (H-Db   restricted)  from  the  influenza  virus 
nucleoprotein  or amino  acids  876-884  (restricted  by  H-Kd)  from  p-galactosidase. 
They  are  expressed  as  part  of a  fusion  protein  with  the  type  III  secreted  protein 
SopE (Salmonella outer proteins E) (Wood et al.,  1996). This previously developed 
system  (Russmann et al.,  1998) allows CTL epitopes to be efficiently delivered  in 
the cytosol of infected cells via the needle complex of the TTSS of S.  typhimurium 
(Galan and Collmer, 1999).2.2.3.2 Culture conditions of S. typhimurium
In order to enhance the efficiency of infection, the logarithmic state of bacteria was 
chosen  to  use  for  infection.  To  obtain  the  optimal  time  point  in  the  course  of 
bacterial growth, the stocks of 4 strains of S.  typhimurium (SL3261, waaN (MsbB), 
C5 (TS) and  Lb5010) were thawed from a -80°C freezer,  and  5 pi  bacterial stock 
was  put  into  10  ml  (1:2000  dilution)  Luria-Bertani  (LB)  broth.  When  recombinant 
bacterium was  used,  LB  broth was supplemented with  100  pg/ml  ampicillin.  After 
16 hours incubation at 37°C for SL3261, waaN and Lb5010 and 30°C for C5 (TS), 
500 pi of each bacterial culture was transferred into a conical flask containing 50 ml 
LB  broth  (1:100  dilution).  The  diluted  bacterial  culture  was  further  incubated  at 
37°C, or for C5 (TS), at 30°C. Every 20 minutes 1   ml of bacterial culture was taken 
out,  and the optical density (OD)  at 581  nm was  recorded,  until the  OD  readings 
were steady. A bacterial growth  curve was depicted  according to the time versus 
OD values, and the time point (180 minutes) which was the mid logarithmic phase 
of bacterial growth was chosen for infection. The bacterial culture at that time point 
was centrifuged 30 minutes at 2150 * g and resuspended at 109 cells/ml in PBS. In 
some  experiments,  heat-killed  bacteria  were  prepared  by  incubating  bacterial 
suspensions at 65°C for 40 minutes. Serial bacterial dilutions in  100 pi were plated 
onto LB agar plates. After overnight incubation at 30°C for C5 (TS) or 37°C for the 
others, the number of colony forming unit (CFU) was counted and the total number 
of bacteria was calculated for checking the multiplicity of infection (M.O.I).
992.2.3.3 Infection of cultured cells with S. typhimurium
To analyse the interaction of BMMac or BMDC with  S.  typhimurium and the post­
infection effects on these two types of cells, the infection was performed as follows. 
The  supernatant of cell  culture was  discarded,  non-adherent cells were  removed 
by washing  the  flask  twice  with  PBS,  and  10  ml  of antibiotic free  IMDM/10 was 
added  to  the  flask.  The  number  of  non-adherent  cells  was  predetermined  at 
approximately  5  x  106  per flask when  the  cells  reached  confluence,  which  were 
then  infected  at various  M.O.I  (bacteria  per cell)  at 30°C for C5  (TS)  or 37°C for 
SL3261  for 2  hours.  Following  this,  the  flask was washed  three  times with  PBS, 
and  10 ml IMDM/10 supplemented with 50 pg/ml gentamicin added.  In order to kill 
extracellular bacteria, the flask was incubated at 37°C for 16 hours.  Following this, 
the  cells  were  harvested  as  described  in  section  2.2.2.3  or  2.2.2.5,  the  pellet 
resuspended in fresh media and the cells used for further experiments.
2.2.3.4 Analysis of infection rate
To investigate the infection rate of cells being infected with S.  typhimurium, 2 x  105  
infected cells in 200 pi were loaded onto the cytoslide device and centrifuged for 5 
minutes at 11  * g  in a Cytospin. The cell layer on the slide was left to air dry, then 
fixed  and  stained  with  the  Diff-Quik  staining  set.  This  comprises  3  solutions; 
Solution  1   is fixative solution containing 0.002 g/L fast green in methanol; Solution 
2  is  made  of  1.1  g/L eosin  G  in  PBS  (pH  6.6)  and  Solution  3  contains  1.22  g/L 
thiazine dye in PBS (pH 6.6). The slide was submerged 5 times in each stain for 1  
second before being rinsed with running water and left to air dry. A small amount of
100mounting media was dropped  onto the slide and  a coverslip was carefully placed 
on it. The slide was then examined under oil immersion using light microscopy at a 
magnification  of  100  x.  The  number  of  cells  that  engulfed  bacteria  within  100 
counted  cells  was  recorded,  triplicate  counts  were  applied  in  three  randomly 
chosen fields, and the mean percentage was calculated as the final infection rate. 
Photographic  images  were  taken  using  a  microscope  equipped  with  a  polaroid 
camera and the images were analysed using Adobe Photoshop software.
2.2.4  Flow cytometry
2.2.4.1  Extracellular staining
Characterisation of cell surface marker expression on the BMMac and  BMDC was 
carried out using flow cytometry. Cells for analysis were aliquoted into FACS tubes 
or 96-well  U-bottomed  plates at a  concentration  of 2  x  105 cells  per tube or well, 
and  washed  twice  with  FACS  wash  buffer  (0.1%  FCS,  0.01%  sodium  azide  in 
PBS).  In order to block non-specific binding, the cell pellet was resuspended in Fc 
block  (anti-CD16/CD32,  1   pg/ml  final  concentration)  and  incubated  on  ice  for  10 
minutes.  Appropriate  first  layer  antibodies  were  then  added  (final  concentration 
shown in Materials 2.1.2) to the tube and cells were incubated on ice in the dark for 
30 minutes.  Following incubation,  cells were washed twice with  FACS wash buffer 
by  centrifugation  at  375  x  g  for  3  minutes  and  the  supernatant  discarded.  Cells 
stained  with  directly  conjugated  antibodies were  then  fixed  by  resuspending  the 
pellet  in  PBS/1 %  paraformaldehyde  (PFA)  and  kept  at  4°C  in  the  dark.  Cells
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containing  a  streptavidin-conjugated  fluorochrome  (final  concentration  0.4  pg/ml) 
and  incubated  on  ice  in  the  dark for another 30  minutes.  These  cells were then 
washed twice and fixed  in  PBS/1 %  PFA.  Fluorescent cells were acquired  using a 
FACSCaliber flow cytometer and analysed using WinMDI FACS analysis software.
2.2.4.2  Intracellular cytokine staining
Cytokine  production  by  S.  typhimurium  infected  cells  was  analysed  using 
intracellular cytokine staining.  BMMac or BMDC were infected with S.  typhimurium 
as described in section 2.2.3.3. After washing three times with PBS, fresh medium 
containing  50  pg/ml  of gentamicin  and  10  pg/ml  of brefeldin-A was  added  to the 
flask. The role of the brefeldin A is to block protein transport from the endoplasmic 
reticulum  to  the  Golgi  apparatus  allowing  the  secreted  cytokine  to  be  confined 
inside the cells and detected with the assistance of a permeabilisation  buffer. The 
cells were then incubated for 6 hours at 37°C,  5% CO2. When cytokine production 
from T cells was measured, T cells were stimulated with the corresponding peptide 
(NP383-391 or NP366-374 at a final  concentration  of  1   pM)  for 6  hours  in  total,  in  the 
presence  of  10  pg/ml  of  brefeldin-A  for  the  last  3  hours’  incubation.  Following 
incubation,  2  x  105 cells were aliquoted  into a  FACS tube. The cells were stained 
for  surface  molecules  as  described  in  2.2.4.1.  The  stained  cells  were  fixed  in 
PBS/2%  PFA for 20  minutes  at  room  temperature.  Fixed  cells were washed  and 
resuspended  into  permeabilisation  buffer  (0.5%  (w/v)  saponin  in  FACS  wash 
buffer) for 20 minutes at room temperature. Staining for intracellular cytokines (final
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temperature in 0.5% saponin. The cells were then washed twice with 0.5% saponin 
followed  by  another  two  washes  with  FACS  wash  buffer,  and  the  pellet  was 
resuspended  in  PBS/1 %PFA.  Cells  were  acquired  using  a  FACSCaliber  flow 
cytometer and analysed using WinMDI FACS analysis software.
2.2.4.3  Annexin V staining
Cell death of BMDC or BMMac after S.  typhimurium infection was evaluated using 
Annexin  V satining  as  a  marker of apoptosis.  Cells were  stained  with  Annexin  V 
and  propidium  iodide  (PI)  according  to  the  manufacturer’s  protocol.  Briefly,  the 
cells were washed twice with cold PBS and then resuspended at a concentration of 
1   x  106 cells/ml in  1   x  binding buffer. A 100 p il (1  x  105) aliquot of the cell solution 
was  then  transferred  to  a  5  ml  FACS  tube,  and  5  pi  of Annexin  V  (final  dilution 
1:20)  and  5  pi  of  PI  (final  concentration  2.5  pg/ml)  were  added.  The  cells  were 
gently vortexed and then incubated for 15 minutes at room temperature in the dark. 
After  incubation,  400  pi  of  1   x  binding  buffer was  added  to  each  tube  and  cells 
were  analysed  by flow cytometry within  one  hour.  For our experiments,  the  cells 
that were apoptotic were those that were Annexin V positive and PI negative.
2.2.5  Griess Assay
To detect the production of reactive nitrogen intermediates such as NO generated 
from  S.  typhimurium  infected  cells  by  L-arginine  oxidation  pathway,  Nitrite  (N02 ),
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quantitated  in  the  cell  culture  supernatant  by  the  Griess  diazotization  reaction. 
NaN02  was  used  to  make  the  standard  curve.  Briefly,  solution  1   (2%
sulphanilamide,  5%  H3P04  in  distilled  water)  and  solution  2  (0.2%
napthylethylenediamine in PBS) were prepared and added in a 1:1  ratio to obtain a 
colourless  solution.  Following  this,  standards  of  sodium  nitrite  were  prepared  in 
PBS by seven two-fold serial dilutions of a  100 pM solution, wells with  no  NaN02 
were  used  as  negative  control.  A  75  pi  aliquot  of supernatant  or standard  to  be 
tested was added to the wells of a 96-well MicroTest III plate in triplicate, and a 25 
pi of the  colourless solution  mixture was then  added  to each  test well.  The  plate 
was  incubated  with  shaking  for  5  minutes  on  a  plate  shaker,  the  absorbance  of 
color reaction was measured at 540 nm wavelength in a microtiter plate reader.
2.2.6  Immunohistochemistrv staining
Tissues  from  mice  were  mounted  in  Tissue-Tek  O.C.T.  Compound,  then  snap- 
frozen  in  a  bath  of  3-methyl-butane  and  dry  ice.  The  tissue  was  cut  in  4  pm 
sections on a cryostat,  and  kept at 4°C until required.  Each section was fixed with 
acetone  for  10  minutes,  rehydrated  in  PBSa  and  blocked  with  10%  normal  goat 
serum  for 20  minutes followed  by  10  minutes  incubation  with  0.3%  H2O2  in  10%
normal  goat  serum  to  quench  the endogenous  peroxidase  activity.  For  three
layered  staining, take  F4/80 as an example,  the section was firstly incubated with 
the  purified  rat anti-mouse  F4/80  antibody  (final  concentration  10  pg/ml)  at  room
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Then the section was incubated with the second antibody, biotinylated anti-rat IgG 
(final concentration  15 pg/ml) at room temperature for 30 minutes followed by five 
washes with PBSa. The section was incubated with Vectastain ABC mixed reagent 
for 30  minutes, which was  made  by mixing 2 drops of Reagent A and  2 drops of 
Reagent B  in  5  ml  PBS  and  standing for 30  minutes at room temperature  before 
use.  Following  this,  the  slide  was  washed  with  PBSa  and  the  enzyme  reaction 
developed with  peroxidase substrate kit following the  manufacturer’s  instructions. 
Briefly, the solution was made by mixing 3 drops of Reagent 1, 2 drops of Reagent 
2 and 2 drops of hydrogen peroxidase solution in 5 ml distilled water. The staining 
was  monitored  visually  under  the  microscope  until  the  desired  intensity  was 
developed. For two layered staining, after 10% goat serum blocking and incubation 
with 0.3% H2O2, the section was incubated with a biotin conjugated antibody for 30 
minutes. After PBSa washes, the section was then incubated with Vectastain ABC 
mixed  reagent.  The  following  steps  were  then  the  same  as  the  three  layered 
staining.
2.2.7  Analysis of message RNA (mRNA)
2.2.7.1  Extraction of mRNA
Total cellular RNA from cells was isolated using the RNeasy Mini kit, which applies 
a  technology that combines the  selective  binding  properties  of a  silica-gel-based 
membrane  with  the  speed  of  microspin  technology.  This  kit  uses  a  specialised 
high-salt buffer system that allows up to  100 pg of RNA longer than 200 bases to
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in the presence of a highly denaturing guanidine isothiocyanate (GITC)-containing 
buffer,  which  immediately  inactivates  RNases  to  ensure  isolation  of  intact  RNA. 
Ethanol is added to provide appropriate binding conditions, and the sample is then 
applied  to  an  RNeasy  mini  column  where  the  total  RNA  binds to  the  membrane 
and contaminants are efficiently washed away,  high-quality RNA is then eluted in 
water.
Approximately  1-5  x  106  BMMac or BMDC were  harvested  and  lysed  by addition 
of buffer RLT (GITC-containing  buffer)  (350 pl/sample). To ensure thorough  lysis, 
the cell lysate was pipetted onto a QIAshredder spin column, which was placed in 
a 2 ml collection tube and the  sample was centrifuged for 2 minutes at maximum 
speed  (15000  x  g).  The column was discarded  and 350 pi of 70% ethanol  (v/v in 
Milli-Q®  water)  was  added  to  the  lysate.  All  the  volume  of the  lysate  was  then 
applied  to  a  RNeasy mini  column  placed  in  a  2ml  collection  tube.  The tube was 
centrifuged for 15 seconds at > 8000 x g, the flow-through was discarded and 700 
pi of buffer RW1  added to the RNeasy column. The sample was centrifuged for 15 
seconds  at  >8000  x  g,  500  pi  buffer  RPE  was  added  to  the  RNeasy  column, 
followed  by  15  seconds  centrifugation  at  >  8000  x  g,  the  flow-through  was 
discarded and another 500 pi  of RPE was applied followed with centrifugation. To 
eliminate  any chance  of possible  buffer  RPE  carryover,  the  RNeasy  column was 
placed  into a  new 2  ml  collection tube and  centrifuged  at full speed for 1   minute. 
RNA was eluted with 3050 pi of RNase-free water into a new 1.5 ml collection tube
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in  each  sample was  measured  by the  optical density at 260  nm  at a  GeneQuant 
pro RNA/DNA calculator (OD260= 40 pg/ml).
2.2.7.2 Digestion of contaminated DNA
To  remove  any  contaminating  genomic  DNA,  the  samples  were  subsequently 
digested with  RNase-free DNase I  Kit.  RNA (1  pg) was added with  1   U of RNase- 
free DNase I  (I U/pl) in  1:10 diluted  10 x DNase I  reaction buffer. The mixture was 
incubated for 15 minutes at room temperature. DNase I was inactivated by addition 
of  1:10  diluted  25  mM  EDTA  solution  and  the  reaction  mixture  heated  for  10 
minutes  at 65°C.  The  samples  were  then  stored  at -80°C  in  10  pi  aliquots  until 
further use.
2.2.7.2 Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
2.2.7.3.1  Reverse-transcription of RNA into complementary DNA (cDNA)
Reverse  transcription  (RT)  is  a  process  that  turns  messenger  RNA  into 
complementary DNA using the enzyme reverse transcriptase.  It was performed by 
mixing  2  pg  of  total  RNA  in  10  pi  diethylpyrocarbonate  (DEPC)-treated  water 
containing 0.5  pg of oligo (dT)i2-is primer (0.5 pg/pl).  This solution was  incubated 
for 10 minutes at 65°C. A  10 pi of solution containing 0.5 pi  reverse transcriptase 
(15  U/pl),  4  pi  of  5  x  reverse  transcriptase  buffer,  40  U  of  rnasin  ribonuclease 
inhibitor  (40  U/  pi),  20  mM  dithiothreitol  and  2  mM  deoxyribonucleoside 
triphosphates  (dNTPs)  were  prepared  and  added  to  the  10  pi  of  RNA  and  oligo
107(dT)  mix,  and the tube was  incubated for 60  minutes  at 37°C  on  a  DNA thermal 
cycler.  The tube was then  heated  to 90°C for 5  minutes,  and  180  pi  of H20 was 
added  to  the  reaction  mixture  to  make  a  1:10  dilution  of  cDNA.  Samples  were 
stored at -20°C until further use.
2.2.7.3.2  Amplification of DNA using the Polymerase Chain Reaction (PCR) 
The principle of PCR is that the two strands of DNA are separated with a brief heat 
treatment  (denaturation),  and,  after  strand  separation,  cooling  of  the  DNA 
(annealing)  in  the  presence  of  a  large  excess  of  the  specific  two  primer  DNA 
oliogonucleotides  allows these  primers to  hybridize to  complementary sequences 
in the two DNA strands. This mixture is then incubated with  DNA polymerase and 
the  four  deoxyribonucleoside  triphosphates  so  that  DNA  is  synthesised 
(amplification).  The  entire  cycle  is  then  repeated  with  the  newly  synthesised 
fragments serving  as  templates  in  their turn,  as the  procedure  is  performed  over 
and over again, the DNA is efficiently amplified.
To amplify the reverse transcribled  cDNA,  50 pi of cDNA in  section 2.2.7.3.1  was 
added to 50 pi of a solution consisting of 1   U of Biotaq™DNA polymerase (5 U/ml), 
200 pM dNTPs, 200 nM forward and reverse primers, and 5 pi of 10 x  PCR buffer, 
p-actin was  used  as  house  keeping gene  in the  reaction.  The  primers details are 
listed  in  Materials  section  2.1.13.  PCR  amplification  was  started  by  an  initial 
denaturation  step  (5  minutes  at 94°C),  completed  by a  final  amplification  step  (7 
minutes  at  72°C),  and  the  PCR  cycles  consisting  of denaturation  (30s  at  94°C),
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carried  out on  a  DNA thermal cycler. To amplify the cDNA specific for p-actin, 22 
cycles of the PCR reaction were performed, whereas 28 cycles were carried out to 
detect CCR7  and  35 cycles was  used  to  CCR6.  A 20  pi  aliquot of PCR  reaction 
product  was  mixed  with  5  pi  of  5  x  gel  loading  buffer  and  subjected  to 
electrophoresis  on  a  2%  agarose  gel.  PCR  products were  visualised  by staining 
with 0.1  pg/ml ethdium bromide.
2.2.7.4  Real-time RT-PCR (TaqMan)
To quantitate the expression of CCR7 and CCR6 at the RNA level before and after 
S.  typhimurium  infection,  the  samples  were  subjected  to  real-time  RT-PCR 
analysis  by  using  Reverse Transcripptase qPCR™  Master  Mix kit with  28S  rRNA 
used as endogenous control.
The  sequence  of the  primers  and  probes  were  designed  by  PrimerExpress™1.0 
(Applied  Biosystems)  by  input  of the  cDNA  sequence  of  targeting  probe,  which 
ideally  should  contain  intron  and  exon  splice  junctions  in  order  to  avoid  the 
disturbance  of the  genomic  DNA  in  the  reaction.  Then  the  desired  primers  and 
probe were chosen manually from the subsequently generated  pool of candidates 
following  the  rules  that  primers  must  not  have  more  than  2  C/G  in  last  5 
nucleotides at the 3 end and  if possible the two primers  have equal Tms (melting 
temperatures). As for the probes, they must not start with a G at the 5 end,  C> G, 
and the Tm of probe must be 7-10°C higher than its corresponding primers.
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resonance  energy transfer (FRET)  for quantification.  For doing  this,  the  probe  is 
designed to hybridize to an internal region of a PCR product and is labelled with a 
fluorescent  dye  on  the  5’  base  (FAM)  and  a  quenching  dye  on  the  3’  base 
(TAMRA).  When  stimulated,  the  excited  fluorescent  dye  transfers  energy  to  the 
nearby  quenching  dye  molecule  rather  than  fluorescing,  resulting  in  a 
nonfluorescent substrate.  During PCR, when the polymerase replicates a template 
on which  a probe is bound,  the 5’ exonuclease activity of the polymerase cleases 
the probe. This separates the fluorescent and quenching dyes and FRET no longer 
occurs.  Fluorescence  increases  in  each  cycle  as the  reactions  proceeds.  All  the 
primers and probes used in assay are listed in Materials section 2.1.14.
Total RNA were extracted from samples following the protocol described in 2.2.7.1. 
A master mix in 20 pi  per well containing 0.125 pi  reverse transcriptase (50  U/pl),
12.5  pi  2  x  reaction  buffer,  0.6  pM  primer  mix  (CCR6  was  0.1  pM)  and  0.1  pM 
probe in  DEPC-treated  H2O was prepared firstly.  RNA in 5 pi was  1:10 (28S RNA 
was  1:50)  diluted  and  added  to  each  well  in  Thermo-Fast®96,  non-skirted  PCR 
tube and each sample was performed in triplicate.  LPS treated BMDC checked by 
RT-PCR was  used for a  CCR7 standard  curve and the  RNA  isolated from spleen 
cells  was  used  for  a  CCR6  standard  curve.  Both  were  optimised  in  preliminary 
experiments.  Negative  control  reactions  had  no  added  RNA  in  the  master mix to 
confirm  that there was  no  non-specific  reaction  in  the assay.  The  plate was then
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consisted  of  30  minutes  at  48°C  and  10  minutes  at  95°C  set  up  for  reverse 
transcription reaction, and the amplification profile was established as 40 cycles of 
15 seconds denaturation  at 95°C  and  1   minute annealing  and  extension  at 60°C 
for cDNA.
To analyse the data generated from the assay, a second set of PCR reactions was 
performed  for  28S  RNA  on  both  the  standard  curve  and  experimental  samples. 
Relative abundance values of experimental samples were then  normalised  by the 
values of their 28S RNA. Thereafter, different samples could be directly compared 
according  to  their  normalised  values  and  the  fold  change  among  samples 
calculated.  In detail,  raw data expressed by circle of threshold (Ct) values for each 
standard  curve were  firstly taken  to  plot a  standard  curve  displayed  as  a  scatter 
graph  with  an  insertion  of a  trendline  and  corresponding  equation  and  R2 value. 
Then  the  Ct  values  of  each  probe  were  calculated  by  averaging  the  triplicate 
values, and standard error (SE) values were obtained subsequently. Following this, 
for test probes,  40-Ct values were  calculated  and  used  in  the  correction  formula. 
For 28S  RNA,  an overall  mean  (and  SE) of Ct values were worked  out for all the 
samples,  and then the  Difference  Factor (DF)  for each  sample was calculated  by 
the following formula:
mean 28S of sample 
DF  =  ---------------------------
mean overall 28S 
Then, the value of all the samples were corrected as below:
111[(40-Ct) mean x probe slope]
Corrected Value = ------------------------------------------
(28S slope x DF)
The slope in the formula was  m,  which was from equation  of line (y =  mx + c) of 
standard  curve.  Following  this,  the  fold  changes  of  the  corrected  data  were 
calculated by:
Fold changes=2(C o rrected  samP,e"correcled control)
The corrected control was the sample that was designated as the “calibrator”  (or 1  
x sample), and all other samples were compared to this calibrator sample. Notably, 
the absolute values calculated for the experimental samples do not have biological 
meaning, while the relative difference in mRNA abundance between samples were 
accurate.
2.2.8  Chemotaxis assay
The in vitro migration of BMDC in response to CC chemokines was assessed  in a 
24-well transwell cell culture chamber with  5.0 pm  pore size polycarbonate filters. 
Approximately 2 x  105 cells in  100 pi of IMDM/10 tissue culture media were added 
to the upper compartment of the chamber.  CCL19 (0.3 pM) or CCL20 (100 ng/ml) 
in  600  pi  of IMDM/10 was  loaded  in  the  lower compartment.  The transwell  plate 
was incubated at 37°C,  5%CC>2 for 4 hours. The cells that had moved through the
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anti-CD11c  and  anti-l-A/l-E  antibodies.  The  double  positive  cells  (defined  as  the 
DC)  were  counted  by  flow  cytometry  and  the  percentage  of  migrated  BMDC 
determined by the number of migrated DC divided by the number of DC seeded in 
the  upper  compartment.  The  lower  compartment  of control  chambers  contained 
media alone. The assay was performed in duplicate.
For the desensitisation experiments, BMDC (3 x  106 cells/ml) were incubated  for 1  
hour at 37°C with 5-10 pg/ml CCL19, control cells were incubated with  PBS for 1  
hour  at  37°C.  After  washing  3  times  with  PBS,  the  cells  were  resuspended  in 
IMDM/10 media and  the number of cells were  adjusted.  Cells (2  x  105/well) were 
seeded  into the upper compartment of the transwell  plate,  and the following steps 
were the same as for the chemotaxis assay described as above.
2.2.9  Labelling cells with the Cell Tracker dves
To investigate the in vivo migration of BMDC and BMMac, cells need to be labelled 
with  fluorescent  cell  trackers.  Vybrant™  CFDA  SE  Cell  Tracker  kit  (containing 
CFDA  SE  (carboxy-fluorescein  diacetate,  succinimidyl  ester;  often  called  CFSE) 
and  CellTracker  Orange  CMTMR  ((5-(and-6)-(((4-chloromethyl)benzoyl)amino) 
tetramethylrhodamine)  were  used.  The  cell  tracker  dyes  contain  a  chloromethyl 
group that reacts with thiol, in a glutathione S-transferase-mediated reaction, which 
is ubiquitous in most cells. Following the reaction, the reagent is transformed into a 
cell-impermeant  fluorescent  dye—thioether  adduct  that  can  be  fixed  with  a
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only to  label the  cells  but also  used  to  measure  the  rate  of T cell  proliferation  in 
vivo  and  in  vitro  due  to  the  fact  that  its  fluorescence  is  split  and  inherited  by 
daughter cells after cell division.
The  stock of the  cell  tracker was  prepared  to  make  5  mM  final  concentration  in 
PBS/0.1 %BSA, which was then aliquoted  into 5 pi samples and stored at -20°C in 
the dark until further use. The cells requiring labelling were harvested and adjusted 
to 107 cells/ml in  IMDM/10 media. The stock of cell tracker was diluted  1:1000 and 
added  into  the  cell  suspension  (final  concentration  5  pM)  and  incubated  for  10 
minutes at 37°C.  After incubation,  labelled  cells were washed twice with  50 ml of 
pre-warmed  PBS/5%FCS  to  stop  the  reaction.  The  cell  suspension  was  filtered 
through 40 pm filter to remove any cell debris and then pelleted  by centrifugation. 
The  labelled  cells were  counted  and  resuspended  to the  appropriate dilution  and 
used for further experiments.
2.2.10  Analysis of T cell response
2.2.10.1  Isolation of CD4 or CD8 Subsets from leukocytes
In  order to analyse the  proliferation  of CD4 or CD8 T cells  in  response to  BMDC 
stimulated  with  recombinant  S.  typhimurium,  T  cell  subsets  were  isolated  (by 
negative selection) from lymphoid tissues using CD4+ or CD8+ T cell isolation kits 
following the manufacturer’s protocol.  Briefly, spleen or lymph nodes were mashed
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in  Milli-Q® water),  2  mM  EDTA in  PBS,  pH  7.2,  filter before  use and  keep cold). 
After  10  minutes  centrifugation  at  300  x  g,  cells  were  filtered  through  40  pm 
strainer and cell number was counted. A cell suspension at a density of 107/40 pi 
was  prepared  and  10  pi  of  biotin  antibody  cocktail  containing  biotin-conjugated 
monoclonal antibodies against CD8a (for CD4 isolation, or CD4 for CD8 isolation), 
CD11b,  CD45R,  DX5  and  Ter-119  was  added  to  107  cells.  After  10  minutes 
incubation at 4~8°C, 30 pi of buffer was added to the cells followed  by addition of 
20  pi  of anti-biotin  MicroBeads  per  107  total  cells.  Following  another  15  minutes 
incubation  at  4-8°C,  the  cells  were  washed  with  T  cell  isolation  buffer  and 
centrifuged at 300 * g for 10 minutes. Cells were then resuspended at a density of 
108 total cells per 500 pi of buffer. A MACS column and a  MACS separator were 
chosen depending on the number of cells being magnetically labelled. A LS column 
(up to 108 labelled cells) or MS column (up to 107) was placed in the magnetic field 
of the MACS separator. The column was pre-wetted with 2 ml of buffer and the cell 
suspension was passed through the column followed by washing three times with 1  
ml  buffer and the entire eluate was collected,  representing the enriched CD4+  (or 
CD8+) T cell fraction.  Purified T cell subsets were counted and used in the further 
experiments.
2.2.10.2  IFN^y Enzyme-Linked Immunosorbent Spot (ELISpot) assay
An  IFN-y ELISpot assay was  used to evaluate T-cell  responses in vitro. A 96-well 
plate was  pre-wetted with  70%  methanol  (v/v in  Milli-Q® water) for  1   minute  and
115washed three times with PBS. The wells were then coated overnight at 4°C with an 
IFN-y  capture  antibody  (final  concentration  10  pg/ml)  in  sterile  PBS.  On  the 
following  day,  the  plate  was  washed  with  PBS  and  blocked  with  T-cell  media 
(RPMI  1640,  10%  FCS,  50  pM  p-ME,  100 U/ml penicillin,  100  pg/ml streptomycin 
and 1   mM sodium pyruvate) for 2 hours at 37°C.  Responder cells (5 *  104~2 x  105  
of CTL cells or fresh T cells from GRb mice) in 50 pi of T-cell media were added to 
each well and the plate was incubated at 37°C, 5% CO2 for 1   hour to allow the cells 
to  settle  down.  For  in  vitro  analysis  of  CTL  lines,  103~105 stimulators,  such  as 
BMMac  or  BMDC,  either  pulsed  with  1   pM  peptide  or  infected  with  recombinant 
Saimonella, were added to each well in 50 pi of T-cell media containing gentamicin 
(final concentration 50 pg/ml in total volume).  For ex vivo T cell responses,  media 
containing  1   pM  NP383-391 peptide in 50 pi was added. After 24 hours of incubation 
at  37°C,  5%  CO2,  wells  were  washed  six times  with  the  150  pl/well  PBS/0.01 % 
Tween®20.  The wells were then  incubated for 2  hours at 37°C with a biotinylated 
anti-IFN-y antibody  in  0.5%  BSA  in  PBSa  (w/v,  final  concentration  2  pg/ml).  After 
washing  six  times  with  PBS/0.01%  Tween®20,  100  pi  of  1:1000  diluted 
Streptavidin-HRP™ enzyme conjugate in sterile PBS was added and the plate was 
incubated  at  room  temperature  for  1   hour.  After  washing  three  times  with 
PBS/0.01 % Tween®20 followed  by three times with  PBSa,  spots were developed 
by  incubation  for  4  minutes  with  3-amino-9-ethylcarbazole  (AEC)  (dissolved  0.4 
mg/ml  in dimethylformamide)  in  0.1  M acetate buffer (0.0074 N  acetic acid,  0.018 
M  sodium  acetic,  pH  5.1),  0.015%  (v/v)  hydrogen  peroxide  was  added  to  the 
solution  before addition. AEC was  removed  by washing the plate with the runningwater.  Following  this,  the  plate  was  then  left  to  dry  overnight  in  the  dark,  spots 
formed by IFN-y-secreting cells were counted under the microscope using the Qwin 
software (Leica).
2.2.10.3 T cell proliferation assay using [3H] thymidine
T cell proliferation in response to BMDC or BMMac stimulation after S. typhimurium 
infection was evaluated using [3H] thymidine (Amersham). T cells (104) in  100 pi of 
T cell  media  isolated from  GRb mice were seeded  into the wells of U-bottom  96- 
well  plates.  BMDC  or  BMMac were  infected  with  recombinant  S.  typhimurium  or 
peptide  pulsed  cells were  used  as  stimulators.  After  infection  or  peptide  pulsing, 
BMDC  or  BMMac  were  harvested  and  103  cells  in  100  pi  media  containing 
gentamicin  (final concentration  50  pg/ml) were added  to the wells.  The  plate was 
then  incubated  in  a  37°C,  5%CC>2  incubator for 4 days.  On  day 4,  the cells were 
pulsed with  [3H] thymidine  (0.5 pCi/well  in  20  pi) for  16  hours.  Following this,  the 
cells were washed and passed through a glass fibre filter. The filter was dried and 
sealed with a plastic bag containing 5 ml of betaplate scint, which was then loaded 
onto  the  1450  Microbeta  Trilux  Scintillation  Counter,  and  the  incorporation  of 
thymidine into the synthesised cellular DNA was determined.
2.2.10.4 T cell proliferation assay using CFSE labelling
To  evaluate  the  capacity  of  BMDC  or  BMMac  to  present  intracellular  bacteria- 
derived  antigens to T cells,  proliferation  of T cells  upon  stimulation was  analysed 
by  CFSE  labelling.  T  cells were  isolated  from  lymph  nodes  of GRb  mice;  when
117purified T cell subsets were used  (CD4 or CD8), T cells were purified by negative 
selection  using  MACS  T  cell  isolation  kit as  described  in  section  2.2.10.1.  Then, 
107 cells/ml were  labelled with  5  pM  CFSE  as described  in  2.2.9.  After labelling, 
105  T  cells  in  100  pi  were  added  to  the  wells  of  U-bottom  96-well  plates.  After 
infection with recombinant S.  typhimurium or peptide pulsing,  104 BMDC or BMMac 
in 100 pi in the presence of  50 pg/ml gentamicin were also added to the wells. The 
culture was  incubated  at 37°C,  5%C02 for 4  days,  the  cells were  harvested  and 
analysed  by flow cytometry,  and the proliferation  of T cells was  measured  by the 
dilution of CFSE-fluorescence intensity at various time points.
2.2.11  Adoptive transfer
2.2.11.1  Adoptive transfer of BMMac or BMDC
The  in  vivo  migration  of  BMDC  or  BMMac  after  S.  typhimurium  infection  was 
investigated by the adoptive transfer of CFSE or CMTMR labelled cells. BMMac or 
BMDC were  prepared  as  previously described  in  2.2.2.3  or 2.2.2.5,  and  infection 
was  performed  as  described  in  section  2.2.3.3.  Overnight  incubation  in  the 
presence of 50 pg/ml gentamicin was used to eliminate the extracellular bacteria. 
The  cells  were  harvested  and  labelled  with  CFSE  or  CMTMR  as  described  in 
section 2.2.9.  Following this, CFSE labelled cells were resuspended at a density of 
1-2  x  107/ml,  and  500 pi of the cell suspension was  i.p.  injected  into a  HLA-B27 
transgenic mouse, 3 mice per group. The mice were observed daily for 2 days. On 
day 2,  all the  mice were  sacrificed  by  a  rising  concentration  of CO2,  and  tissues
118taken  to  make single cell  suspensions for analysis.  First of all,  5  ml  of PBS was 
injected  into  the  peritoneal  cavity  by  a  5  ml  syringe  and  25  G  needle,  and  the 
abdomen was massaged for two minutes. The  peritoneal fluid was then aspirated 
into the syringe and the recovered lavage was expelled  into a 5 ml tube on ice for 
analysis.  Following  this,  spleen,  liver,  Peyer’s  Patches  (PPs)  mesenteric  lymph 
nodes  (LN),  inguinal  LN  and  popliteal  LN  were  isolated  and  stored  in  PBS.  To 
analyse the number of migrating CFSE labelled cells in different organs, single cell 
suspensions were prepared from each organ. Spleen and liver were cut into pieces 
and  digested  with  tissue  digesting  media  (1  mg/ml  collagenase  type  IV  and  0.5 
mg/ml DNase I  in RPMI/5%FCS) for 30 minutes at 37°C with constant shaking. All 
the LNs and PPs were mashed with the edge of two frosted slides. Cells were then 
passed through a 40 pm strainer, washed in FACS wash buffer (0.1% FCS, 0.01% 
sodium azide in PBS) and  resuspended into 1% (w/v) PFA. All samples were then 
analysed by flow cytometry with the 2 x 106 cells collected for each sample. CFSE 
positive  cells  that  appeared  on  FL1  channel  were  calculated.  The  mice  with  no 
transfer of CFSE labelled cells were used as controls.
2.2.11.2  Co-transfer of GRb T cells and BMDC
In  order  to  assess  the  capacity  of  the  BMDC  to  present  bacterial  antigens  to 
antigen specific naive T cells in vivo, GRb T cells and recombinant S.  typhimurium 
infected  BMDC  were  co-transferred  into  HLA-B27  mice.  Firstly,  lymphatic T  cells 
were  isolated from two GRb  x  HLA-B27/p2m mice;  cells were pooled and labelled 
with CFSE as described in section 2.2.9. One million CFSE labelled GRb T cells in
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vein. On the following day,  recombinant S.  typhimurium infected or peptide pulsed 
BMDC  were  harvested  and  5  x  106 cells  in  500 jil  of PBS were  i.p.  injected  into 
HLA-B27 mice previously injected with GRb T cells, 3 mice each group. Mice were 
monitored daily.  Up to 8 days after BMDC transfer, spleen and lymph nodes were 
taken  for  analysis.  Cells  were  isolated  as  described  in  section  2.2.11.1.  After 
washing with FACS wash buffer, 2 x 106 cells from each organ were aliquoted into 
the wells of U-bottom 96-well plates, extracellular FACS staining was performed as 
described  in  section 2.2.4.1  and  intracellular cytokine staining was carried  out as 
described  in section 2.2.4.2. TCR Vp7 antibody staining was used, since >90% of 
lymphatic  T  cells  from  GRB  x  HLA-B27/hp2m  mice  expressed  the  transgene- 
derived human Vp7 molecule (Roddis et al., 2004), allowing GRb lymphatic T cells 
to be visualised by this antibody staining. The stained cells were then analysed by 
flow cytometry and T cell proliferation was assessed by the loss of intensity of the 
CFSE fluorescence. The function  of T cells was  analysed  by  intracellular staining 
of IFN-y or granzyme B.
2.2.12  Statistical analysis
Data were  analysed  using  S-Plus  (r)  6.2  for Windows  and  Microsoft  Excel  2002. 
Statistical  analysis  was  performed  by  Xikun  Wu  from  Institute  for Animal  Health 
according  to  the  directions  given  by  the  Institute  for  Animal  Health  statistics 
advisory  desk.  In  chapter 4,  statistical  significance  was  analysed  using  one-way
120ANOVA  (Analysis  of  Variance),  and  two-sample  student’s  T-test  was  used  in 
chapter 5.
121Chapter 3: In  vitro  optimisation of experimental 
system
3.1  Introduction
In this study, an adoptive transfer was designed to study trafficking and antigen 
transportation by macrophages and DC. Since tissue derived macrophages and 
DC can only be isolated  in small numbers,  BMMac or BMDC were used  in this 
study in order to do large-scale adoptive transfer.  Experimentally,  macrophages 
and  DC can  be propagated from bone marrow precursors cultured with distinct 
cytokines. Macrophages are generated in response to M-CSF (also called CSF- 
1) and  DC are produced  in  response to GM-CSF  (Caux et al.,  1997;  Pannetier 
et al., 2004; Szabolcs et al.,  1996).
Salmonella  is  a  known  causative  agent of ReA and  therefore was  used  as the 
infection agent and source of antigen in this experimental system. As described 
in  the  materials  and  methods,  various  attenuated  strains  are  available  in  our 
laboratory.  As  S.  typhimurium  can  be  cytotoxic  for  cultured  macrophages  by 
inducing  apoptosis  (Chen  et al.,  1996a;  Monack et al.,  1996),  and  healthy  live 
cells  were  required  for adoptive  transfer,  BMMac were  used  to  determine  the 
bacteria  strain,  infectious  dose  and  time  point  at  which  infected  cells  were 
harvested.  BMMac and  BMDC were then  infected with  Salmonella under these 
predetermined  conditions  and  the  consequences  of  infection  subsequently 
compared  by  assessing  infection  rate,  changes  of cell  surface  molecules,  NO 
production and cytokine secretion.
122The  aim  of  the  following  studies  was  to  optimise  the  in  vitro  experimental 
system to obtain viable  S.  typhimuhum infected  macrophages and  DC carrying 
Salmonella  intracellularly.  These  infected  cells  will  be  then  used  for  adoptive 
transfer into mice and their migratory properties assessed.
1233.2 Results
3.2.1 Generation of primary cultures of BMMac and BMDC
3.2.1.1 Generation of BMMac
BMMac were  generated  by  culturing  freshly  isolated  bone  marrow from  HLA- 
B27  mice  in  IMDM  medium  supplemented  with  20%  Ladmac  cell  culture 
supernatant as described in the materials and methods, which is consistent with 
the reported use of the supernatant from this cell line (Ponniah et al.„  1996).  To 
standardise  the  BMMac  culture,  supernatants  were  collected  from  different 
batches  of Ladmac cell culture over  10  months to obtain  sufficient amounts  of 
supernatant  for  future  BMMac  culture.  To  assure  that  these  supernatants 
contained  comparable amounts of M-CSF,  an  ELISA was  used to quantify the 
M-CSF  present.  From  a  standard  curve  generated  by  serial  dilution  of mouse 
recombinant  M-CSF  (Figure  3.1  A),  the  amount of M-CSF was  calculated  and 
compared among different batches of culture supernatant (Figure 3.1  B).  It was 
found  that these  supernatants  contained  levels  of M-CSF  ranging  from  30~45 
ng/ml. Therefore, the final concentration of M-CSF used  in  BMMac culture was 
equivalent to 6~9 ng/ml recombinant M-CSF.
3.2.1.2 Generation of BMDC
3.2.1.2.1  Selection of FCS
Our  protocol  to  generate  BMDC  with  GM-CSF  was  adapted  from  previous 
publications (Lutz et al.,  1999;  Lutz et al.,  2000).  In these studies, the batch of 
FCS  influenced  both  cell  yield  and  DC  maturation  (Lutz et al.,  1999).  A major 
component  in  FCS  that  may  potentially  influence  the  maturation  state  and
124outgrowth  of  DC  is  endotoxin  contamination.  Thus,  8  batches  of  FCS  (Table 
3.1) were obtained from different companies and tested for endotoxin  levels by 
LAL assay  (Ochiai et al.,  2003;  Takagi  et al.,  1981).  The amount of endotoxin 
contamination  in  these samples was  calculated  according  to  a  standard  curve 
generated  from  serial  dilution  of  commercial  endotoxin  with  a  known 
concentration  in  the  LAL  assay.  Overall,  comparing  8  samples  as  shown  in 
Figure  3.2  A,  we  found  that sample  H  contained  the  highest  concentration  of 
endotoxin  (nearly  50  EU/ml).  In  contrast,  the  level  of endotoxin  in  the  other 7 
samples was  less than  5  EU/ml.  Among these 7  FCS  samples  (Figure  3.2  B), 
samples A, D, E contained the lowest level of endotoxin (1  EU/ml). As sample E 
had  limited  availability  from  the  suppliers,  sample  A  and  D  were  chosen  and 
tested for effects in DC culture, with samples C and H used as intermediate and 
high endotoxin controls respectively.
DC  were  generated  from  bone  marrow culture  in  the  presence  of GM-CSF  in 
medium supplemented with  10% of samples A,  C,  D or H.  DC were harvested 
at  day  7,  and  the  maturation  state  and  contamination  with  granulocytes 
analysed by flow cytometry as described  in materials and methods. CD11c was 
used  as  a  dendritic  cell  marker  throughout  this  study.  Gr-1  was  used  as  a 
marker indicating contamination of granulocytes.  I-A/I-E and other costimulatory 
molecules  such  as  CD40,  CD54,  CD80  and  CD86  were  used  to  measure  the 
maturation  of  DC.  Figure  3.3  shows  that  cells  generated  from  a  culture 
supplemented with  FCS sample A had the  lowest expression  of Gr-1  (7.7%),  I- 
A/l-E  (56.1%),  CD54  (68.9%),  CD86  (34.6%)  and  CD80  (76.7%)  and  the 
second  lowest expression  of CD40  (29.5%).  Notably,  cells grown  in  sample  H,
125which contained the highest level of endotoxin,  had the highest Gr-1  expression 
(13.6%)  indicating  the  greater  higher  contamination  with  granulocytes. 
Therefore, sample A was chosen as the source of FCS for future BMDC culture 
throughout this study.
3.2.1.2.2  Growth state of BMDC
To further optimise production of BMDC, we analysed  how varying the number 
of  seeded  bone  marrow  cells  and  the  duration  of  culture  affected  DC  yield, 
purity and maturation state.  Bone marrow cells were serially diluted from 5 x  106 
to 1.5 x  105, and seeded into individual wells of 6-well plates followed by culture 
with recombinant GM-CSF. At day 5 and day 7, nonadherent and adherent cells 
were harvested separately. Cell counting was performed and cell yield including 
both populations was calculated as the number of total cells harvested from the 
culture divided  by the number of originally seeded  cells. After evaluation of cell 
yield,  the cells were then  double stained with  antibodies against CD11c and  I- 
A/l-E or Gr-1.  Upon analysis of Gr-1  expression, we found that the nonadherent 
population  was  contaminated  with  15%  -  40%  of granulocytes,  in  comparison 
with  only  8%  ~  12%  granulocyte  contamination  of  the  adherent  population 
(Figure  3.4).  In  terms  of  l-A/l-E  expression,  we  found  that  there  were  two 
populations  generated  from  our  DC  culture  regardless  of  number  of  seeded 
cells: cells with high levels of l-A/l-E expression and cells with low levels of l-A/l- 
E (Figure 3.4).  In order to achieve a greater number of adherent cells,  100 mm 
bacteriological petri dishes were replaced with T75 tissue culture flasks.
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Figure  3.1  Quantification  of  the  M-CSF  contained  in  the  supernatant  harvested  from 
different batches of Ladmac cell  culture.  Ladmac cells were cultured  in  DMEM/10 medium 
for  two  weeks,  the  supernatant  was  harvested  and  the  level  of  M-CSF  contained  in  the 
supernatant was quantified by ELISA using murine recombinant M-CSF to generate a standard 
curve (A). The equivalent concentration of M-CSF in different batches of culture supernatant (B) 
was calculated according to the equation generated from the standard curve. Each bar indicates 
different batch of Ladmac cell culture supernatant.  Results represent the mean values ± SD of 
triplicates for each sample in the assay.
127Table 3.1 Source of the FCS tested in LAL assay.
Name Supplier Catalogue number Batch number
A Harlan S-0001E 3011101
B Gibco 10106 40F6042F
C Harlan S-0001E 10504
D Harlan 009501 91607
E Gibco 10106 40G8431F
F Sigma-Aldrich F7524 093K3396
G Autogen Bioclear S0415 318A
H Gibco 10106 40F6043F
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Figure 3.2 Comparison of the endotoxin level contained in different batches of FCS using 
the LAL assay.  Eight samples of FCS obtained from different companies were tested, and the 
endotoxin  level  of  samples  was  calculated  according  to  the  standard  curve.  (A)  Overall 
comparison  of 8  samples.  (B)  Comparison  of 7  samples  excluding  H  which  contains  a  higher 
level of endotoxin  compared to the  other 7  samples.  Results  represent  mean  values ± SD  of 
triplicates for each sample.
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Figure 3.3  Further selection  of low endotoxin  FCS based  on  effects  in  DC  culture.  Four 
samples of FCS (A, C, D and H) chosen from the LAL assay were used in 7 day DC cultures in 
the presence of GM-CSF.  DC were harvested at day 7 and the maturation state of the DC was 
analysed  by flow cytometry.  Cells  were  stained with  CD11c  (APC),  Gr-1  (FITC),  l-A/l-E  (PE), 
CD40  (Biotin),  CD54  (FITC),  CD80  (Biotin)  and  CD86  (PE).  Biotinylated  antibodies  were 
followed  by  staining  with  streptavidin-Cy-chrome.  The  expression  of  the  other  cell  surface 
markers were analysed on CD11c (+) cells. The percentage of cells falling into each quadrant is 
indicated.
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Figure 3.4 Comparison  of cell  surface marker expression  of non-adherent and  adherent 
cells  generated  from  DC  cultures  seeded  with  different  numbers  of  bone  marrow  cells.
Bone marrow cells were serially diluted and  seeded  into 6-well  plates followed  by culture with 
recombinant  GM-CSF  for  7  days.  At  day  7,  nonadherent  and  adherent  cells  were  harvested 
separately. The cells were stained with antibodies against CD11c (APC conjugate),  l-A/l-E (PE) 
and  Gr-1  (FITC).  The expression  level  of l-A/l-E and  Gr-1  of CD11c  (+) cells were compared 
(percentage shown on the top right corner).
131We next investigated the influence of duration of culture and  number of seeded 
cells on the cell yield of our DC culture. We found that the cell yield was poor at 
day 5  (1.1  ~ 2.1  fold  increase).  However,  the  cell  numbers  increased  by 2.3 ~
6.4  fold at day 7 (Table 3.2). As for the influence of number of seeded cells, we 
found  that at day  7,  as  the  numbers of seeded  cells  decreased,  the  cell yield 
initially  increased,  peaking  (6.4  fold  increase)  at  6.2  x  105,  and  declined 
afterwards.  Interestingly,  there  was  an  increased  ratio  of  adherent  cells  to 
nonadherent cells  in  the  culture  as the  seeded  cell  number decreased,  which 
favoured our aim to obtain  more adherent cells from the  DC culture.  To obtain 
sufficient adherent cells  for adoptive  transfer,  2  x  106  in  10  mis  per flask was 
chosen as the seeding cell number for future BMDC culture.
3.2.1.2.3  Selection of recombinant GM-CSF
Since  recombinant  GM-CSF  supplied  from  two  different  companies,  Autogen 
Bioclear and R&D Systems have been used in our lab for DC culture, we set out 
to  compare  these  two  sources  of  GM-CSF  for  DC  production.  Bone  marrow 
cells  were  cultured  in  the  presence  of GM-CSF  supplied  from  either Autogen 
Biolcear  or  R&D  Systems  for  7  days.  At  day  7,  the  adherent  cells  were 
harvested and stained with  antibodies against CD11c and  l-A/l-E or Gr-1.  Flow 
cytometry analysis showed  that cells generated  from  the two different sources 
of GM-CSF had comparable expression of CD11c and  l-A/l-E, but slightly lower 
expression  of  Gr-1  was  observed  on  cells  supplemented  with  GM-CSF  from 
R&D Systems (Figure 3.5 A),  indicating  lower contamination with granulocytes. 
In addition, there was about 3-fold increase in adherent cells in the cultures with
132GM-CSF  from  R&D  Systems,  compared  to  only  a  1-fold  increase  in  cultures 
supplemented  with  the  GM-CSF  from  Autogen  Bioclear  (Figure  3.5  B),  thus, 
GM-CSF from R&D systems was selected.
3.2.2  Characterisation of BMMac and BMDC
3.2.2.1 Phenotypic analysis of BMMac
Macrophages  were  generated  by  culturing  bone  marrow  cells  isolated  from 
HLA-B27  transgenic  mice  for  3  weeks  in  medium  supplemented  with  20% 
Ladmac  cell  supernatant.  Adherent  cells  were  harvested  and  stained  with  a 
panel  of  antibodies  against  various  cell  surface  molecules  as  described  in 
materials and methods. Flow cytometric analysis showed that BMMac displayed 
expression  of  the  myeloid  cell  related  markers  CD11b  and  F4/80,  but  not 
CD11c.  Cells did not express MHC class II  (l-A/l-E), whereas class I  H-2kd  and 
HLA-B27  expression  was  detected  (Figure  3.6).  BMMac  lacked  expression  of 
Gr-1, CD3 and B220 (Figure 3.6), thus indicating an absence of granulocytes,  B 
cells and T cells in our BMMac culture.
3.2.2.2 Phenotypic analysis of BMDC
BMDC were generated from  HLA-B27 transgenic bone marrow cells by culture 
for 7 days from HLA-B27 mice in the presence of GM-CSF and stained with the 
same panel of antibodies as BMMac.  From flow cytometry analysis (Figure 3.7) 
we found that our BMDC displayed  high expression  of CD11b and CD11c,  and 
low expression  of F4/80.  BMDC expressed  similar levels of class  I  H-2Kd  and 
HLA-B27.  Class  II  l-A/l-E  expression  showed  subdivision  into  l-A/l-Ehigh  and
133Table 3.2 Selection of the seeded cell numbers and harvest day for DC culture. Since the 
number of seeded  cells  and  the day of harvest could  affect the  maturation  state and  yield  of 
cultured DC, these two conditions were optimised. Serial dilutions of BM cells were seeded in 6- 
well plates and incubated in the presence of GM-CSF for 7 days. At day 5 and 7, non-adherent 
and adherent cells were harvested and counted  separately.  The yield of culture was indicated 
by the fold  change  of cell  numbers,  which  was  calculated  as  number of total  cells  harvested 
from the culture divided by the number of originally seeded cells.
Day 5 Day7
No. of seeded cells  State  Cell no. Overall Yield State Cell no. Overall Yield
5.0 x 106 N*
A**
5.2 x106  
8x105
6 x 106 1.2 N
A
1.1 x 107  
3.3 x 106
1.4 x 107 2.8
2.5 x 106 N 3.2 x106 4 x 106 1.6 N 6.6x10® 9.1 x 10® 3.6
A 8 x 105 A 2.5x10®
1.2 x106 N 2 x 106 2.6 x 106 2.1 N 3x 10® 4.9 x 10® 3.9
A 6.4 x104 A 1.9x 10®
6.2 x105 N 6.4 x105 6.9 x 106 1.1 N 1.5 x 10® 4x 10® 6.4
A 4.8 x 104 A 2.5x10®
3.1 x 105 N 3 x 105 3.4 x 105 1.1 N 4.3 x10s 1.4 x 10® 4.8
A 4 x 104 A 1  x 10®
1.5 x 105 N 1.8 x 105 1.9 x 105 1.3 N 1.8 x 10® 3.4 x 10® 2.3
A 1.6 x 104 A 1.6 x 10®
* N: Non-adherent  ** A: Adherent
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Figure 3.5 Comparison of the effect of recombinant murine GM-CSF supplied  by Autogen 
Bioclear and  R&D  Systems  on  DC  culture.  BMDC  were  generated  in  the  presence of GM- 
CSF. At day 7, the adherent cells were harvested and stained with the antibodies against CD11c 
(APC  conjugate),  l-A/l-E  (PE)  and  Gr-1  (FITC).  (A)  Percentage  of  cells  expressing  indicated 
markers.  (B) The yield of culture expressed as fold change, which was calculated as the number 
of harvested cells divided by the number of seeded bone marrow cells.
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Figure 3.6  Phenotypic analysis of BMMac.  Macrophages were generated  by 3-week culture 
of  bone  marrow  cells  isolated  from  HLA-B27/(32m  transgenic  mice  in  the  presence  of  20% 
Ladmac cell supernatant. At day 21,  adherent cells were harvested and the phenotype of cells 
analysed by flow cytometry. Cells were stained with a panel of antibodies against the following 
cell surface molecules: CD11b (Biotin), CD11c (Biotin),  F4/80 (FITC),  l-A/l-E (PE), H-2Kd (PE), 
HLA-B27 (FITC), Gr-1  (FITC), CD3 (APC) and B220 (PE). Biotinylated antibodies were detected 
with streptavidin-Cy-chrome. Each plot shows expression of the indicated cell surface marker as 
a solid  red  histogram.  Background  staining  using  isotype-matched control  antibodies  is shown 
as  an  empty  histogram.  These  data  are  representative  of  all  BMMac  preparations  used 
throughout the studies.
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Figure  3.7  Phenotypic  analysis  of  BMDC.  DC  were  generated  by  7-day  culture  of  bone 
marrow  cells  isolated  from  HLA-B27/p2m  transgenic  mice  in  the  presence  of  the  GM-CSF 
supplied by R&D Systems. At day 7, adherent cells were harvested and the phenotype of cells 
analysed by antibody staining and flow cytometry. Cells were stained with a panel of antibodies 
against:  CD11b  (Biotin),  CD11c  (Biotin),  F4/80  (FITC),  l-A/l-E  (PE),  H-2Kd  (PE),  HLA-B27 
(FITC),  Gr-1  (FITC),  CD3  (APC)  and  B220  (PE).  Biotinylated  antibodies  were  detected  with 
streptavidin-Cy-chrome.  Each  plot shows expression  of the  indicated  cell  surface marker as a 
solid red histogram. Background staining using isotype-matched control antibodies is shown as 
an empty histogram. These data are representative of all  BMDC preparations used throughout 
the studies.
137I-A/I-Elow populations. As for BMMac,  Gr-1,  CD3  and  B220 expression was  not 
detected.
3.2.3  Selection of bacteria strains for infection
3.2.3.1 Selection of culture time
Four  strains  of attenuated  S.  typhimurium were  available  in  our  laboratory  and 
tested  for  their  ability  to  infect  and  activate  BMMac.  The  time  point  at  which 
bacteria were in mid-logarithmic phase of growth was determined for subsequent 
use  in  infections.  Based  on  the  growth  curves  of those  strains  (SL3261,  waaN, 
C5 (TS) and LB5010)(Figure 3.8),  180 minutes was selected  as the time point of 
mid-logarithmic  phase  growth  for the  4  strains.  The  CFU  of each  strain  at this 
time point subsequently determined (Table 3.3).
3.2.3.2 Select the optimal strain for infection
BMMac  were  infected  with  SL3261  at  M.O.I’s  of  10,  50  or  100,  and  the 
expression of CD40 on infected  F4/80 (+) macrophages analysed as a marker of 
activation.  Uninfected and  LPS treated cells served as the negative and positive 
controls respectively. As shown in Figure 3.9 uninfected macrophages expressed 
low levels of CD40 (4.2%),  in contrast with the  high expression  of CD40 on  LPS 
treated  macrophages  (95.8%).  After  infection  with  SL3261  at  10  M.O.I,  37%  of 
F4/80 (+) cells expressed CD40 compared to  11% and 4.2% at M.O.I’s of 50 and 
100 respectively.
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Figure 3.8 Growth curves of 4 attenuated strains of S. typhimurium. Stocks of 4 strains of S. 
typhimurium  (SL3261,  waaN,  C5  (TS)  and  LB5010)  were  thawed  in  LB  broth.  After  16  hours 
incubation, the bacterial culture was diluted and further incubated,  and the OD values at 581 nm 
were  recorded  every  20  minutes.  The  optimal  time  point  (180  minutes)  of the  mid  logarithmic 
phase of bacterial growth, as indicated by the arrow, was chosen for infection.
139Table 3.3 The mean CFU count of 4 strains of S. typhimurium at 180 minutes. The stocks 
of 4 strains were thawed in  LB broth. After 16 hours incubation,  bacterial cultures were diluted 
and further incubated for 180 minutes. Bacteria were then pelleted and resuspended in a known 
volume,  and  then  serial  dilutions  were  performed  and  plated  onto  LB  agar  plates.  The  CFU 
were  counted  after  overnight  incubation.  Results  represent  mean  values  of  three  replicate 
experiments.
Bacteria strain Mean CFU
SL3261 1.45 x 10° CFU/ml
waaN 8.57 x 107 CFU/ml
C5 (TS) 5.77 x  107 CFU/ml
Lb5010 8.3 x 107 CFU/ml
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Figure  3.9  Analysis  of  the  effect  of  SL3261  infection  on  CD40  expression  by  BMMac.
BMMac were infected with SL3261  at various MOI as indicated. Cells were harvested 24 hours 
post  infection  and  double  stained  with  antibodies  against  F4/80  (PE) and  CD40  (Cy-chrome). 
The percentage of double positive staining cells is shown on the top right corner of density plot. 
The plot on the top row is the control of F4/80 versus  isotype control  antibody, from which the 
quadrant  was  set.  Uninfected  cells  and  LPS  treated  cells  serve  as  controls  for the  infection. 
Data are the representative of 3 experiments.
141As shown  in  Figure  3.10,  8.3%  of uninfected  macrophages expressed  CD40,  in 
contrast with  70.1%  LPS  treated  macrophages.  After  infection  with  waaN  at  10 
M.O.I, 51.2% of macrophages expressed CD40 (+); this decreased to 34.7% and 
11.1% at 50 and  100 M.O.I respectively.
In  contrast to  SL3261  and waaN,  infection with  increasing  doses of C5  (TS) did 
not  lead  to  reductions  in  CD40  expression.  Even  when  the  M.O.I  increased  to 
500, there were still 43.6% of infected cells expressing CD40 (Figure 3.11).
We then set out to compare the activation caused  by infection macrophages with 
each of these 4 strains in the same experiment. Macrophages were infected at 10 
M.O.I  and  levels  of  CD40  and  CD54  analysed.  We  found  (Figure  3.12)  that 
uninfected  macrophages  did  not  express  CD40  and  had  very  low-level 
expression  of  CD54.  Macrophages  treated  with  LPS  had  high  expression  of 
CP40  and  CD54.  In  this experiment,  infection with  SL3261  resulted  in  a  slightly 
increased expression of CD40 but no increase of CD54 as is also observed upon 
infection  with  waaN.  Lb5010  infected  macrophages  showed  moderately 
increased CD40 while CD54 remained at a low level of expression.  However, for 
the C5 (TS)  infected macrophages,  CD40 and  CD54 were both substantially up- 
regulated  compared  with  uninfected  macrophages  and  the  other  3  bacterial 
infection groups. This indicated that C5 (TS) at 10 M.O.I could effectively activate 
the  BMMac resulting  in  high  expression  of cell  surface  receptors.  Therefore,  C5 
(TS) was used in the following experiments.
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Figure  3.10  Analysis  of  the  effect  of  waaN  infection  on  CD40  expression  by  BMMac.
BMMac were infected with  waaN  at various  MOI  as  indicated.  Cells were  harvested 24  hours 
post  infection  and  double  stained  with  antibodies  against  F4/80  (PE) and  CD40  (Cy-chrome). 
The percentage of double positive staining cells is shown on the top right corner of density plot. 
The  plot on  the  top  row  is  the  control  of  F4/80  versus  Ig,  from  which  the  quadrant was  set. 
Uninfected  cells  and  LPS  treated  cells  serve  as  controls  for  the  infection.  Data  are  the 
representative of 3 experiments.
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Figure  3.11  Analysis  of the  effect  of  C5  (TS)  infection  on  CD40  expression  by  BMMac.
BMMac were infected with C5 (TS) at various MOI as indicated. Cells were harvested 24 hours 
post infection  and  double  stained  with  antibodies  against  F4/80  (PE) and  CD40  (Cy-chrome). 
The percentage of double positive staining cells is shown on the top right corner of density plot. 
The  plot  on  the  top  row  is  the  control  of  F4/80  versus  Ig,  from  which  the  quadrant was  set. 
Uninfected  cells  and  LPS  treated  cells  serve  as  controls  for  the  infection.  Data  are  the 
representative of 3 experiments.
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Figure  3.12  Comparison  of  the  effects  of  infecting  BMMac  with  the  4  strains  of  S. 
typhimurium.  BMMac were  infected with 4  strains  of S.  typhimurium as  indicated  at  10  MOI. 
Cells  were  harvested  24  hours  post  infection  and  double  stained  with  F4/80  (PE)  and  CD40 
(Cy-chrome)  or  F4/80  (PE)  and  CD54  (FITC).  Uninfected  and  LPS  treated  BMMac  serve  as 
controls.
1453.2.4 Comparison of the infected BMMac and BMDC
After  determining  the  strain  of  S.  typhimurium  and  infection  dose,  we  then 
compared the effect of infection on BMDC as well as BMMac.
3.2.4.1  Infection rate
We  assessed  the  number  of  cells  carrying  intracellular  bacteria  24-hours  post 
infection  of  BMMac  and  BMDC  with  C5  (TS)  at  1   or  10  M.O.I.  Cytospin  slides 
were  prepared  and  cell  morphology  analysed  (Figure  3.13).  As  expected, 
uninfected  cells  had  no  bacterium  either outside  or inside  cells,  and  these  cells 
retained  good  viability  and  had  intact  nucleus  and  cytoplasm  (top  panel).  In 
contrast, at 1   M.O.I, some bacteria were seen  inside the cells (middle panel).  10 
times  higher  M.O.I  resulted  in  more  BMMac  and  BMDC  carrying  intracellular 
bacteria (bottom panel). As a result of the infection, some cells started to show an 
enlarged cytoplasm with  the presence of more vacuoles.  This was more evident 
for the infected BMMac than BMDC. We next calculated the infection rate of both 
types of cells, which  is expressed  as the  percentage of cells that internalised  at 
least  one  bacterium  within  100  counted  cells.  We  found  that  the  infection  rate 
was  less than  10%  for both  types of cells at  1   M.O.I.  As the  M.O.I  increased to 
10,  there were 40%  of BMMac and  30%  of BMDC carrying  intracellular bacteria 
(Figure 3.14).
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Figure 3.13  Morphological  changes of BMMac and  BMDC  24 hours after exposure 
to C5 (TS).  BMMac (left panel) and  BMDC (right panel) were  infected with  C5 (TS) at 1  
and  10  MOI.  Infected  cells  were  harvested  24  hours  post-infection  and  cytospins 
prepared. Slides were stained with the Diff-Quick staining set.  Photographic images were 
taken at a magnification of x100. Arrows indicate the internalised bacteria.
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Figure 3.14 Infection rate of BMMac and BMDC 24 hours after exposure to C5 (TS).  BMMac 
and  BMDC were infected with C5 (TS) at 1   and  10 M.O.I.  Cytospin slides of infected cells were 
made and stained by Diff-Quick staining set. The slide was examined under a light microscopy at 
a magnification of x100. The infection rate, expressed as the percentage of cells that internalized 
bacteria within 100 counted cells in three randomly chosen fields was compared between BMMac 
and BMDC. Results represent mean value of two independent experiments.
1483.2.4.2 Alteration of cell surface molecule expression
The  expression  of  a  number  of  cell  surface  molecules  involved  in  antigen 
presentation  and  co-stimulation  of T  cells  was  evaluated  by  flow  cytometry  on 
BMMac  and  BMDC  24  hours  after  C5  (TS)  infection.  Compared  to  uninfected 
cells,  indicated  as  medium  treated  cells  (Figure  3.15),  LPS  treated  cells  or C5 
(TS) infected BMMac showed greatly increased expression of CD40 and CD54, a 
moderate  increase  of  CD80  and  CD86,  but  no  change  in  expression  of  either 
MHC class II  l-A/l-E or class I  H-2Dd and  HLA-B27.  However,  in contrast to their 
uninfected  counterparts  (Figure  3.16),  LPS  treated  or  C5  (TS)  infected  BMDC 
dramatically increased the expression of CD86, CD80, CD40.  Unlike BMMac, the 
expression  of MHC  class  II  l-A/l-E  in  BMDC was  also  significantly  upregulated. 
CD54 expression was increased to a moderate extent,  and the expression of H- 
2Dd and  HLA-B27 was slightly increased.  Infection did not change expression of 
CD11  b, CD11  c or F4/80 on either type of cells.
3.2.4.3 Nitrite production
The production of reactive NO was assessed by quantitating the accumulation of 
NO2"  in  the  supernatant  of  infected  cells  at  24  hours  post  infection  using  the 
Griess assay.  Infection with  C5  (TS)  at  10  M.O.I  induced  significant amounts of 
reactive NO from both BMDC and BMMac, which followed the same trend as that 
of LPS treated  cells (Figure 3.17).  More NO was detected from C5 (TS) infected 
BMDC than BMMac.
1493.2.4.4 Secretion of pro-inflammatory cytokines
The production of a range of pro-inflammatory cytokines by BMMac and BMDC in 
response  to  C5  (TS)  infection  was  examined  by  flow  cytometry.  No  cytokines 
were detected  in uninfected either BMMac or BMDC, whereas TNF-a, IL-6,  IL-12 
(p40)  were  expressed  by  LPS  treated  BMMac  and  BMDC.  IFN-y  was  not 
detected  in  untreated  or  treated  cells.  Upon  C5  (TS)  infection  (10  M.O.I),  we 
found  that the  majority  of BMMac expressed  large  amounts  of TNF-a,  IL-6  and 
IL-12p40.  In contrast, only a small proportion of BMMac expressed TNF-a, IL-6 or 
IL-12p40  after  SL3261  infection  (Figure  3.18).  In  BMDC,  however,  it  was 
observed that both strains induced expression of TNF-a,  IL-6 and  IL-12p40 upon 
infection at 10 M.O.I, and that SL3261  did so to a greater extent than to C5 (TS) 
(figure  3.19).  Finally,  although  a  similar  pattern  of  cytokine  production  was 
detected  on  both  cell  types  after  10  M.O.I  C5  (TS)  infection,  overall,  BMDC 
expressed lower amounts of cytokines compared to BMMac.
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Figure  3.15  Alteration  of  cell  surface  marker  expression  on  BMMac  after  24  hours 
exposure  to  C5  (TS).  BMMac  were  infected  with  C5  (TS)  at  1   and  10  MOI  for 2  hours.  In 
parallel,  cells  cultured  in  medium  or  in  the  presence  of  1|ig/ml  LPS  were  used  as  controls. 
Following  infection,  remaining  bacteria  were  washed  away  and  the  cells  cultured  for  an 
additional 24  hours  in the presence of 50  pg/ml gentamicin.  Cells were harvested and stained 
with antibodies recognizing CD54, H-2Dd, HLA-B27, CD11b,  F4/80, CD40, l-A/l-E, CD80, CD86 
and  CD11c.  Histograms  show expression  of markers  of BMMac  under different conditions  as 
indicated. Results are representative of two independent experiments.
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Figure  3.16  Alteration  of  cell  surface  marker  expression  on  BMDC  after  24  hours 
exposure  to  C5  (TS).  BMDC  were  infected  with  C5  (TS)  at  1   and  10  MOI  for  2  hours.  In 
parallel,  cells  cultured  in  medium  or  in  the  presence  of  1pg/ml  LPS  were  used  as  controls. 
Following  infection,  remaining  bacteria  were  washed  away  and  the  cells  cultured  for  an 
additional 24 hours in the presence of 50 pg/ml  gentamicin.  Cells were harvested and stained 
with antibodies recognizing CD54, H-2Dd, HLA-B27, CD11b,  F4/80, CD40, l-A/l-E, CD80, CD86 
and  CD11c.  Histograms  show  expression  of markers  of  BMDC  under  different  conditions  as 
indicated. Results are representative of two independent experiments.
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Figure 3.17 Nitrite production  by  BMMac and  BMDC 24 hours after exposure to C5 (TS).
BMMac and BMDC were infected with C5 (TS) at 10 MOI for 2 hours.  In parallel, cells cultured 
in  medium  or  in  the  presence  of  1pg/ml  LPS  were  used  as  controls.  Following  infection, 
remaining bacteria were washed away and the cells were cultured for an additional 24 hours in 
the  presence  of  50  |ng/ml  gentamicin.  Supernatants  of  cultures  were  harvested,  and  nitrite, 
which  is  the  stable  product  of  nitric  oxide,  was  measured  by  the  Griess  assay.  The 
concentration of nitrite was calculated  using a standard curve of sodium  nitrite.  Results are the 
mean values ± SD of triplicate for each sample.
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Figure 3.18 Cytokine secretion of BMMac 24 hours after exposure to C5 (TS) or SL3261.
BMMac were infected with C5 (TS) or SL3261  at 10 MOI for 2 hours. In parallel, cells cultured in 
medium or in the presence of 1pg/ml LPS were used as controls. Following infection, remaining 
bacteria  were  washed  away  and  the  cells  were  cultured  for  an  additional  24  hours  in  the 
presence of 50 pg/ml gentamicin. Cells were harvested and stained with antibodies recognising 
TNF-a (APC), IL-6 (PE), IL-12p40 (PE) and IFN-y (FITC). Percentage of cytokine secreting cells 
is indicated. Data are representative of 3 experiments.
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Figure 3.19  Cytokine secretion  of BMDC  24  hours after exposure to  C5  (TS)  or SL3261.
BMDC  were  infected with  C5(TS) and  SL3261  at  10  MOI  respectively for 2  hours.  In  parallel, 
cells cultured  in  medium  or in  the  presence  of  1   (ig/ml  LPS were  used  as  controls.  Following 
infection, remaining bacteria were washed away and the cells were cultured for an additional 24 
hours in the presence of 50 pg/ml gentamicin. Cells were harvested and stained with antibodies 
recognising  TNF-a  (APC),  IL-6  (PE),  IL-12  (PE)  and  IFN-y  (FITC).  Percentage  of  cytokine 
secreting cells is indicated. Data are representative of 3 experiments.
1553.3 Discussion
The  aim  of this  part of study was to  set  up  a  reproducible  in  vitro experimental 
system  to  supply  a  large  number  of  S.  typhimurium  activated  but  relatively 
healthy BMMac and BMDC for in vivo adoptive transfer.
We have employed murine bone marrow cells that were grown in the presence of 
M-CSF  (CSF-1),  a  colony-stimulating  factor that  has  been  shown  to  induce the 
proliferation  and  differentiation  of  macrophages  from  their  precursor  cells 
(Tushinski  et al.,  1982).  Although  in  a few studies  the  investigators  have  used 
highly  purified  M-CSF to culture  BMMac (Tushinski  and  Stanley,  1983),  in  most 
studies  crude  supernatants  generated  from  transformed  cell  lines  such  as 
Ladmac cells have been used as a source of M-CSF (Calamai et al.,  1982; Hume 
and Gordon,  1983;  Lee and Wong,  1982;  Ponniah et al.,  1996). The Ladmac cell 
line  was  made  by  transfecting  highly  enriched  macrophage  progenitors  from 
mouse bone marrow cells with  a  human oncogene,  R-myc, therefore resulting in 
its  constitutive  secretion  of  M-CSF  that  was  capable  of  supporting  the  in  vitro 
proliferation  of bone marrow macrophages (Sklar et al.,  1985). A previous study 
used 20% of this supernatant in cultures to supply the required amount of M-CSF 
(Ponniah  et  al.,  1996).  In  our study,  we  quantified  the  M-CSF  contained  in  the 
supernatant  collected  from  different  batches  of  Ladmac  cell  cultures  and  found 
that 20%  Ladmac cell supernatant was equivalent to 6~9  ng/ml  recombinant M- 
CSF, which was similar to the required concentration of M-CSF (1000~2000U/ml 
corresponds  to  6~12  ng/ml)  for  yielding  a  maximum  proliferative  response  in 
BMMac culture  (Tushinski  et al.,  1982).  Furthermore,  unlike the short period  of
156culture for BMMac used  in other studies (Calamai et al.,  1982)  (Pannetier et al., 
2004) we cultured BMMac for 3 weeks in order to improve cell yield.
Some reports have shown that the generation of exclusively immature DC by the 
use of GM-CSF alone (Inaba et al.,  1992;  Labeur et al.,  1999;  Lu et al.,  1997; Lu 
et al.,  1995), whereas others yielded mature DC by combination of GM-CSF and 
IL-4  (Garrigan  et al.,  1996)  (Antonysamy et al.,  1999;  lldstad  and  Sachs,  1984; 
Mayordomo et al.,  1997).  IL-4  is typically  used  in  combination with  GM-CSF for 
the  generation  of  DC  from  human  monocyte-derived  DC,  where  it  inhibits  the 
outgrowth of macrophages (Menges et al., 2005).  However, for the generation of 
murine  BMDC,  IL-4  is  not  required  to  influence  the  simultaneous  outgrowth  of 
macrophages  especially  when  high  dose  of  GM-CSF  are  used  in  the  culture. 
Instead,  it acts  on  immature  DC  to  promote  their  maturation  (Lutz et al.,  2000) 
and  also  enhances  their  LPS-induced  IL-12  production  (Hochrein  et  al.,  2000; 
Lutz et al., 2002). A panel of stimulators such as TNF-a,  LPS or CD40 L can also 
be  used  to  induce  further  maturation  of  DC  in  the  later  stages  of  culture 
(Banchereau and Steinman,  1998; Celia et al.,  1997). Thus, in order to yield more 
immature  DC,  we  chose  to  use  GM-CSF  alone  for  our  BMDC  culture  with  the 
absence of IL-4 or other maturation stimulators. A commercial source of GM-CSF 
was  used  due  to  a  lack  of a  GM-CSF  secreting  cell  line  in  our  laboratory.  We 
adapted our protocol from previously described methods (Inaba et al.,  1992; Lutz 
et al.,  1999).  It has  been  documented  that GM-CSF  can  stimulate three distinct 
types  of  myeloid  cells,  i.e.  granulocytes,  macrophages  and  DC  (Inaba  et  al., 
1992;  Lutz  et  al.,  2000).  In  these  studies,  three  stable  populations  were 
generated with  GM-CSF:  DC and  granulocytes  in  nonadherent or semi adherent
157state  with  macrophages  in  a  firmly  adherent  state.  However,  after some  major 
modifications made to the basic protocol applied by those investigators,  Lutz and 
colleagues found that application  of a very  low seeding  density of bone  marrow 
cells (2 x  105/ml) and the reduction of GM-CSF dose (10 ng/ml) at a later stage of 
culture  could  dramatically  reduce  granulocyte  contamination  (Lutz et al.,  1999). 
We followed their protocol with some further modifications. We found that after 7- 
days  stimulation  with  GM-CSF,  adherent  cells  expressed  comparable  levels  of 
the  DC marker CD11c on their surface as nonadherent cells (Figure 3.4).  These 
cells  have  been  assumed  to  be  macrophages  in  other studies  without detailed 
characteristation  of  this  population  (Inaba  et  al.,  1992;  Lutz  et  al.,  1999). 
Furthermore,  by  harvesting  solely adherent populations,  we further  reduced  the 
contamination of granulocytes to less than  10% of cells expressing Gr-1  (20% of 
nonadherent cells expressing Gr-1). More importantly, compared to non-adherent 
cells,  adherent  cells  showed  a  more  immature  phenotype  illustrated  by  the 
greater  proportion  of  cells  expressing  low  levels  of  MHC  class  II  (Figure  3.4), 
which  was  also  observed  in  other  studies  (Menges  et  al.,  2005;  Peche  et  al., 
2005;  Vecchione  et  al.,  2002)  regardless  of  species.  Given  all  these  reasons, 
instead  of the  nonadherent population,  we  harvested  the  adherent population  of 
our DC culture. Adherent BMDC have been chosen to be used in studies such as 
that by Muthana and colleagues (Muthana et al., 2004) although the nonadherent 
population  of  BMDC  is  generally  used  (Fischer et  al.,  2001;  Lutz et  al.,  1999). 
One  of  the  aims  of  our  BMDC  culture  was  to  generate  immature  DC  before 
infection with S. typhimurium and to have large numbers for adoptive transfer into 
mice.  Unfortunately,  discarding  nonadherent  populations  from  our  DC  culture 
resulted  in  wasting  more  than  half the  population  of CD11c  (+)  DC.  In  order to
158enrich  nonadherent  cells  and  achieve  a  maximal  purity  of  BMDC  culture,  we 
employed  tissue  culture  flasks  instead  of  petri  dishes  to  grow  the  cells,  which 
allowed  more  space  for  cells  to  grow  in  an  adherent  state.  Muthana  and 
colleagues  also  employed  tissue  culture  flasks  for  propagating  their  adherent 
BMDC (Muthana et al., 2004). After 7-days culture using this approach, we found 
that two thirds of cells generated were adherent.
The  day  of harvesting  the  DC  culture  can  influence  the  maturation  state  of DC 
(Lutz et al.,  1999). We found that harvesting DC at day 5 also led to a lower yield 
(Table  3.2).  Although  Lutz  et  al  found  that  BMDC  purity  and  yield  could  be 
further  enhanced  if the  culture  was  extended  until  day  10~12,  many  of  these 
BMDC  might  have  reached  their  final  stage  of  maturation  and  thus  started  to 
show signs of apoptosis (Lutz et al.,  1999). More importantly, they found that the 
optimal  stimulation  of  allogeneic  T  cells  was  on  days  8~10.  Thus  to  obtain  a 
balance  of  immature  DC  with  a  good  yield  of  cells,  day  8  was  chosen  as  the 
harvest day to maintain a high cell yield and optimal T cell stimulation capacity.
Phenotypically, we distinguish  BMDC from  BMMac by their different myeloid  cell 
surface  marker  expression.  BMDC  were  defined  as  CD11b  (+)  CD11c  (+), 
whereas  BMMac were CD11b (+)  CD11c (-)  (Figure  3.6 and  3.7).  This definition 
was  also  applied  by  Macpherson  and  colleagues  to  sort  their  DC  and 
macrophages from mesenteric lymph nodes or Peyer’s patches (Macpherson and 
Uhr, 2004). The overall characterisation of these two types of cells is summarised 
in Table 3.4.
159Table 3.4 Comparison of cell surface molecules expression on BMDC and BMMac
Molecule BMDC BMMac
CD11b (+++) (++)
CD11c (+++) (-)
F4/80 (+) (++)
Class II (++) (-)
Class I (+++) (+++)
HLA-B27 (+) (+)
Gr-1 (-) (-)
CD3 (-) (-)
B220 (-) (-)
160However  both  BMMac  and  BMDC  expressed  F4/80,  an  established  marker for 
macrophages  (Sadahira  and  Mori,  1999).  F4/80  was  also  found  consistently  at 
low levels on BMDC generated by principle DC protocols (Inaba et al.,  1992; Lutz 
et  al.,  1999),  which  revealed  that  F4/80  is  not  specifically  expressed  by 
macrophages.  So far macrophages  have  no distinctive  cell-surface  antigen that 
allows for their enrichment (van Furth,  1992). Thus, although we used F4/80 as a 
marker for macrophages, it is important to be aware that F4/80 cannot be used to 
distinguish BMMac from BMDC.
Mouse MHC class II  l-A/l-E was not expressed by BMMac, but was expressed by 
BMDC,  further  supporting  the  claim  that  these  were  two  distinct  populations. 
Furthermore, the class II expression on  BMDC was heterogeneous,  as shown  in 
Figure  3.7,  two  subpopulations could  be detected  by their distinct level  of MHC 
class  II  expression,  the  MHC  class  lllo w   cells  referred  to  as  immature  DC 
compared  to  MHC  class  llh ,9h   cells  referred  to  as  mature  DC.  Such 
heterogeneous expression on  BMDC cultures is an agreement with other studies 
(Cheminay et al., 2002; Inaba et al.,  1992; Lutz et al.,  1999).
Unlike  class  II  molecules,  MHC  class  I  molecules  are  expressed  on  nearly  all 
tissue cells,  and  in this study,  we found that BMDC and  BMMac both expressed 
the mouse  MHC  class  I  molecule-H-2Kd.  HLA-B27 was also expressed  by both 
types  of cells  as the  bone  marrow was  derived  from  HLA-B27  transgenic mice. 
Modifications to the cultures also ensured a low number of contaminating Gr-1  (+) 
granulocytes  in  the  cultures.  The  absence  of  B220  (+)  and  CD3  (+)  cells  also 
confirmed  the  purity  of  the  culture;  the  use  of  adherent  populations  in  both
161cultures ensured a lower level of contaminating cells since granulocytes, T and B 
cells all grow in a nonadherent state.
In  summary,  highly  enriched  cultures  of  macrophages  and  DC  were  generated 
from the bone  marrow of HLA-B27 transgenic mice and  could  be grown  in  large 
numbers for all subsequent experiments.
S.  typhimurium  is  a  causative  organism  for  ReA  accounting  for  60%  of 
Sa/mone//a-induced  ReA  cases  (Maki-lkola  O,  1991).  Consequently,  it  is 
imperative to  know what effect  S.  typhimurium has  on  the  immune system  and, 
specifically,  its  effect  on  the  cells  it  invades,  i.e.  macrophages  and/or  DC.  To 
investigate  this,  BMMac  and  and  BMDC  were  infected,  in  vitro,  with  several 
attenuated  strains  of  S.  typhimurium  at  different  M.O.I,  and  the  effect  on 
expression  of  cell  surface  molecules  analysed.  The  reason  for  use  of  the 
attenuated strain  is that infection with  such strains  in  mice causes an  analogous 
pathology to that observed in man caused by the wild type S.  typhimurium. Since 
S.  typhimurium induced gastroenteritis can trigger ReA in humans,  inoculation of 
attenuated  S.  typhimurium in  mice serves a good  model for the study of ReA in 
humans.
It  was  important  to  establish  an  infection  protocol  that  led  to  a  good  rate  of 
infected  cells that  remained  in  an  activated  but  healthy  state.  Firstly,  we  had to 
choose  the  state  of  bacterial  growth.  Bacteria  in  logarithmic  growth  are  more 
active,  viable  and  have  increased  invasive  ability  as  compared  to  stationary 
phase  bacteria.  In  previous  work  in  our  lab,  when  stationary  phase  of bacteria
162were used to infect macrophages, the maximal  infection  rate was only  10%. We 
found  that  the  infection  rate  using  mid-log  phase  bacteria  (180  minutes) 
enhanced infection rate up to approximately 50%.
We  then  set  out  to  select  the  optimal  strain  and  infection  conditions  using 
BMMac.  Experiments  for  optimisation  of  strains  and  titration  of  M.O.I  revealed 
that SL3261  and waaN were not suitable agents for our experiments, since even 
at low M.O.I  (10),  cells showed  poor signs of activation.  This was due to the fact 
that cells were killed to a much greater extent by these trains than by Lb5010 and 
C5  (TS)  (Figure  3.9-3.12).  SL3261  and  waaN  infected  cell  death  were  also 
reflected  by  the  profiles  of  FSC  vs  SSC  and  further  confirmed  by  cytospin 
preparations (data not shown).
The  apparent  cytotoxicity  of SL3261  and  waaN  strains to  macrophages  at  high 
M.O.I  is  not unexpected.  Using  time-lapse  video  microscopy,  it has  been  found 
that  cytotoxicity  caused  by  Salmonella  is  initially  manifested  by  inhibition  of 
membrane  ruffling  and  macropinocytosis  in  infected  macrophages,  followed  by 
cell  death  (Chen  et  al.,  1996a).  It  was  also  reported  that  Salmonella  cytotoxic 
effects are strictly dependent upon the expression of invasion-associated Type III 
protein-secretion  (Hersh  et  al.,  1999;  Monack  et  al.,  1996).  The  4  strains  of 
Salmonella we  used  are all attenuated  in different ways.  SL3261  and waaN  are 
mutants  in  aroA  (auxotrophic)  or  waaN  (catalyse  lipid  A  biosynthesis)  genes 
respectively,  which  encode  proteins that are  not required  for bacterial entry into 
cells,  so  they  remain  cytotoxic to  macrophages.  In  contrast,  Lb5010  is a  poorly 
invasive  mutant,  which  may  somewhat  impair  its  cytotoxic  ability  and  result  in
163less macrophages being killed. For C5 (TS), it is possible that the 2-hour infection 
of  macrophages  and  bacteria  at  30°C  restricts  the  optimal  expression  of  its 
TTSS.  Consequently,  infected  cells  keep  a  healthy  appearance  in  the  presence 
of infection at high M.O.I. Together with its ability to persist in  peripheral areas in 
vivo and readily cause arthritis, we decided to use this strain of S.  typhimurium to 
carry on the following experiments
In  terms of the  infection  rate,  our data suggested  that  under the  same  infection 
conditions, there are more BMMac (40%) compared to BMDC (30%) infected with 
S.  typhimurium resulting in more S.  typhimurium residing inside the infected cells 
(Figure  3.13).  However,  it  was  reported  that  when  bovine  monocyte-derived 
macrophages and  DC were  infected with  S.  typhimurium at a M.O.I  of  10,  there 
was only approximately 10% of infected cells carrying intracellular bacterium, and 
no  difference  was  detected  between  macrophages  and  DC  regarding  of  the 
number  of  bacteria  recovered  intracellularly  (Norimatsu  et  al.,  2003).  This 
discrepancy may due to the  application  of different protocols  in  determination of 
the infection  rate.  In their study, they lysed  infected cells and then calculated the 
CFU,  according  to  the  number  of  cells  put  into  infection  and  figured  out  the 
infection  rate.  In  contrast,  we  counted  the  visible  bacteria  inside  the  cells  to 
obtain the  infection  rate on  cytospin  preparation from  infected  cells.  Notably, we 
also  found  that there were  some  cells  with  numerous  intracellular  bacteria  and 
some cells with just one engulfed bacterium (Figure 3.13), which again would not 
be  reflected  in  their  protocol.  Furthermore,  it  was  suggested  that  these 
intracellular  S.  typhimurium  may  not  necessarily  represent  a  static  population, 
and their fate may differ depending on whether they were up taken  by BMDC or
164BMMac.  Indeed,  it  has  been  demonstrated  that  after  infection  of  RAW264.7,  a 
macrophage  cell  line,  a  rapid  proliferation  of  wild-type  S.  typhimurium  was 
observed. This proliferation  required virulence genes encoded  by SPI-2,  since a 
mutant strain deficient in SPI-2 function did  not replicate.  In contrast,  the data of 
the fate of intracellular S.  typhimurium inside  DC  remain  controversial,  although 
SPI-2  mediated  virulence  factors  were  also  activated  in  BMDC,  no  increase  of 
intracellular bacteria, either wild type or SPI-2 deficient, was observed  in infected 
BMDC,  indicating that intracellular S.  typhimurium in  BMDC were a  non-dividing 
population  (Jantsch  et al.,  2003).  However,  another study  also  claimed  that  not 
only  could  S.  typhimurium  survive  within  DC,  but  some  replication  of  these 
bacteria  could  also  occur  intracellularly,  as  has  been  observed  for  cultured 
macrophages  (Marriott  et  al.,  1999a).  Further  studies  about  the  fate  of 
intracellular S. typhimurium inside DC and macrophages will be required.
We  have  shown  that  BMMac  and  BMDC  were  both  activated  by  C5  (TS) 
infection,  reflected  by upregulation of a number of cell surface molecules (Figure 
3.15 and  3.16), which  is consistent with the findings of others (Yrlid et al., 2000). 
Firstly,  in  response to C5 (TS)  infection, we found that BMMac greatly increased 
CD40 and CD54, whereas,  BMDC markedly increased  CD80,  CD86 and MHC-II 
but  to  lesser  extent  increased  CD40  and  CD54.  Low-dose  S.  typhimurium 
infection has also been shown to induce a marginal increase in CD40 on BMMac 
with  no  detectable  increase  in  expression  of  the  other  surface  molecules 
(Norimatsu  et  al.,  2003).  CD40  and  CD40  ligand  belong  to  the  TNF  family  of 
receptor  and  ligands.  These  molecules  play  a  role  in  stimulating  the  T-cell 
response,  and  CD40  is  also  involved  in  macrophage  and  B  cell  activation.
165Previous studies have demonstrated that in vitro treatment of Sa/A7?o/7e//a-infected 
macrophages  from  BALB/c  mice  with  soluble  trimeric  CD40  ligand  results  in 
elevated  production  of interleukin  12p70  by these  cells,  suggesting  CD40-CD40 
ligand  interactions  are  significant events  in  the  protective  response  against this 
intracellular pathogen  in  mice (Marriott et al.,  1999b). A heightened susceptibility 
to intracellular pathogens is observed  in CD40L-/- mice, which  is associated with 
impaired  macrophage  activation  and  an  altered  inflammatory  response,  as 
reflected  by  low  levels  of  TNF,  NO  (Soong  et  al.,  1996)  and  IL-12  production 
(Campbell  et al.,  1996).  These  studies  in  combination  with  our  results  showing 
that  BMMac  expressed  higher  levels  of  inflammatory  cytokines  compared  to 
BMDC upon S. typhimurium infection suggest that macrophages contribute to the 
first line against S. typhimurium invasion to a greater extent than DC.
CD54,  also known as intercellular adhesion  molecule  1   (ICAM-1),  binds to T cell 
integrin  LFA-1,  which  stabilizes  the  association  between  the  antigen-specific T 
cell  and  antigen-presenting  cell.  Together with  other  members  of same  family, 
such as I CAM-2 and  ICAM-3,  it also plays part in  recruitment of immune cells to 
inflammatory sites,  especially it is used for circulating monocytes to navigate out 
of vessels and enter peripheral tissue sites. Therefore,  significant upregulation of 
CD54  expression  on  BMMac  in  response  to  C5  (TS)  infection  is  not  only  an 
indicator of macrophage  activation  but  also  contributes  to  their emigration  from 
site of infection, which could also be utilized by intracellular bacteria as a vehicle 
to  facilitate  their  dissemination.  Therefore,  activation  of  macrophages  upon  S. 
typhimurium infection could be a double-edged sword.
166On  the  other  hand,  costimulatory  molecules  CD80  (B7-1)  and  CD86  (B7-2) 
together  with  MHC  molecules  are  involved  in  antigen  presentation  and 
stimulation  of T cells.  Compared  to  a  moderate  increase  of their expression  on 
BMMac, they were dramatically elevated by BMDC after C5 (TS) infection (Figure 
3.16).  Selective  upregulation  of costimulatory  molecules  by  BMDC  is consistent 
with  their  more  potent  ability  to  stimulate  T  cell  responses.  This  issue  will  be 
further  discussed  in  chapter  6.  BMMac  failed  to  increase  expression  of  either 
MHC class  I  or class  II.  Rather,  some downregulation  of class  I  molecule  H-2Dd  
was  observed.  In  striking  contrast,  class  I  (H-2Dd  and  HLA-B27)  and  class  II  I- 
A/l-E  were  both  upregulated  on  BMDC.  These  differences  point  to  further 
differences  in  antigen  presentation  capacity.  These  results  are  consistent  with 
other reports that co-incubation of BMDC or BMMac with  S.  typhimurium results 
in  upregulation  of a  number of cell  surface  molecules  (Niedergang  et al.,  2000; 
Norimatsu et al., 2003; Yrlid et al., 2000).  Furthermore, it has been demonstrated 
that such  upregulation  of cell  surface  molecules  does  not require  internalisation 
of  the  bacteria,  nor  does  it  require  that  the  bacteria  are  viable,  since  similar 
upregulation  of the  surface  molecules  is  observed  upon  co-culture  of BMDC  or 
BMMac with S.  typhimurium in the presence of CCD, an inhibitor of phagocytosis 
or with heat-killed bacteria (Svensson et al., 2000; Yrlid et al., 2000).  In the latter 
study, it was shown that PhoP, the gene involved  in cell invasion encoded by the 
SPI-1,  does  not appear to  influence  surface  expression  of molecules  by  BMDC 
(Svensson et al., 2000).
Co-incubation  of  BMMac  or  BMDC  with  LPS  resulted  in  effects  on  surface 
molecule  expression  similar  to  those  observed  with  intact  bacterium,  that  is,  a
167shift  from  a  population  with  heterogeneous  levels  of  expression  of  to  a  more 
uniform  population  expressing  a  similar,  high  level  of some  molecules,  such  as 
CD40  on  BMMac (Figure 3.15). This also confirmed that bacterial viability is not 
required for S. typhimurium-mduced activation of both BMMac and BMDC.
NO is one of the radicals belonging to the RNS, together with ROS, generated by 
the NADPH oxidase and  iNOS (MacMicking et al.,  1997). The production of RNS 
and  ROS  by phagocytes  is of particular significance in  resistance to  intracellular 
pathogens (Vazquez-Torres et al., 2000a). We have shown that both BMMac and 
BMDC  produced  significant  amounts  of  NO  in  response  to  C5  (TS)  infection 
(Figure3.17).  NO was also produced by LPS treated cells. Additionally, we found 
that there was a greater amount of NO generated by BMDC compared to BMMac 
in  response  to  either  C5  (TS)  infection  or  LPS  treatment.  NO  production  by 
macrophages  has  been  extensively  demonstrated  and  accepted  as  a  major 
innate  defence  mechanism  to  restrict  bacterial  replication  as  discussed  above 
(Vazquez-Torres  et  al.,  2000a).  However,  the  production  of  NO  from  BMDC  in 
our  study  was  not  in  line  with  another  report  that  shows  BMDC  are  poor 
producers of NO after S.  typhimurium infection whereas macrophages are robust 
inducers  of  NO  (Yrlid  et  al.,  2000).  On  the  contrary,  other  studies  have  shown 
that murine DC greatly enhance the expression of iNOS and  NO production after 
ingestion  of  Salmoneila,  indicating  that  DC  may  also  participate  in  the  innate 
defence against intracellular bacteria (Eriksson et al., 2003; Muthana et al., 2004; 
Norimatsu  et  al.,  2003).  The  reasons  underlying  these  conflicting  results  are 
unclear,  although the  use of different populations of DC  (adherent vs adherent),
168DC  at  different  maturational  stages  or  application  of  different  protocols  might 
influence the NO production against S. typhimurium.
We  also  showed  that  C5  (TS)  infection  of  both  BMDC  and  BMMac  resulted  in 
increased production of a range of cytokines,  including TNF-a, IL-6 and IL-12p40 
but  not  IFN-y (Figure  3.18  and  3.19),  which  was demonstrated  by other reports 
(Norimatsu  et  al.,  2003;  Yrlid  et  al.,  2000).  Of  note,  we  found  that  selectively 
secreted  large  amount of TNF-a but only  small  quantities  of  IL-12p40  and  IL-6 
BMMac  upon  C5  (TS)  infection.  In  comparison,  overall  lower  levels  of  these 
cytokines were detected  after C5  (TS)  infection  of BMDC.  The  reduced  level  of 
cytokine  secretion  by  BMDC  may  due  to  the  shortened  incubation  time  after 
addition of brefeldin A during performance of intracellular cytokine staining,  since 
we  applied  overnight  incubation  (12  hours)  for  BMMac  but  6  hours  for  BMDC 
before  we  detected  any  cytokine  expression.  However,  it  is  also  possible  that 
these two types of cells exhibit inherent difference in cytokine production after S. 
typhimurium  infection.  Although  we  did  not  test  IL-1 p  production,  it  has  been 
reported that IL-1 p is also produced by both types of APCs upon  S.  typhimurium 
infection at a  level similar to other cytokines (Marriott et al.,  1999a;  Norimatsu et 
al., 2003).
The  detection  of  cytokine  production  after  S.  typhimurium  infection  suggested 
that  both  cells  participate  in  initiating  a  proinflammatory  response.  Previous 
studies  using  CCD  treatment  and  green  fluorescent  protein  (GFP)  have  shown 
that  although  CCD  treatment  leads  to  partial  inhibition  of  cytokine  production, 
significant  cytokine  production  by  both  types  of  cells  occurs  in  the  absence  of
169bacterial  internalization,  since  a  major fraction  of cytokine  producing  cells were 
GFP negative, did not contain internalised bacteria  (Yrlid and Wick, 2002).  In our 
study, we also observed a similar effect when we studied the cytokine response 
of  BMDC  using  GFP  S.  typhimurium  (data  not  shown).  Four  fractions  of  cells 
were  present  in  the  coculture  of  DC  and  GFP  S.  typhimurium.  A:  GFP(+) 
cytokine(+),  B:  GFP(-)  cytokine(-),  C:  GFP(+)  cytokine(-)  and  D:  GFP(-) 
cytokine(+).  B  and  C  represent  cell  populations  that  failed  to  activate  cytokine 
production even when they were invaded. These cells perhaps have succumbed 
to the virulence factor secreted by bacteria such as SPI-2 encoding genes.  More 
interestingly,  the  existence  of  D  population  suggests  that  cell  contact- 
independent  soluble  components  of  bacteria  also  contribute  to  overall  cytokine 
production  consistent  with  the  finding  that  LPS  stimulation  also  dramatically 
induced  significant  amounts  of  cytokine  production  from  both  types  of  cells 
(Figure  3.18  and  3.19).  Interestingly,  it  has  been  previously  reported  that 
although  bacterial  viability  is  not  absolutely  required  for  cytokine  production  by 
infected  BMDC, the amount of cytokine detected  is significantly enhanced  by co­
incubation of APC with viable bacteria (Yrlid et al., 2000). This is in contrast to the 
case  for  infected  BMMac,  which  produce  approximately  the  same  amount  of 
cytokines using heat-killed or viable bacteria.
Previous  studies  of  IL-12p40  production  after  S.  typhimurium  infection  have 
yielded contradictory results.  Norimatsu and colleagues found that after exposure 
to  S.  typhimurium,  IL-12p40  was  released  from  infected  BMDC  but  not  from 
BMMac,  whereas  IL-10  expression  was  upregulated  in  BMMac  but  not  BMDC 
(Norimatsu  et  al.,  2003).  This  discrepancy  may  due  to  the  low  dose  of  S.
170typhimurium (0.001  M.O.I)  used  in their study of bovine  cells,  whereas we  used 
10  M.O.I  infection  in  our  mouse  model.  In  addition,  different  protocols  were 
applied in their and our studies, which may also play a part in generation of these 
different results.  IFN-y was suspected to be produced  by activated  macrophages 
in  our  early  studies  of  T  cells  responses,  assessed  by  ELISpots  assay.  In 
addition,  during  the  primary  response  of  oral  Salmonella  infection,  splenic 
macrophages are the main population producing IFN-y (Kirby et al., 2002). Based 
on  these  observations,  we  tested  IFN-y  production  on  S.  typhimurium  infected 
macrophages  and  DC  using  intracellular  cytokine  staining.  However,  no  IFN-y 
was detected in either BMMac or BMMac in response to C5 (TS) infection or LPS 
stimulation in vitro.
1713.4 Conclusion
We  have  established  an  optimal  in  vitro  experimental  system  for  supplying 
attenuated  S.  typhimurium  strain  C5  (TS)  infected  BMMac  and  BMDC  in  large 
numbers.  Increased expression  of a  numbers of cell surface  molecules together 
with  several  inflammatory cytokines and  NO were observed.  The fact that these 
activated  cells  carried  many  intracellular  bacteria  but  remained  healthy  in 
appearance was also achieved.  These  infected  cells are suitable to be  used for 
adoptive  transfer  into  mice  to  investigate  their migration  in  vivo  in  the  following 
chapter.
172Chapter 4: Migration of S. typhimurium infected 
BMDC and BMMac
4.1  Introduction
In the mouse oral infection model, S. typhimurium invades the intestinal mucosa 
mainly  through  M  cells,  colonizes  the  Peyer’s  Patches,  spreads  to  the 
mesenteric lymph nodes and finally disseminates to the spleen and liver (Jones 
and  Falkow,  1996).  In  addition,  it  has  been  shown  that  CD18-expressing 
phagocytes  including  DC  and  macrophages  are  involved  in  an  M-cell- 
independent  pathway  that  permits  bacteria  transportation  across  the  intestinal 
epithelium  (Vazquez-Torres  et  al.,  1999).  Although  the  interaction  of  S. 
typhimurium  with  APCs  such  as  DC  and  macrophages  in  vitro  has  been 
extensively demonstrated  (Chen et al.,  1996a;  Monack et al.,  1996;  Yrlid et al., 
2000;  Yrlid  and  Wick,  2000),  the  in  vivo  migration  pattern  of  those  cells  in 
response to  S.  typhimurium infection  has not been  addressed.  Using a system 
in  which  bone  marrow  derived  APCs  are  infected  in  vitro  and  then  their 
migration  is  examined  in  vivo  after  adoptive  transfer  into  mice  will  allow  the 
migratory patterns of APCs post S. typhimurium-infection to be studied.
S.  typhimurium infection  can trigger ReA (Hannu  et al.,  2002),  and  Saimonelia 
antigens such as LPS have been detected in synovial cells of patients with ReA 
(Granfors  et  al.,  1990).  In  patients  with  early  stage  Salmonella  infections, 
Salmonella could  be  identified  in  peripheral  blood  monocytes  (Kirveskari et al., 
1998),  suggesting  that  monocytes  play  a  role  in  transporting  Salmonella 
antigens to the joints of patients with  ReA,  although, convincing data to support
173this  assumption  are  still  lacking.  Additionally,  persistent  production  of  anti- 
Salmonella antibodies of IgM,  IgG,  and  IgA classes  is  known  to  be  present in 
Salmonella-triggered  ReA  (Maki-lkola  et  al.,  1991),  indicating  persistence  of 
Salmonella or components  in  the arthritic patients.  It  has  been  suggested  that 
HLA-B27 impairs the elimination of Salmonella within the host cells (Laitio et al., 
1997; Virtala et al.,  1997), which may offer an explanation for the persistence of 
ReA-triggering microbes in susceptible HLA-B27 individuals. HLA-B27 restricted 
CD8  T  cells  with  ReA  recognising  Salmonella  have  also  been  identified  in 
synovial fluids of patients (Hermann et al.,  1993).
In  order to  provide  insight  into  the  pathogenesis  of  ReA,  we  have  utilised  an 
HLA-B27  transgenic  mouse  and  Salmonella  infection  system  to  examine 
whether Salmonella-Infected  BMMac and BMDC can migrate to inflamed joints. 
After characterisation  of DC  and  macrophages  infected  with  S.  typhimurium in 
vitro, their in vivo migration was subsequently investigated  by adoptive transfer 
of fluorescently-labelled  cells  into  HLA-B27  transgenic  mice.  The  presence  of 
labelled cells in  non-lymphoid and  lymphoid tissues was examined 2 days after 
transfer under different conditions.
1744.2 Results
4.2.1 Migration profile of BMDC and BMMac after C5 (TS) infection
4.2.1.1 Migration profile of BMDC
To  investigate  the  in  vivo  migration  profile  of  BMDC  in  response  to  C5  (TS) 
infection,  BMDC  were  infected  with  C5  (TS)  at  10  M.O.I,  with  uninfected  cells 
serving as control.  Cells were harvested at 24 hours post-infection and labelled 
with the fluorescent dye CFSE prior to adoptive transfer. Approximately 5 x  106 
CFSE  labelled  cells  per  mouse  were  injected  intraperitoneally.  Single  cell 
suspensions were obtained from various non-lymphoid and lymphoid organs 48 
hours  post-injection  and the  CFSE  labelled  cells  (FL1+) were detected  by flow 
cytometry,  using  cells from  a  mouse that received  no  injection  of CFSE+  cells 
as  a  control  to  set the  CFSE+  region  gate.  An  example  of the  appearance  of 
recovered  cells  from  the  spleen  of  a  recipient  mouse  is  displayed  in  Figure
4.1 A. The number of labelled  cells appearing  in  R1  (CFSE+ cells) after 2  x  106 
total cells were collected  was compared  between  mice  receiving  uninfected  or 
C5 (TS)  infected  BMDC.  Compared to  uninfected  cells,  the  number of C5 (TS) 
infected  BMDC was significantly  reduced  in  the  peritoneal  lavage  (PL)  (Figure 
4.1B).  On the contrary, the number of C5 (TS) infected  BMDC was significantly 
increased  in  the  spleen  compared  to  the  number  of  uninfected  cells  (Figure 
4.1C). This was also observed in MLN (Figure 4.1 D). The number of uninfected 
and  C5  (TS)  infected  BMDC  was  similar  in  non-lymphoid  organs  such  as  the 
liver and  lung  (Figure 4.1E,  F), and other lymphoid tissues such as inguinal LN 
(ILN), popliteal LN (PLN) and Peyer’s Patches
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Figure  4.1  (A-l)  In  vivo  migration  profile  of  C5  (TS)  infected  BMDC  compared  to 
uninfected  BMDC.  Uninfected and  10  MOI C5 (TS) infected  BMDC were labelled with  CFSE. 
The  labelled  BMDC  were  subsequently  adoptively  transferred  into  mice  by  intraperitoneal 
injection.  Forty-eight  hours  later,  spleen,  liver  and  lung  were  digested  with  digesting  media 
containing collagenase (1  mg/ml) and DNase (0.5 mg/ml); lymph nodes (LN) and  PPs (Peyer’s 
Patches)  were  mashed  with  the  edges  of two  frosted  slides.  Numbers  of  labelled  cells  were 
calculated within 2  x  106 cells collected for each sample by flow cytometry.  (A) An example of 
how the number of labelled cells was derived from the spleen of a recipient mouse. Inset shows 
a control mouse without transfer, from which the region was set. (B-l) Empty circles (o) indicate 
uninfected  DC  and  solid  circles  (•)  indicate C5  (TS)  infected  BMDC.  Each  bar represents the 
mean  value  of  15  animals  unless  specifically  indicated.  Data  are  pooled  from  5  independent 
experiments  and  statistic  significance  was  analysed  using  one-way  ANOVA.  Number  of 
transferred cells recovered from PL (peritoneal lavage)(B), spleen (C) and MLN (mesenteric LN) 
(D), liver (E) and lung (F), ILN (inguinal LN)(G), PLN (popliteal LN)(H) and PPs (I). ***, p < 0.01.
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H •  ••(PPs) (Figure 4.1G,  H and  I). Thus, compared to their uninfected counterparts, 
a  decreased  number  of  transferred  cells  was  found  in  PL,  but  significantly 
greater  numbers  of  C5  (TS)  infected  BMDC  were  recovered  from  the  spleen 
and MLN.
4.2.1.2  Migration profile of BMMac
In order to evaluate their in vivo migratory ability after infection with C5 (TS), the 
same  procedure  of  adoptive  transfer  as  BMDC  was  performed  on  BMMac. 
Transferred  BMMac could  be detected  in  recipient mice although the  numbers 
were  lower than the  numbers of BMDC detected  (Figure 4.2A). After statistical 
analysis of all the data pooled from 5 independent experiments, we found that in 
PL, as found for BMDC, there was a greater number of uninfected than infected 
BMMac present (Figure 4.2B).  However,  unlike BMDC, an increased number of 
C5 (TS)  infected  BMMac was  not observed  in the spleen  or MLN  compared to 
uninfected  cells  (Figure  4.2C  and  D).  Comparable  numbers  of  uninfected  and 
C5 (TS) infected cells were also found in the liver and  lung (figure 4.2E and  F), 
and ILN and PLN (Figure 4.2G and H).  However, a slightly increased number of 
C5 (TS) infected BMMac compared to uninfected cells was found in PPs, which 
was statistically significant (figure 4.2I). Taken together, compared to uninfected 
cells,  C5  (TS)  infected  BMMac were decreased  in  number in  PL but increased 
in PPs with no differences in number in the others organs analysed.
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Figure 4.2  In  vivo  migration  profile  of C5  (TS)  infected  BMMac  compared  to  uninfected 
BMMac.  Uninfected  and  10  MOI  C5  (TS)  infected  BMMac  were  labelled  with  CFSE.  The 
labelled BMMac were subsequently adoptively transferred into mice by intraperitoneal injection. 
Forty-eight  hours  later,  spleen,  liver  and  lung  were  digested  with  digesting  media  containing 
collagenase (1  mg/ml) and  DNase (0.5 mg/ml);  lymph  nodes  (LN) and  PPs were mashed with 
the edges of two frosted  slides.  Numbers of labelled  cells were calculated within 2  x  106 cells 
collected for each sample by flow cytometry. (A) An example of how the number of labelled cells 
was  derived  from  the  spleen  of  a  recipient  mouse.  Inset  shows  the  control  mouse  without 
transfer, from which the region was set.  (B-l) Empty circles (o) indicate uninfected  BMMac and 
empty diamonds (0) indicate C5 (TS) infected  BMMac.  Each  bar represents the mean value of 
the  number  of  animals  as  indicated.  Data  are  pooled  from  5  independent  experiments  and 
statistic  significance  was  analysed  using  one-way  ANOVA.  Number  of  transferred  cells 
recovered from PL(B), spleen (C) and MLN (D), liver (E) and lung (F), ILN (G), PLN (H) and PPs 
(I). **,p< 0.05.
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0 0 0 0 0 0 04.2.2 In vivo fate of transferred cells.
An  argument  can  be  made  that  recovered  cells  may  have  been  taken  up  by 
endogenous  phagocytes  after  transfer,  hence  the  migration  profiles  we 
observed  might  not  be  the  behaviour of the transferred  cells.  To  address  this 
question,  BMDC  were  generated  from  BALB/c  mice,  and  uninfected  and  C5 
(TS)  infected  cells  were  transferred  into  HLA-B27  mice  after  CFSE  labelling. 
Cells were isolated 48 hours post-transfer from various tissues and stained with 
an antibody recognising  HLA-ABC.  Endogenous cells from  HLA-B27 host mice 
would  show  positive  staining  with  this  antibody,  whereas  the  transferred  cells 
would  be not stained. Therefore,  measuring the percentage of cells positive for 
CFSE,  HLA-ABC  or  both,  it  was  possible  to  distinguish  between  transferred 
cells that have or have not been internalised by host cells.  In PL (Figure 4.3), as 
shown previously a greatly reduced number of C5 (TS) infected (CFSE+) BMDC 
compared  to  uninfected  cells  were  recovered.  Upon  further  analysis  of these 
CFSE  (+)  cells,  less  than  15%  of  uninfected  and  around  20%  of  C5  (TS) 
infected  transferred  cells  expressed  HLA-ABC,  suggesting  that a  proportion  of 
transferred  cells  were  engulfed  by  endogenous  cells  and  that  this  effect was 
augmented  by  C5  (TS)  infection.  There was an  increased  proportion  of CFSE 
(+)  transferred  cells  (range  from  22%  to  37%)  expressing  HLA-ABC  in  the 
spleen  and  the  percentage  was  comparable  between  uninfected  and  C5  (TS) 
infected transferred cells (Figure 4.4).  In MLN (Figure 4.5) up to 70% and 62.6% 
of  uninfected  and  C5  (TS)  infected  CFSE  (+)  cells  expressed  HLA-ABC. 
However,  it  is worthwhile  to  mention  that a  very  small  population  of cells was 
recovered  from  MLN,  which  could  explain  why  a  higher  percentage  was
185observed.  Overall,  the data  showed  that approximately  one  third  of recovered 
transferred cells represented those engulfed by endogenous cells.
4.2.3  Recovery of bacteria from adoptively transferred cells in tissue.
To assess the role of BMDC in transportation of bacteria,  cells were infected in 
vitro  with  S.  typhimurium  strain  SL3261  engineered  to  express  GFP.  As  the 
bacteria were labelled with GFP, cells were labelled with the red fluorescent dye 
CMTMR  prior to adoptive transfer.  Labelled  cells were  recovered  from  various 
organs  at  48  hours  post-transfer  and  the  number  of  labelled  cells  in  those 
organs calculated. As previously observed S. typhimurium infected BMDC could 
be  recovered  from  spleen  and  liver and  to  a  lesser extent from  MLN  and  PPs 
(Figure 4.6 A).  In parallel, 2  x  106 cells from spleen and  liver,  and 2 x  105 cells 
from  MLN  and  PPs  were  lysed  with  Triton  X-100,  and  serial  dilutions  of the 
lysate plated on agar plates with and without addition of ampicillin (A+/-). As the 
GFP  plasmid  carries an  ampicillin-resistant gene,  the  presence  of colonies  on 
ampicillin  agar plates would  indicate  the  presence  of S.  typhimurium that  had 
infected the cells in vitro and was carried by these cells to the various organs in 
vivo.  Bacterial  colonies  (A+/-)  were  cultured  out,  mainly from  spleen  and  liver 
(Figure  4.6  B)  of 2  out  of  3  mice  receiving  GFP  expressing  SL3261  infected 
BMDC.  The  mouse  for which  no A+  bacteria  colonies  could  be  cultured  also 
exhibited  very  low  numbers  of  recoverable  transferred  cells  in  all  tissues, 
indicating an association between the number of recovered CMTMR+ cells and 
bacterial colonies from all the tissues analysed.
186Gated with R1
Uninfected
#1
aHLA-ABC
Figure 4.3  Investigation  of the fate  of adoptively transferred  BMDC  in  peritoneal  cavity.
DC were generated from bone marrow of BALB/c mice in the presence of GM-CSF. Uninfected 
and C5 (TS) 10 MOI infected DC were adoptively transferred to HLA-B27/p2m transgenic mice 
by intraperitoneal  injection  after labelling with  CFSE.  Two mice for the  uninfected  DC transfer 
group  and  3  mice  for  C5  (TS)  were  used.  Forty-eight  hours  later,  the  peritoneal  cavity  was 
washed,  and  cells were  harvested from  the  peritoneal  lavage and  stained  with  isotype control 
antibody  (APC  conjugate)  and  antibody  recognizing  HLA-ABC  (APC  conjugate).  The 
percentage  of  cells  double  positive  for  CFSE  and  HLA-ABC  is  indicated.  Results  are 
representative of two independent experiments.
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Figure  4.4  Investigation  of the  fate  of  adoptively transferred  BMDC  in  spleen.  DC  were 
generated from  bone marrow of BALB/c mice in the presence of GM-CSF.  Uninfected and C5 
(TS)  10  MOI  infected  DC  were  adoptively  transferred  to  HLA-B27/(32m  transgenic  mice  by 
intraperitoneal  injection  after  labelling  with  CFSE.  Two  mice  for  the  uninfected  DC  transfer 
group  and  3  mice for C5  (TS) were  used.  Forty-eight  hours  later,  spleens were  digested  with 
collagenase  (1  mg/ml)  and  DNase  (0.5  mg/ml),  and  splenic  cells  stained  with  isotype control 
antibody  (APC  conjugate)  and  antibody  recognizing  HLA-ABC  (APC  conjugate).  The 
percentage  of  cells  double  positive  for  CFSE  and  HLA-ABC  is  indicated.  Results  are 
representative of two independent experiments.
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Figure 4.5  Investigation  of the fate of adoptively transferred  BMDC  in  mesenteric lymph 
nodes (MLN).  DC were generated from  bone marrow of BALB/c mice in the presence of GM- 
CSF. Uninfected and C5 (TS) 10 MOI infected DC were adoptively transferred to HLA-B27/p2m 
transgenic  mice  by  intraperitoneal  injection  after  labelling  with  CFSE.  Two  mice  for  the 
uninfected  DC transfer group and  3 mice for C5 (TS) were used.  Forty-eight hours later,  MLN 
were mashed and the cells stained with  isotype control antibody (APC conjugate) and antibody 
recognizing  HLA-ABC  (APC conjugate).  The percentage of cells double positive for CFSE and 
HLA-ABC is indicated. Results are representative of two independent experiments.
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Figure  4.6  Intracellular  transportation  of  S.  typhimurium  in  BMDC  along  with  their 
migration. BMDC were infected with GFP-expressing S.  typhimurium strain SL3261  at 10 MOI. 
Twenty-four  hours  after  infection,  BMDC  were  labelled  with  5  |iM  CMTMR  and  adoptively 
transferred  to  HLA-B27/(32m  mice  (n=3)  by  intraperitoneal  injection.  Forty-eight  hours  later, 
spleen,  liver,  mesenteric  lymph  nodes  (MLN)  and  Peyer’s  Patches  (PPs)  were  isolated  and 
examined for migrated cells by flow cytometry. The numbers of CMTMR labelled cells within 2 x 
106  tissue cells are shown  in  panel A.  In  parallel,  2  x  106  cells from  spleen or liver or 2  x  105  
cells from  MLN  or PPs were  lysed with  0.2% Triton X-100.  Serial dilutions of the lysates were 
plated on agar plates without and with antibiotic (ampicillin indicated as A-/A+) to enumerate the 
total number of intracellular bacteria.  CFU were counted  in different tissues as shown  in  panel 
B.
190In  order  to  evaluate  the  ability  of  BMMac  to  transport  bacteria  after  S. 
typhimurium  infection,  similar  procedures  as  for  BMDC  were  carried  out  on 
BMMac.  Since  previous  results  had  shown  that  an  increased  level  of  BMMac 
cell death compared to BMDC occurred after infection with SL3261  at a M.O.I of 
10  (Figure  3.19),  the  M.O.I  was  reduced  to  1   M.O.  in  these  experiments.  To 
improve  the  efficiency  of  cells  being  recovered,  a  higher  concentration  of 
CMTMR  (25  pM)  was  used  to  label  the  cells  prior  to  adoptive  transfer. 
Moreover, as the numbers of S. typhimurium infected BMMac were recovered in 
very  small  numbers  compared  to  BMDC  in  all  organs  apart  from  PL,  lysates 
were  prepared  from  tenfold  more  tissues  cells  compared  to  BMDC.  Although 
small numbers of BMMac were recovered from tissues (Figure 4.7 A),  bacterial 
colonies  (both A+/-)  were  cultured  from  the  spleen  and  liver of the three  mice 
that had received GFP expressing SL3261  infected BMMac (Figure 4.7 B).
In  order  to  further  confirm  the  presence  of  bacteria  being  transported  to  the 
tissues  by transferred  cells,  confocal  microscopy was  used  to  detect GFP and 
CMTMR expression in cells.  Firstly,  BMMac were infected with GFP expressing 
SL3261  at 1   M.O.I and cells were harvested and labelled with 5 pM CMTMR 24 
hours  post-infection.  Cytospin  slides  were  prepared  from  these  labelled  cells 
and  examined  by  confocal  microscopy.  The  images  clearly  showed  that  GFP 
expressing bacteria (green) were present in CMTMR positive cells (red) (Figure 
4.8A  top  panels).  In  addition,  confocal  images  revealed  that  the  majority  of 
bacteria  were  detected  as yellow  indicating  they were  intracellular,  although  a 
few bacteria were surface bound, as indicated by their green fluorescence in the
191confocal  image  (Figure  4.8A  bottom  panel).  We  observed  that  about  33%  of 
BMMac were infected, which was similar to the previous data (Figure 3.14).
Examination  of  tissues  from  mice  receiving  transferred  BMMac  after  GFP 
SL3261  infection  by  confocal  microscopy  revealed  that  GFP  bacteria  were 
present  in  spleen  (Figure  4.8B).  However,  although  CMTMR  labelling  of cells 
was clearly visualised in cytospin preparations (Figure 4.8 A right column), none 
was detectable in tissues under confocal microscopy.
Taken together,  these data suggested that both  BMDC  and  BMMac were able 
to  carry  bacteria  to  the  tissues  such  as  the  spleen  and  liver  after  adoptive 
transfer.
4.2.4  Localisation of migrated BMDC in spleen
Since CFSE  labelling was  undetectable  under confocal microscopy,  in order to 
determine  the  localisation  of transferred  BMDC  after  migration  to  the  spleen, 
serial sections were prepared and analysed  by immunohistochemistry. An anti- 
FITC antibody was used to detect CFSE  labelled transferred cells and an anti- 
CD11c antibody as a  marker for DC.  Transferred  cells were distributed  mainly 
around  red  pulp with  some entering the  T cells zone of the white  pulp  (Figure 
4.9 left column). As expected, there were a greater number of cells stained with 
the anti-CD11c antibody compared to the anti-FITC antibody on serial sections 
due to the  presence  of endogenous  DC  (Figure 4.9  right column).  However,  it 
was evident that cells staining with both antibodies were co-localised on serial
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Figure  4.7  Intracellular  transportation  of  S.  typhimurium  in  BMMac  along  with  their 
migration. BMMac were infected with GFP-expressing S.  typhimurium strain SL3261  at 1   MOI. 
Twenty-four  hours  after  infection,  BMMac  were  labelled  with  25  pM  CMTMR  and  adoptively 
transferred  to  HLA-B27/|32m  mice  (n=3)  by  intraperitoneal  injection.  Forty-eight  hours  later, 
spleen,  liver,  mesenteric  lymph  nodes  (MLN)  and  Peyer’s  Patches  (PPs)  were  isolated  and 
examined for migrated cells by flow cytometry. The numbers of CMTMR labelled cells within 2 x 
106  tissue cells are shown  in  panel A.  In  parallel,  2  x  107  cells from  spleen  or liver or 2  x   106  
cells from  MLN  or PPs were  lysed with  0.2% Triton X-100.  Serial dilutions of the  lysates were 
plated on agar plates without and with antibiotic (ampicillin indicated as A-/A+) to enumerate the 
total  number of intracellular bacteria.  CFU were counted  in different tissues as shown  in panel 
B.
193Figure  4.8  Visualisation  of  GFP-expressing  S.  typhimurium  in  vitro  and  in  vivo  by 
confocal  microscopy.  (A)  BMMac were  infected  with  GFP-expressing  S.  typhimurium strain 
SL3261  at  1   MOI. The cells were  labelled  with  5  pM  CMTMR.  Cytospin  slides were  prepared 
from 2  x  105  labelled cells and examined  by confocal  microscopy.  (B)  BMMac were adoptively 
transferred into HLA-B27/(32m mice by intraperitoneal  injection after GFP SL3261  infection at 1  
MOI  and  CMTMR  labelling.  Sections  were  prepared  from  spleens  isolated  from  the  recipient 
mice  and  examined  by  confocal  microscopy  after  fixation.  Intracellular  S.  typhimurium  were 
visualized  by  GFP  fluorescence  (green),  and  CMTMR  was  detected  by  red  fluorescence.  In 
both A and  B,  panels show (clockwise from top left) GFP fluorescence,  CMTMR fluorescence, 
and  a  confocal  image  of  green  and  red  fluorescence.  Co-labelling  appears  yellow  in  the 
confocal image.sections  confirming  that the  distribution  of the  transferred  cells was  similar to 
endogenous DC.
To  further  examine  the  influence  of  BMDC  transfer  on  cell  distribution  in  the 
spleen,  cryostat  sections  were  prepared  from  the  mice  with  no  transfer, 
uninfected  DC  transfer  and  C5  (TS)  infected  DC  transfer  and  analysed  by 
immunohistochemistry.  As  shown  in  left  columns  of  Figure  4.10,  a  normal 
spleen from a mouse receiving no cell transfer showed evenly distributed areas 
of  white  pulp  with  similar  sizes.  DC,  identified  by  anti-CD11c  staining,  were 
distributed  uniformly  in  marginal  zones,  which  form  the  outer boundary  of the 
white pulp.  Uninfected  DC transfer caused  an enlargement of white pulp areas 
and  a  marked  increase  in  the  number of  DC.  Although  they  were  still  mainly 
confined  to  marginal  zones,  some  DC  appeared  to  cluster and  to  enter the  T 
cells  zones  (Figure 4.10  middle  left).  C5  (TS)  infected  DC  transfer  resulted  in 
the  fusion  of greatly  enlarged  areas  of white  pulp  (Figure  4.10  right  bottom). 
Increased  numbers  of  DC  were  observed  within  marginal  zones  and  the 
accumulated  DC  formed  clusters  and  had  migrated  into  the  centres  of T  cell 
zones to a greater extent than  that observed  with  uninfected  DC transfer.  The 
latter suggests a  greater extent of interaction  of DC with  T cells  localised  in  T 
cell zone (Figure 4.10 right bottom).
4.2.5  The ability of transferred cells to migrate to inflamed limbs
The  ability  of  S.  typhimurium  strain  C5  (TS)  to  grow  in  vivo  in  areas  of  low 
temperature makes this bacterium useful for inducing inflammatory arthritis.
195Anti-FITC Anti-CD11c
#1
#2
#3
Figure  4.9  Co-localisation  of  anti-FITC  and  anti-CD11c  staining  in  spleens  of  mice 
injected with  CFSE  labelled  DC.  BMDC  were  infected  with  C5  (TS) at  10  MOI.  Twenty-four 
hours  after  infection,  uninfected  and  C5  (TS)  infected  CFSE-labelled  DC  were  adoptively 
transferred  to  HLA-B27/(32m  mice.  Forty-eight  hours  later,  mice  were  sacrificed  and  serial 
sections were prepared from spleens and examined  by immunohistochemistry. Transferred DC 
were detected with  rabbit anti-FITC antibody followed  by biotin  conjugated  anti-rabbit  IgG  (left 
panel).  Sections  in  right  panels  were  stained  with  biotin  conjugated  anti-CD11c  antibody. 
Sections  in  all  panels were then  incubated  with  Vector ABC  complex and  the colour reaction 
(red)  was  developed  by  Vector  NovaRed  kit  before  counterstaining  with  hematoxylin.  Insets 
show  isotype control  staining.  Original  magnification,  x   20  in  all  panels.  Results  come from  3 
different  mice  as  indicated,  and  the  data  are  derived  from  3  independent  experiments.
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Figure  4.10  Histological  changes  in  the  spleen  induced  by  DC  transfer.  BMDC  were 
infected  with  C5  (TS)  at  10  MOI.  Twenty-four  hours  after  infection,  uninfected  and  C5  (TS) 
infected CFSE-labelled DC were adoptively transferred to HLA-B27/p2m mice. Forty-eight hours 
later,  spleen  sections  were  prepared  from  normal  mice  (top  panel),  mice  receiving  uninfected 
DC  (middle  panel) and  mice  receiving  C5  (TS)  infected  DC  (bottom  panel)  and  examined  by 
immunohistochemical  staining.  All  sections  were  stained  with  biotin  conjugated  anti-CD11c 
antibody followed  by  incubation  with  Vector ABC  complex  and  then  the  colour  reaction  (red) 
was  developed  by  Vector  NovaRed  kit  before  counterstaining  with  hematoxylin.  Original 
magnification,  x   4  in  left  panel  and  x   20  in  right  panel.  These  are  representative 
photomicrographs of histology from 3 experiments.
197Previous  study  has  shown  that  after  intravenous  infection  with  C5  (TS),  mice 
develop  inflamed  joints  by  3-4  weeks  post  inoculation  (Hormaeche  et  al., 
1981).  Cryostat sections were prepared from  inflamed joints after inflammatory 
arthritis  was  induced  in  mice  infected  with  intravenous  injection  of  C5  (TS). 
Immunohistochemistry  revealed  that  there  were  numerous  macrophages, 
indicated  by  F4/80  staining,  accumulated  and  infiltrated  in  those  areas  of 
inflammation  (Figure  4.11).  This  model  therefore  provides  an  opportunity  to 
address whether S.  typhimurium activated  macrophages are able to migrate to 
inflamed limbs after adoptive transfer.
BMMac were adoptively transferred to mice that had developed  inflamed joints 
induced  by  i.v.  C5  (TS),  and  cells were  recovered  from  PL,  axillary  LN  (ALN) 
and  PLN,  front  and  rear  paws  and  bone  marrow  (BM).  In  agreement  with 
previous  results,  a  greatly  reduced  number  of  C5  (TS)  infected  BMMac 
remained  in  PL  compared  to  uninfected  BMMac  (Figure  4.12A).  Very  few 
BMMac either uninfected or C5 (TS) infected, migrated into the LNs draining the 
paws.  In  contrast,  transferred  BMMac  were  isolated  from  the  inflamed  paws, 
and  C5  (TS)  infection  of  BMMac caused  an  enhancement  in  the  numbers we 
observed.  To  exclude  the  possibility  that  the  presence  of  transferred  cells  in 
digested  paws were from  BM  cell contamination,  BM  alone was also examined 
and  not found  to  contain  any  labelled  cells.  The  appearance  of the  recovered 
BMMac from paws is highlighted in Figure 4.12B.
To  evaluate  whether  BMDC  also  have  the  ability  to  migrate  to  inflamed 
peripheral  tissues  after  transfer,  BMDC  were  injected  into  mice  that  had
198developed  inflammatory  arthritis  after  i.v.  C5  (TS)  infection.  We  found  that 
greatly decreased  numbers of C5 (TS)  infected  BMDC compared to uninfected 
cells were seen in PL (Figure 4.13). Uninfected and C5 (TS) infected transferred 
BMDC were observed in LNs draining the paws,  and the numbers were greater 
from uninfected than C5 (TS) infected  BMDC transfer group, although variation 
existed  among  the  three  mice  in  both  groups.  In  contrast  to  the  results  with 
BMMac,  few if any transferred  BMDC were  recovered  from  either front or rear 
paws (Figure 4.13).  These data suggest that  BMDC  migrate to draining  lymph 
nodes rather than the inflamed limbs.
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Figure  4.11  Infiltration  of  macrophages  into  inflamed  tissues  in  C5  (TS)-induced 
inflammatory  arthritis.  HLA-B27/p2m  mice  were  injected  with  C5  (TS)  via  the  tail  vein  and 
mice  were  monitored  for  development  of  inflammatory  arthritis.  Sections  were  prepared  and 
F4/80  expression  in  inflamed  joints  was  examined  by  immunohistochemistry.  Sections  were 
counterstained with hematoxylin.
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Figure 4.12 Investigation of BMMac migration to  inflamed  peripheral tissue after C5 (TS) 
infection.  BMMac  were  infected  with  C5  (TS)  at  10  MOI.  Uninfected  and  C5  (TS)  infected 
BMMac  were  labelled  with  CFSE  before  adoptive  transfer  to  HLA-B27/(32m  mice  (n=3)  by 
intraperitoneal  injection. The recipient mice were previously induced to develop  inflamed joints 
by intravenous injection of C5 (TS). The labelled cells were recovered from tissues as indicated 
on the top of each column 48 hours post DC transfer.  Paws were digested with collagenase (1 
mg/ml) and DNase (0.5 mg/ml) for 2 hours and filtered through 40 pm strainers to eliminate cell 
debris and  bones. The number of migrated cells within 2  x   106 tissue cells from each organ  is 
indicated on the right corner of each  plot. A mouse without transfer was used as a control.  (A) 
Overall distribution of recovered  BMMac in  indicated tissues.  PL,  peritoneal  lavage. ALN+PLN, 
pooled  axillary and  popliteal  LN.  BM,  bone  marrow.  (B)  Highlighted  distribution  of transferred 
cells  recovered from  paws  of a  mouse that received  C5  (TS)  infected  BMMac.  Inset shows a 
control mouse without cell transfer, from which the region was set.
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Figure 4.13  Investigation  of BMDC  migration  to  inflamed  peripheral  tissue  after C5 (TS) 
infection.  BMDC were  infected  with  C5 (TS) at  10  MOI.  Uninfected and  C5 (TS)  infected  DC 
were labelled with CFSE before adoptive transfer to HLA-B27/p2m mice (n=3) by intraperitoneal 
injection. The recipient mice were previously induced to develop inflamed joints by intravenous 
injection  of C5 (TS). The labelled cells were recovered from tissues as  indicated on the top of 
graphs 48 hours post DC transfer.  Paws were digested with collagenase (1  mg/ml) and DNase 
(0.5 mg/ml) for 2 hours and filtered through 40 pm strainers to eliminate cell debris and bones. 
The number of migrated cells within 2 x   106  tissue cells from each organ is indicated on the right 
corner  of each  plot.  A  mouse  without  transfer was  used  as  a  control.  PL,  peritoneal  lavage. 
ILN+PLN, pooled inguinal and popliteal LN. BM, bone marrow.
2034.3 Discussion
In  this chapter,  the in  vivo  migration  pattern  of S.  typhimurium-infected  BMDC 
and  BMMac  was  investigated  using  a  model  of  adoptive  transfer  of  CFSE 
labelled  cells  into  mice or mice with  Salmonella  induced  inflammatory arthritis. 
Furthermore, their interaction with host cells, transportation of bacteria and their 
localisation after migration into tissues were also evaluated.
Compared to their uninfected counterparts, a significantly smaller number of C5 
(TS)  infected  BMDC  was  recovered  from  PL  (injection  site),  but  a  greater 
number  was  found  in  spleen  and  MLN.  C5  (TS)  infected  BMMac  were  not 
recovered  from  these  organs  although  their  number  was  also  reduced 
significantly  from  PL  (Figure  4.1  and  4.2).  Although  these  two  types  of  cells 
share  some  similar  responses  upon  S.  typhimurium  infection  in  vitro,  such  as 
upregulation  of  cell  surface  molecules,  production  of  cytokines  and  NO,  as 
detailed  in chapter 3, their in  vivo migration was different. This further confirms 
that  these  two  types  of  cells  are  distinct  populations  after  they  have  been 
cultured from a common precursor in vitro as claimed in chapter 3.
It  is  well  known  that  upon  contact  with  inflammatory  signals,  immature  DC 
undergo a maturation process and migrate from the periphery to the T cell area 
of  LN,  where  they  launch  the  adaptive  immune  response  (Banchereau  et  al., 
2000). Although  using a different agent (irradiated  mycobacterium tuberculosis) 
to  activate  cells  in  vitro,  it  has  been  reported  recently  that  DC  but  not 
macrophages migrate to the draining LN after co-transfer (Bhatt et al., 2004).  In 
addition,  these  transferred  DC  were  able  to  initiate  a  local  primary  Th1
204response,  indicated by IFNy secretion by antigen specific T cells. Macrophages 
failed to do so due to their failure to migrate to draining LNs (Bhatt et al., 2004). 
Macrophages  and  DC,  both  phagocytic  cells,  are  able  to  capture  antigen  and 
induce inflammatory response in the periphery.  However,  macrophages have a 
greater  ability  than  DC  to  engulf  bacteria  in  vitro,  manifested  by  a  higher 
infection  rate  and  increased  cytokine  production.  DC  are  more  sensitive  than 
macrophages  to  danger  signals  and  migrate  efficiently  to  SLO  where  they 
present antigen to T cells.
The  role  of  macrophages  in  antigen  presentation  is  more  ambiguous.  In  our 
experiments, there were no more antigen stimulated cells than  uninfected cells 
migrating to  SLO. What roles do  macrophages  play at this stage?  It has  been 
observed that subcutaneous challenge with outer membrane protein A (OmpA) 
of gram-negative bacteria  induces an enlargement of draining  LN with a higher 
proportion  of DC and  macrophages (Jeannin  et al.,  2003); Adoptive transfer of 
OmpA pulsed DC and macrophages into footpads demonstrated that the higher 
proportion  of DC  in  draining  LN  was  due  to  their migration  from  periphery.  In 
contrast,  it was concluded,  due  to the  absence  of transferred  macrophages  in 
draining  LN, that the higher proportion of macrophages in draining LN occurred 
mainly from recruitment of peripheral blood macrophage precursors (Jeannin et 
al.,  2003).  Taken  together  with  their  greater  production  of  inflammatory 
cytokines  in  response  to  S.  typhimurium  infection,  these  data  suggest  that 
macrophages  function  primarily  to  control  bacterial  replication  through  innate 
immunity  and  recruitment  of  more  phagocytic  cells  rather  than  by  initiating 
specific adaptive immunity.
205Surprisingly,  significantly  greater  numbers  of  S.  typhimurium  infected 
macrophages compared to uninfected  cells were  recovered  in  PPs  (Figure 4.2 
I).  For  this  reason,  we  tested  whether  macrophages  showed  enhanced 
expression  of  lymphocyte  Peyer’s  patch  adhesion  molecule  (LPAM-1,  also 
named  a4:p7)  after  S.  typhimurium  infection.  This  molecule  is  normally 
expressed  by  a  subset  of T  cells  and  contributes  to  their  homing  to  mucosal 
endothelia  including  PPs  (Mora  et  al.,  2003).  Expression  of  integrin  a4  (no  p 
subunit antibody available) was tested on  BMMac and  BMDC with and without 
S.  typhimurium  infection.  We  found  that  it was  constantly  expressed  on  both 
types of cells;  S.  typhimurium infection did not increase its expression on either 
BMMac or BMDC (data not shown).
It has been previously shown that DC but not macrophages are able to migrate 
to draining  LNs in  vivo after being activated  by various stimuli in vitro (Bhatt et 
al.,  2004;  Jeannin et al.,  2003).  Therefore,  the migration  patterns we observed 
after  S.  typhimurium  infection  followed  the  general  migration  pattern  of these 
two types of cells upon encountering microbes or microbial products.
In  order  to  establish  whether  the  transferred  cells  had  been  taken  up  by 
endogenous cells, BMDC were propagated from BALB/c bone marrow cells and 
transferred  into  HLA-B27  mice.  If  HLA-B27  negative  transferred  cells  were 
engulfed  by  HLA-B27  expressing  endogenous  cells,  a  CFSE  and  HLA-B27 
double  positive  population  would  be  detected.  An  increasing  proportion  of 
transferred  cells  from  PL  (<20%),  spleen  (<40%)  to  MLN  (<70%)  had  been 
engulfed  by  host  cells  (Figure  4.3-4.5).  Therefore,  it  is  possible  that  the
206migration  profiles  we  observed  for  transferred  DC  and  macrophages  after  S. 
typhimurium infection might not be the cells we originally transferred.  However, 
the percentage of engulfed cells in the PL (CFSE+ & HLA-ABC+) was less than 
15  or  20%  for  uninfected  and  S.  typhimurium  infected  DC  respectively, 
indicating  that  after  two  days  in  vivo,  only  a  small  proportion  of  cells  were 
engulfed in PL. The slightly increased percentage of the scale of infected versus 
uninfected  DC  that  was  internalised  might  suggest  that  transferred  S. 
typhimurium infected DC provided an increased “danger signal” to the host than 
uninfected cells.
The  higher proportion of engulfed cell  population  observed  in  spleen  and  MLN 
could  be  partly  artefactual,  related  to  the  fact  that  relatively  few  CFSE+  cells 
were  detected  in  these  organs.  Thus,  the  presence  of  a  small  number  of 
autofluorescent  host  cells  in  the  CFSE+  gate  would  make  the  apparent 
population  of CFSE+  HLA-B27+  cells seem  bigger than  it actual was. A larger 
number of cells would need to be acquired to address this.  For transferred cells 
that were taken  up by host cells,  there are two  possibilities to account for their 
localisation  in  spleen  and  MLN.  One  is  that  cells  were  taken  up  firstly  by 
endogenous  cells  in  the  PL,  which  then  migrated  to  the  spleen  and  MLN. 
Another is that injected cells migrated firstly to spleen  and  MLN and then were 
engulfed  by  host  cells  in  these  organs.  If the  former  possibility were  true,  we 
would  have  expected  to  find  a  similar  pattern  of  migration  for  DC  and 
macrophages,  rather  than  the  differential  migration  patterns  observed. 
Therefore, our overall data support the latter explanation.
207Since all cells have a  limited  life span  (Opferman  and  Korsmeyer,  2003),  cells 
transferred  into  mice  must undergo  eventual  cell  death  and will  be  cleared  by 
host  cells  through  phagocytosis.  After  acting  with  T  cells,  migrating  DC  are 
thought to  die within  the  LN,  because  they  can  be  detected  in  afferent  lymph 
that  access  the  T-cell  areas,  but  not  in  efferent  lymph  (Banchereau  and 
Steinman,  1998;  Steinman,  1991).  It  has  also  been  suggested  that  CTL- 
mediated killing of DC is important to avoid unnecessary further presentation of 
antigen  and  to  eliminate  infected  cells  themselves;  this  mechanism  is 
particularly  important  for  the  host  to  clear  virus  infection  (Ronchese  and 
Hermans,  2001).  Therefore,  the  increased  proportion  of engulfed,  transferred 
DC in SLO may reflect the physiological clearance of these cells.
To  further  clarify  that  the  migration  pattern  observed  was  the  behaviour  of 
transferred  cells,  fixation  of  cells  prior  to  transfer,  as  has  been  attempted  in 
other  studies  (Ibrahim  et  al.,  1992;  Rosen  and  Gordon,  1990),  may  prove 
useful.  In  this  case,  for example,  active  migration  of transferred  DC would  be 
abolished  and  they  should  not  be  found  in  SLO.  However,  if  transferred  S. 
typhimurium infected  DC could still be recovered from SLO,  this would  indicate 
that  endogenous  cells  were  responsible  for  transporting  CFSE+  cells  after 
phagocytosis.
Transportation of S.  typhimurium by BMDC and  BMMac was also examined.  In 
order  to  visualise  bacteria  by  confocal  microscopy  and  also  to  identify  the 
presence of transported  bacteria  recovered from tissues,  S.  typhimurium strain 
SL3261  engineered  to  express  GFP  was  utilised  in  these  experiments.  This
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by  culturing  on  ampicillin  containing  agar  plates.  The  results  shown  in  Figure 
4.6 and 4.7 revealed that S.  typhimurium was carried to tissues by both  BMDC 
and  BMMac.  Although  a  different strain  of  S.  typhimurium was  used  in  these 
experiments,  a  similar  pattern  of  migration  to  that  observed  with  C5  (TS) 
infected  cells  was  seen.  Notably,  though  the  recovery  of  CMTMR  labelled 
BMDC  seemed  lower than  BMMac  (tenfold  lower)  (panel  A of  Figure 4.6  and 
4.7). This was potentially due to the use of a lower concentration of CMTMR for 
DC (6  pM vs 25  pM),  which  could  have  led to some  recovered  cells  not being 
visualised  by flow cytometry.  The similar efficiency of bacterial  recovery (panel 
B of Figure 4.6 and 4.7) may be related to their similar infection rate after in vitro 
infection. However, it should be noted that 10 times more tissue cells were used 
for measuring CFU for macrophages than DC (legend of Figure 4.6 and 4.7).
The presence of GFP expressing  S.  typhimurium in the spleen was confirmed 
by confocal imaging (Figure 4.8 panel B). Although we have successfully shown 
the  colocalisation  of GFP  bacteria  (green)  and  CMTMR  labelled  cells  (red)  on 
cytospin slides after in vitro infection (Figure 4.8 panel A), we failed to visualise 
the  red  fluorescence  of CMTMR  in  tissues  (Figure 4.8  panel  B);  this was  also 
true  for  CFSE  labelling.  Therefore,  we  chose  to  show the  presence  of CFSE 
labelled cells in vivo by using an anti-FITC antibody and non-immunofluorescent 
detection  rather  than  direct  confocal  analysis  of  the  CFSE.  Although  S. 
typhimurium infected macrophages did not show an enhanced ability to migrate 
to the spleen and MLN,  a small number of cells were constantly found  in these 
tissues.
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has  been  extensively  studied  in  vitro  (Chakravortty  et  al.,  2002;  Garvis  et  al., 
2001;  Svensson  et  al.,  1997b;  Yrlid  et  al.,  2001a),  but  little  direct  analysis  of 
these  interactions  in  vivo  has  been  reported.  Using  combined  confocal  laser 
scanning  microscopy  and  computerised  image  analysis  techniques  with 
immunostained  sections  of liver,  Richter-Dahlfors  and  colleagues  have  shown 
that S.  typhimurium resides intracellularly in macrophages of mouse liver when 
the  mouse  is  infected  intravenously  with  only  a  small  number  of  bacteria, 
conditions they claim mimic a natural infection (Richter-Dahlfors et al.,  1997).  In 
another  study,  S.  typhimurium  was  shown  to  be  transported  from  the 
gastrointestinal  tract  to  the  bloodstream  by  CD18-expressing  phagocytes, 
possibly  consisting  of  DC  and/or tissue  macrophages  as  early  as  15  minutes 
after  oral  inoculation  (Vazquez-Torres  et  al.,  1999).  More  recently,  DC  have 
been  shown  to  express  tight  junction  proteins  and  penetrate  gut  epithelial 
monolayers to access the  lumen  and directly sample  bacteria  in  vivo; this was 
demonstrated  by  infection  the  ligated  loop  of the  small  intestine  in  mice  with 
GFP-expressing S. typhimurium (Rescigno et al., 2001).
Our  results  show  that  adoptively  transferred  infected  DC  and  macrophages 
were  able  to  transport  intracellular  S.  typhimurium,  acquired  from  in  vitro 
infection,  to two  of the  major organs  involved  in  the  systemic infection  (spleen 
and  liver).  Together  with  the  published  observations  discussed  above,  these 
results suggest that these  cells  may be  used  by  S.  typhimurium for the spread 
of this intracellular pathogen throughout the body.  Unlike BMDC, we did not find
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spleen  and  draining  LNs.  However,  they were  able to  reach  all the tissues we 
examined  in  small  numbers.  In  infected  macrophages,  S.  typhimurium  has 
evolved  a  mechanism  that  depends  on  the  activity  of  its  SPI-2  type  three 
secretion  system  to  shield  itself  from  cytosolic  anti-Salmonella  activity  and 
thereby  to  survive  and  replicate  itself  in  a  modified  vacuole  (Linehan  and 
Holden,  2003);  Furthermore,  enzymes  and  products  synthesised  by  S. 
typhimurium  efficiently  reduce  the  effectiveness  of  bacteriocidal  and 
bacteriostatic free  radicals  (such  as  NO)  generated  by  macrophages  (Linehan 
and  Holden,  2003).  Together with  their  ability  to  access  various  tissues  after 
adoptive  transfer,  macrophages  are  likely  to  be  used  by  S.  typhimurium  as  a 
vehicle to facilitate their systemic spreading.
The  histological structure of the spleen  is divided  into  red  pulp and white  pulp, 
with  marginal  zone  encircling  the  white  pulp.  The  complex  architecture  of the 
spleen  facilitates  close  contact  between  blood-borne  antigens  and  immune 
cells,  which  are  segregated  according  to  their  functions  into  distinct  splenic 
compartments (Yadava et al.,  1996).  Circulating  antigens are  initially screened 
in the marginal zone,  in which  extremely  potent phagocytic cells,  the  marginal 
zone  macrophages,  are  present  and  can  phagocytose  large  foreign  particles, 
such as bacteria and effete  red  blood cells.  Further filtration  of the blood takes 
place in the filtration beds of the red pulp, where the majority of endogenous DC 
normally  reside  and  can  further  screen  blood  borne  antigens.  After  taking  up 
antigen,  DC  migrate  to  the  outer  area  of  white  pulp,  in  which  they  present 
antigen  to  T  cells  and  lead  to  clustering  and  enrichment  of antigen-specific T
211cells.  B and T cells recirculate also through the outer area of white pulp on their 
way  to  follicles  and  the  inner  area  of  the  white  pulp  respectively,  which 
facilitates the DC antigen presentation to T cells (Kraal,  1992).
We  have  demonstrated  by  immunohistochemistry  that  transferred  DC  mainly 
migrated  into  red  pulp  and  marginal  zone  areas.  Some  cells,  especially  S. 
typhimurium  infected  DC,  also  appeared  interspersed  around  the  white  pulp. 
Staining  of  serial  spleen  sections  with  various  antibodies  revealed  that  anti- 
FITC staining  (indicating  transferred  DC)  was  co-localised  with  the distribution 
of endogenous CD11c expressing cells (Figure 4.9).
In  the spleen,  CD11c +  DC  can  be further divided  into three subsets:  CD8a+, 
CD8a-CD4+,  and  CD8a-CD4-  (Kirby  et  al.,  2001;  Moser  and  Murphy,  2000). 
Subset-specific  responses  of  splenic  DC  to  Salmonella  infection  have  been 
documented  (Kirby  et al.,  2001).  In  that study,  CD4+  DC were  shown  to  alter 
their localisation from the white pulp borders and  margins of the B cell areas to 
the centre of B cell area with their numbers remaining constant post  -Salmonella 
infection.  Conversely,  the  red  pulp  CD8+  and  CD8-CD4-  DC  dramatically 
increased  in  number concomitant with  redistribution  within  the  red  pulp  as  an 
early  response,  followed  by  migration  to  T  cells  area  later  during  Salmonella 
infection (Kirby et al., 2001).
Our data showed that CD11c staining in both the red pulp and the white pulp of 
spleen  sections  appeared  more  frequent  than  could  be  accounted  for  by 
coincident  anti-FITC+  staining.  This  suggested  that  both  transferred  and
212endogenous  DC were  able to  migrate to  T cell  area to  present antigens  upon 
Salmonella  infection.  The  antigens  acquired  by  these  cells  may  differ,  as 
endogenous  DC  could  take  up  the  dead  transferred  cells  or  engulf  bacteria 
released  by dead  cells.  Migration  of transferred  DC from the  red  pulp to white 
pulp  by  24  hours  after  intravenous  or  subcutaneous  injection  has  been 
previously  reported  (Austyn  et  al.,  1988).  In  addition,  data  from  more  recent 
studies  have  confirmed  that  endogenous  CD11c+  DC  also  migrate  from  the 
marginal  zone  of the  spleen  into  the  CD4+  T  cell  area  after  they  sense  the 
presence  of antigens from  the  blood  stream  (Leisewitz et al.,  2004;  Sher and 
Reis e Sousa,  1998).  In  contrast,  Leisewitz and colleagues showed that during 
infection,  macrophages  remain confined to the  red  pulp area and  B cells show 
no appreciable change in distribution (Leisewitz et al., 2004).
It  has  been  shown  that  BMDC  and  BMMac  are  efficient  at  processing  and 
presenting  bacterial  antigens  from  S.  typhimurium  infections,  although  the 
pathways they use to accomplish this are not identical (Yrlid et al., 2000).  Both 
CD8a+  and  CD8a-  splenic  DC  are  able  to  process  live  bacteria  for  peptide 
presentation on MHC-I and MHC-II in vitro (Yrlid and Wick, 2002).  Furthermore, 
splenic DC  isolated  from  S.  typhimurium  infected  mice  could  present bacterial 
antigens  upon  co-culture with  specific T cells  directly  ex  vivo  (Yrlid  and Wick, 
2002).  S.  typhimurium can  induce apoptosis of infected macrophages (Chen et 
al.,  1996a; Chen et al.,  1996b; Monack et al.,  1996).  Interestingly, an alternative 
antigen  presentation  pathway whereby bystander DC  present antigens derived 
from  macrophages  induced  to  undergo  apoptosis  by  S.  typhimurium also  has
213been  confirmed  (Yrlid  and  Wick,  2000).  Therefore,  antigen  presentation 
occurring in natural Salmonella infections could be complex.
Compared  to the  normal  spleen,  disruption  of normal  splenic architecture was 
noticeable  after  DC  transfer  (Figure  4.10).  The  latter  was  manifested  as  the 
enlargement and fusion  of white  pulp areas,  presumably due to the expansion 
of clones of T cells  and/or immigration  of transferred  and  endogenous  DC.  In 
comparison to the small number of DC distributed along the marginal zone and 
red pulp in a normal spleen, a large number of CD11c+ cells was observed after 
transfer  of  S.  typhimurium  infected  DC;  this  was  also  observed  to  a  lesser 
extent  in  the  spleen  of  mice  receiving  uninfected  DC.  Since  relatively  small 
number of transferred DC (even Salmonella infected) were detected (Figure 4.9, 
left column),  recruitment of CD11c+ cells from blood-borne cells likely occurred. 
Such  a  mechanism  has  been  suggested  in  a  previous  study  showing  that 
splenic DC numbers increase after administration of soluble  Toxoplasma gondii 
extract, which was assumed to result from an influx of blood-borne cells (Reis e 
Sousa  et  al.,  1997).  Thus,  the  increase  in  CD11c+  cell  number  is  a 
consequence of the migration of transferred  DC endogenous DC to the spleen. 
These findings  are  consistent with  a  previous study showing  that the absolute 
number  of  CD8a+  and  CD8a-CD4-  DC,  but  not  CD4+  DC  are  significantly 
increased in the spleen after oral Salmonella infection (Kirby et al., 2001).
Previous reports suggest that monocytes play a role in transporting Salmonella 
antigens to the joints of patients with  ReA (Kirveskari et al.,  1998),  since in our 
model,  it  was  not  possible  to  obtain  large  numbers  of  monocytes  to  do  the
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used. To examine the ability of BMDC and  BMMac to traffick to inflamed joints, 
CFSE  labelled  cells  were  injected  i.p.  into  mice  that  had  received  an  i.v. 
injection  of C5  (TS)  3 weeks  previously;  the  latter  has  been  shown  to  induce 
inflammatory  arthritis  efficiently  in  mouse  (Hormaeche  et  al.,  1981).  In  our 
study, the large number of F4/80+  macrophages infiltrating  into inflamed tissue 
(Figure  4.11)  indicated  that  the  inflammatory  arthritis  induced  by  i.v  C5  (TS) 
served  as a surrogate  model  of ReA with  augmented  inflammation  in  affected 
joints.  The  number of transferred  cells  in  various tissues  was examined  using 
flow  cytometry  48  hours  post-transfer.  A  small  number  of  BMDC  were 
recovered  from  pooled  draining  LN  (ILN+PLN)  but  none  were  present  in 
inflamed  tissue  (Figure  4.13).  In  contrast,  a  marked  number  of  BMMac  were 
recovered  from  the  inflamed  tissues  but  no  transferred  cells were  detected  in 
draining  LN  (Figure 4.12 A).  Moreover,  S.  typhimurium infection enhanced this 
effect by increasing the number of cells in inflamed joints. An absence of either 
BMDC  or  BMMac  in  bone  marrow excluded  the  possibility that the  cells were 
derived  from  the  bone  marrow  of  digested  inflamed  tissues.  Although  it  is 
possible that transferred cells reach the inflamed joints via the blood stream, we 
did  not find  any  transferred  cells  in  blood  samples  in  one  experient  (data  not 
shown).  This  may be due  to the time  point (2  days  after transfer) at which we 
acquired  blood  samples  being  too  late  to  capture  the  transferred  cells  in  the 
blood  stream;  additionally,  the  small  blood  volume  analysed  could  limit  our 
ability  to  detect  transferred  cells.  Therefore,  it  would  be  of  interest  to  further 
investigate the route by which transferred cells migrate to inflamed tissues.
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appeared  to  be  a  real  population  (Figure  4.12  B).  The  small  number  of 
recovered  BMMac could  be  related  to  the  technical  difficulty  in  obtaining  cells 
from limbs. Cells were isolated from inflamed paws by enzyme digestion alone. 
Further  purification  by  methods  such  as  Percoll  treatment  could  improve  the 
recovery cells from those inflamed tissues.
The striking  ability of BMMac,  but not BMDC to  migrate to  inflammatory areas 
indicates that macrophages  may  play  a  more  important antigen  transportation 
role  than  DC  in  the  pathogenesis  of  ReA.  ReA  is  characterised  by  chronic 
inflammation of joints. This is due to persistence of nonviable bacteria and their 
products (such as LPS), which leads to the recruitment of leukocytes,  including 
mononuclear phagocytes,  into the  inflamed  synovium  (Colmegna et al.,  2004). 
We have demonstrated in our mouse model that recruitment of macrophages to 
the  inflammatory  joints  occurs.  Some  studies  have  investigated  the 
mechanisms  behind  this  pattern  of  migration  of  macrophages.  It  has  been 
shown  that  a  significant  number  of  adoptively  transferred  F4/80+  Mac-1 + 
splenocytes are able to  migrate  into the  synovium  of collagen-induced  arthritis 
(Nanki  et  al.,  2004).  Furthermore,  in  that  study,  it  was  demonstrated  that 
treatment with anti-fractalkine significantly reduced the  migration of the Mac-1 + 
splenocytes  into  the  synovium,  resulting  in  the  amelioration  of  arthritis.  By 
testing  expression  of  CX3CR1  on  transferred  macrophages  and  fractalkine 
(unique  ligand  of  CX3CR1)  expression  in  the  synovium  of  collagen-induced 
arthritis mice, they found that the interaction of FKN-CX3CR1  partially mediated 
this specific migration of macrophages.  Results from atherothesclerosis studies
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migration.  In  this  regard,  two  pairs  of chemokines  and  their  receptors  MCP-1 
(CCL2)  (Gu  et  al.,  1998)  (Gosling  et  al.,  1999)-CCR2  (Boring  et  al.,  1998; 
Dawson  et  al.,  1999)  and  IL8  (CXCL8)-CXCR2  (Boisvert  et  al.,  1998),  were 
shown to be important. Accordingly, an increased expression of IL-8 and MCP- 
1a  is  observed  in  inflamed  knees  of  rabbits  with  induced  acute  experimental 
arthritis  (Lopez-Armada  et  al.,  2002).  Earlier  studies  have  shown  that 
fluorescently  labelled  resident  peritoneal  macrophages,  but  not  thioglycollate- 
elicited  macrophages  are  able  to  migrate  to  the  inflamed  peritoneal  cavity 
following  intravenous  adoptive  transfer  (Rosen  and  Gordon,  1990).  This  is 
mediated  through  a  complement  receptor  3  (CR3)-dependent  mechanism,  as 
this effect could be abolished by in vitro preincubation of labelled cells or in vivo 
treatment  of the  recipient with  5C6,  an  anti-mouse  CR3  monoclonal  antibody. 
However,  in the absence of an inflammatory stimulus there was no migration of 
cells  to  the  peritoneal  cavity,  and  fluorescently  labelled  macrophages 
accumulated  in  the  red  pulp  and  marginal  zone  of  the  spleen.  Moreover, 
migration  of  macrophages  required  viable  injected  cells  as  cells  fixed  with 
paraformaldehyde  did  not  migrate  and  were  cleared  in  the  pulmonary 
microvasculature (Rosen and Gordon,  1990).  In this context,  it would be useful 
to examine whether in  our hands  BMMac could  still  migrate  into the peripheral 
tissues  in  the absence  of inflammation. Analysis  of the  migration  of fixed  cells 
would also reveal whether viable cells were required.
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Using  adoptive  transfer  of  fluorescently  labelled  cells  by  i.p.  injection,  we 
showed that under normal conditions, S. typhimurium infected BMDC migrate to 
the spleen  and  MLN  and  emigrate  out of the  peritoneal  cavity.  Conversely,  S. 
typhimurium  infected  BMMac  were  not  retrieved  in  increased  numbers 
compared to uninfected cells from any organs apart from PPs, but their number 
was  significantly  reduced  in  the  peritoneal  cavity.  Intracellular  bacteria  were 
carried  to the spleen  and  liver by  S.  typhimurium  infected  BMDC and  BMMac, 
suggesting their potential  role  in  bacterial transportation  during  S.  typhimurium 
infection.  However,  in  a  Salmonella  induced  inflammatory  arthritis  model, 
BMDC were found in draining LNs rather than inflamed limbs, whereas BMMac, 
especially after S.  typhimurium infection,  were found  in  inflamed  limbs,  but not 
in draining LNs.
218Chapter 5: Investigation of mechanisms behind 
distinct migration profile of C5 (TS) infected 
BMDC and BMMac
5.1  Introduction
Immature  DC are  located  in  most tissues and  play a sentinel  role  in  peripheral 
organs, where they continuously sample their environment.  Upon  triggering  by 
microbial  infection  or  their  products,  by  inflammatory  cytokines  or  by  tissue 
damage, they move to secondary lymphoid organs where they meet T cells (de 
Saint-Vis et al.,  1998). The fine positioning within the tissues of the different DC 
subsets and their migration upon encountering stimulations are tightly regulated 
by  a  variety  of  molecules  directing  cell  trafficking,  among  which  chemokines 
have  been  shown  to play a  predominant role  (Caux et al.,  2000).  Chemokines 
exert  their  function  through  interactions  with  their  corresponding  receptors, 
which  are  a  family  of  G  protein-coupled  receptors.  By  modulation  of  their 
expression  on  the  surface  of  cells,  chemokine  receptors  are  considered  as 
crucial factors for directing the movement of cells (D'Ambrosio et al., 2003).
Two chemokine  receptors (CCR7  and  CCR6) were chosen to be studied  here. 
Upregulation of CCR7 upon  DC maturation has been demonstrated as the main 
factor governing skin DC migration to SLO under inflammatory and steady-state 
conditions  (Ohl  et  al.,  2004).  CCR6  is  one  of  the  inflammatory  chemokine 
receptors  expressed  on  immature  DC  (Schutyser  et  al.,  2003),  and  is  the
219receptor of chemokine CCL20/MIP-3a.  In  DC,  CCR6 expression  is restricted to 
skin and gut epithelium (Sierro et al., 2001).
As ubiquitous cells residing in the majority of tissues and accumulated in areas 
of  inflammation,  macrophage  trafficking  is  also  regulated  by  chemokines 
secreted  by tissue cells or infiltrated  leukocytes through  the  interaction with  an 
array  of  chemokine  receptors  (Baggiolini  and  Loetscher,  2000;  Rossi  and 
Zlotnik, 2000). For example, modulation of CCR5 expression in macrophages is 
important for their activation and recruitment at inflammatory sites (Bosco et al., 
2004).
Previous studies have shown that maturation  after exposure to  S.  typhimurium 
confers on  BMDC the ability to be  recruited towards the  CCR7  ligands  CCL19 
and CCL21,  but not to the CCR6 ligand CCL20 in vitro (Cheminay et al., 2002). 
Moreover,  a correlation  between  switch  in  chemokine  receptor expression  and 
the in vivo migration  pattern of DC and  macrophages has been suggested,  but 
not been verified  in a previous study (Jeannin et al.,  2003). We have observed 
the differential migration  pattern of DC and macrophages in vivo after exposure 
to S.  typhimurium in vitro in chapter 4.  In this chapter, we set out to explore the 
possible mechanisms  behind  these distinct migration  patterns,  focusing  mainly 
on the  role of chemokine  receptors CCR7 and  CCR6.  Furthermore, the role of 
chemokines  in  the  migration  of  S.  typhimurium  infected  DC  in  vivo  was 
investigated.
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5.2.1 Detection of apoptosis of S. typhimurium infected BMMac and BMDC
Since  unlike  BMDC,  no  increased  number  of  C5  (TS)  infected  BMMac  were 
recovered  in  organs  examined  apart  from  PPs,  together  with  the  greatly 
reduced  number  of  them  found  in  PL  compared  to  uninfected  cells,  it  was 
suspected  that this  effect  maybe  due  to the  cell  death  Salmonella could  have 
potentially  induced  (Chen  et  al.,  1996a;  Monack  et  al.,  1996).  To  examine 
whether  BMDC  and  BMMac  exposed  to  the  S.  typhimurium  strain  C5  (TS) 
underwent  apoptotic  cell  death,  and  to  determine  whether this  could  partially 
explain their differential in vivo migration, apoptosis was detected using annexin 
V staining of C5 (TS) infected  BMDC and BMMac.  Firstly, the level of apoptosis 
on  infected  cells  at  various  time  points  after  C5  (TS)  infection  was  tested. 
Figure 5.1  A shows that less than 20% of apoptotic cells was observed among 
BMMac at 24, 48 and 72  hours post-infection.  C5 (TS) infection did  not induce 
more  macrophages  to  undergo  apoptosis,  as  uninfected  and  C5  (TS)  infected 
cells  showed  a  comparable  level  of  apoptosis.  A  similar  level  of  apoptosis 
(<20%) was also observed for uninfected or C5 (TS) infected BMDC at 24 hours 
post-infection.  At  later  time  points  (48  and  72  hours),  however,  differences 
between infected and uninfected BMDC were apparent. Although less than 20% 
of  uninfected  BMDC  displayed  signs  of  apoptosis,  nearly  40%  of  C5  (TS) 
infected  BMDC were apoptotic at 48 and 72  hours post-infection (right panel of 
Figure 5.1A).
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of  CFSE  labelling  on  cell  death  was  considered  as  well.  At  24  hours  post­
infection, infected cells were harvested and labelled with CFSE, and the level of 
apoptosis  was  then  tested.  Figure  5.1B  shows  that  the  level  of apoptosis  on 
either  uninfected  or  C5  (TS)  infected  cells  remained  less  than  20%  for  both 
BMMac  and  BMDC.  Hence,  compared  to  the  cells  without  CFSE  treatment, 
CFSE  labelling  did  not cause  a  higher level  of apoptosis  at this time  point for 
either cell type.  To  further test the  effects  of CFSE,  CFSE  labelled  cells were 
seeded  back to flasks and  harvested at 72 hours post infection.  No increase in 
apoptosis among  BMMac was  observed  at this time  point.  In  contrast,  60%  of 
C5  (TS)  infected  BMDC  compared  to  less  than  20%  of  uninfected  BMDC 
underwent  apoptosis.  In  summary,  BMDC,  but  not  BMMac  were  induced  to 
undergo  apoptosis  upon  exposure  to  C5  (TS).  CFSE  labelling  did  not  cause 
further apoptosis  among  BMMac,  but  this  procedure  did  increase  the  level  of 
apoptosis of BMDC at 72 hours post-infection.
5.2.2  Analysis of CCR7 and CCR6 expression on BMMac and BMDC upon 
S. typhimurium infection by RT-PCR
To determine whether infection with  S.  typhimurium would  alter the expression 
of CCR7 and CCR6 on  BMDC and  BMMac,  CCR7 and CCR6 gene expression 
was analysed at the mRNA level by RT-PCR. CCR7 and CCR6 expression was 
detected  on  uninfected  BMDC.  Upon  S.  typhimurium  (C5  (TS)  or  SL3261) 
infection or LPS treatment,  CCR7 expression was maintained,  whereas,  CCR6 
expression  was  downregulated  (Figure  5.2  upper  panel).  In  contrast,  CCR7
222expression  was  not  detected  on  uninfected  BMMac.  However,  upon  LPS 
stimulation  or  C5  (TS)  infection,  but  not  SL3261  infection,  the  expression  of 
CCR7  on  BMMac  was  detectable,  especially  on  LPS  treated  BMMac.  CCR6 
showed  a  very  faint  band  on  uninfected  BMMac  samples,  and  expression 
became apparent upon  LPS stimulation or S.  typhimurium infection (Figure 5.2 
bottom  panel).  Thus,  RT-PCR  data  revealed  that  CCR7  expression  was 
increased on BMMac upon S.  typhimurium infection or LPS treatment, although 
differences were not detected for BMDC.  CCR6 expression was downregulated 
on BMDC but slightly increased on BMMac after infection or LPS stimulation.
5.2.3  Quantification of CCR7 and CCR6 expression on BMDC and BMMac 
by real-time RT-PCR
Detection  of chemokine  receptor expression  by  RT-PCR  is  only  qualitative.  In 
order  to  accurately  assess  alterations  in  chemokine  receptor  expression  on 
cells  in  response  to  S.  typhimurium,  a  semi-quantitative  method  to  analyse 
mRNA  levels,  namely,  real-time  RT-PCR was  used.  Figure  5.3  shows  that  in 
comparison  to  uninfected  cells,  CCR7  expression  increased  by  10  fold  on 
BMDC  upon  C5  (TS)  infection.  The  positive  control,  LPS  treated  BMDC  also 
showed  a  large  (16-fold)  increase  of  CCR7  expression  (Figure  5.3A).  On  the 
contrary,  CCR6 expression was clearly downregulated on C5  (TS) infected (21 
fold)  and  LPS  treated  BMDC  (30  fold)  compared  to  uninfected  BMDC  (Figure 
5.3B).  BMMac increased  CCR7  expression  by 6 fold  and  8 fold  (Figure  5.4A), 
and decreased CCR6 expression by 4 fold and 3 fold (Figure 5.4B) in response 
to C5 (TS) infection or LPS treatment respectively. Hence, the expression of
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Figure 5.1  Levels of apoptosis of BMMac and  BMDC  after infection with C5 (TS).  BMMac 
and  BMDC  were  infected  with  C5  (TS)  at  10  MOI.  (A)  Cells  were  harvested  at  time  points 
indicated  and  stained  with  annexin V (Cy-chrome)  and  propidium  iodide  (PI).  (B) At 24  hours 
post  infection,  all  cells  were  harvested  and  labelled  with  CFSE.  Half  of  them  were  directly 
stained  with  annexin  V  (Cy-chrome)  and  PI.  The  other  half  were  seeded  back  to  flask  and 
further incubated for 48  hours  (72  hours  post-infection).  These cells were then  harvested  and 
stained  with  annexin  V  (Cy-chrome)  and  PI.  The  percentage  of  apoptotic  cells,  which  were 
annexin V (+) but PI (-), was determined by density plot analysis.  Results are representative of 
three independent experiments.
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Figure 5.2 Alteration of CCR7 and CCR6 expression by BMDC and BMMac in response to 
Salmonella infection.  BMDC (upper panel) and BMMac (lower panel) were infected with either 
C5 (TS) at 10 MOI or SL3261  at 1   MOI.  Uninfected or LPS (1|ig/ml) treated cells were used as 
controls. Twenty-four hours post-infection,  RNA was extracted from  harvested cells. CCR7 and 
CCR6  gene  expression  was  analysed  by  RT-PCR.  PCR  products  for  each  condition  were 
loaded onto the gel as indicated. (3-actin was conducted as a loading control. M, marker.
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Figure  5.3  Semi-quantitative  analysis  of  CCR7  and  CCR6  expression  in  response  to 
Salmonella infection in BMDC by real-time RT-PCR. BMDC were infected with C5 (TS) at 10 
MOI.  Uninfected and LPS treated cells were used as controls. Twenty-four hours post infection, 
cells were harvested and  RNA was isolated from  each  sample.  Expression of CCR7 (panel A) 
or  CCR6  (panel  B)  was  analysed  by  real-time  RT-PCR.  The  fold  change  of expression  was 
calculated according to “calibrator” (uninfected cells) and compared among samples. The value 
on the top of each bar is the actual fold change of each sample.  Results are representative of 3 
experiments.
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Figure  5.4  Semi-quantitative  analysis  of  CCR7  and  CCR6  expression  in  response  to 
Salmonella infection  in  BMMac by  real-time RT-PCR.  BMMac were infected with C5 (TS) at 
10  MOI.  Uninfected  and  LPS  treated  cells  were  used  as  controls.  Twenty-four  hours  post 
infection,  cells were  harvested  and  RNA was  isolated  from  each  sample.  Expression of CCR7 
(panel A) or CCR6 (panel B) was analysed by real-time RT-PCR. The fold change of expression 
of each sample was calculated according to “calibrator” (uninfected cells) and compared among 
samples. The value on the top of each bar is the actual fold change of each sample. Results are 
representative of 3 experiments.
227CCR7 and CCR6 on  BMDC and  BMMac appeared to follow a similar pattern  in 
response to Salmonella infection or LPS stimulation.
As  BMMac and  BMDC  showed  different patterns of migration  in  vivo,  we  next 
set out to compare the level of CCR7 and CCR6 expression on these two types 
of cells  using  one  as  a  “calibrator”  (uninfected  BMMac).  The feasibility  of this 
analysis  is  based  on  the  presence  of  a  comparable  amount  of  RNA  in  all 
samples. We found that the expression of CCR7 on uninfected BMDC was 241- 
fold higher than  uninfected  BMMac (Figure 5.5 A). Although LPS treatment and 
C5  (TS)  infection  induced  a  similar  level  of  increase  in  both  types  of  cells 
compared to their uninfected counterparts,  CCR7 expression was much  higher 
in  C5  (TS)  infected  BMDC  than  C5  (TS)  infected  BMMac  (744  fold  vs  6  fold) 
(Figure  5.5A).  The  base  line  CCR6  expression  in  uninfected  BMDC  was  also 
higher  than  that  in  uninfected  BMMac  by  13  fold,  although  after  C5  (TS) 
infection,  CCR6 expression in BMMac and BMDC was similar,  3-fold and 4-fold 
less  compared  to  uninfected  BMMac.  However,  due  to  their  different  level  of 
base line expression, the extent of alteration  induced  by C5 (TS)  infection was 
greater  for  BMDC  than  for  BMMac  (16-fold  vs  5-fold)  (Figure  5.5B).  Taken 
together, upregulation of CCR7 and down regulation of CCR6 were observed on 
both types of cells in response to C5 (TS) infection, but due to the different base 
lines  of expression  in  uninfected  cells,  CCR7  expression  in  C5  (TS)  infected 
BMDC  was  much  greater  than  BMMac,  whereas,  CCR6  expression  after  C5 
(TS) infection was comparable.
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Figure  5.5  Comparison  of  CCR7  and  CCR6  expression  between  BMDC  and  BMMac.
BMMac (white bars) and  BMDC  (grey bars) were  infected with  C5 (TS)  at  10 MOI.  Uninfected 
and LPS treated cells were used as controls.  Cells were harvested 24 hours post-infection and 
RNA was  isolated  from  each  sample.  Expression  of CCR7  (panel A)  or CCR6  (panel  B)  was 
analysed  by  real-time  RT-PCR.  The  fold  change  of  expression  was  calculated  according  to 
“calibrator”  (uninfected  BMMac)  and compared  among  samples.  The value on the top of each 
bar is the actual fold change of each sample. Results are representative of 3 experiments.
2295.2.4 Detection of CCR7 expression on BMDC and BMMac using CCL19 
fusion protein
To  confirm  the  increased  expression  of  CCR7  on  BMDC  and  BMMac  in 
response to  C5  (TS)  infection,  a  CCL19-Fc (Fc,  fragment crystallizable) fusion 
protein  was  used  to  detect  CCR7  protein  levels.  Since  CCL19  is  one  of the 
ligands  of  CCR7,  by  testing  the  binding  to  this  particular  fusion  protein,  the 
levels of CCR7 protein on BMDC and BMMac and its alteration after stimulation 
could  be  analysed  by  flow cytometry.  Twenty-four  hours  after exposure  to  C5 
(TS) or LPS,  BMDC showed  greatly  increased  binding of CCL19-Fc compared 
to  uninfected  cells  (Figure  5.6).  In  striking  contrast,  compared  to  control 
unstained  cells,  uninfected  BMMac  did  not  show  any  binding  of  CCL19-Fc, 
indicating no CCR7 expression at the protein level on BMMac before stimulation 
(Figure 5.7).  However,  after C5 (TS) infection or LPS treatment,  BMMac started 
to  show  binding  to  CCL19-Fc,  but  the  level  of  increase  was  moderate  in 
comparison  to  that  in  BMDC  after  infection.  These  data  confirmed  that  the 
expression  and  alteration  of  CCR7  on  these  two  types  of cells  at the  protein 
level were consistent with its change at the mRNA level.
5.2.5 Functional test of chemokine receptors on BMDC and BMMac by 
chemotaxis assay
Following  the  detection  of  CCR7  up-regulation  with  concomitant  CCR6 
downregulation  on  BMDC  upon  C5  (TS)  infection,  the  changes  in  migratory 
capacity  of BMDC  towards  the  chemokines  CCL19  and  CCL20  after C5  (TS) 
infection were assessed  by in vitro chemotaxis assay, with LPS treated cells as
230a positive control.  Figure 5.8 shows that uninfected  BMDC exhibited a low level 
of migratory capacity (10%) towards CCL19 compared to that of medium alone 
(5%). This was consistent with the previous data that showed CCR7 expression 
on uninfected  BMDC. After exposure to C5 (TS) or LPS, the capacity of BMDC 
to  migrate  towards  CCL19  was  significantly  enhanced,  as  more  than  30%  of 
cells migrated compared to less than  10% of cells to medium alone.  Uninfected 
BMDC migrated towards CCL20, although the capacity was low. Approximately 
10% of cells were able to migrate towards CCL20 compared to 5% background 
migration in medium alone.  However, after exposure to C5 (TS) or LPS,  BMDC 
lost their ability to migrate towards CCL20 (Figure 5.9). These results confirmed 
that  both  CCR7  up-regulation  and  CCR6  down regulation  on  BMDC  were 
functional, which  conferred  a gain  in  responsiveness to the  chemokine  CCL19 
and  loss in  responsiveness to the chemokine  CCL20 after C5  (TS) infection or 
LPS treatment.
5.2.6  Preincubation with CCL19 induce desensitisation of CCR7 on BMDC
G  protein  coupled  receptors  become  desensitised  after  stimulation  with  their 
ligands,  resulting  in  a  failure  of  cells  to  migrate  towards  their  ligands  upon 
subsequent  exposure  (Kohout  et  al.,  2004).  In  order  to  test  if  the  in  vivo 
migration of C5 (TS)  infected  BMDC to SLO was related to CCR7  upregulation 
upon  infection,  we  decided  to  evaluate  the  consequences  of  in  vitro 
desensitisation of CCR7 with  its ligand  CCL19.  Firstly, the conditions for CCR7 
desensitisation were optimised  using the chemotaxis assay.  Figure 5.10 shows 
that after 45 minutes incubation with various concentrations of
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Figure 5.6 Expression of CCR7 protein and its alteration in response to C5 (TS) infection 
on  BMDC detected  by CCL19 fusion  protein.  BMDC were  infected with  C5 (TS) at 10  MOI. 
Uninfected and  LPS treated  DC were used  as controls. Twenty-four hours  post infection,  cells 
were harvested  and  incubated  with  the CCL19-Fc recombinant protein,  which was a fusion  of 
mouse CCL19 and the human lgG1  constant region, followed by goat anti-human IgG (PE). For 
control staining, cells were incubated in the absence of fusion protein. Histograms show staining 
of DC treated as indicated.
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Figure 5.7 Expression of CCR7 protein and  its alteration in response to C5 (TS) infection 
on BMMac detected by CCL19 fusion protein. BMMac were infected with C5 (TS) at 10 MOI. 
Uninfected and LPS treated cells were used as controls. Twenty-four hours post infection, cells 
were harvested  and  incubated with  the CCL19-Fc recombinant protein,  which was a fusion of 
mouse CCL19 and the human lgG1  constant region, followed by goat anti-human IgG (PE). For 
control staining, cells were incubated in the absence of fusion protein. Histograms show staining 
of BMMac treated as indicated.
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Figure 5.8  Migration  of BMDC towards  CCL19  (MIP-3(3)  in  response to C5 (TS)  infection.
BMDC were infected with C5 (TS) at 10 MOI. Uninfected and LPS treated cells used as controls 
for infection.  The  functional  migration  of DC  towards  CCL19  (30  nM)  24  hours  post  infection 
was  analysed  by  a  chemotaxis  assay,  with  medium  alone  as  a  control  for specific  migration. 
Migration was  measured  by the  percentage of migrated  cells.  Data  represent  mean values  of 
duplicates performed in transwells. Results are representative of two experiments.
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Figure 5.9  Migration  of BMDC towards CCL20 (MIP-3a)  in  response to  C5 (TS)  infection.
BMDC were infected with C5 (TS) at 10 MOI. Uninfected and LPS treated cells used as controls 
for infection. The functional migration of DC towards CCL20 (100 ng/ml) 24 hours post infection 
was  analysed  by  a  chemotaxis  assay,  with  medium  alone  as  a  control  for specific  migration. 
Migration was  measured  by the  percentage of migrated  cells.  Data  represent mean  values  of 
duplicates performed in transwells. Results are the representative of two experiments.
235CCL19,  the migratory capacity of C5  (TS)  infected  BMDC towards CCL19 was 
greatly  diminished.  Optimal  desensitisation  was  obtained  by  incubation  of the 
cells with  CCL19  at a  concentration  of 5  pg/ml,  and  a  higher concentration  of 
CCL19 (10 pg/ml) did  not further enhance the effect (Figure 5.10).  Notably, the 
responsiveness of uninfected  BMDC to  CCL19 was  also slightly  reduced  after 
CCR7  desensitisation.  CCL20,  a  CCR6  ligand  was  used  as  a  control  for 
specificity  of  migration  after  desensitisentation.  Compared  to  the 
responsiveness to CCL19,  no responsiveness to CCL20 was observed with the 
levels the same as that with media alone.
5.2.7  Decreased migration of BMDC to spleen and MLN caused by CCL19- 
mediated CCR7 desensitisation
In  order to test if the in  vivo  migration  of C5  (TS)  infected  BMDC to  SLO was 
dependent on  CCR7,  C5  (TS)  infected  BMDC were desensitised  by incubation 
with 5 pg/ml CCL19 prior to adoptive transfer (cells incubated with  PBS served 
as the non-desensitised control).  In  parallel,  a small fraction of transferred cells 
was  left  to  set  up  a  chemotaxis  assay  to  ascertain  that  the  transferred  cells 
were indeed desensitised.  Figure 5.11  shows that compared to more than 30% 
of non-desensitised  cells  migrating towards  CCL19  in  a chemotaxis assay,  the 
ability  of desensitised  cells  to  migrate  to  CCL19  was  greatly  reduced,  to just 
over 10% (Figure 5.11). These results indicated that the desensitised cells used 
in in vivo transfer lost much of their responsiveness to CCL19.
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Figure  5.10  Selection  of  the  concentration  of  CCL19  required  for  DC  in  vitro 
desensitisation.  BMDC were infected with  C5 (TS) at  10 MOI with  uninfected cells  used as a 
control. Twenty-four hours after infection,  DC were harvested and split into 3 parts, which were 
incubated at 37°C for 1   hour in the presence of PBS, 5 |ag/ml or 10 p.g/ml of CCL19 respectively. 
After washing  off the  residual  chemokine,  cells  were  seeded  into  the  upper  compartment  of 
transwells  with  CCL19  (30  nM),  CCL20  (100  ng/ml)  or  medium  alone  in  the  bottom 
compartment.  Migration  was  measured  by  the  percentage  of  migrated  cells.  Data  represent 
mean  values  of  duplicates.  Results  are  representative  of  two  experiments.  ND,  non- 
desensitised.
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Figure 5.11  In  vitro assessment of the desensitisation  of DC  used for adoptive transfer.
BMDC  were  infected  with  C5  (TS)  at  10  MOI.  Twenty-four  hours  after  infection,  cells  were 
harvested.  Half were  incubated  with  5  )ig/ml  CCL19  (indicated  as  desensitised,  D),  while  the 
other  half  were  incubated  with  PBS  only  (indicated  as  non-desensitised,  ND).  Following 
incubation at 37°C for 1   hour, cells were labelled with CFSE before washing 3 times with  PBS. 
Some  cells  were  set  up  in  the  transwell  assay  before  the  majority  of  them  were  adoptively 
transferred to mice.  Data are expressed as the mean percentage of migrated cells for duplicate 
wells.
238The  migration  pattern  of  desensitised  and  non-desensitised  C5  (TS)  infected 
BMDC was compared  in  two  independent experiments.  In  both,  a comparable 
number of cells were  recovered  in the  PL 48  hours post-transfer (Figure 5.12a 
A,  5.12b A).  In  addition,  a  significant  reduction  in  the  number of desensitised 
cells  migrating  to the  MLN  was  observed  in  one  experiment  but  not the  other 
(Figure  5.12a  B,  5.12b  B).  Inconsistent  results  were  observed  with  respect to 
the effects  of desensitisation  on  migration  to the  spleen.  Thus,  the  number of 
desensitised  cells  migrating to the spleen was  reduced  in  one experiment,  but 
not the other (Figure 5.12aB,  5.12b B).  In the ILN,  only a small number of cells 
were  recovered  in  both  groups,  with  a  slight  (but  not  statistically  significant) 
reduction apparent for desensitised cells (Figure 5.12a B, 5.12b B).
Taken together,  the  results from the two desensitisation  experiments  indicated 
that  the  migration  of  C5  (TS)  infected  BMDC  toward  MLN  was  inhibited 
significantly  by  in  vitro  CCR7  desensitisation;  a  firm  conclusion  on  whether 
migration  of  the  same  cells  to  the  spleen  was  also  inhibited  by  CCR7 
desensitisation could not be made at this stage.
5.2.8  Differential dependence on CCR7 in mediating DC migration to 
spleen and MLN
Since  results  generated  using  in  vitro  desensitisation  were  inconsistent,  we 
decided to  use a  potentially more definitive model to assess the  role of CCR7, 
namely  CCR7  deficient  mice  (denoted  as  CCR7  knockout  (KO))  described 
earlier ((Forster et al.,  1999).  Bone  marrow cells  isolated from  CCR7  KO  mice
239(BALB/c background) were  kindly  provided  by  Dr.  Martin  Lipp  (Max-Delbruck- 
Center  for  Molecular  Medicine,  Berlin,  Germany).  DC  were  generated  from 
bone  marrow  cells  isolated  from  CCR7  KO  or  BALB/c  mice.  Infection  and 
adoptive transfer procedures were then  performed  as in  previous experiments, 
and  the  number  of  CFSE  labelled  cells  in  PL,  spleen,  MLN  and  ILN  were 
compared between two groups 48-hours post-transfer.
Two independent experiments were performed with  similar results. A small but 
significant  reduction  was  observed  in  the  number  of  CFSE  labelled  cells 
recovered from the PL of mice receiving CCR7 KO DC compared to BALB/c DC 
(Figure  5.13A).  In  contrast,  similar  numbers  of  CCR7  KO  and  WT  DC  were 
recovered  from  the  spleens  of  recipient  mice,  indicating  that  CCR7  was  not 
required  for migration to this  organ.  Strikingly,  however,  virtually  no  CCR7  KO 
DC migrated to MLN or ILN (Figure 5.13B); for MLN, the difference between WT 
and CCR7 KO DC was highly statistically significant (p<0.001). Therefore, these 
data  indicate  a  strict  requirement  for  CCR7  in  guiding  migration  of  S. 
typhimurium infected BMDC to LN, but not spleen.
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Figure 5.12a Effect of in  vitro CCR7 desensitisation on  DC migration to lymphoid organs 
(Experiment 1). BMDC were infected with C5 (TS) at 10 MOI. Twenty-four hours after infection, 
cells were  harvested.  Half were  incubated with  5  pg/ml  CCL19  (indicated  as desensitised,  D), 
while  the  other  half  were  incubated  with  PBS  only  (indicated  as  non-desensitised,  ND). 
Following incubation at 37°C for 1   hour,  cells were labelled with CFSE before washing 3 times 
with  PBS.  Cells  were  then  adoptively  transferred  to  HLA-B27/(32m  mice  by  intraperitoneal 
injection  (3  mice  for  ND  group  and  4  for  D  group).  Forty-eight  hours  post-transfer,  CFSE 
labelled cells were enumerated in suspensions from  peritoneal  lavage (PL), spleen,  mesenteric 
lymph  nodes  (MLN)  and  inguinal  lymph  nodes  (ILN)  by flow  cytometry.  (A)  Number of CFSE 
labelled cells in  PL.  (B)  Number of CFSE  labelled cells  in spleen,  MLN  and  ILN.  ** p<0.05 vs 
ND (Two-sample student’s T-test).
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Figure 5.12b  Effect of in  vitro CCR7 desensitisation  on  DC  migration to  lymphoid  organs 
(Experiment 2).  BMDC were infected with C5 (TS) at 10 MOI. Twenty-four hours after infection, 
cells  were  harvested.  Half were  incubated  with  5  pg/ml  CCL19  (indicated  as  desensitised,  D), 
while the other half were incubated with PBS only (indicated as non-desensitised,  ND).  Following 
incubation  at 37°C for  1   hour,  cells were  labelled with  CFSE  before washing  3 times with  PBS. 
Cells were then adoptively transferred to  HLA-B27/p2m  mice  by intraperitoneal  injection  (3 mice 
of  each  group).  Forty-eight  hours  post-transfer,  CFSE  labelled  cells  were  enumerated  in 
suspensions from  peritoneal  lavage (PL),  spleen,  MLN  and  inguinal  LN  (ILN)  by flow cytometry. 
(A) Number of CFSE labelled cells in PL.  (B) Number of CFSE labelled cells in spleen, MLN and 
ILN. * p=0.05 vs ND (Two-sample student’s T-test).
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Figure  5.13  Differential  dependence  of  CCR7  in  mediating  DC  migration  to  spleen  and 
lymph  nodes.  BMDC  were  propagated  by  7-day  culture  of  bone  marrow  cells  isolated  from 
BALB/c  or  CCR7  KO  mice  in  the  presence  of  GM-CSF.  CCR7  KO  bone  marrow  cells  were 
generously provided by Dr. Martin Lipp from Germany. At day 8, adherent cells were infected with 
C5 (TS) at 10 MOI.  Cells were harvested and  labelled with CFSE 24 hours after infection. CFSE 
labelled  cells  (1><107 /mouse)  were  then  adoptively  transferred  to  BALB/c  recipient  mice  by 
intraperitoneal  injection  (4  mice  of each  group).  Forty-eight  hours  post-transfer,  CFSE  labelled 
cells  were  enumerated  in  suspensions  from  PL,  spleen,  MLN  and  ILN  by  flow  cytometry.  (A) 
Number of CFSE labelled cells in PL. (B) Number of CFSE labelled cells in spleen, MLN and ILN. 
Results  are  representative  of two  independent  experiments with  the  similar results.  ** p<0.01, 
*** p<0.001  vs BALB/c (Two-sample student’s T-test).
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In  this  chapter,  possible  mechanisms  behind  the  differential  migration  of  S. 
typhimurium  infected  BMDC  and  BMMac  were  explored.  Firstly,  we  asked 
whether  the  fact  that  transferred  BMMac  were  relatively  undetectable  in 
lymphoid  organs  compared  to  BMDC,  was  due  to  a  greater  induction  of 
apoptosis  upon  infection.  Secondly,  we  determined  whether  chemokine 
receptor  expression  was  modulated  by  S.  typhimurium  infection,  focusing  on 
CCR7  and  CCR6.  Thirdly,  we tested  whether the function  of CCR7  on  BMDC 
could  be  desensitised  by  in  vitro  exposure  to  its  ligand  and  whether  in  vivo 
migration  of the  C5  (TS)  infected  BMDC  to  SLO  could  be  inhibited  by  CCR7 
desensitisation.  Fourthly,  a  role  for CCR7  in  the  migration  pattern  of DC  after 
C5 (TS) infection was assessed using CCR7 deficient cells.
The effect of S. typhimurium infection on apoptosis was measured by annexin V 
staining.  This  assay  detects  the  presence  of  phosphatidylserine  (PS),  a 
membrane  phospholipid,  on  the  surface  of cells.  As  one  of the  early  signs  of 
apoptosis,  PS  is  translocated  from  the  inner to  the  outer leaflet of the  plasma 
membrane,  thereby exposing  PS to the external  cellular environment.  Annexin 
V is  a  35-36  kDa  Ca2+ dependent phospholipid-binding  protein that has a  high 
affinity for PS,  thus serving  as a sensitive probe for flow cytometric analysis of 
cells that are undergoing apoptosis.
We  demonstrated  that  BMMac  (either  uninfected  or C5  (TS)  infected)  did  not 
show a greater tendency to undergo apoptosis than  BMDC (Figure 5.1).  In fact, 
lower  rate  of cell  death  of  macrophages  compared  to  DC  observed  in  our in
244vitro  system  suggests  that  macrophages  may  not  die  in  large  numbers  after 
adoptive  transfer.  Thus,  these  results  raised  the  possibility  that  the  poor 
detection of macrophages  after transfer might be due to their ability to migrate 
to  areas  such  as  peripheral  tissues,  making  them  hard  to  be  detected.  Our 
results  supported  this  possibility,  since  transferred  macrophages  but  not  DC 
indeed were able to migrate to the inflamed peripheral tissues in small numbers 
(Figure  4.12).  Whether  this  migration  also  occurs  under  non-inflammatory 
conditions is worthy of further investigation.
The  migration  profile  of  macrophages  observed  here  is  consistent  with  other 
studies.  Geissman  et  al  (Geissmann  et  al.,  2003)  studied  migration  of 
macrophage  precursors,  a  subpopulation  of  monocytes  whose  phenotype 
defined  as  Gr-1+CX3CR1l0 W CCR2+CD62L+.  These  cells  were  almost 
undetectable  in  all  tissues  analysed  except the  spleen  one  day  after adoptive 
transfer into  naive  mice.  However,  if these  cells were  transferred  into  animals 
with experimentally induced peritonitis, they infiltrated the inflammatory area, ie, 
the  peritoneal  cavity.  The  relationship  between  our  BMMac  and  the  particular 
population  of monocytes described  in  their study would  an  interesting  issue to 
consider.
Various  other  studies  have  examined  the  migration  of  macrophages  after 
adoptive  transfer.  In  one,  CFSE  labelled  macrophages  stimulated  with  a 
microbial product in vitro could not be detected at any time point analysed after 
injection into the footpads of mice (Jeannin et al., 2003). Another paper reported 
that  viable  cells  accumulate  predominantly  in  the  spleen  and  liver while  non-
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Gordon,  1990)  after  i.v  transfer.  It  is  possible  that  viable  cells  could  also  be 
trapped  in  the  pulmonary  microvasculature,  but  to  a  lesser  extent  than  non- 
viable cells.
BMDC  were  induced  to  undergo  apoptosis  to  a  greater  extent  than 
macrophages  when  left  in  culture  for two  days  post  infection.  Supporting  our 
results,  it has been  previously shown that S.  typhimurium can  induce BMDC to 
undergo  apoptosis  in  a  dose-dependent  manner  (Yrlid  et  al.,  2001b).  A 
contributing  factor  may  be  cultured  BMDC  have  reached  their  final  stage  of 
maturation  by 7-8 days  (Lutz et al.,  1999).  Indeed,  in  our study, we found  that 
DC were sensitive to even very minor procedures such as changing the medium 
and pipetting, which would mature DC, demonstrated by 4-8 fold upregulation of 
CCR7 mRNA (data  not shown).  Furthermore,  after being  induced to mature  by 
treatment  with  TNF-a,  40%  of  BMDC  appear  apoptotic  following  6  hours  of 
culture in  medium alone. The implication  is that mature DC are relatively short­
lived, at least in vitro (Sanchez-Sanchez et al., 2004).
Results from cross-transfer experiments suggested that transferred  BMDC also 
undergo  some  apoptosis  in  vivo.  In  the  peritoneal  lavage,  nearly  15%  of 
uninfected BMDC were engulfed by endogenous cells, indicated by their double 
staining  for  CFSE  and  HLA-ABC.  S.  typhimurium  infection  augmented  this 
effect by another 5% (Figure 4.3).  Signs of apoptosis on transferred cells would 
be  sensed  by  endogenous  cells  such  as  peritoneal  macrophages,  resulting  in 
the apoptotic cells being  phagocytosed.  Thus,  about  15%  of uninfected  BMDC
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adoptive  transfer.  Finally,  CFSE  labelling  did  not  increase  the  level  of  the 
apoptosis  on  uninfected  cells  but enhanced  the  level  of apoptosis  on  C5  (TS) 
infected  cells  suggesting  a  synergistic  effect  of  CFSE  labelling  and  C5  (TS) 
infection on BMDC.
Several lines of evidence suggest that DC  reprogram their chemokine  receptor 
expression  profile during defined  maturation  stages (Fleming et al., 2003;  Sato 
et al.,  2001;  Yanagawa  and  Onoe,  2003).  Functional  maturation  is  associated 
with loss of responsiveness to chemokines present at sites of inflammation and 
acquisition of a receptor repertoire that renders these cells responsive to signals 
that  guide  their  localisation  in  lymphoid  organs  (Sozzani  et  al.,  1999).  As 
mentioned  in  Chapter  1,  immature  DC  respond  to  a  large  spectrum  of 
chemokines through specific receptors (Table 1.2).
Different immature DC subsets display unique sensitivity to certain chemokines, 
which allows them to be recruited to various peripheral tissues where they play 
a  sentinel  role.  For  instance,  a  previous  study  has  reported  that  F4/80-B220- 
CD11c+  DC  expressing  CCR1  and  CCR5  are  mobilized  rapidly  into  the 
circulation  in  mice  injected with propionibacterium acnes to  induce granulomas 
in  the  liver,  and  are  recruited  into  inflammatory tissue  by  CCL3/MIP-1a,  which 
binds to  CCR1  and  CCR5  (Yoneyama  et al.,  2001).  CCL20/MIP-3a,  produced 
by keratinocytes, is important in recruiting Langerhans cells (skin dendritic cells) 
to the epidermis through  CCR6  (Charbonnier et al.,  1999).  Interestingly,  it has 
been  shown that  Salmonella,  but  not indigenous  bacteria  of the  intestinal flora
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epithelial  cell  lines  (Sierro  et  al.,  2001).  Such  a  mechanism  could  be 
instrumental in initiating adaptive immune responses in the gut upon Salmonella 
infection.  Based on these observations, CCR6 was investigated in our study as 
a representative chemokine receptor expressed on immature DC.
After  antigen  uptake,  inflammatory  stimuli  turn  off  the  responsiveness  of 
immature  DC  to  chemokines  specific  for  immature  DC  through  receptor 
down regulation.  Consequently,  maturing  DC  escape from the  local gradient of 
chemokines  that  immature  DC  respond  to  (Banchereau  et  al.,  2000). 
Meanwhile,  upon  maturation,  DC  upregulate  the  chemokine  receptor  CCR7 
(Yoshida et al.,  1997),  and  acquire  responsiveness to CCL19 and CCL21.  The 
role  of these two  co-receptor chemokines  in  recruiting  DC  differs according to 
their site of expression.  CCL21  is expressed  on  lymphatic vessels  and  directs 
maturing DC to leave inflamed tissues and enter the lymph stream (Gunn et al., 
1998;  Saeki et al.,  1999).  CCL19 and  CCL21  are  both  secreted  by the stromal 
cells  in  the T  cell  zones  and  are  responsible  for directing  mature  DC to enter 
SLO (Dieu et al.,  1998; Ngo et al.,  1998).  Both chemokines are full agonists with 
similar  receptor  binding  affinities  and  chemotactic  potencies  for  CCR7  (Ott  et 
al.,  2004;  Sullivan  et  al.,  1999;  Yoshida  et  al.,  1998).  The  reason  for  the 
existence of two ligands for CCR7 is not clear.
Real-time  RT-PCR  results  clearly  showed  that  S.  typhimurium  infection  drove 
BMDC and  BMMac to alter expression  of these two chemokine receptors, with 
CCR7  expression  upregulated  and  CCR6  downregulated  (Figure  5.3  and  5.4).
248However,  the  presence  of  the  bands  on  the  gel  from  our  RT-PCR  results 
demonstrated that CCR7 and CCR6 were expressed on these two populations. 
This is inconsistent with a previous study showing CCR6 mRNA expression was 
not detectable by RT-PCR in immature and mature DC (Cheminay et al., 2002). 
Nevertheless,  the  detailed  expression  of  CCR6  on  different  DC  subsets  was 
addressed  using  EGFP/CCR6  knock-in  mice  (EGFP  expressed  under  the 
CCR6  promoter to visualise CCR6 expression)  (Kucharzik et al.,  2002).  In this 
study,  it was shown  that most CD11b+  myeloid  DC expressed  CCR6,  but that 
CD8a+  lymphoid  DC  are  negative  for  CCR6;  epidermal  Langerhans  cells 
expressed  CCR6,  but  at  lower  levels  than  splenic  myeloid  DC.  CD11c+  DC 
generated from culture of bone marrow precursors from the  knock-in  mice with 
GM-CSF also expressed CCR6. Therefore, our results agreed with the study of 
CCR6  knock-in  mice,  indicating  that  CCR6  is  indeed  expressed  on  BMDC. 
CCR6  expression  on  major  DC  subsets  suggest  that  its  ligand,  CCL20, 
participates in determining the positioning of DC subsets, including DC recruited 
from bone marrow, in peripheral tissues.
Our  real-time  RT-PCR  results  confirmed  that  BMDC  down-regulated  CCR6 
expression  and  coordinatedly  upregulated  CCR7  expression  upon  S. 
typhimurium infection or LPS treatment (Figure 5.4B).  Due to the previous lack 
of an antibody against the murine CCR7 protein,  CCR7 protein expression was 
measured using a CCL19-Fc fusion protein (Figure 5.6). These results indicated 
that  increases  in  CCR7  mRNA  were  associated  with  increased  surface 
expression  of  CCR7.  Increased  CCR7  protein  expression  on  matured  BMDC
249has recently been shown  using an anti-CCR7 antibody (Cheminay et al., 2002) 
(Ritter et al., 2004).
Our  results  showing  a  “switch”  of chemokine  receptors  on  DC  are  consistent 
with the studies of others (Moutaftsi et al., 2004).  It has been suggested that the 
downregulation  of CCR6  and  upregulation  of  CCR7  underlies  langerhans  cell 
migration  from  skin  to  lymphoid  tissue  (Fleming  et al.,  2003).  Similarly,  CCR1 
and  CCR5  are  downregulated  upon  DC  maturation,  whereas  CCR7  is 
selectively  upregulated  facilitating  their  migration  from  peripheral  tissues  to 
regional  lymph  nodes  (Yanagawa  and  Onoe,  2003).  Studies  from  human 
monocyte  derived  DC  further  reveal  the  dynamic  modulation  of  chemokine 
receptors  on  DC  at  different  stages  of  development  (Moutaftsi  et  al.,  2004). 
These  authors  found  that  cell-surface  expression  of  CCR1,  CCR3  and  CCR5 
was  increased  during  differentiation  of  immature  DC  from  monocytes.  In 
contrast,  expression  was  decreased  during  the  development  of  immature  DC 
into mature DC, while CCR7 expression was detected on mature DC, but not on 
monocytes  or  immature  DC  (Sato  et  al.,  2001).  Moreover,  DC  also  switched 
their functional  migration  towards  different  chemokines.  That  is,  immature  DC 
and their precursor monocytes,  but not mature DC migrated  in  response to the 
inflammatory  chemokine  CCL5,  whereas  mature  DC,  but  not  monocytes  or 
immature  DC,  migrated to CCL19  (Sato et al.,  2001).  In this respect,  our study 
also  demonstrated  that  the  switch  in  chemokine  receptors  on  BMDC  was  a 
functional  switch.  More  mature,  infected  BMDC  migrated  towards  CCL19, 
whereas  downregulation  of  CCR6  expression  resulted  in  a  loss  in  ability  to 
migrate  towards  the  CCR6  ligand  CCL20  (Figure  5.8-5.9).  These  results  are
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exposured to S. typhimurium migrated not only towards CCL19 but also CCL21, 
another CCR7  ligand,  but not CCL20.  More  interestingly,  they also found  that 
the  changes  in  DC  migration  required  neither  viable  S.  typhimurium  nor 
bacterial  internalisation,  since  similar  alterations  were  observed  following 
coincubation  with  heat-killed  Salmonella  or  when  CCD  was  present  in  the 
infection culture (Cheminay et al., 2002).
Maturation  of  DC  has  been  described  as  a  general  phenomenon  observed  in 
response  to  viable  bacteria,  or  bacterial  products  such  as  LPS  (Cutler et  al., 
2001;  Svensson  et  al.,  2000).  Our  earlier  results  have  shown  that  S. 
typhimurium induced the  maturation  of BMDC  by  upregulation of costimulatory 
molecules such as CD80,  CD86,  CD40 and  MHC class  II  l-A/l-E (Figure 3.16). 
Here,  we  showed  that  CCR7  upregulation  occurred  upon  S.  typhimurium 
induced  maturation  of  BMDC,  which  served  as  another  parameter to  confirm 
DC maturation.  Interestingly, by FACS-sorting of BMDC into immature (CD11c+ 
MHCIIl0 W )  and  mature  (CD11c+MHCIIh '9h)  populations  followed  by  RT-PCR 
analysis of CCR7 gene expression,  it has been shown that CCR7 is expressed 
on  mature  DC  but not on  immature  DC  (Cheminay et al.,  2002).  However,  our 
uninfected BMDC displayed quite a high level of CCR7 expression as compared 
to uninfected  BMMac at both the mRNA and  protein  level (Figure 5.5-5.7). This 
is  owing  to  the  fact  that  even  prior  to  infection  our  BMDC  culture  was  a 
heterogenous population comprising mature MHC  llh l9h  and  immature MHC lllo w  
subpopulations  (Figure  3.7).  S.  typhimurium  infection  or  LPS  treatment 
dramatically  increased  the  MHC  llh i9h   subpopulation  and  decreased  the  MHC
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infected  or LPS treated  BMDC.  Other studies  have  also  confirmed  that CCR7 
expression on murine BMDC  is an  indicator of the maturity (Ritter et al.,  2004). 
Consistent  with  our  results,  they  found  that  about  40%  of their  unstimulated 
BMDC  were  positive  for  CCR7  mRNA,  and  incubation  with  LPS  induced  the 
maturation  of all  BMDC  in  culture.  Interestingly,  LPS treatment only marginally 
increased  the  number  of  mature  CCR7+  splenic  DC,  indicating  their  more 
mature state (Ritter et al., 2004).
CCR7  has  also  been  proposed  to  play  a  number  of  additional  roles  in  the 
immune system. For example, CCR7 induces intracellular signalling that inhibits 
apoptosis of mature  DC  (Sanchez-Sanchez et al.,  2004).  Stimulation  of CCR7 
with  its  ligands  induce  activation  of  PI3k  and  prolonged  activation  of  its 
downstream  effector  Akt1,  a  common  signalling  pathway  that  regulates 
apoptosis in a variety of cells (Strasser et al., 2000). Akt1  may then activate IkB 
kinase,  which  induces  degradation  of  IkB.  Upon  IkB  degradation,  NFkB 
translocates  to  the  nucleus  and  stimulates  transcription  from  a  variety  of 
antiapoptotic genes (Datta et al.,  1999;  Karin and  Lin,  2002).  Since it has been 
suggested  that  DC terminate their life  cycle  in  the  lymph  node  (Kamath  et al.,
2002),  an extended  longevity, favoured  by signalling from  CCR7, may increase 
the  probability  of  antigen  presentation  and  stimulation  of  antigen-specific  T 
cells.  In  this  regard,  our  results  showed  both  a  high  degree  of  apoptosis 
detected on  C5 (TS)  infected  BMDC and  an  upregulation  of CCR7 expression. 
An explanation for this discrepancy could be that an antiapoptotic effect exerted 
from  CCR7 signalling  might be overwhelmed  by an apoptotic effect induced by
252S.  typhimurium  infection.  Conversely,  a  lack  of  a  protective  effect  of  CCR7 
expression might have been due to the absence of the chemokine ligand.
Although both BMDC and  BMMac upregulated CCR7 expression upon C5 (TS) 
infection  or  LPS  treatment,  uninfected  BMDC  had  a  much  higher  level  of 
expression  of  CCR7  mRNA  than  uninfected  BMMac  (Figure  5.5).  Such 
differences were further confirmed using a CCL19-fusion protein for detection of 
CCR7  at the  protein  level.  Uninfected  BMDC  had  a  detectable  level  of CCR7 
expression,  which  was  greatly  increased  following  infection  (Figure  5.6). 
However,  uninfected  BMMac  expressed  no  detectable  CCR7  protein;  upon 
infection,  expression  became detectable but remained  low compared to BMDC 
(Figure 5.7). As a  key chemokine receptor responsible for cellular trafficking to 
the SLO, the dramatic difference between the levels of CCR7 protein expressed 
on  these  two  cell  populations  may  ultimately  determine  their  differential 
migration  patterns  in  vivo.  Conversely,  CCR6  was  observed  to  be 
downregulated on both cell types.
The  large  difference  between  CCR7  expression  on  BMDC  and  BMMac  has 
been  clearly demonstrated  by  RNase  protection  assay  in  another study  (Bhatt 
et  al.,  2004).  Furthermore,  chemokine  receptor  expression  on  DC  and 
macrophage  has  been  shown  previously  to  be  modulated  in  a  consistent way 
with  what we found  in  our study  (Jeannin  et al.,  2003).  In  this  previous study, 
immature  DC  exposed  to  outer  membrane  protein  A  (a  microbial  product  of 
gram-negative bacteria) gradually acquired CCR7 expression  (detected at RNA 
and protein levels), whereas CCR1  and CCR5 expression disappeared after 24
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CCR5,  but  not  CCR7  were  constitutively  expressed  by  macrophages.  Upon 
stimulation,  CCR7  expression  was  induced  within  24  hours  on  macrophages 
with CCR1  and CCR5 expression down-regulated concomitantly (Jeannin et al.,
2003).  Taken  together,  these  results  further  confirm  that  the  “switch”  of 
chemokine receptors on  both  DC and  macrophages  is a  general  phenomenon 
upon stimulation with microbes or their products.
Results from the chemotaxis assay demonstrated  that CCR7  upregulation  and 
CCR6  downregulation  on  BMDC  in  response  to  C5  (TS)  infection  or  LPS 
treatment were  both  functional  events,  since  after stimulation,  BMDC  lost the 
ability  to  migrate  towards  CCL20,  but  acquired  the  ability  to  migrate  towards 
CCL19  (Figure  5.8-5.9).  As  a  result,  the  functional  responsiveness  to  CCL19 
was  greater than  the  responsiveness  to  CCL20  (20%  vs  up  to  5%)  upon  C5 
(TS)  infection.  This  may  be  sufficient  to  allow  infected  BMDC  to  migrate  to 
where their ligands are, in vivo, such as SLO. Although the functional migratory 
ability  of  BMMac was  tested  by  the  same  chemotaxis  assay  used  for  BMDC, 
BMMac did  not show any  ability  to  migrate  towards  CCL19  (data  not shown). 
This is likely due to several factors. Firstly,  macrophages are adherent cells and 
attach to the surface of culture flasks in a short time (van  Furth,  1992), and this 
feature  has been  used to  remove  macrophage from other nonadherent cells in 
culture  (Lutz et al.,  1999).  Therefore,  during the 4-hour incubation time  in the 
chemotaxis  assay,  they  might  simply  have  attached  to  the  bottom  of 
polycarbonate  filter.  Secondly,  the  level  of  CCR7  on  BMMac,  even  after 
upregulation  upon  stimulation,  is  far  lower  than  on  BMDC.  This  may  not  be
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macrophages  to  migrate  in  the  chemotaxis  assay  might  be  due  to  another 
technical problem,  since we  used  5.0  jum  pore size  polycarbonate filters in the 
assay.  This  pore  size  is  suitable  for  DC,  but  could  be  too  small  for 
macrophages.  Jeannin  and  colleagues  performed  in  vitro  chemotaxis  assays 
successfully  on  both  DC  and  macrophages  using  8.0  |nm  pore  size  filter, 
although they also claimed that a longer incubation period (24 hours) is required 
to observe macrophage migration than  DC migration, which was observed only 
after 90 minutes exposure to CCL21  (Jeannin et al., 2003).
Potentially,  three approaches  can  be  used  to  block the  effect of CCR7:  in  vivo 
neutralisation with  an  anti-CCR7  antibody,  desensitisation  using  CCR7  ligands 
and  use  of  CCR7  deficient  mice.  Due  to  the  previous  lack  of  a  commercial 
mouse  CCR7-specific  monoclonal  antibody,  desensitisation  of  CCR7  was 
initially  chosen  to  block the  effect of CCR7.  Since  CCL19  has  been  shown  to 
have  a  4-fold  better  efficacy  for  desensitisation  than  CCL21  (Kohout  et  al.,
2004),  CCL19  was  chosen  to  desensitise  CCR7.  This  process  of  agonist 
specific desensitisation is called “homologous desensitisation” (Ali et al., 1999).
Since  it  has  been  suggested  that  homologous  desensitisation  requires 
preincubation with a high concentration of chemokines (Maghazachi, 2000), we 
firstly  set  out  to  choose  the  optimal  concentration  of  CCL19.  Based  on  the 
finding  that  5  |ig/ml  and  10  pg/ml  of  CCL19  exerted  comparable  effects  on 
desensitisation on C5 (TS) infected BMDC (Figure 5.10), 5 (j,g/ml of CCL19 was 
used.  C5  (TS)  infected  BMDC  migration  towards  CCL19  in  vitro  was  greatly
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chosen to serve as a control for the  specificity of desensitisation.  Interestingly, 
we found that the level of migration of desensitised  BMDC (either uninfected or 
C5 (TS)  infected) toward  CCL20 or in medium alone was also reduced  (Figure 
5.10).  This  could  indicate  that  in  addition  to  homologous  desensitisation,  so 
called  “heterologous  desensitisaton”  has  also  occurred.  Another  possibility  is 
that DC themselves produce some CCL19, which  is responsible for stimulating 
the  background  migration.  In  this  case,  CCL19  desensitisation  would  still  be 
considered homologous.
A  comparable  number  of  cells  were  recovered  from  the  PL  after  injection  of 
desensitised  or non-desensitised  BMDC  (Figure  5.12a A and  Figure  5.12b A), 
which indicated that a comparable number of cells had been transferred into the 
peritoneal  cavity  two-days  previously.  In  contrast,  significantly  fewer 
desensitised cells were found in MLN (Figure 5.12a B and Figure 5.12b B). This 
result suggested  that the  migration  of  BMDC  to  the  regional  LNs  in  vivo was 
dependent on  the  upregulated  expression  of CCR7  caused  by  S.  typhimurium 
infection.
Although, the two desensitisation experiments gave similar results in  MLN, the 
differences observed  in the second  experiment were  not statistically significant 
(p=0.05).  This  might  relate  to  the  fact  that smaller  numbers  of CFSE  labelled 
cells  were  retrieved  from  all  organs  we  examined  in  this  experiment.  As  the 
numbers of labelled  cells  present  in  MLN  were small,  a  moderate reduction  in 
numbers may not readily show obvious significance.  In addition, smaller sample
256numbers (3  mice  per group  in  this experiment in  contrast to 4  mice  in the first 
experiment) could be another factor affecting the significance of results.
Considerable  variance  existed  between  two  desensitisation  experiments  with 
the  respect  to  the  effect  on  cell  migration  to  the  spleen.  Variability  may  be 
caused  firstly  by  extensive  manipulation  of  DC  required  in  the  experiments. 
Additionally,  desensitisation  is a complex process that involves a diverse array 
of  signalling  molecules  (Maghazachi,  2000).  Therefore,  differing  signalling 
pathways could  have  occurred  during  two experiments.  Since the spleen  data 
failed to show consistent results from two desensitisation experiments, we were 
unable to draw any firm conclusion as to whether CCR7 was required to guide 
DC to the spleen.
Even  in  MLN,  the  accumulation  of  injected  BMDC  was  only  reduced,  but  not 
abolished  by  CCR7  desensitisation.  This  could  be  due to two  reasons.  Firstly, 
results from the in vitro chemotaxis assay had shown that CCR7 desensitisation 
was  not  able  to  completely  block  migration  of  CCL19  (Figure  5.11).  This 
residual  effect  of  CCR7  in  vitro  most  likely  was  responsible  for  the  residual 
migration to the  SLO in  vivo.  Secondly,  other molecules apart from CCR7 may 
also play a role in the directing of mature DC migration to regional lymph nodes. 
A role for CCR8  and  other chemokine  pathways  in the  migration  of monocyte- 
derived  DC to  lymph  nodes  has  been  demonstrated  recently (Qu et al.,  2004). 
Additionally,  acquisition  of  other  receptors  such  as  CXCR5  as  DC  matured 
enables  them  to  migrate  to  chemokines  BLC/CXCL13,  which  is  constitutively 
produced  in  B  cell  follicles  in  SLO  (Oppenheim  et al.,  2002;  Wu  and  Hwang,
2572002;  Yu  et al.,  2002).  Hence,  the  CXCR5-BLC/CXCL13  axis  may  potentially 
also contribute to the migration of BMDC we observed in our study.
To provide a  clear answer regarding the  role of CCR7  in directing  migration of 
transferred DC, CCR7 deficient mice (Forster et al.,  1999) were used. We found 
that  migration  of  DC  to  the  MLN  was  highly  CCR7-dependent,  as  few  if any 
CCR7  deficient  DC  were  found  in  MLN.  Reduced  numbers  of CCR7-deficient 
DC  were  also  found  in  ILN,  although  the  difference  was  not  statistically 
significant,  likely due to the  relatively smaller number of wild type  DC detected 
in this location.  However,  DC migration to the spleen seemed to be unaffected 
by CCR7 deficiency,  as comparable  numbers  of CCR7  deficient and wild type 
DC were observed in spleen.
Surprisingly,  a slight,  but significant reduction  in the  number of CCR7 deficient 
cells was also observed in the PL (Figure 5.13A). This was unlikely to be due to 
variability in the number of injected cells, we carefully injected equal number of 
S.  typhimurium infected  BMDC  into the  peritoneal  cavity of mice in each group 
(1x107/mouse).  One possibility was that the efficiency of infection with  C5 (TS) 
differed  between  the  two  groups.  This  could  lead  to  differences  in  DC 
maturation state and survival. Alternatively,  CCR7  itself could play a role in  DC 
retention and/or survival in the PL.
Together with  data from  desensitisation  experiments,  results from experiments 
using CCR7 deficient DC clearly demonstrated that the migration to the MLN of 
S.  typhimurium infected BMDC after i.p. adoptive transfer was highly dependent
258on  the  CCR7-CCL19/CCL21  axis.  These  data  are  in  agreement with  previous 
findings  that  in  vitro  differentiated  CCR7-deficient  DC  fail  to  migrate  into  the 
draining  LN  (popliteal  LN)  36  hours  after  intracutaneous  injection  into  the 
footpad of mice (Ohl et al.,  2004).  In contrast,  CCR7 deficiency failed to inhibit 
the  migration  of  DC  to  spleen,  suggesting  that  migration  of  S.  typhimurium 
infected BMDC to the spleen was not CCR7-dependent.
The  inconsistent results observed  in  desensitisation  experiments could  be due 
to the  possible occurrence of heterologous desensitisation  of other chemokine 
receptors.  Homologous  desensitisation  occurs  in  receptors  in  the  agonist- 
occupied  state  and  involves  phosphorylation  by  G-protein-coupled  receptor 
kinases.  These  phosphorylated  receptors  associate  with  members  of  the 
arrestin family of proteins resulting in a decreased affinity of the receptor for G- 
proteins  and  internalisation.  Heterologous  desensitisation  (also  called  cross­
desensitisation)  occurs  when  a  receptor  loses  its  responsiveness  following 
phosphorylation  by  second  messenger-activated  kinases  (i.e.  protein  kinase A 
or protein  kinase  C).  These  kinases  can  be  activated  by different receptors or 
signaling  processes  (Chuang  et  al.,  1996;  Freedman  and  Lefkowitz,  1996). 
Heterologous desensitisation does not require agonist occupancy and does not 
lead to arrestin-mediated  receptor internalisation  (Ali et al.,  1999).  Since many 
cells,  for  example  DC,  have  multiple  GPCRs  that  signal  through  common 
effectors,  it  is  not  surprising  that  cross-regulation  can  occur  in  the  signaling 
pathways  from  one  G-protein  coupled  receptor to  another  (Hosey,  1999).  As 
mentioned  earlier,  the  potential  occurrence  of  heterologous  desensitisation  of 
other  chemokine  receptors  was  indicated  in  Figure  5.10.  Thus,  after  CCL19-
259induced  desensitisation,  either  uninfected  or  C5  (TS)  infected  DC  showed  an 
impaired  ability  to  migrate  to  CCL20  (ligand  for  CCR20)  compared  to  non­
desensitised  cells.  Some  other  chemokine  receptors  (so  far  unknown)  might 
also  have  been  cross-desensitised  in  the  first  desensitisation  experiment, 
directly affecting the migration of DC to the spleen.
DC, after encountering antigen  in the peripheral tissues,  migrate to the draining 
LN  through  afferent  lymphatics,  and  settle  in  the  vicinity  of  high  endothelial 
venules  (HEVs)  in  the  paracortex  (T  cell  zone)  displaying  antigens  for 
lymphocytes  to  screen.  Most  lymphocytes  enter  the  lymph  nodes  from  the 
peripheral  blood  and further migrate  into the  lymph-node  parenchyma through 
HEVs.  If seen  and  activated  by  antigen,  lymphocytes  proliferate  and  undergo 
profound  differentiation  (Miyasaka  and  Tanaka,  2004).  As  mentioned  earlier, 
and in more detail in another report,  CCL21  is expressed on  HEVs and CCL19 
is  produced  by  stromal  cells  in  the  T  cell  zone  surrounding  HEVs.  Therefore, 
both are responsible for bringing mature DC and  naive lymphocytes together in 
SLO  through  their  CCR7  expression  (Dieu  et  al.,  1998;  Ngo  et  al.,  1998) 
(Miyasaka  and  Tanaka,  2004).  CCR7  deficiency  on  DC  hence would  severely 
affect this migratory process of DC, as we found in our study.
DC  access the  spleen  initially via the  blood.  Migration  to the  lymphoid  regions 
(white pulps) of spleen then occurs through the interaction of CCR7 with CCL19 
and CCL21.  However,  another function  of the spleen  is to filter the effete cells, 
debris and microorganisms that have entered the blood stream. This function is 
exerted  primarily  in  the  red  pulp  of spleen.  Since  the  DC  we  transferred  had
260reached  their final  stage  of development  (in  vitro  cultured  for 7  days followed 
with  infection  with  Salmonella),  the  ultimate  fate  of  these  transferred  cells  is 
death  and  they  will  be  cleared  by  the  host  eventually.  Once  they  access  the 
blood, it is likely that they would be trapped in the red pulp of the spleen and be 
degraded  as effete or unhealthy cells.  Thus,  initial  entry of DC  into the spleen 
may  not  require  the  involvement  of  CCR7.  Whether  the  CCR7-deficient  DC 
enter the white  pulp  is  an  interesting  question  for further study.  Nevertheless, 
even  if they  cannot  migrate  autonomously  to  the  white  pulp,  entering  the  red 
pulp  DC  could  still  be  able  to  play  a  role  in  antigen  presentation  through  the 
participation  of  endogenous  DC;  a  pathway  which  has  been  suggested  in 
another  study  of  ani\-Salmonella  immunity  (Yrlid  and  Wick,  2000)  and  also 
implicated in our immunohistochemical staining of the spleens of mice receiving 
adoptively transferred cells (Figure 4.9 and Figure 4.10).
2615.4 Conclusion
Based on the differential migration pattern of DC and macrophages observed in 
chapter 4, we set out to explore the potential mechanisms behind these results. 
Apoptotic  cell  death  was  first  evaluated  on  BMDC  and  BMMac  after C5  (TS) 
infection. BMMac did not show a greater susceptibility to apoptosis than BMDC, 
which excluded the possibility that the low recovery of BMMac in vivo was due 
to  a  greater extent of cell  death  after C5  (TS)  infection.  Secondly,  changes  in 
expression  of CCR7  and  CCR6  upon  S.  typhimurium  infection  were  analysed 
for both types of cells.  CCR6 was greatly downregulated  on  BMDC  in contrast 
to a slight decrease on  BMMac upon  infection.  CCR7 was highly expressed on 
uninfected  BMDC but absent on  uninfected  BMMac at the  protein  level, and  its 
expression  was  highly  increased  on  C5  (TS)  infected  BMDC  and  moderately 
increased  on  C5  (TS)  infected  BMMac  at  either  the  mRNA  or  protein  levels. 
Although  expression  followed  a  similar  pattern  with  these  two  chemokine 
receptors on  the two  cell types,  differences  in  the  absolute  level of expression 
upon  S.  typhimurium  infection  may  be  responsible for the differential  migration 
profiles  exhibited  in  vivo.  Finally,  in  order  to  determine  whether  CCR7 
upregulation was playing  a  major role in the specific migration  of BMDC to the 
SLO  upon  S.  typhimurium  infection.  Two  approaches  were  taken.  Initially,  in 
vitro CCR7 desensitisation was performed  prior to adoptive transfer of infected 
BMDC.  Variability  in the  results of these experiments meant that it was difficult 
to  draw  conclusions  regarding  the  role  of  CCR7  in  migration  to  the  spleen, 
although,  the  migration  of infected  DC to the  MLN was consistently diminished 
by  in  vitro  desensitisation  of  CCR7.  Subsequently,  experiments  using  CCR7 
deficient  BMDC  clearly showed  migration  of S.  typhimurium-mfeciedi  BMDC to
262the MLN was  mediated  by  a  CCR7-dependent mechanism,  whereas migration 
of same cells to the spleen was not regulated by CCR7.
263Chapter 6: Antigen presentation ability of BMDC 
and BMMac upon recombinant S. typhimurium 
infection
6.1  Introduction
The immune system has evolved two lines of defense to protect against harmful 
microorganisms  such  as  S.  typhimurium.  The  first  line  of defense,  the  innate 
immune  system,  includes  physical  barriers such  as skin,  mucous  membranes, 
and  non-specific  engulfment  of  invading  microorganisms  by  phagocytic  cells 
such  as  macrophages,  immature  DC  and  polymorphonuclear  neutrophils.  An 
array of elimination  mechanisms  generated  by these  phagocytic cells  includes 
secretion  of inflammatory cytokines such  as TNF-a,  IL-1,  IL-6,  IL-12  and  IL-18 
and  production  of  oxygen  and  nitrogen  radicals  such  as  NO  (Wick,  2004). 
However,  in  most cases  of  Saimonelia  infection,  the  innate  immune  response 
fails  to  eliminate  the  bacteria  from  the  host.  Under  such  circumstances,  the 
second line of defense, the acquired immune system, with T and B lymphocytes 
as  key  components,  is  required  for  eradication  of  bacteria  and  protection 
against re-infection with the same pathogen (Mittrucker et al., 2000). The innate 
immune  system  is  linked  to  the  adaptive  immune  system  through  a  group  of 
cells  collectively  called  APCs  including  DC,  macrophages  and  B  cells.  These 
cells  function  to  take  up  bacterial  antigens,  process  the  proteins  into  peptide 
fragments and  present the peptides to T lymphocytes (CD4+  and  CD8+) in the 
context  of  major  histocompatibility  complex  (MHC)  molecules.  DC  and 
macrophages  could  both  play  a  part  as  phagocytes  to  control  invasion  of
264Salmonella  in  the  innate  immune  response.  In  addition  they could  both  act as 
APC to induce specific immune responses to combat the bacterial infection.
In this chapter, we set out to  look into the antigen  presentation  capacity of DC 
and  macrophages  upon  bacterial  infection,  and  whether  this  capacity  differs 
between these two types of APCs, with respect to their ability to present antigen 
to  either  memory  T  cells  or  naive  T  cells.  Finally,  the  ability  of  adoptively 
transferred  S.  typhimurium  infected  BMDC  migrating  to  SLO  to  present 
Salmonella  antigen  to  naive  T  cells  was  investigated  using  a  co-adoptive 
transfer system.
2656.2 Results
6.2.1 In vitro system
6.2.1.1 Comparison of the ability of BMDC and BMMac to stimulate 
previously stimulated T cells
The  response  of  previously  activated  T  cells  to  antigen  presented  by  S. 
typhimurium infected BMDC and BMMac was determined in vitro using the IFN- 
y  ELISpot  assay.  CTL  specific  for  NP383  and  BG876  were  used  in  this 
experiment,  and  the  generation  of  these  two  T  cell  lines  is  described  in  the 
materials  and  methods.  The  NP383CTL  responds  to  the  HLA-B27  restricted 
epitope 383-391  from influenza A virus nuclear protein, and BG876CTL responds 
to the  H-Kd restricted  epitope  876-884 from  p-galactosidase.  These  CTLs  had 
been generated by a primary stimulation in vivo followed by in vitro stimulations 
and so represented a population of antigen experienced T cells. The CTLs were 
used to assess Salmonella specific responses by using recombinant Salmonella 
expressing  these  T  cell  epitopes,  as  described  in  materials  and  methods. 
BMDC and BMMac were infected with recombinant Salmonella, co-cultured with 
the  T  cell  lines  and  IFN-y  production  measured  as  an  indication  of  a  T  cell 
response.  IFN-y  ELISpot  assays  showed  that  both  BMDC  and  BMMac  were 
able  to  stimulate  NP883  cytotoxic  (Figure  6.1 A)  and  BG876  T  cell  responses 
(Figure  6.1 B)  after  peptide  pulsing  or  infection  with  recombinant  SL3261.  In 
addition,  this  stimulation  was  antigen  specific since  infection with  recombinant 
SL3261  expressing the irrelevant peptide failed to induce IFN-y production from 
the antigen specific T cells.  Notably, peptide- pulsed BMDC and BMMac
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Figure 6.1  Analysis of T cells responses in  vitro induced by  recombinant S.  typhimurium 
SL3261  infected  DC and  Mac  using  IFN-y ELISpot assay.  Specific CTL lines were prepared 
and  105  T  cells  were  seeded  into  wells  of 96-well  plates.  In  parallel,  DC  or  Mac  were  either 
pulsed with  1   pM  peptide or infected with  recombinant SL3261  as indicated and  104 cells were 
added to each well. After 48 hours incubation, T cell responses were measured by production of 
IFN-y,  which  was  detected  by  IFN-y  ELISpot.  Spots  formed  by  IFN-y  secreting  cells  were 
counted  and  results  expressed  as  mean  values  ±  SD  of  triplicates  performed  in  assay.  (A) 
NP38 3-39i  CTL  line  response.  (B)  BG876-884  CTL  line  response.  Results  are  representative  of 2 
experiments.
267showed  a  strong  ability to  stimulate  CTL  responses  indicating  that the  testing 
system was working efficiently.
6.2.1.2  Comparison of the ability of BMDC and BMMac to stimulate a naive 
T cell response
To  analyse  an  HLA-B27  restricted  T  cell  response,  our group  have  previously 
established  a  human  TCR  transgenic  mouse  line  (denoted  as  GRb)  on  the 
human  HLA-B27/p2m  background.  Characterisation  of  GRb  mice  has 
demonstrated that not only CD8+,  but CD4+  T cells are  restricted  by HLA-B27 
(Roddis et al., 2004). Owing to this novel feature of GRb derived  CD4+ T cells, 
the ability of BMDC and BMMac to stimulate a naive CD4+ T cell response was 
measured  using  3H-thymidine  proliferation  assay.  Firstly,  we  found  that  NP383- 
391,  but not BG876-884 peptide-pulsed  BMDC were able to induce the proliferation 
of  naive  GRb  CD4+  T  cells  (Figure  6.2  top  panel).  More  importantly, 
recombinant  SL3261np3 8 3 -3 9 i  infected  BMDC  were  also  able  to  stimulate  naive 
GRb  CD4+  T  cell  proliferation.  In  addition,  this  stimulation  showed  antigen 
specificity as no response was observed with  BMDC  infected with  recombinant 
SL3261B G 876-884 (ie, expressing an irrelevant peptide) (Figure 6.2 bottom panel). 
In  contrast,  neither peptide  pulsed  (Figure  6.2  top  panel)  nor bacteria  infected 
BMMac (Figure 6.2 bottom panel) were able to induce a response by naive GRb 
CD4+ T cells.
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Figure 6.2 In vitro naive T cell responses induced by recombinant SL3261  infected BMDC 
and BMMac. Naive CD4 T cells were purified from spleens and lymph nodes of GRb transgenic 
mice by negative selection.  CD4 (5 x  104) cells were seeded into the wells of 96-well plates.  In 
parallel,  BMDC  and  BMMac  (2  x  104) were  infected  with  recombinant S.  typhimurium SL3261 
(lower panel) or pulsed with peptide (used as controls) (upper panel) as indicated. After 4 days 
incubation,  the  plates were  pulsed  with  3H-thymidine for  16  hours.  Data are expressed as the 
mean values ± SD of triplicates performed in assay.  Results represent two experiments.
2696.2.1.3 Stimulation of the GRb CD4+ and CD8+ naive T cell response by 
BMDC
As mentioned earlier,  both  CD8+ and  CD4+ T cells from  GRb mice are able to 
recognise the MHC class I,  HLA-B27 restricted epitope. We determined whether 
both CD4+ and CD8+ naive T cells were able to be stimulated  by BMDC in the 
context of HLA-B27  restriction.  Figure  6.3  (top  panels)  shows  that  both  CD4+ 
and CD8+ naive T cells were efficiently stimulated by NP383.391, but not BG876-884 
peptide-pulsed  BMDC.  In  addition,  infection  with  the  relevant  recombinant 
Salmonella  strain  (SL3261np3 8 3 -3 9 i),  but  not  the  irrelevant  recombinant 
Salmonella  (SL3261bg8 7 6 -8 8 4 )  was  able  to  induce  both  CD4+  and  CD8+  T cell 
proliferation.
6.2.1.4 Kinetics of in vitro T cell response
To study the kinetics of the T cell response stimulated  by recombinant SL3261 
infected  BMDC,  T cell  responses were  assessed  over 4  days  after stimulation 
using CFSE labelling. CFSE fluoresence is split between daughter cells as cells 
divide,  so we can measure proliferation by a loss in CFSE density. Figure 6.4 A 
and  B  show  typical  profiles  of  responding  and  non-responding  T  cells  after 
stimulation.  Figure 6.4  C  and  D show several  points of information.  Firstly,  the 
antigen specificity of the response was apparent, as a high percentage of CFSE 
loss was  observed  when  BMDC were  pulsed with  NP383-391 peptide or infected 
with  recombinant  Salmonella  expressing  the  relevant  antigen,  but  not  when 
exposed  to  irrelevant  antigen  (NP366-374)-  Secondly,  the  efficiency  of  antigen 
stimulation  recombinant  Salmonella-mfected  BMDC was  comparable to that of 
peptide pulsed ones. Thirdly, the stimulated T cell response was observed from
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Figure 6.3  In  vitro  naYve  T  cell  responses  induced  by  recombinant SL3261  infected  DC.
Naive CD4 (left panel) or CD8 (right panel) T cells were purified from spleens and lymph nodes 
of GRb transgenic mice by negative selection. CD4 (5 x 104) or CD8 (3 x  104) cells were seeded 
into  the  wells  of  96-well  plates.  In  parallel,  BMDC  were  infected  with  recombinant  S. 
typhimurium SL3261  (lower panel)  or  pulsed  with  peptide  (used  as  controls)  (upper panel)  as 
indicated. After 4 days  incubation, the plates were pulsed with 3H-thymidine for 16 hours.  Data 
are expressed as the mean values ± SD of triplicates performed in assay. Results represent two 
experiments.
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Figure  6.4 Time  course  of  in  vitro T  cell  responses  stimulated  by  recombinant  SL3261 
infected  DC. CD4 or CD8 T cells were prepared from the spleens of GRb transgenic mice by 
negative  selection.  T  cells  were  labelled  with  CFSE,  and  then  105 cells were  seeded  into the 
wells  of  96-well  plates.  In  parallel,  BMDC  (104)  were  either  infected  with  recombinant  S. 
typhimurium SL3261  or pulsed with  1   pM peptide as indicated. The cells were harvested at the 
indicated  time  points  and  stained  with  anti-CD4  antibody  (Cy-chrome)  and  anti-CD8  antibody 
(APC conjugate). The proliferation of T cell subsets is expressed as the percentage of cells that 
have divided at least once as assessed by flow cytometry.  (A,  B) Typical CFSE profiles of how 
the percentage was derived.  (C,  D) CD4 or CD8 T cell responses as indicated.  Results are the 
representative of 2 experiments.
272day 2  and  by day  3-4,  almost  100%  of T  cells  had  responded  and  exhausted 
their CFSE labelling. Finally, CD8+ T cells responded more rapidly than CD4+ T 
cells. Around 50% of CD4+ cells vs 75% of CD8+ T cells had responded at day 
2  after  stimulation,  although  no  difference  was  observed  at  later  time  points 
(day 3 and day 4).
6.2.2  Adoptive transfer system
To  evaluate  the  HLA-B27  restricted  T  cell  response  in  vivo,  CFSE-labelled 
naive  GRb  T  cells  and  recombinant  S.  typhimurium  infected  BMDC  were  co- 
adoptively  transferred  into  HLA-B27  transgenic  mice.  GRb  T  cells  were 
detected in various tissues 3 days after injection of BMDC using an anti-human 
Vp7  TCR  antibody.  The  antigen  presenting  ability  of  BMDC  under  different 
conditions was compared.  Figure 6.5 A and  B show the typical CFSE profile of 
responding and non-responding GRb T cells respectively. Mice receiving BMDC 
pulsed  with  relevant  or  irrelevant  peptide  were  used  as  positive  and  negative 
controls  respectively.  In  MLN  (Figure  6.5B),  nearly  80%  compared  to  40%  of 
transferred  CD8+ T cells were  CFSE  low after co-transfer with  BMDC  infected 
with SL3261NP383-39i or SL3261NP366-374 respectively. Among CD4+ T cells, more 
than  40%  when  injected  with  SL3261NP383-39i-infected  BMDC  compared  to 
about  20%  when  transferred  with  BMDC  infected  with  control  recombinant 
Salmonella. A similar effect was also observed  in  ILN.  More than 60% of CD8+ 
and 40% of CD4+ T cells were stimulated  by the co-transfer of SL3261np383-39i 
infected  BMDC whereas the antigen  non-specific response was less than  10% 
for both  CD4+  and  CD8+  T cells.  Interestingly,  although  the antigen  specific T
273cell  response  was  similar  in  both  tissues,  BMDC  infected  with  the  irrelevant 
recombinant  bacteria  induced  a  higher  non-specific  T  cell  response  in  MLN 
(40% CD8+ and 20% CD4+) than in ILN  (both less than 10%).
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Figure 6.5 Analysis of in vivo T cell  response by co-adoptive transfer of GRb T cells and 
recombinant S.  typhimurium infected  BMDC.  106 T cells isolated from GRb transgenic mice 
were adoptively transferred  into  HLA-B27 transgenic mice by intravenous  injection  after CFSE 
labelling. On the following day, 5 x   106 recombinant SL3261  infected or peptide pulsed BMDC as 
indicated  were  harvested  and  intraperitoneally  injected  into  these  mice.  On  day  3  after  DC 
transfer,  cells  were  isolated  from  mesenteric  lymph  nodes  (MLN)  and  inguinal  lymph  nodes 
(ILN) and stained with anti-CD8 (APC), anti-CD4 (cychrome) and anti-human V07 Ab (PE), the 
latter recognising  transferred  GRb  T cells.  The  stained  cells were  analysed  by flow cytometry 
and  the  T  cell  response  was  assessed  by  the  percentage  of cells  that  have  divided  at  least 
once. Bars represent the mean value of 3 mice of each group part from 2 for the NP366.374 group. 
(A) Typical profile of how the percentage of CFSE fluorescence loss was derived. (B, C) GRb T 
cell responses in MLN and ILN respectively. Results are representative of 2 experiments.
2756.3 Discussion
In  this  chapter,  the  ability  of  BMMac  and  BMDC  to  present  bacterial  antigens 
after  recombinant  S.  typhimurium  infection,  to  different  T  cell  subsets  in  vitro 
and in vivo, was investigated.
In  order to  look  at the  antigen  presenting  function  of BMDC  and  BMMac,  our 
group have developed a double transgenic model system (GRb), in which the a 
and  p chains of a TCR,  originally derived  from  an  HLA-B27-positive  individual, 
are expressed  as a transgene  in  an  HLA-B2705/p2m transgenic mouse  (Weiss 
et al.,  1990) using a mouse genomic cassette vector.  It has been demonstrated 
that these  double  transgenic  mice  produce  fully  functional  CD4+  and  CD8+  T 
cell  subsets,  both  of which  are  restricted  by  HLA-B27  (Roddis  et  al.,  2004). 
These mice are  used  in  our study to provide  HLA-B27 restricted CD4 and  CD8 
transgenic T cells to study the  antigen  presentation  capability of macrophages 
and  DC  upon  S.  typhimurium  infection.  In  order  to  look  at  antigen  specific T 
cells responses,  recombinant S.  typhiumurium expressing was utilised,  in which 
MHC  class  l-restricted  antigenic  epitopes  consisting  of  amino  acid  residues 
383-391  (HLA-B27 restricted) or 366-374 (H-Db restricted) of the influenza virus 
nucleoprotein,  or  residues  876-884  (H-Kd  restricted)  of  p-galactosidase,  were 
expressed as fusion  proteins with the type  III  secreted  protein Sop E (Wood et 
al.,  1996)  using  S.  typhimurium  strain  SL3261.  This  recombinant  system, 
together with the T cells derived from GRb transgenic mice, enabled us to study 
HLA-B27-restricted T cell responses resulting from  recombinant S.  typhimurium 
infection.
276Although  recombinant Salmonella are  both  available for strain  SL3261  and  C5 
(TS),  C5  (TS) was  not  used  for experiments  in  this  chapter  because  previous 
work  by  my  colleague  has  suggested  that  antigen  presentation  was  more 
efficient after infection with  SL3261  than  C5 (TS).  The possible explanation for 
the  lower  efficiency  of  C5  (TS)  in  an  antigen  presentation  assay  is  that  this 
strain optimally grows at 30°C (Hormaeche et al.,  1981), at this temperature, the 
efficiency  of the  Salmonella  TTSS,  by  which  Salmonella  deliver their effector 
proteins such as SopE into host cells, might be affected resulting in less antigen 
(epitope) delivered through the fusion protein.
Macrophages and  DC both play an important role in the bridging the innate and 
adaptive  immune  responses to  S.  typhimurium infection.  This  is  manifested  by 
their sentinel  function  in  capturing  bacteria  coupled  with  their ability  to  act  as 
APC.  Although  these two types  of cells are  both  able to degrade bacteria  and 
process  bacterial  proteins  into  peptide  fragments,  it  has  been  suggested  that 
the pathways they  use to accomplish  this may  not identical  (Yrlid et al.,  2000). 
In  addition,  according  to  their  different  regulation  of  MHC  class  II  and 
costimulatory molecules upon  S.  typhimurium infection, their capacity to present 
processed  bacterial  peptides  to  CD4+  and  CD8+  T  cells,  and  therefore  to 
initiate an effective immune response against this bacterium, may differ.
Due to the association  of reactive arthritis with  the  MHC  I  molecule,  HLA-B27, 
and  the  normal  function  of  HLA-B27  to  present  peptides  for  recognition  by 
CD8+  T cells,  the  ability  of BMDC  and  BMMac to  present peptides to CD8+ T 
cells  after  S.  tyhphimurium  infection  was  firstly  compared  using  an  IFN-y
277ELISpot assay. We showed that recombinant S.  typhimurium infection rendered 
both  BMDC  and  BMMac  able  to  efficiently  induce  a  response  by  CTL  T  cell 
lines against either NP383-391  or BG876-884 in  an  antigen  specific manner (Figure
6.1  A and  B).  The  reason why  bacterial  infection  could  result in  a CD8+ T cell 
response  in  our  study  is  worthy  of  discussion  here.  Typically,  “exogenous” 
antigens  such  as  bacteria  are  internalised  by  APC  and  processed  within 
phagolysosomal compartments,  producing  peptides that are loaded onto MHC- 
II  molecules  in  compartments of the endosomal  system  and transported to the 
cell  surface  for  recognition  by  CD4+  T  cells  (Wolf  and  Ploegh,  1995).  In 
contrast, “endogenous” antigens are synthesised within the presenting cells and 
processed within the cytosol by the proteasome,  and  produce peptides that are 
transported  into  the  endoplasmic  reticulum  by  the  TAP.  Peptides  are  then 
loaded  onto  MHC-I  molecules  in  the  endoplasmic  reticulum,  which  then 
transported  to  the  cell  surface  and  presented  to  CD8+  cytotoxic  T  cells 
(Heemels and  Ploegh,  1995).  However,  numerous studies have suggested that 
these two  pathways are  not completely separated  (Jondal et al.,  1996;  Lechler 
et al.,  1996;  Rock,  1996).  For instance, exogenous antigens can also enter the 
conventional  class  I  processing  pathway  by  penetration  from  vesicular 
compartment  into  the  cytosol,  as  achieved  by  some  microbes  (Brunt  et  al., 
1990; Yewdell et al.,  1988).
Since  S.  typhimurium  is  initially  extracellular  upon  entering  a  host  but  can 
ultimately reside  inside host cells and  grow as an  intracellular bacterium,  it has 
been  reported  that  two  pathways  of  antigen  processing  may  potentially  be 
involved  in  antigen  presentation from  S.  typhimurium (Svensson et al.,  1997a).
278S.  typhimurium  has  evolved  a  system  termed  the  TTSS  to  deliver  bacterial 
effector proteins  such  as  SopE  from  the  bacterial  cytoplasm  into  the  host cell 
cytosol using a supramolecular structure called the needle complex (Galan and 
Collmer,  1999).  In our study,  recombinant S.  typhimurium was prepared  based 
on  this  mechanism,  which  enabled  expression  of  MHC  I  restricted  T  cell 
epitopes  (NP383-391  or  BG876-884)  as fusion  proteins with  SopE  in  the  cytosol  of 
infected APC during  S.  typhimurium infection.  In this respect,  our results are in 
agreement with  previous  studies  that  both  BMMac  and  BMDC  are  efficient at 
processing S.  typhimurium derived  peptides for MHC I  presentation using a Crl- 
OVA expressing system (Svensson et al.,  1997a; Yrlid et al., 2000).
CD8+ T cells contribute to the protective immune response to Salmonella, since 
p2m-deficient mice were  shown  to  be  more  susceptible to  Salmonella  infection 
(Lo  et  al.,  1999)  (Mastroeni  et  al.,  1992)  (Nauciel,  1990).  Nevertheless,  it  is 
clear that CD4+  T cells  play  a  more  important  role  in  immunity to  Salmonella, 
particularly from adoptive transfer experiments (Mastroeni et al.,  1992) (Nauciel, 
1990).  In  addition,  in  the  case  of  HLA-B27  associated  diseases,  adoptive 
transfer  studies  showed  that  CD4+  T  cells  were  more  efficient  in  transferring 
inflammatory  disease  from  disease-prone  HLA-B27+  transgenic  rats  to  HLA- 
B27  nude  rats  (Breban  et  al.,  1996).  However,  in  these  circumstances,  MHC 
class  II  molecules,  which  are conventionally recognised  by CD4+ T cells, were 
not  required  for  disease  development  because  MHC  ll-negative,  HLA-B27+ 
transgenic  mice  still  developed  spontaneous  disease  (Khare  et  al.,  1998).  In 
view of the  identification  of HLA-B27-reactive  human  CD4+  T  cells from  HLA- 
B27+  SpA patients (Boyle et al.,  2001),  this  unconventional  recognition  pattern
279of  HLA-B27  specific  CD4+  T  cells  has  been  suggested  to  contribute  to  the 
pathogenesis of SpA (Boyle and Hill Gaston, 2003).
Our group has established a double transgenic mouse model (GRb) that can be 
used to test this notion. As mentioned earlier, the CD4 T cells in GRb transgenic 
mouse,  specifically  respond  to  the  HLA-B27  restricted  peptide  NP383.391  with  a 
similar efficiency to  CD8+ T cells (Roddis et al.,  2004). We used  CD4+ T cells 
from  GRb  mice  to  analyse  the  naive  T  cell  response  induced  by  HLA-B27 
specific  NP383-391  recombinant  S.  typhimurium  (SL3261Np383)  infected  APC. 
Notably,  we  found  that  only  BMDC,  but  not  BMMac,  were  able  to  stimulate 
naive  CD4+  T  cells  response  upon  recombinant  SL3261np383  infection;  this 
presentation was  in  an antigen specific manner as control peptide recombinant 
S. typhimurium (SL3261bg876) infected BMDC failed to do so (Figure 6.2).
This  discrepancy  between  these  two  types  of  cells  in  their ability  to  stimulate 
naive T cells has been  reported  in a previous in vitro study (Yrlid et al., 2001b). 
The failure of macrophages to stimulate naive T cells in vitro led  us to study of 
antigen  presentation  in  vivo  only  using  DC.  The  results  (which  will  be  further 
discussed  later)  were  in  agreement with  another study  showing  that  DC were 
indeed able to stimulate naive T cells after adoptive transfer in vivo (Yrlid et al., 
2001a). More recently,  it was reported that macrophages as well as DC present 
Sa//7 ?OA?e//a-derived  antigen  to  naive  or  memory  CD4+,  but that  DC  are  much 
more  efficient than  macrophages  for stimulating  CD4+  T  cells  (Kalupahana  et 
al.,  2005).  All  these  observations  suggest  that  DC  have  superior  antigen 
presenting  ability  to  macrophages,  especially  with  respect  to  presentation  of
280antigen  to  naive  T  cells.  Two  reasons  suggested  by  our  study  could  be 
responsible  for  this:  (1)  Insufficient  surface  expression  of  MHC  and 
costimulatory molecules needed to prime naive T cells on  BMMac compared to 
BMDC  after  S.  typhimurium  infection.  After  infection  with  SL3261,  BMMac  in 
most cases failed to upregulate costimulatory  molecules such as CD80,  CD86; 
MHC class II molecules were poorly induced in all infections.  In contrast, BMDC 
greatly  increased  the  expression  of all  these  molecules  after in  vitro  infection 
(data  not  shown).  (2)  Upon  S.  typhimurium  infection,  BMDC  but  not  BMMac 
migrated  efficiently  to  SLO,  where  naive  T  cells  circulate.  Positioning  in 
appropriate  sites  is  a  prerequisite  for  antigen-bearing  DC  to  encounter  and 
subsequently  prime  naive  T  cells.  These  two  factors  together  with  unique 
expression  of  several  other  molecules  on  DC  (including  OX40-L  and  4-1BB) 
(Banchereau et al.,  2000) contribute to the superior capacity of DC to stimulate 
naive T cells.
Both  CD4+  and  CD8+  were  able  to  respond  to  HLA-B27  restricted  peptide 
presented  by  BMDC  after  recombinant  bacteria  infection  (Figure  6.3).  The 
ability  of  immature  BMDC  to  phagocytose  and  present  Salmonella-derived 
antigens  to  CD8+  and  CD4+  T  cells  has  been  reported  (Svensson  et  al., 
1997b).  In  that  study,  the  mouse  MHC  I  (Kb)-restricted  257-264  epitope  from 
chicken  egg  OVA and the  MHC  II  (l-Ak)-restricted 46-61  epitope from hen egg 
white  lysozyme  were  expressed  as  fusion  proteins  in  the  cytoplasm  of  S. 
typhimurium  as  Crl-OVA  and  Crl-HEL  fusion  proteins,  and  antigen  processing 
and  presentation  was  analysed  using  T  cell  hybridomas.  The  presentation  of 
Salmonella antigen to CD4+ in their study was by MHC II molecules, whereas in
281our study, CD4+ T cells were primed by the MHC I molecule HLA-B27. Another 
study,  using a similar antigen  model system  (Crl-OVA)  in  E.  coli, demonstrated 
that  MHC  I  presentation  to  CD8+  T  cells  occurred  by  a  cytosolic  MHC-I 
presentation  pathway,  which  required  the TAP  and  could  be  abrogated  by the 
proteasome inhibitor MG132 (Svensson and Wick,  1999).
In order to test the in vivo antigen  presentation  ability of BMDC loaded with  S. 
typhimurium derived  antigen in vitro,  CFSE labelling was chosen to monitor the 
T  cells  response.  For this  purpose,  an  in  vitro  assay  was  performed  firstly  to 
determine the best time point at which to analyse T cell response. Data from the 
in  vitro  CFSE  proliferation  assay  clearly  demonstrated  that  naive  GRb  T cells 
were primed by SL3261np383 (HLA-B27 restricted)-infected, but not antigen non­
specific SL3261NP366 (H-2Db restricted)-infected  BMDC,  suggesting the antigen 
specificity of T cell response.  In addition, the results indicated that the efficiency 
of  presentation  was  comparable  between  peptide  pulsed  BMDC  and 
recombinant S.  typhimurium infected  BMDC.  This suggested  that by two-hours 
post-infection,  BMDC had phagocytosed and processed S.  typhimurium derived 
antigen  in  an efficient way,  reflecting their antigen  processing and presentation 
ability. The T cell response was observed from day 2 after mixture of T cells and 
BMDC.  At  day  3,  almost  all  CD4+  and  CD8+  had  responded  and  exhausted 
their CFSE fluorescence,  but the  antigen  non-specific  response  remained  at a 
very  low  level.  By  day  4,  no  further T  cell  response  could  be  detected  (since 
most  cells  were  already  CFSE'),  but  T  cells  started  to  exhibit  some  level  of 
antigen  non-specific  response.  For  this  reason,  day  3  appeared  to  be  the
282optimal time point for observing the antigen specific T cell response under these 
conditions, and was chosen to be used as the time point for the in vivo assay.
Interestingly,  in  the  same  experiment we  also  found  that  naive  CD8+  T  cells 
responded more rapidly than CD4+ T cells. At day 2, 75% of CD8 compared to 
50% of CD4 T cells had  been activated and divided.  The reason for the slightly 
more  rapid  activation  of CD8+  than  CD4+  T  cells  is  unknown,  but  it could  be 
related  to  recognition  on  HLA-B27.  At  present,  we  do  not  know  the 
requirements  for  HLA-B27  presentation  to  CD4+  T cells.  Data  from  our group 
reveal that despite the  requirement for MHC  II  expression for the development 
of  a  substantial  CD4+  population,  the  CD4+  GRb  T  cell  response  can  be 
generated  in  the  absence  of  mouse  MHC  II  (Roddis  et  al.,  2004).  Although 
recognition  of an  abnormally folded  HLA-B27 complex,  such as a homodimeric 
structure  of  HLA-B27,  has  been  suggested  to  explain  this  unconventional 
recognition  (Boyle and  Hill  Gaston,  2003), whether these aberrant structures of 
HLA-B27  are  able  to  present  antigenic  peptide  to  CD4+  T  cells  is  unknown. 
HLA-B27  lacking  associated  p2m  is  prone  to  misfold  and  form  those  aberrant 
structures  (Luthra-Guptasarma  and  Singh,  2004).  However,  in  our study,  HLA- 
B27 was expressed together with  human  p2m  in our HLA-B27 transgenic mice. 
In  another study of HLA-B27 transgenic mice  it was clearly shown that cells in 
these mice display expression of free heavy chains of HLA-B27 on cell surface. 
Furthermore,  in  vivo  treatment  with  anti-HC-specific  antibody  delays  the 
development  of  spontaneous  arthritis  (Khare  et  al.,  1996).  Therefore,  even  in 
the  presence  of human  p2m,  heavy chains  of HLA-B27  are  still  able to form  a 
homodimeric  structures.  More  recently,  Kollnberger  and  colleagues  further
283showed that  HLA-B27  heavy chain  homodimers were  ligands for paired  Ig-like 
receptors  (Kollnberger  et  al.,  2004),  providing  a  possible  explanation  for  the 
pathogenesis  of  HLA-B27  associated  spondyloarthritis.  Whether this  particular 
binding also occurs between  HLA-B27 and CD4+ T cells in our system requires 
further investigation.
We  next tested  the  ability of S.  typhimurium-mfectedi  BMDC to stimulate naive 
GRb T cells in vivo by adoptive transfer of CFSE  labelled GRb T cells followed 
by  recombinant  S.  typhimurium  infected  BMDC  into  HLA-B27  recipient  mice. 
Specific  CD8  and  CD4  T  cell  responses  were  elicited  in  MLN  and  ILN  of 
recipient mice.  Interestingly, except for one mouse given peptide (NP383)-pulsed 
BMDC,  the  other two  mice  in  this group  showed  a  lower T  cell  response than 
mice  given  SL3261np383  infected  BMDC.  This  contrasted  with  results  from  in 
vitro  assay,  which  consistently  showed  that  peptide  pulsed  BMDC  elicited  a 
better  response  than  bacteria  infected  BMDC.  The  in  vitro  results  may  reflect 
that  bacterial  infected  BMDC  need  to  process  the  bacterial  antigen  to  obtain 
peptide,  likely generating  less peptide than  used to pulse DC,  in addition to the 
negative effect on antigen presentation of intracellular Salmonella (Cheminay et 
al.,  2005).  However,  for  in  vivo  presentation,  cell  contact  between  DC  and  T 
cells would be dependent on DC migrating to SLO after adoptive transfer, which 
requires  CCR7  upreguation.  In  this  circumstance,  bacterial  infected  DC  likely 
had much higher expression of CCR7 than peptide-pulsed DC, since uninfected 
DC  had  only  a  low  level  of  CCR7  expression  (reflected  in  Figure  5.3).  CCR7 
upregulation  would  drive  more  infected  BMDC  to  SLO  such  as  MLN  than 
peptide pulsed BMDC, which would facilitate in vivo DC and T cell interaction. In
284addition, infected  DC will express higher levels of co-stimulatory molecules than 
uninfected,  peptide-pulsed  DC.  These factors could  counter the  higher level of 
peptide-MHC  on  peptide-pulsed  DC,  and  result  in  a  greater  T  cell  response 
being  observed  in  mice  given  infected  BMDC  than  the  mice  given  peptide 
pulsed BMDC.
Notably,  a  slightly  higher  non-specific  response  from  mice  receiving  BMDC 
infected with  SL3261np366 was  observed  in  MLN  than  in  ILN.  This could  reflect 
the greater numbers of BMDC that reach  MLN as opposed to  ILN. Although we 
attempted  to analyse the T cell  response  in the spleen,  visualisation  of GRb T 
cells  in  this  location  was  difficult  due  to  the  presence  of  strongly  auto 
fluorescent  cells,  which  masked  the  intermediate  staining  of  the  human  Vp7 
antibody.
The  ability  for  S.  typhimurium  loaded  BMDC  to  generate  a  bacteria-specific T 
cell  response  in  recipient  mice  has  been  reported  in  a  previous study (Yrlid  et 
al.,  2001a),  but there are several differences between our and their studies.  (1) 
They  used  S.  typhimurium  expressing  OVA  as  a  model  antigen,  whereas we 
used  S.  typhimurium expressing  NP383-391 peptide.  (2)  Mice  in their study were 
given  DC  infected  with  S.  typhimurium  expressing  OVA  on  two  occasions  a 
week apart.  Only  one  injection  of S.  typhimurium  infected  BMDC was given to 
mice  in  our study.  (3)  They  analysed  the  T  cell  response  two weeks  after the 
last administration, whereas day 3 after DC injection was used  in our study. (4) 
To  detect  the  response,  they  isolated  splenocytes  from  immunised  mice  and 
restimulated them for 24 hours with  DC infected with heat-killed  S.  typhimurium
285expressing  OVA;  whereas,  adoptive  transfer  of  naive  T  cells  from  GRb  mice 
and  no  further  ex  vivo  stimulation  was  performed  in  our  study.  (5)  They 
analysed  T  cell  response  by  intracellular  IFN-y  staining,  while,  in  our  study, 
CFSE  labelling  was  used.  In  our  study,  some  functional  tests  of  our  T  cell 
response,  including  IFN-y  and  granzyme  B  staining,  were  attempted  without 
success due to a technical problem.
Taken together, our study combined with the previous study (Yrlid et al., 2001a) 
demonstrated  that  BMDC  infected  with  S.  typhimurium  in  vitro  were  able  to 
efficiently  stimulate  a  T  cell  response.  Our  model,  in  which  S.  typhimurium- 
infected  BMDC generated from  HLA-B27 transgenic mice were able to present 
MHC  I antigen to naive CD4 T cells from GRb mice,  could be used as a tool to 
further investigate the antigen  processing and  presentation pathway involved in 
this  unusual  recognition  with  respect  to  their  potential  role  in 
spondyloarthropathies such as ReA.
2866.4 Conclusion
In this chapter,  a differential  antigen  presentation  ability of BMDC  and  BMMac 
was demonstrated using a GRb transgenic mouse model. After S.  typhimurium 
infection,  BMDC  and  BMMac  both  efficiently  presented  bacterial-derived 
antigen to specific antigen  experienced  cytotoxic T cells,  whereas,  only  BMDC 
were  able to activate  GRb  naive  T cells.  In  addition,  it was shown  that  BMDC 
infected  with  S.  typhimurium  in  vitro  could  prime  GRb  naive  T  cells  in  vivo. 
Exploring  the  unique  feature  of our GRb  mice  in  which  CD4+  T cells are also 
restricted  by  the  MHC  I  molecule  HLA-B27,  we  showed  that  both  CD8+  and 
CD4+  T  cells  are  efficiently  stimulated  by  adoptive  transfer of S.  typhimurium- 
infected, HLA-B27+ BMDC. The unusual recognition of MHC l-restricted peptide 
by  CD4+  T  cells  makes  this  model  of  potential  use  for  deciphering  the 
pathogenesis of HLA-B27 associated disease.
287Chapter 7: General discussion
Infection  of  mice  with  S.  typhimurium  results  in  systemic  infection  and  the 
resultant disease  resembles typhoid fever caused  by  S.  typhi in  humans (Wick 
et  al.,  2004).  After  oral  ingestion  and  colonisation  of  the  small  intestine,  S. 
typhimurium penetrates the intestinal epithelium and enters the Peyer’s patches 
mainly  through  M  cells  or  in  some  cases  by  an  M  cell-independent  pathway. 
Subsequently,  the  bacteria  spread  into  the  draining  mesenteric  lymph  nodes 
and  disseminate  via  the  bloodstream  to  the  spleen  and  liver,  where  they 
replicate inside phagocytic cells (Niedergang et al., 2000).
The  innate  immune  response  to  S.  typhimurium  infection  involves  recognition 
of bacterial  components,  such  as  LPS  and  flagellin  through  TLR (Aderem  and 
Ulevitch, 2000),  leading to phagocytosis of bacteria and activation of cells (Yrlid 
et  al.,  2000).  In  addition,  bacterial  components  also  induce  a  massive 
inflammatory  response  in  the  surrounding  tissue.  As  a  consequence, 
inflammatory mediators such as chemokines and cytokines are released, which 
function  to  activate  and  attract  various  cell  types  to  the  site  of  infection, 
amplifying the innate response.
Bacterial  uptake  and  destruction  by  phagocytic  cells  facilitate  host  protection. 
Phagocytic cells,  including macrophages (Fields et al.,  1986; Wick et al.,  1995), 
neutrophils  (Yang  et  al.,  2002)  and  DC  (Yrlid  et  al.,  2001a;  Yrlid  and  Wick, 
2002),  are  critical  components  of  the  innate  immune  response  to  S. 
typhimurium  infection.  The  capacity  of these  phagocytic cell  subpopulations to 
engulf  GFP+  S.  typhimurium  in  the  spleen  has  been  assessed  (Yrlid  et  al.,
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greatest  capacity  to  associate  with  GFP+  S.  typhimurium  in  vivo,  followed  by 
macrophages  (CD11c-F4/80+  cells)  and  splenic  DC  (CD11c+MHCII+  cells), 
which  had  the  lowest  fraction  of GFP+  cells.  In  addition,  another study  using 
GFP  expressing  S.  typhimurium  showed  that  all  three  splenic  DC  subsets 
associate  with  S.  typhimurium  (Yrlid  and  Wick,  2002).  At  the  lowest  dose  of 
bacteria administered (108),  a higher percentage of GFP+ cells was detected in 
the  CD8a+  DC  subset  than  in  CD4+  and  DN  populations.  Conversely,  at  a 
higher dose of bacteria (109),  a similar percentage of GFP+ cells was detected 
in  each  subset  (Yrlid  and  Wick,  2002).  In  our  study,  although  we  did  not 
analyse  neutrophils,  we  found  that  BMMac  (CD11b+  CD11c-  cells)  had  a 
greater  capacity  to  internalise  S.  typhimurium  than  BMDC  (CD11b+  CD11c+ 
cells)  after  high  dose  in  vitro  infection  (10  M.O.I)  (Figure  3.14),  which  is  in 
agreement with above observations.
Upon phagocytosis,  production of cytokines and  NO are important mechanisms 
in  combating  S.  typhimurium  infection.  Infection  studies  in  mice  using 
neutralising  antibodies  and  knockout  mice  have  shown  that cytokines  such  as 
TNF-a, IFN-y and IL-12 are important in the early stages of Salmonella infection 
and  enhance  host  survival  (Eckmann  and  Kagnoff,  2001).  In  our  study,  we 
found  that  BMMac produced  greater amounts  of TNF-a and  to a  lesser extent 
IL-12p40  than  BMDC  in  response  to  S.  typhimurium  infection.  Consistent with 
these findings,  it has been demonstrated that cells producing TNF-a during the 
early  stage  of  oral  Salmonella  infection  are  mainly  neutrophils  and 
macrophages rather than DC (Wick et al., 2004). Given the critical role of TNF-a
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production  of  large  amounts  of  TNF-a  by  BMMac  observed  in  our  study 
suggests  an  important  in  vivo  contribution  of  macrophages  in  controlling 
bacterial replication during the early stage of Salmonella infection.
Several  IL-12  family  cytokines  have  been  identified.  Among  them,  IL-12p70, 
consisting  of covalently linked  IL-12p40 and  IL-12p35  subunits,  is essential for 
protection  against intracellular pathogens  including  Salmonella,  and  acts as by 
enhancing  the  induction  of  Th1  immune  responses  (Schuetze  et  al.,  2005). 
Heterodimerisation of IL-12p40 with the p19 (a p35-related subunit) forms IL-23 
(Oppmann  et  al.,  2000),  which  has  been  suggested  to  be  a  critical  factor for 
autoimmune  inflammatory  responses (Cua  et al.,  2003)  and  T cell  proliferation 
(Oppmann et al., 2000). The third  identified member of the IL-12 cytokine family 
is  IL-27,  which  is  a  heterodimeric  protein  consisting  of  Epstein  Barr  virus 
induced protein 3 (EBI3, a p40 related subunit) and p28 (a p35 related subunit). 
The  function  of  IL-27  is  still  in  debate,  but some  studies  show that  IL-27  acts 
synergistically  with  IL-12p70  to  play  a  role  in  initiation  of  a  Th1  response 
(Takeda  et al.,  2003).  Since  the  IL-12p40  subunit  is  a  component of IL-12p70 
and  IL-23,  IL-12p40 production cannot be directly related with the production of 
IL-12p70;  additional  signals  are needed to facilitate the actual  production of IL- 
12p70.  In addition to this, a homodimer of p40,  IL-12(p40)2,  also exists and has 
been suggested to act as an antagonist of IL-12p70 by competing for binding to 
the IL-12 receptor IL-12Rp1  (Gillessen et al.,  1995).  Interestingly, a recent study 
has  shown  that  the  IL-12p40  subunit  itself  has  a  role  in  host  resistance  to 
Salmonella  that  is  independent  of  IL-12p70  an  IL-23  (Lehmann  et  al.,  2001).
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induce  macrophages and  DC to  produce  IL-12p40,  the  role of IL-12p40 during 
Salmonella  infection  appears  to  be  complex.  This  issue  could  be  further 
addressed  by  measuring  and  comparing  the  production  of  IL-12p40  and  IL- 
12p70 in response to Salmonella infection in the future work.
Direct  ex  vivo  analysis  of  intracellular  cytokine  production  by  defined  cell 
populations  from  Sa/n7one//a-infected  mice  has  revealed  that  NKT  cells  and 
TCRap  T  cells  are  early  sources  of  IFN-y  (Kirby  et  al.,  2002).  Surprisingly, 
macrophages were  also  reported  to  be  efficient  producers  of IFN-y during  the 
early  stage  of  primary  infection  with  S.  typhimurium  (Kirby  et  al.,  2002). 
However,  we failed to detect any production of IFN-y from  macrophages in  our 
study, which  represents a discrepancy between our results and the other work. 
In this  respect,  it is worth  noting  that small  number of contaminating  CD8a+ T 
cells  or  NK cells  can  lead  to  the  erroneous  conclusion  that  macrophages  are 
producing IFN-y (Schleicher et al., 2005).
Another  aspect  of  the  innate  immune  response  is  represented  by  the 
recruitment  of  large  numbers  of  cells  to  inflamed  tissues,  which  is  stimulated 
through  the  release  of  chemokines  after  infection.  CXCL8/IL-8  is  secreted  by 
epithelial  cells,  attracting  neutrophils  that  subsequently  migrate  through  the 
epithelial  layer  into  the  intestinal  lumen  in  response  to  Salmonella  infection 
(Gewirtz  et  al.,  2000;  Gewirtz  et  al.,  2001).  Another  chemokine,  CCL20  is  of 
particular  importance  in  attracting  cells  such  as  immature  DC  to  inflamed 
intestinal  tissue  in  response  to  Salmonella  infection  (Izadpanah  et  al.,  2001),
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for stimulation of epithelial CCL20 production (Sierro et al., 2001).
DC  and  macrophages  are  also  prominent  producers  of  various  chemokines 
upon  stimulation  (Foti  et al.,  1999;  Sallusto  et al.,  1999).  Kinetic studies  have 
shown that DC produce inflammatory (such as CCL3, CCL4, CCL5 and CXCL8) 
and  constitutive  chemokines  (including  homeostatic  and  dual  function 
chemokines such  as CCL19 and  CCL17)  in a time-ordered fashion  (Sallusto et 
al.,  1999).  At  early  time  points  (3-24h  after  stimulation)  large  amounts  of 
inflammatory  chemokines  are  produced.  This  declines  at  later time  points  (10- 
30h),  when  constitutive  chemokines  are  selectively  upregulated  instead.  A 
similar  pattern  of  regulation  of  inflammatory  chemokines  (CCL3  and  CCL5) 
upon DC maturation was observed in another study (Foti et al.,  1999).
In  contrast,  activated  macrophages  also  produce  a  similar  spectrum  of 
inflammatory chemokines,  but do not produce constitutive chemokines (Sallusto 
et  al.,  1999).  In  addition,  the  production  of  inflammatory  chemokines  by 
macrophages is sustained,  and the level of production  is increased at later time 
points.  These observations  imply a  differential  role of DC  and  macrophages  in 
recruiting  various  cell  types.  For  DC,  the  production  of  inflammatory 
chemokines  at  early  time  points  when  DC  are  still  in  the  peripheral  tissues 
contributes  to  the  recruitment  of  cells  such  as  immature  DC  and  their 
precursors,  neutrophils  and  macrophages,  which  express  the  receptors  for 
those chemokines. This recruitment is important to enhance and sustain antigen 
sampling. At later time points when  DC have already reached the lymph nodes,
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DC  to  attract  naive  T  and  B  cells  as  well  as  maturing  DC,  which  all  express 
CCR7.  Moreover,  the  production  of  CCL17  might  favour  the  interaction  of 
mature  DC  with  distinct  T  cell  subsets  that  express  CCR4.  This  phase  of 
recruitment  functions  to  prime  T  cells  and  to  initiate  the  acquired  immune 
responses.  Unlike  DC,  macrophages  sustain  the  production  of  inflammatory 
chemokines  but  lack the  ability  to  produce  constitutive  chemokines.  This  may 
function to continually recruit immature DC, neutrophils and macrophages to the 
site  of  inflammation  in  order  to  amplify  the  cascade  of  immune  responses. 
Notably,  not only the whole bacteria or LPS,  but also cytokines such as TNF-a, 
generated  upon  infection,  can  induce  DC  and  macrophages  to  produce 
inflammatory chemokines (Sallusto et al.,  1999). Therefore, these observations, 
together with our results that macrophages produce more TNF-a than DC upon 
Salmonella infection,  support the notion that macrophages may be more potent 
than DC in attracting newly recruited phagocytic cells to the site of infection.
DC  and  macrophages are  also thought to contribute to systemic dissemination 
of  bacteria  during  Salmonella  infection.  A  previous  study  has  shown  that  S. 
typhimurium is found  in the bloodstream within  CD18+ expressing  phagocytes, 
including  DC  and  tissue  macrophages,  as  early  as  15  minutes  after  oral 
inoculation  (Vazquez-Torres  et al.,  1999).  Interestingly,  our study also  showed 
that intracellular S.  typhimurium could be transported to the spleen and liver via 
the  trafficking  of  DC  and  macrophages,  and  was  detected  two  days  after  i.p. 
adoptive  transfer  (Figure  4.6  and  Figure  4.7).  Hence,  the  transferred  DC  and 
macrophages  are  able  to  gsin  access  to  the  bloodstream.  Bloodstream
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facilitate antigen  presentation  in the spleen  and  LNs and  the development of a 
systemic  immune  response,  and  on  the  other  hand,  provide  a  means  for 
systemic dissemination of S.  typhimurium throughout the body.
The innate immune system can restrict replication of S. typhimurium to a certain 
degree, but acquired immunity is required for effective control and eradication of 
bacteria. The fact that Salmonella has evolved an array of virulence systems to 
force  its  uptake  by  host  cells,  promote  its  intracellular  survival  and  cause 
apoptosis of infected  cells (Hansen-Wester and  Hensel,  2001) makes acquired 
immunity particularly important for clearing of Salmonella infection.
A prerequisite for initiating acquired  immune responses against S.  typhimurium 
is  the  participation  of  DC.  DC  are  characterised  by  their  unique  migratory 
capacity,  first  to  the  sites  of  infection  and  then  to  the  draining  LN,  which  is 
facilitated  by a switch  in the expression of chemokine receptors (Fleming et al., 
2003;  Ohl  et  al.,  2004;  Yanagawa  and  Onoe,  2003).  Immature  DC  express 
receptors  for  inflammatory  chemokines  such  as  CCR1,  CCR2,  CCR5,  CCR6 
and  CXCR1. These chemokines guide  DC to inflammatory sites where antigen 
sampling  can  take  place  and  maturation  can  be  induced.  The  maturation 
process,  which  is  triggered  by  microbial  products  or  inflammatory  cytokines, 
leads  to  down-regulation  of  receptors  for  inflammatory  chemokines  and  up- 
regulation  of  receptors  for  constitutive  chemokines  such  as  CCR7.  The 
expression of CCR7 may drive the maturing DC first towards the lymphatics and
294then  into  T  cell  areas  within  the  lymph  nodes,  where  they  encounter  and 
stimulate naive T cells.
In  our study,  BMDC  underwent a switch  of expression  of chemokine  receptors 
upon  infection with  S.  typhimurium.  Examined  as a  representative  receptor for 
inflammatory  chemokines,  CCR6  was  shown  to  be  down regulated,  whereas 
CCR7 was greatly  upregulated  (Figure  5.3).  Furthermore,  we showed that this 
was  a  functional  switch  in  chemokine  responsiveness,  demonstrated  by  an  in 
vitro chemotaxis assay (Figure 5.8  and  Figure 5.9).  Loss of responsiveness to 
the CCR6  ligand,  CCL20  may allow DC to escape from  the  peripheral tissues. 
Conversely,  acquiring  CCR7  expression  was  shown  to  be  necessary  for 
migration  of Salmonella infected-DC to  lymph  nodes  (Figure 5.13).  In contrast, 
although  BMMac  showed  a  similar  pattern  in  the  switch  of  their  chemokine 
receptors,  CCR7 expression  on  Sa/mone//a-infected  macrophages was far less 
than  on  DC  (Figure  5.5).  This  may  be  the  reason  why  macrophages failed  to 
migrate  to  SLO  in  vivo  (Figure  4.2).  Rather,  these  cells  migrated  to  inflamed 
joints after adoptive transfer (Figure 4.12).  This differential  migration  pattern  of 
DC  and  macrophages  implies  different  consequences  of  bacterial  uptake  by 
these two cell types: T cell priming by DC and transport of Salmonella to various 
peripheral tissues by macrophages.
Using  recombinant  S.  typhimurium expressing T cell epitopes for infection,  our 
study  showed  that  both  BMDC  and  BMMac  could  efficiently  stimulate  antigen 
experienced  CD8+  T  cells  (Figure  6.1).  However,  only  BMDC  were  able  to 
activate  naive  T  cells  (Figure  6.2).  More  importantly,  adoptive  transfer  of
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specific  naive  T  cells  in  vivo  (figure  6.5).  These  results  provide  evidence that 
adoptive transfer of S.  typhimurium  infected-BMDC was  an  effective  approach 
to deliver antigen  in  vivo.  Due to the  lack of an  appropriate antigen  model, we 
have not tested for the induction of MHC-II  restricted CD4+ T cell responses by 
BMDC  upon  S.  typhimuhum  infection.  However,  previous  data  has shown  that 
BMDC  can  process  Salmonella  antigens  not  only  for  MHC-I  presentation  to 
CD8+ T cells, but also for MHC-II presentation to CD4+ T cells (Svensson et al., 
1997b).
After  specific  immune  responses  are  induced,  the  immune  effectors  are 
attracted to the sites of infection. At this stage,  macrophages are also important 
effector  cells  for  resolving  infection  with  intracellular  bacteria.  Activation  of 
macrophages  by cytokines  such  as  IFN-y and  TNF-a,  leads to an  induction  of 
bactericidal  mechanisms  in  macrophages  (Gulig  et  al.,  1997;  Nauciel  and 
Espinasse-Maes,  1992).  These  mechanisms  include  not  only  production  of 
reactive  oxygen  and  nitrogen  intermediates  but  also  improved  handling  of 
bacteria-containing  phagosomes,  rendering  the  bacteria  accessible  to  lytic 
effector  molecules  from  the  lysosomes  (Mittrucker  and  Kaufmann,  2000). 
Salmonella  use  an  SPI-2  TTSS  mediated  mechanism  to  allow them  to  reside 
within  the  modified  phagosomes,  altering  the  trafficking  of lysosomes to avoid 
fusion of phagosomes with  lysosomes (Linehan and  Holden, 2003).  In addition, 
SPI-2  minimises  contact  of  Salmonella  phagosomes  with  vesicles  rich  in 
NADPH  oxidase  or  iNOS,  thus  reducing  exposure  to  reactive  oxygen  and 
nitrogen  intermidiates  (Linehan  and  Holden,  2003).  Recently,  a  study  has
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intracellular  survival  advantage  of  Salmonella  conferred  by  SPI-2,  therefore 
enhancing  the  antimicrobial  activity  of macrophages  (McCollister et al.,  2005). 
These  effects  confirm  the  important  role  of  cytokine-mediated  activation  of 
macrophages in the host response against Salmonella infection.
Taken together, the available data suggest that although  macrophages and DC 
are  both  involved  in  ar\W-Salmonella  immunity,  the  precise  role  that  they  play 
differs.  Macrophages  serve  as  a  major contributor to  the  innate  response  and 
function  primarily  to  control  bacterial  replication,  provide  the  initial  source  of 
cytokines such as TNF-a and  IL-12 and  recruit new cells to the site of infection. 
In  addition,  macrophages  also  serve  as  an  important  effector of the  acquired 
immune system  and  facilitate  elimination  of invading  bacteria.  In  contrast,  DC, 
serving as a critical link between the innate and acquire immune system and as 
the  most  potent  APC,  function  primarily  in  triggering  T-cell  responses,  being 
particularly  crucial  for  naive  T  cell  responses.  This  requires  distinct  migratory 
patterns  of  DC  at  different  stages  of  infection,  which  is  mediated  by  complex 
regulation  of  chemokine  and  chemokine  receptor  expression  by  infection- 
associated signals.
In  addition  to  furthering  our  understanding  of  the  distinct  functions  of 
macrophages  and  DC  during  Salmonella  infection,  our  studies  also  have 
implications for the role of macrophage and DC in the pathogenesis of ReA.
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were  detected  in  the  inflamed  joints  of  mice  previously  infected  with  C5  (TS) 
(Figure 4.12-4.13).  CD18-expressing  cells,  representing  cells of the  monocyte- 
macrophage  lineage  and  consisting  of  DC  and/or  tissue  macrophages,  have 
been demonstrated to carry S. typhimurium in the bloodstream of mice after oral 
inoculation  (Vazquez-Torres et al.,  1999).  Our experimental data provide direct 
evidence  for a  pathway  in  which  activated  macrophages  are  able  to  traffic to 
peripheral tissues such as limbs from the peritoneal cavity; this occurred via the 
bloodstream,  as  cells  also  could  be  detected  in  the  spleen  and  liver (data  not 
shown).
Although  this  distinctive  migration  of  macrophages  was  observed  under 
conditions  of induced  inflammatory  arthritis,  parallels  may  exist for an  antigen 
transportation role in ReA. ReA can occur following Salmonella infection (Mattila 
et  al.,  1998).  In  conjunction  with  this,  the  gastrointestinal  tract  is  the  largest 
reservoir  of  macrophages  in  the  body  (Smith  et  al.,  1997),  and  macrophages 
may pick up  Salmonella antigens from  the original  infection  site  (e.g.  intestinal 
tract)  and  then  gain  access  to  the  bloodstream  as  CD18+  cells.  Alternatively 
blood borne monocytes can  encounter Salmonella antigens in the bloodstream 
and  differentiate  into  macrophages.  In  addition  to  this,  50%  of synovial  tissue 
cells  are  populated  by  macrophages  recruited  from  peripheral  blood  (Gaston, 
1998).  This  property  of  the  synovium  increases  the  likelihood  that  bacterial 
antigens within macrophages could gain access to joints from the blood stream. 
Whether migration  of infected  macrophages to  sterile joints also  occurs  needs 
to be addressed in future work.
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associated with transferred  macrophages within the joints.  Since,  in our model, 
C5 (TS) was used to induce inflammatory arthritis and for macrophage infection, 
it was  not possible to define the  source of bacteria  in  the joints.  To tackle  this 
problem,  inflammatory  arthritis  could  be  induced  by  other  agents  such  as 
collagen  (Nanki  et  al.,  2004),  and  identification  of  bacteria  transported  by 
macrophages  could  be  demonstrated  by  co-localisation  of  staining  with  a 
macrophage  marker  (e.g.  F4/80)  and  a  bacterial  marker  (e.g.  LPS)  in  the 
inflamed joint tissue. This experiment is feasible because our previous work has 
shown  these  antibodies  to  efficiently  identify  macrophages  or  S.  typhimurium 
even in paraffin sections of joint tissues.
In contrast,  S. typhimurium-infected  DC were not detected in the inflamed joints, 
but were detected  in the adjacent LNs (Figure 4.13). This fits with the view that 
DC position themselves in SLO to stimulate T cells, a process that is enhanced 
by the  increased  surface expression  of co-stimulatory  molecules  induced  upon 
Salmonella  infection.  Furthermore,  we  observed  HLA-B27-restricted  activation 
of naive CD8+ or CD4+ T cells in  LNs of mice receiving Sa/mone//a-infected DC 
(Figure 6.5).  In this  respect,  our results were in  support of the notion that HLA- 
B27-reactive CD4+ T cells are functional in vivo and may play a pathogenic role 
in SpA (Boyle et al., 2001; Roddis et al., 2004).
Once  in  the  joints,  production  of  inflammatory  cytokines  such  as  TNF-a  from 
activated  macrophages  is  sufficient  to  cause  a  local  inflammation.  Various
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et al.,  2001)  produced  by  macrophages  may attract more  phagocytes such  as 
macrophages  and  immature  DC.  In  addition,  effector  T  cells  could  also  be 
attracted  to  the  sites  of  inflammation.  Production  of  Th1  cytokines,  including 
TNF-a  and  IFN-y  and  Th2  cytokines  such  as  IL-4  by  effector  T  cells  would 
subsequently  be  produced  at the tissue  site.  HLA-B27  could  contribute to and 
alter  this  process  through  unconventional  recognition  by  T  cell  subsets, 
including  CD8+,  CD4+  T  cells  and  NK  cells  (Reveille  and  Arnett,  2005).  An 
inappropriate cytokine milieu could be pathogenic rather than act to resolve the 
inflammation.  Alternatively,  HLA-B27  might  also  facilitate  the  persistence  of 
intracellular bacteria (Laitio et al.,  1997),  increasing the duration and severity of 
the disease (Ekman et al., 2000).
Overall,  it appears that macrophages are  more  likely than  DC to play a  role  in 
transporting  Salmonella  antigens to  the joints.  In  addition,  macrophages  might 
also be the initial source of inflammatory cytokines and  chemokines that attract 
more  immune  cells  into the joints.  In  contrast,  DC  serve  as APCs to  HLA-B27 
restricted  T cells,  either in  a  conventional  or non-conventional way.  Therefore, 
in different ways, these two types of cells could potentially both contribute to the 
pathogenesis of ReA.
In our study,  S.  typhimurium infected-DC showed a significantly greater capacity 
to migrate to the spleen and MLNs compared to uninfected DC after i.p. transfer 
into mice.  By using CCR7 deficient cells, we demonstrated that migration to the 
MLNs was CCR7-dependent, but to the spleen was CCR7-independent.
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studied as potential draining LNs for peritoneal cavity in our study. This notion is 
supported  by previous studies showing that radiolabelled fused  aluminosilicate 
particles translocate  mainly to  MLNs and  parathoracic  LNs after being  injected 
into  the  peritoneal  cavity  in  dogs  (Snipes  et  al.,  1983).  Similarly,  it  has  been 
shown that the  highest concentrations of gold  colloid  (198-Au) are found within 
the  omentum  and  MLNs  after  i.p.  injection  into  mice  (Williams  and  Bradley, 
1989).  Moreover,  labelled  neutrophils were detected  in the MLNs of mice after 
i.p. injection (Miyazaki et al., 2004). These studies demonstrated that MLNs can 
drain  the  peritoneal  cavity.  However,  other  studies  have  suggested  that  the 
principle  draining  LNs  for the  peritoneal  cavity  are  the  parathymic/mediastinal 
LNs; this was shown  using transfer of diluted  India ink (Geissmann et al., 2003; 
M.  F.  Abu-Hijleh,  1994).  Thus,  the  issue  of whether  MLN  could  directly  drain 
peritoneal cavity remains controversial.  In our study, we did not assess whether 
S.  typhimurium  infected-DC  could  also  be  found  in  greater  number  in 
parathymic LNs, but this issue be worthy of investigation in the future work.
If DC did  not enter MLNs through  lymphatics draining  the  peritoneal cavity,  by 
what  alternative  pathways  could  they  gain  access  to  MLNs?  There  are  two 
possibilities:  first,  DC  could  access  MLNs  from  the  peritoneal  cavity  by  direct 
movement through the lymphatic stomata,  a mechanism that can  be enhanced 
by  NO  (Li  and  Li,  2004).  Second,  DC  could  enter MLNs  through  HEV via  the 
blood;  the feasibility of this second  option  calls for further discussion. With the 
respect to  the  first step  of such  a  pathway,  the  presence  of transferred  DC  in
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The precise way in which DC did so is not clear, but it has been speculated that 
DC  may  first migrate  to  the  draining  lymph  nodes  and  then  enter the efferent 
lymph to gain  access to the  blood  (Randolph  et al.,  2005).  However,  this  idea 
would be challenged by a widely-accepted view that DC die after their arrival in 
LNs, and therefore can not leave LNs through efferent lymphatic vessels; this is 
supported  by their absence  in  the  efferent  lymph  (Banchereau  and  Steinman, 
1998;  Steinman,  1991).  However,  another study seems to counter this idea by 
showing  that  -10%  of  the  DCs  that  enter  the  LN  exit  by  the  efferent  route 
(Dandie et al.,  1994).
After entry into the  bloodstream,  DC could  have gained entry to the  LNs,  such 
as MLNs and  ILNs, through the HEV. Arguing against this idea is data showing 
that  DC  are  unable  to  enter  the  LNs  through  blood  after  i.v  administration 
(Austyn  et  al.,  1988),  and  that  only  PDC  precursors,  but  not  myeloid  DC 
precursors are able to transmigrate across HEVs directly from the bloodstream 
(Yoneyama et al.,  2004).  However,  it has also  been  suggested  that a  pathway 
may exist whereby  myeloid  DC  can  migrate  into  LNs via  HEV (Cavanagh  and 
Von Andrian, 2002).  Direct evidence to support this notion has been provided in 
an  in  vivo  study  showing  that  infection  of  mice  with  mouse  mammary  tumour 
virus induces a strong  migration of MDC to the  popliteal  LNs via  HEVs (Martin 
et al., 2002).
Although  the  exact  pathways  by  which  DC  accessed  MLNs  is  unknown,  the 
migration of DC to MLNs was clearly dependent upon CCR7 expression (Figure
3025.13).  Migration  of  DC  to  the  draining  LNs  through  afferent  lymph  has  been 
demonstrated to be CCR7-dependent (Ohl et al.,  2004).  In  addition,  a pathway 
involving  DC  migration  to  MLN  via  HEVs  would  likely  be  CCR7-dependent,  in 
keeping with the expression of its ligands on HEVs (Gunn et al.,  1998;  Luther et 
al.,  2000).  At  present,  the  dependence  of  CCR7  expression  for  direct  DC 
movement through lymphatic stomata is not known.
Interestingly,  our results showed that transferred  DC localised  mainly in the red 
pulp and  marginal zone areas of the  spleen  (Figure 4.10  middle panel).  Some 
cells,  especially  S.  typhimurium  infected  DC  migrated  into  the  centre  of white 
pulp  (T  cell  zone)  (Figure  4.10  lower  panel).  These  results  suggested  the 
existence of a secondary migration of S.  typhimurium infected-DC from red pulp 
to white  pulp  after they  had  arrived  in the  spleen.  Although  migration  of DC to 
the  spleen  was  not  mediated  by  CCR7,  this  secondary  migration  of  DC  could 
potentially be affected by CCR7 owing to expression of CCR7 ligands within the 
white pulp (T cells zones), but not red pulp. A simple way to study this would be 
to  investigate  the  localisation  of  CCR7  deficient  DC  within  the  spleen  after 
transfer.
Other studies have also shown that CCR7 expression  by DC is required for the 
entry  of  DC  into  lymphoid  tissue  under  both  steady  state  and  inflammatory 
conditions  (Martln-Fontecha  et al.,  2003;  Ohl  et al.,  2004).  However,  it cannot 
be  excluded  that  other  signals  in  addition  to  CCR7  are  also  involved  in 
controlling  this  migration  pathway.  In  a  recent  study,  it  has  been  shown  that 
CCR8 and  its cognate ligand CCL1  are also involved  in the migration of mouse
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DC  also express other chemotactic  receptors  such  as  CXCR4,  that potentially 
contribute  to  DC  migration  into  lymphoid  tissues  (Sozzani,  2005).  Finally, 
molecules other than chemokines and chemokine  receptors,  such as adhesion 
molecules,  are  crucially  involved  in the  process  of DC  migration.  For example, 
data have shown that mice defective in the  p2  integrins (Xu et al.,  2001) or a6 
integrins  (Price  et al.,  1997)  display  a  reduction  in  the  migration  of cutaneous 
DC to the draining LNs.  On the contrary,  mice defective in JAM-A,  an adhesion 
molecule expressed by DCs and the lymphatic endothelium,  have an enhanced 
migration  of skin  DC to  LNs  (Cera et al.,  2004). All these findings  indicate that 
migration of DC is a multistep process involving multiple molecules.
DC-based  vaccination  has  been  used  in  immunotherapy,  especially  in  the 
treatment of cancer. A DC vaccine, such as DC loaded with tumour associated 
antigen,  has  been  used  in  clinical treatment of patients with  cancer (Figdor et 
al.,  2004).  Currently,  there  are  two  general  approaches  to  load  antigens  onto 
DC: the in vivo route and ex vivo route (Gilboa, 2004).
Several  strategies  to  target  antigens  to  DC  in  vivo  have  been  described.  For 
example,  targeting  of  antigens  to  DC  in  mice  through  the  DC  specific  cell- 
surface  molecule  DEC205,  combined  with  an  additional  treatment  such  as  a 
CD40-specific antibody to  activate  DC,  has  been  shown  to  stimulate  immunity 
(Bonifaz et al.,  2002). Although,  it is  in  theory an  ideal  solution to  load  tumour 
antigens onto a patient’s own DC,  its effectiveness could be compromised if DC 
function has been adversely affected in patients with cancer (Vicari et al., 2004).
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increasing  attention  due  to  the  efficiency  of such  a  process,  and  the  ability  to 
control  the  manipulation  and  generation  of  optimally  differentiated 
immunostimulatory  DC.  In  addition,  for  cancer  treatment,  this  method  could 
circumvent  possible  defects  in  patient  DC  (Vicari  et  al.,  2004).  Therefore, 
adoptive  transfer  of  antigen  loaded  DC  has  been  widely  used  in 
immunotherapy.  Several  clinical  trials  have  demonstrated  that  immunisation 
with  tumour  antigen-pulsed  DC  could  break  tolerance  against  antigens 
expressed  by  tumour cells,  and  in  some  cases,  generate  appreciable  clinical 
responses.  Hence,  this  represents  a  promising  method  for  the  treatment  of 
malignancies (Cerundolo et al., 2004; Engleman, 2003; Peng et al., 2005).
Our  results  have  some  implications for the  practical  application  of this type  of 
DC  vaccination.  Firstly,  CCR7  expression  can  mediate  DC  migration  from 
peripheral  tissues  to  LNs,  and  the  level  of  migration  is  associated  with  the 
extent of maturation, due to the  higher expression of CCR7. This  indicates that 
DC do not have to be directly injected  into draining  LNs, which  may potentially 
destroy  the  architecture  of the  LNs,  even  though  this  approach  is  thought to 
avoid the need for DC migration into the LNs (Jonuleit et al., 2001).  Instead, our 
results  favour  the  idea  that  DC  can  be  administered  intradermally  or 
intravenously,  after  which  DC  will  migrate  to  the  LNs  to  exert  their  antigen 
presentation  role.  Secondly,  full  activation  of  DC  is  required  for  the  effective 
priming.  Our  in  vivo  study  indicated  that  recombinant  S.  typhimurium  infected 
DC showed  a  slightly greater stimulation  of antigen  specific CD8+  T cells than
305peptide-pulsed  DC  (Figure  6.5).  This  is  thought  to  be  due  to  their  lower 
expression of CCR7 and costimulatory molecules compared to bacteria-infected 
DC.  These  results are consistent with  the  current  consensus that activation  of 
DC  is  essential  to  induce  immunity  during  immunotherapy  (Tan  and  O'Neill, 
2005).
Taken  together,  our study demonstrated  that CCR7  mediated  migration  of DC 
to  SLO  is  a  prerequisite  for  induction  of a  therapeutic T  cell  response.  In  this 
respect,  the  results  therefore  contribute  to  further  understanding  of  the 
biological mechanisms underlying DC-based immunotherapy.
Overall,  the findings presented  in this thesis broaden  our knowledge about the 
contributions of macrophages and  DC  in  ant\-Salmonella  immunity.  In  addition, 
the  differential  migration  profiles  of  macrophages  and  DC  upon  Salmonella 
infection  also shed  light on  their distinct roles  in  the pathogenesis of ReA.  The 
presence of transferred  macrophages in the joints provides direct evidence that 
transportation  of bacteria  by  macrophages from  one  peripheral  site  to  another 
could  occur in  vivo.  Finally,  this  is the first report showing  that the  migration  of 
DC to MLNs,  but not to spleen,  is mediated by CCR7 after i.p.  injection.  CCR7- 
mediated  migration  was  followed  by  the  induction  of  antigen  specific  T  cell 
responses  in  LNs,  providing  information  relevant  to  the  application  of  DC 
vaccine-related immunotherapy.
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